data_2l9n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l9n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 52' ' ' GLN . 70.4 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.705 0.288 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HB3' HD22 ' A' ' 51' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.42 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' A' ' 53' ' ' THR . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CE2' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.427 ' HE2' ' CD1' ' A' ' 142' ' ' TYR . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.427 ' CD1' ' HE2' ' A' ' 137' ' ' MET . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 108' ' ' PHE . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 155' ' ' LEU . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.671 0.272 . . . . 0.0 110.563 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.407 ' O ' ' CG2' ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 209' ' ' VAL . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.431 ' HE3' ' CZ ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.414 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.789 0.328 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.454 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 53' ' ' THR . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 56' ' ' VAL . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 75' ' ' PHE . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' CE ' HD23 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.421 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 158' ' ' ILE . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 3.2 m-70 . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.62 0.247 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 235' ' ' GLU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 178' ' ' LEU . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 181' ' ' ASN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.421 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 202' ' ' TYR . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 200' ' ' GLU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 229' ' ' LYS . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.457 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 51' ' ' LEU . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 ' CE1' ' A' ' 57' ' ' PHE . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 75' ' ' PHE . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HG2' ' CZ2' ' A' ' 39' ' ' TRP . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CZ ' ' HE3' ' A' ' 137' ' ' MET . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.411 ' HE3' ' CZ ' ' A' ' 108' ' ' PHE . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.409 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.409 ' CE1' ' HG2' ' A' ' 169' ' ' ARG . 16.8 m80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.863 0.363 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 209' ' ' VAL . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' LEU . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 213' ' ' ASP . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 38' ' ' GLY . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.427 ' CH2' ' HE3' ' A' ' 85' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.702 0.286 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG2' HD23 ' A' ' 71' ' ' LEU . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' CG2' ' A' ' 56' ' ' VAL . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CH2' ' A' ' 39' ' ' TRP . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.406 ' HA ' ' CG2' ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.406 ' CG2' ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.612 0.244 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 211' ' ' LEU . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 211' ' ' LEU . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.468 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.404 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.404 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 202' ' ' TYR . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 195' ' ' LYS . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.437 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.891 0.377 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.437 HD23 ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 57' ' ' PHE . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 75' ' ' PHE . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' CE ' HD23 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 144' ' ' VAL . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 108' ' ' PHE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.688 0.28 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.461 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 207' ' ' GLU . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.449 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 230' ' ' GLY . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.345 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' CA ' ' A' ' 50' ' ' VAL . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.464 ' CD2' ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' CA ' ' HD3' ' A' ' 35' ' ' LYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CE1' HG23 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 142' ' ' TYR . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 8.0 p80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.96 0.41 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 212' ' ' ILE . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.453 ' HB2' ' CD1' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 181' ' ' ASN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.402 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.407 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.409 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 217' ' ' PHE . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.421 ' HB ' ' CG2' ' A' ' 209' ' ' VAL . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 212' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 216' ' ' CYS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.414 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.595 0.236 . . . . 0.0 110.689 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' HG11 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 38' ' ' GLY . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.451 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 47' ' ' LEU . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HG2' ' CE1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 71' ' ' LEU . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' CG2' ' A' ' 56' ' ' VAL . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 75' ' ' PHE . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 157' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.429 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 211' ' ' LEU . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 235' ' ' GLU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' GLN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.421 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 64.0 m-80 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.41 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 174' ' ' LEU . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.432 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.822 0.344 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.487 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' CE1' ' A' ' 57' ' ' PHE . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 27' ' ' PHE . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CE1' HG23 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.424 HD22 ' CB ' ' A' ' 56' ' ' VAL . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 22' ' ' ARG . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 39' ' ' TRP . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 91' ' ' GLY . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.647 0.26 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.421 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.402 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.412 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' CA ' ' A' ' 91' ' ' GLY . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 29' ' ' ILE . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.468 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 57' ' ' PHE . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.402 ' CG2' HD22 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.436 ' CE1' HG23 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.402 HD22 ' CG2' ' A' ' 56' ' ' VAL . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.417 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.417 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.718 0.294 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.438 HD23 ' CZ ' ' A' ' 176' ' ' PHE . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.432 ' CG1' ' CG2' ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' A' ' 196' ' ' VAL . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' N ' ' CD1' ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.416 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.421 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 51' ' ' LEU . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.469 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' GLY . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 83' ' ' ILE . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 75' ' ' PHE . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 29' ' ' ILE . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.412 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.737 0.304 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.403 HD12 ' CG2' ' A' ' 194' ' ' ILE . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 195' ' ' LYS . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.401 ' N ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.852 0.358 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 31' ' ' CYS . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.475 ' CH2' ' HE2' ' A' ' 85' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.426 ' CD2' ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.45 HG23 ' CE1' ' A' ' 57' ' ' PHE . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' THR . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.421 HG22 ' CE1' ' A' ' 75' ' ' PHE . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.433 ' CD1' HD12 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.414 ' CD1' HG23 ' A' ' 144' ' ' VAL . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 142' ' ' TYR . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 29' ' ' ILE . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.414 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 47' ' ' LEU . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG2' HD22 ' A' ' 71' ' ' LEU . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' CG2' ' A' ' 56' ' ' VAL . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.415 ' CZ ' HG22 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CE ' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 137' ' ' MET . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.404 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 159' ' ' LYS . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 237' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.418 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.445 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.408 ' HA ' HG11 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' PHE . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 34' ' ' ASN . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.842 0.353 . . . . 0.0 111.422 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 35' ' ' LYS . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' GLU . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 56' ' ' VAL . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CE1' HG22 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.432 HG22 ' CE1' ' A' ' 75' ' ' PHE . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 141' ' ' HIS . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.467 ' O ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.414 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 212' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 217' ' ' PHE . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 225' ' ' LYS . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.42 ' CE ' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.571 0.224 . . . . 0.0 110.51 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.413 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' VAL . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 31' ' ' CYS . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 34' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.4 HD23 ' CE ' ' A' ' 85' ' ' LYS . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.426 HG13 ' CE3' ' A' ' 39' ' ' TRP . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.444 HG21 ' CE1' ' A' ' 57' ' ' PHE . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 28' ' ' GLU . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.419 HG21 ' CE1' ' A' ' 75' ' ' PHE . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.4 ' CE ' HD23 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 29' ' ' ILE . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.414 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CD1' HD11 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 t60 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.469 ' CE2' HD13 ' A' ' 211' ' ' LEU . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.401 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 179' ' ' PRO . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.427 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.469 HD13 ' CE2' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.434 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.4 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.522 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.393 . . . . 0.0 111.268 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG2' HD22 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 53' ' ' THR . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.412 HD22 ' CG2' ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 76' ' ' GLY . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HG2' HD22 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.41 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 168' ' ' GLU . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.563 0.22 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CD2' ' CD1' ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.441 ' HB2' ' CA ' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.441 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.44 ' CD1' ' CD2' ' A' ' 176' ' ' PHE . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.479 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 211' ' ' LEU . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 197' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 201' ' ' ASP . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 168' ' ' GLU . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 217' ' ' PHE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.405 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.791 0.329 . . . . 0.0 110.996 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 29' ' ' ILE . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.469 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 34' ' ' ASN . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.568 ' CH2' ' HD3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.455 ' CD1' ' HD2' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 51' ' ' LEU . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.438 ' CE2' HG22 ' A' ' 83' ' ' ILE . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.416 ' CG2' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 HG22 ' CE2' ' A' ' 75' ' ' PHE . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.568 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG2' ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.407 ' HD2' ' CG2' ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.876 0.37 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . 0.441 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.433 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.748 0.308 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.423 ' HB3' HG11 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 18' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 32' ' ' TYR . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.4 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.452 ' CH2' ' HE2' ' A' ' 85' ' ' LYS . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 111.287 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 39' ' ' TRP . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.449 HG11 ' CE3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 ' N ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.416 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 27' ' ' PHE . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' GLU . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.438 ' CD1' HG22 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 75' ' ' PHE . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 112' ' ' ALA . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.444 ' N ' ' CG2' ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.422 ' CB ' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.422 ' CD1' ' CB ' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.401 ' CE ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' A' ' 108' ' ' PHE . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 167' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.648 0.261 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.405 ' CB ' ' HA2' ' A' ' 183' ' ' GLY . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 209' ' ' VAL . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 207' ' ' GLU . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.481 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.481 ' CB ' ' HB3' ' A' ' 202' ' ' TYR . 1.4 mt-30 -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 201' ' ' ASP . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 226' ' ' LYS . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . 0.463 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.764 0.316 . . . . 0.0 110.954 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.402 ' CZ2' ' HG2' ' A' ' 85' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.823 0.344 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.411 ' CD2' ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 53' ' ' THR . 90.8 m-70 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.413 ' CG2' HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 53' ' ' THR . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 76' ' ' GLY . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.413 HG22 ' CD1' ' A' ' 75' ' ' PHE . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.487 ' O ' HD23 ' A' ' 88' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HA ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 29' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 112' ' ' ALA . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 114' ' ' ILE . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.403 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 133' ' ' ILE . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 167' ' ' ILE . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.852 0.358 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . 0.414 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 201' ' ' ASP . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 233' ' ' SER . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.475 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 32' ' ' TYR . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.392 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.462 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 47' ' ' LEU . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.431 ' O ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.534 ' CE1' ' CG2' ' A' ' 53' ' ' THR . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.443 ' CD2' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 75' ' ' PHE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' CB ' HD12 ' A' ' 51' ' ' LEU . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.932 0.396 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.412 ' CD1' ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.401 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 198' ' ' GLU . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . 0.408 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 174' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . 0.427 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' PHE . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.47 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 38' ' ' GLY . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.426 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.813 0.34 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.469 ' HA ' HG13 ' A' ' 50' ' ' VAL . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' LEU . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 51' ' ' LEU . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 57' ' ' PHE . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 28' ' ' GLU . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' A' ' 56' ' ' VAL . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.418 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.418 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HE2' ' CZ2' ' A' ' 39' ' ' TRP . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 35.8 t30 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.445 ' HB2' ' CA ' ' A' ' 183' ' ' GLY . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.404 ' O ' ' CZ ' ' A' ' 217' ' ' PHE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 194' ' ' ILE . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 212' ' ' ILE . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -71.48 -171.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp 77.74 -54.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.471 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 56.7 t80 64.34 102.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -131.26 119.87 17.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.24 52.73 4.4 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.459 2.106 . . . . 0.0 112.67 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.0 m -165.32 31.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.21 -61.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.987 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -76.59 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.068 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.23 150.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -91.01 -45.83 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.8 tt 59.91 92.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.923 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.1 p -59.0 169.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.755 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.02 23.8 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG13 ' HB2' ' A' ' 52' ' ' GLN . 70.4 t -59.05 159.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.839 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.405 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.407 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.405 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.473 ' HB3' HD22 ' A' ' 51' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.435 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.413 ' HB3' ' CB ' ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.435 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.493 ' CZ3' HD22 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -59.94 -35.33 74.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -59.54 -26.38 65.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.95 28.84 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.646 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 t -104.74 125.42 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.761 0.315 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.67 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -106.24 156.59 18.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.63 136.44 34.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.493 HD22 ' CZ3' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.473 HD22 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.42 ' HB2' HG13 ' A' ' 15' ' ' VAL . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.43 HG23 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' CE1' HG23 ' A' ' 53' ' ' THR . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.409 HG23 ' CE2' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.466 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.422 ' CE ' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.41 ' CE2' HG22 ' A' ' 144' ' ' VAL . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.427 ' HE2' ' CD1' ' A' ' 142' ' ' TYR . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.427 ' CD1' ' HE2' ' A' ' 137' ' ' MET . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.41 HG22 ' CE2' ' A' ' 108' ' ' PHE . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.411 ' HA ' ' CE2' ' A' ' 142' ' ' TYR . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 155' ' ' LEU . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -109.16 136.51 48.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -151.7 136.87 17.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.35 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -110.62 175.25 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.563 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.407 ' O ' ' CG2' ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 209' ' ' VAL . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.449 ' CG1' ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.431 ' HE3' ' CZ ' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.84 -69.16 0.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.59 159.59 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -133.46 137.72 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -60.96 103.16 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.98 139.13 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.73 84.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.74 -57.8 1.79 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.78 -42.5 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.7 138.8 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -103.86 -46.31 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -153.24 37.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.895 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.368 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -123.94 -45.97 1.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 mt 63.27 105.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.89 144.62 26.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 80.29 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 91.66 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -163.4 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.58 45.2 1.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -161.06 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.724 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.33 131.02 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -105.24 -66.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 tt -166.55 92.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.3 p -146.56 116.72 7.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -176.78 -52.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -112.31 151.53 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.434 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.414 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HG2' ' N ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' N ' ' HG2' ' A' ' 33' ' ' LYS . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.4 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.414 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -41.62 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -59.38 -23.45 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.19 -21.19 3.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -55.9 148.3 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -78.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.4 ' HD2' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER 62.22 146.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.94 143.27 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.454 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.454 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.409 ' CG2' HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.423 ' CE1' HG23 ' A' ' 53' ' ' THR . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 56' ' ' VAL . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.416 ' CE2' HG21 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 75' ' ' PHE . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' CE ' HD23 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.421 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.44 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 158' ' ' ILE . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.4 HG23 ' O ' ' A' ' 155' ' ' LEU . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -69.52 149.99 47.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -105.13 138.14 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 111.587 -179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 214' ' ' PRO . 3.2 m-70 -109.57 146.69 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.422 ' CE2' ' HB2' ' A' ' 235' ' ' GLU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.447 ' CD1' ' N ' ' A' ' 178' ' ' LEU . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.421 ' CG1' ' N ' ' A' ' 181' ' ' ASN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.421 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . 0.409 ' HB2' ' CG1' ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.428 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.428 ' HB2' ' O ' ' A' ' 202' ' ' TYR . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.409 ' CG1' ' HB2' ' A' ' 200' ' ' GLU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.55 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.4 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.416 ' NZ ' ' HB3' ' A' ' 229' ' ' LYS . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -88.89 -68.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.54 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 4.0 ptpp? -145.4 138.07 26.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.63 105.61 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.6 m -122.11 -42.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.017 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -71.23 172.67 8.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.045 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.43 -67.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.95 55.68 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.53 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -63.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.418 ' HB3' ' CD2' ' A' ' 249' ' ' PHE . 0.8 OUTLIER -174.26 -168.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 50.53 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.418 ' CD2' ' HB3' ' A' ' 247' ' ' GLU . 3.3 p90 -97.37 28.83 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.003 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.738 0.304 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -129.08 -61.28 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 mt -135.92 -50.79 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.42 127.22 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -72.93 -61.98 1.42 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.871 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 37.9 Cg_endo -67.97 -55.61 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.239 1.96 . . . . 0.0 112.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m 54.24 24.28 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 t30 179.46 51.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -169.29 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pt -99.5 173.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.74 82.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.0 tt -60.62 100.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.961 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.6 p -65.48 179.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -79.32 60.79 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.023 0.44 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.77 151.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.989 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.409 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.423 ' HB3' ' CD2' ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' A' ' 45' ' ' LYS . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.457 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -34.91 72.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -63.26 -27.38 69.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.45 -23.69 3.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.605 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.38 128.11 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.09 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -59.2 145.8 41.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.432 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -171.69 164.76 6.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.927 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -115.4 152.64 32.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.401 HG13 ' N ' ' A' ' 51' ' ' LEU . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.423 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.44 HG21 ' CE1' ' A' ' 57' ' ' PHE . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.44 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.409 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.404 HG21 ' CE2' ' A' ' 75' ' ' PHE . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HG2' ' CZ2' ' A' ' 39' ' ' TRP . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.411 ' CZ ' ' HE3' ' A' ' 137' ' ' MET . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.411 ' HE3' ' CZ ' ' A' ' 108' ' ' PHE . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.409 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 -108.17 109.27 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -128.6 136.86 51.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.409 ' CE1' ' HG2' ' A' ' 169' ' ' ARG . 16.8 m80 -115.82 164.68 14.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.407 ' CD1' ' HG ' ' A' ' 190' ' ' LEU . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.407 ' HG ' ' CD1' ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 209' ' ' VAL . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 174' ' ' LEU . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 213' ' ' ASP . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -85.98 -82.3 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.5 mp -154.39 174.52 14.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.996 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 111.05 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.98 132.75 35.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 31.1 t -127.53 52.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -63.51 -66.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.76 33.29 21.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.65 -135.03 12.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -123.05 114.13 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.05 -177.95 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.82 93.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -140.65 30.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.939 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.831 0.348 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 48.9 m 59.9 95.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.2 pt -156.41 28.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.269 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.41 ' CD2' ' HA ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 179.73 -62.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.51 63.93 2.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -52.56 93.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.525 2.15 . . . . 0.0 112.376 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -61.89 -73.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.59 80.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.4 tm0? -177.09 -59.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.832 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.88 168.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.171 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -135.23 28.77 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.43 169.79 16.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.41 ' HA ' ' CD2' ' A' ' 4' ' ' PHE . 11.4 t -165.61 -167.86 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.026 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 75.71 -59.61 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 13.3 t -105.36 152.87 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.139 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.454 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 38' ' ' GLY . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.445 ' HE3' ' HG3' ' A' ' 45' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -55.93 -30.7 62.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.8 p -83.16 -25.5 31.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.24 68.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.602 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 7.2 p -158.88 88.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.02 119.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HG3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -179.06 -174.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 0.0 111.061 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -162.54 127.44 3.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.671 179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.424 ' CG2' ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' CG2' HD23 ' A' ' 71' ' ' LEU . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.432 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.432 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.4 HD23 ' CG2' ' A' ' 56' ' ' VAL . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE1' ' CG2' ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.45 ' CG2' ' CE1' ' A' ' 75' ' ' PHE . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.427 ' HE3' ' CH2' ' A' ' 39' ' ' TRP . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.406 ' HA ' ' CG2' ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.406 ' CG2' ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -101.91 126.39 48.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -170.02 145.06 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -99.2 176.87 5.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.554 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.405 ' HB2' ' CB ' ' A' ' 211' ' ' LEU . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.42 ' CE1' HD12 ' A' ' 211' ' ' LEU . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.468 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.404 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.404 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.402 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.402 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.433 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 202' ' ' TYR . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.42 HD12 ' CE1' ' A' ' 176' ' ' PHE . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 195' ' ' LYS . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.414 HD12 ' CD1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.93 -66.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 tp -106.02 117.34 33.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 128.52 43.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.97 111.36 23.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.87 -51.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.45 125.9 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -111.34 -61.83 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.44 73.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.91 -61.52 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -145.47 176.37 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 31.16 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 85.37 2.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.816 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -97.79 150.44 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.465 HG23 ' CD2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -179.15 -35.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.465 ' CD2' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -105.36 -52.44 2.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.934 0.397 . . . . 0.0 110.243 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.416 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 1.3 m -177.1 -62.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.277 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 67.9 Cg_endo -72.47 116.7 4.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.212 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -64.32 -66.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.98 104.96 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -176.59 -45.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.801 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 pt -110.36 -25.19 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.251 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.03 -59.97 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -162.94 151.35 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -149.05 -164.5 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.85 -59.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.7 134.33 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.171 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.401 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.448 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.458 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.437 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -39.51 76.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.2 p -64.35 -27.08 68.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.82 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.34 49.11 3.56 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.0 m -97.9 29.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 111.255 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 56.44 72.18 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.04 162.47 14.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.68 148.89 44.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.013 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.437 HD23 ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.429 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.449 HG23 ' CE1' ' A' ' 57' ' ' PHE . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.402 ' CG2' HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.449 ' CE1' HG23 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.417 ' CE2' HG21 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.417 HG21 ' CE2' ' A' ' 75' ' ' PHE . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' CE ' HD23 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.401 ' CG2' ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.4 ' CE1' HG22 ' A' ' 144' ' ' VAL . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.4 HG22 ' CE1' ' A' ' 108' ' ' PHE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.38 127.3 52.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -169.38 136.79 1.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -99.66 -176.21 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.671 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.461 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.461 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.411 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.449 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.406 ' HB3' ' HG3' ' A' ' 207' ' ' GLU . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.409 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.409 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.449 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HG3' ' N ' ' A' ' 230' ' ' GLY . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.77 -73.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -105.01 120.86 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -69.0 123.19 20.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 m -94.67 -23.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.01 40.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 101.3 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.97 -107.42 3.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -116.22 113.08 22.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -76.69 -174.88 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . 0.424 ' HB2' ' CD2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER -126.11 -55.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.702 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 250' ' ' GLU . 29.1 p90 -179.7 -43.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 249' ' ' PHE . 16.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.911 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -73.25 147.49 44.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.36 -41.63 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -110.83 -32.83 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m 64.1 121.41 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.66 91.08 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.395 2.063 . . . . 0.0 112.276 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.73 160.51 31.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -59.46 107.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -169.07 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -129.44 174.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.121 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 41.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.69 30.86 5.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -122.66 114.59 20.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -176.88 -40.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.57 156.85 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 ' CG2' ' HA ' ' A' ' 56' ' ' VAL . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.415 ' HE3' ' CA ' ' A' ' 45' ' ' LYS . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.424 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -39.51 67.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.78 -18.54 40.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.142 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.87 67.59 1.98 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.645 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.87 -44.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -177.82 125.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.416 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -174.42 -166.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.17 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -168.98 135.88 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.464 ' CD2' ' CZ3' ' A' ' 39' ' ' TRP . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' CA ' ' HD3' ' A' ' 35' ' ' LYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.422 HG23 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 ' HA ' ' CG2' ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' CE1' HG23 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.412 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.428 ' CZ ' HG22 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.428 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.423 ' CD2' HG13 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.423 HG13 ' CD2' ' A' ' 142' ' ' TYR . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -66.64 150.07 49.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -104.73 137.44 42.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 111.089 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 8.0 p80 -109.82 141.04 43.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.161 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 212' ' ' ILE . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.428 ' HB2' ' HB2' ' A' ' 211' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.402 ' HB2' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.453 ' HB2' ' CD1' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.402 ' CG1' ' N ' ' A' ' 181' ' ' ASN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.402 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.407 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.44 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.44 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.409 ' O ' ' CE1' ' A' ' 217' ' ' PHE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.421 HG22 ' CD1' ' A' ' 217' ' ' PHE . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.421 ' HB ' ' CG2' ' A' ' 209' ' ' VAL . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.421 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.453 ' CD1' ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 212' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.4 ' O ' ' N ' ' A' ' 216' ' ' CYS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.421 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.413 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.413 ' CG ' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.414 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.414 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.417 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.402 HG13 ' HB2' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -90.56 -67.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.11 126.48 18.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 110.71 18.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.26 101.57 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.77 179.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.67 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -30.16 71.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -111.57 72.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.555 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.21 113.24 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.345 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.05 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.87 -69.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -151.99 -50.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -113.95 -47.06 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 8.5 tt -176.27 -43.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.4 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 25.9 p90 -65.64 166.58 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 t -93.9 137.95 22.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.68 -25.2 15.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -113.58 102.7 10.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -49.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -46.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.53 175.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -109.3 -36.41 6.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 tt -177.13 97.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.66 161.27 32.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.89 -63.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.713 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -123.65 -179.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.689 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.402 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.447 ' HB3' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.403 ' O ' HG11 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.405 HG13 ' N ' ' A' ' 38' ' ' GLY . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.405 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.464 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -45.33 76.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -26.93 65.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.02 -17.22 6.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.571 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.43 138.74 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 151.44 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.464 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -176.78 154.23 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.9 139.31 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.54 ' HA ' HG11 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 47' ' ' LEU . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.421 ' HG2' ' CE1' ' A' ' 32' ' ' TYR . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.401 ' CG2' HD23 ' A' ' 71' ' ' LEU . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.401 HD23 ' CG2' ' A' ' 56' ' ' VAL . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.42 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.42 HG23 ' CE1' ' A' ' 75' ' ' PHE . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 157' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.429 ' HA ' ' CE1' ' A' ' 142' ' ' TYR . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 142.26 36.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -143.69 136.89 27.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 9.3 t-160 -123.32 119.73 30.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.473 ' O ' ' N ' ' A' ' 211' ' ' LEU . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.423 ' CD2' ' HB3' ' A' ' 235' ' ' GLU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.426 ' CD2' ' HB3' ' A' ' 186' ' ' LEU . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 205' ' ' GLN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.421 ' N ' ' CG1' ' A' ' 180' ' ' VAL . 64.0 m-80 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.426 ' HB3' ' CD2' ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.435 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.41 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.473 ' N ' ' O ' ' A' ' 174' ' ' LEU . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -69.1 -39.59 78.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.69 151.12 41.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.56 131.03 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.38 116.57 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.47 -30.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.72 50.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -97.76 40.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.93 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.25 2.7 4.42 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.88 143.14 5.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.741 0.305 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.64 83.87 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -111.57 -34.23 6.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.2 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.851 0.357 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -35.58 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.04 36.2 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 t80 60.43 108.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.008 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.06 149.85 60.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.42 -27.99 27.44 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.571 2.181 . . . . 0.0 112.383 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 156.43 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -61.74 111.55 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -48.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.1 pt -102.15 -179.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -133.12 84.11 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.437 HD12 ' N ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -73.49 -5.61 41.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.634 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.437 ' N ' HD12 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -65.07 140.51 58.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -176.65 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.8 t -73.66 155.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.435 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.432 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -56.54 -41.96 77.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.7 p -59.67 -27.28 66.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.18 44.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.34 139.93 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.81 126.68 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.52 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.52 138.67 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.142 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.487 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.432 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.437 HG23 ' CE1' ' A' ' 57' ' ' PHE . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.435 ' CG1' ' HB3' ' A' ' 27' ' ' PHE . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.437 ' CE1' HG23 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.428 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.424 HD22 ' CB ' ' A' ' 56' ' ' VAL . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CZ ' ' CD ' ' A' ' 22' ' ' ARG . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.437 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HG2' ' CZ2' ' A' ' 39' ' ' TRP . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 91' ' ' GLY . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.412 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -82.21 116.05 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -148.51 140.93 24.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.156 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 -152.93 122.74 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.682 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.421 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.419 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.402 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.412 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.408 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.408 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.417 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -49.97 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.36 174.59 11.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -141.23 134.81 29.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.985 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -104.95 105.23 15.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.4 m -144.52 -47.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.13 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -82.59 166.6 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.18 78.63 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.17 -53.63 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.52 127.01 39.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 -171.75 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.81 90.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.12 -31.43 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.836 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 tpp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 116.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.2 tt -178.96 106.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.9 144.95 55.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.936 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.435 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -78.9 -52.3 1.26 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.514 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 5' ' ' THR . 74.4 Cg_endo -76.55 -29.52 5.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.446 2.097 . . . . 0.0 112.676 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -103.01 131.51 49.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.998 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -114.44 29.43 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -120.88 -43.77 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.32 176.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -105.39 -29.27 10.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.87 177.52 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.06 -27.97 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 65.55 18.59 11.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.459 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.36 177.61 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.419 ' CG1' ' HG2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' CA ' ' A' ' 91' ' ' GLY . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' C ' HG13 ' A' ' 29' ' ' ILE . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 HG13 ' C ' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.406 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.444 ' HB2' ' HB2' ' A' ' 35' ' ' LYS . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.428 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -58.94 -31.27 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -61.04 -31.84 71.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.85 -8.83 4.53 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.447 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 14.3 p -86.72 145.57 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.237 0.518 . . . . 0.0 111.119 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.19 130.79 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.408 ' HD2' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -135.78 171.22 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.08 132.66 43.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.468 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 57' ' ' PHE . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.402 ' CG2' HD22 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.436 ' CE1' HG23 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.402 HD22 ' CG2' ' A' ' 56' ' ' VAL . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.459 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.433 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.432 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.417 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.417 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 mm100 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 -102.86 116.03 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.32 136.99 52.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.165 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -120.76 140.35 51.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.438 ' CZ ' HD23 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.47 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.47 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.438 HD23 ' CZ ' ' A' ' 176' ' ' PHE . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.432 ' CG1' ' CG2' ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG2' ' CG1' ' A' ' 196' ' ' VAL . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.414 ' HB2' ' CG2' ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' N ' ' CD1' ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -112.22 -177.65 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.87 123.42 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.42 110.41 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.52 157.57 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 8.6 m -58.53 -37.02 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -178.11 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.938 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.47 -71.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.72 34.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 247' ' ' GLU . 2.1 m-20 -136.04 -174.52 3.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.716 0.293 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 246' ' ' ASP . 4.7 mt-10 82.2 -13.37 0.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -96.67 -47.91 5.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 55.41 94.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.711 0.291 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.62 177.43 11.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.42 -46.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -134.97 144.04 47.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.411 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -87.02 -52.34 0.42 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 5' ' ' THR . 49.5 Cg_exo -55.84 106.46 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.541 2.16 . . . . 0.0 112.233 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 43.25 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -153.5 29.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -178.82 -63.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.3 tp -143.0 118.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.89 42.23 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.988 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -158.79 -53.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.004 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p 55.09 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.174 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 t30 73.92 -60.58 0.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.78 147.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.948 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.421 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.416 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.421 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 51' ' ' LEU . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -59.07 -34.21 71.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -60.25 -28.11 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.808 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.53 24.46 3.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.818 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t -107.64 145.65 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.34 142.61 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -167.43 147.9 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.94 132.62 39.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.488 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.469 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.419 ' CD2' ' HB2' ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.469 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 76' ' ' GLY . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CD2' HG21 ' A' ' 83' ' ' ILE . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.43 HG21 ' CD2' ' A' ' 75' ' ' PHE . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 29' ' ' ILE . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.412 ' HA ' ' CG2' ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.421 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.412 ' CG2' ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.1 131.68 39.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.9 136.84 49.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.319 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -127.21 164.2 22.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.479 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.403 HD12 ' CG2' ' A' ' 194' ' ' ILE . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.421 HG13 ' N ' ' A' ' 195' ' ' LYS . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . 0.421 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.401 ' N ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.479 ' O ' ' N ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -103.62 -176.9 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.64 168.92 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 142.42 28.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 134.51 54.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.42 -33.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.306 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.54 99.62 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.41 37.13 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 113.69 29.31 2.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -99.41 -175.56 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 45.84 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.372 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.97 89.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -133.19 -50.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -59.66 -177.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.26 -47.09 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.995 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -167.3 -51.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m 61.34 118.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.42 100.07 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.382 2.055 . . . . 0.0 112.243 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -132.18 -46.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -171.36 -39.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.0 pt20 -57.0 -49.3 76.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.099 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.7 pt -161.57 109.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.003 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -95.58 65.36 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.94 -83.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 14.2 p 48.85 -161.88 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.136 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 t30 78.11 -60.33 0.41 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.14 138.11 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.481 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' CG2' ' HB2' ' A' ' 31' ' ' CYS . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.61 -36.35 71.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t -60.6 -31.94 71.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.67 25.36 4.3 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.74 151.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 0.0 111.149 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.12 98.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.487 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.58 157.25 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.426 ' CD2' ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.407 HG11 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.408 ' CD2' ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.45 HG23 ' CE1' ' A' ' 57' ' ' PHE . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 53' ' ' THR . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CE1' HG22 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.421 HG22 ' CE1' ' A' ' 75' ' ' PHE . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.475 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.433 ' CD1' HD12 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.433 HD12 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.414 ' CD1' HG23 ' A' ' 144' ' ' VAL . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.414 HG23 ' CD1' ' A' ' 142' ' ' TYR . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -111.04 117.08 32.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -156.26 152.6 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -99.09 170.95 8.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.639 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.479 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.428 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.479 ' HD3' ' CZ ' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -83.85 -78.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.35 174.6 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -122.38 110.38 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.33 123.25 23.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.3 m -140.98 165.17 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.147 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.3 78.2 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -78.06 -35.3 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -162.2 -56.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -119.37 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -70.24 -24.9 63.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.91 87.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -37.87 69.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -106.52 167.36 9.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 mt 73.31 -59.78 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -74.94 126.6 31.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.407 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -91.1 -52.35 0.3 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.407 ' CD ' ' N ' ' A' ' 5' ' ' THR . 32.0 Cg_exo -58.38 97.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.572 2.181 . . . . 0.0 112.132 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m 63.64 136.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.024 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -107.56 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -137.59 -58.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.9 pt -88.35 147.38 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -74.26 -49.83 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.9 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -61.03 122.59 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -177.73 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.1 t -107.86 159.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.039 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 29' ' ' ILE . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.414 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.425 ' CH2' HD21 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -44.3 75.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 27.9 p -59.44 -27.51 66.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.85 -19.33 4.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.763 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 22.6 t -53.85 141.98 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 111.329 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.14 131.98 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.53 173.01 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -115.44 137.57 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.086 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 47' ' ' LEU . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.414 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 ' CG2' HD22 ' A' ' 71' ' ' LEU . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' CG2' ' A' ' 56' ' ' VAL . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' CZ ' HG22 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG22 ' CZ ' ' A' ' 75' ' ' PHE . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CE ' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 137' ' ' MET . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.404 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 159' ' ' LYS . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . 0.4 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.04 112.86 21.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.73 164.54 23.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.222 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -130.05 -177.7 4.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.416 ' HB2' ' CB ' ' A' ' 239' ' ' LEU . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 237' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.418 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.408 HG11 ' HA ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.445 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.445 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.421 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.408 ' HA ' HG11 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.421 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.42 ' O ' ' N ' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . 0.499 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -177.39 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.416 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 2.7 mm? -80.23 112.65 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 111.198 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -121.42 148.57 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.98 153.86 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.2 t 68.62 -68.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.255 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.55 71.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.824 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.25 31.26 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 130.34 -93.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.423 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.77 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 0.0 111.004 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 62.61 148.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -157.82 42.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -92.53 146.35 23.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.923 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.875 0.369 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 174.98 7.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.0 pt -110.73 -40.34 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -112.21 -28.31 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m 64.12 125.76 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.812 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 118.81 5.9 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.383 2.055 . . . . 0.0 112.316 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -89.99 -49.92 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -114.8 -51.9 2.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.54 65.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.972 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER 57.96 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.06 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.54 -49.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.402 ' CD1' ' CG1' ' A' ' 60' ' ' VAL . 8.7 tt -166.23 123.53 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 -56.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -138.7 29.88 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.49 155.09 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.402 ' CG1' ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.419 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 57' ' ' PHE . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.431 ' HB2' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.461 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 34' ' ' ASN . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.429 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -26.08 67.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.45 25.46 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.84 -82.19 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.991 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 p -166.58 160.62 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -43.99 143.7 1.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.284 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -135.76 170.47 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.84 121.11 10.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.422 ' HA ' ' CB ' ' A' ' 35' ' ' LYS . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.417 ' N ' HG12 ' A' ' 50' ' ' VAL . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.405 ' CG2' ' CD2' ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 28' ' ' GLU . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.402 ' CG1' ' CD1' ' A' ' 12' ' ' LEU . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' CD2' ' CG2' ' A' ' 56' ' ' VAL . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.432 ' CE1' HG22 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.432 HG22 ' CE1' ' A' ' 75' ' ' PHE . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.42 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.432 ' O ' ' CG ' ' A' ' 141' ' ' HIS . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -111.58 124.59 52.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.525 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -124.71 167.44 14.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.414 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.467 ' O ' ' CD2' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.414 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.435 HG22 HD11 ' A' ' 212' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.416 ' CD1' HD12 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.416 HD12 ' CD1' ' A' ' 217' ' ' PHE . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 225' ' ' LYS . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.42 ' CE ' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.444 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.76 -75.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.41 135.77 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 39.4 pttt -139.24 132.72 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -79.04 154.81 29.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.29 -31.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -105.49 133.15 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 30.78 4.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.08 -40.12 2.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -153.25 133.47 13.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -104.67 -77.59 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -111.09 -26.37 9.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.21 31.8 10.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.941 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t 61.09 112.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.5 tt -171.3 55.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 64.9 t80 66.32 -73.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.84 114.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.894 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.68 75.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.355 2.037 . . . . 0.0 112.217 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -157.31 160.14 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -67.02 79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.22 -51.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -142.77 167.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -156.18 93.15 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.71 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -111.45 -20.76 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.334 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -124.76 -68.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.43 29.63 7.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -157.4 -177.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.413 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.46 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.413 ' CD1' ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.442 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG12 ' A' ' 37' ' ' VAL . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' CG2' ' HB2' ' A' ' 31' ' ' CYS . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 34' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.41 ' N ' HG11 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.512 ' CE3' ' HB3' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -59.3 -40.81 87.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -59.27 -22.61 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.14 17.54 5.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.707 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.58 127.62 42.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.771 0.32 . . . . 0.0 110.992 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.12 135.53 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -159.42 171.75 19.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.167 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -119.92 145.03 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.052 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.4 HD23 ' CE ' ' A' ' 85' ' ' LYS . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.426 HG13 ' CE3' ' A' ' 39' ' ' TRP . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.413 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.444 HG21 ' CE1' ' A' ' 57' ' ' PHE . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' N ' ' O ' ' A' ' 28' ' ' GLU . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.419 ' CE1' HG21 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.419 HG21 ' CE1' ' A' ' 75' ' ' PHE . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.4 ' CE ' HD23 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.401 HG21 ' CD1' ' A' ' 29' ' ' ILE . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.414 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.414 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CD1' HD11 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.419 HD11 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -107.08 113.38 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.408 ' O ' ' N ' ' A' ' 215' ' ' GLY . . . -153.36 154.5 34.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -173.17 129.81 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.503 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.469 ' CE2' HD13 ' A' ' 211' ' ' LEU . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.401 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.401 ' N ' ' HG2' ' A' ' 179' ' ' PRO . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.442 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.427 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.469 HD13 ' CE2' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 170' ' ' ALA . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.449 ' HG3' ' CZ ' ' A' ' 176' ' ' PHE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.434 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.503 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -100.46 -30.42 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.8 132.45 36.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -143.66 119.25 10.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.87 101.74 9.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.0 -61.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -109.34 -28.21 9.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.36 121.52 10.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.49 29.88 3.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.429 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -143.41 -48.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.87 0.367 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.06 147.21 30.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 -66.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 59.57 33.96 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.748 0.309 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -160.25 -169.29 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 mt 66.61 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -161.68 96.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -147.97 115.1 4.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.63 18.91 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.604 2.203 . . . . 0.0 112.988 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m 64.54 37.63 7.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -146.23 -70.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -179.44 50.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mt 71.94 -61.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 67.9 37.92 2.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tt -156.4 74.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.77 141.21 30.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.6 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 t -106.17 155.88 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.4 ' HB2' ' CG2' ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.479 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.406 ' CD1' HG23 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.522 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.418 ' HB2' ' CB ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -56.96 -39.88 75.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 t -64.38 -26.49 68.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.84 31.41 2.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -98.73 135.75 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.99 103.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.05 158.42 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -99.64 137.07 38.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.268 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.418 HG22 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.412 ' CG2' HD22 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.418 ' CE1' HG22 ' A' ' 53' ' ' THR . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.413 HG22 ' CE2' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.412 HD22 ' CG2' ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.4 ' O ' ' N ' ' A' ' 76' ' ' GLY . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.461 ' O ' ' HG2' ' A' ' 86' ' ' GLN . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.431 ' HG2' HD22 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.41 ' O ' ' HA3' ' A' ' 91' ' ' GLY . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.432 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 168' ' ' GLU . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . 0.414 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.432 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.81 114.25 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.418 ' HB3' ' N ' ' A' ' 216' ' ' CYS . . . -170.22 175.01 5.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 -175.8 119.56 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.478 ' O ' ' N ' ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CD2' ' CD1' ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.441 ' HB2' ' CA ' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.441 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.44 ' CD1' ' CD2' ' A' ' 176' ' ' PHE . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.479 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.466 ' CG1' HD21 ' A' ' 211' ' ' LEU . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 197' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.408 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.408 ' CG ' ' HB3' ' A' ' 201' ' ' ASP . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.479 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.46 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 168' ' ' GLU . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.418 ' N ' ' HB3' ' A' ' 170' ' ' ALA . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CE1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.404 HD11 ' CE1' ' A' ' 217' ' ' PHE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.405 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.422 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -70.41 -74.2 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.37 141.31 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -97.89 121.13 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.49 136.05 38.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.99 127.15 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.87 81.38 1.76 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -98.72 -63.53 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.66 -65.42 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.13 -55.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -171.4 -46.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -177.38 105.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.97 30.81 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.68 150.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.78 -75.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -179.42 66.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.62 111.07 4.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.745 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.37 111.64 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.439 2.093 . . . . 0.0 112.233 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -174.49 -178.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -97.9 37.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.68 -33.03 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 pt -128.56 -179.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -119.06 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -162.2 117.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -99.81 -169.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 60.34 80.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 48.5 t 65.07 153.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.996 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' A' ' 29' ' ' ILE . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' A' ' 18' ' ' VAL . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.427 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.401 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HB2' ' CB ' ' A' ' 32' ' ' TYR . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 34' ' ' ASN . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.596 ' CE3' ' HB3' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -58.81 -37.84 77.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -59.57 -27.22 66.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.2 3.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -96.87 140.33 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.54 117.24 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.596 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -135.15 179.91 6.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.616 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.16 150.02 40.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.455 ' CD1' ' HD2' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' N ' ' A' ' 51' ' ' LEU . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.464 ' N ' HG13 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.407 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 65' ' ' VAL . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.438 ' CE2' HG22 ' A' ' 83' ' ' ILE . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.416 ' CG2' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG22 ' CE2' ' A' ' 75' ' ' PHE . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.568 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.407 ' CG2' ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.401 ' HA ' ' HB2' ' A' ' 119' ' ' CYS . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.407 ' HD2' ' CG2' ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . 0.401 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -72.13 144.22 48.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -105.16 162.4 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.133 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 -162.64 177.09 9.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.556 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.422 ' HB3' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.441 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . 0.441 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.422 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.433 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . 0.434 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.556 ' O ' ' N ' ' A' ' 174' ' ' LEU . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.407 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.92 -167.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.7 mp -92.62 170.17 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -106.1 145.42 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -60.33 116.49 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.3 m -137.15 -46.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.91 48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.15 -33.52 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.26 -43.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.577 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -176.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -68.65 -73.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.32 85.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.21 133.13 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.821 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.88 128.81 31.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.52 -78.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.417 ' CD2' ' HD2' ' A' ' 6' ' ' PRO . 0.4 OUTLIER -164.93 -171.1 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.861 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.66 -67.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.457 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 57.7 Cg_endo -71.8 -47.15 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.225 1.95 . . . . 0.0 112.507 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -105.61 -179.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -156.79 76.35 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -45.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 pt -104.9 179.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.77 80.17 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.9 tt -83.29 -36.62 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 72.6 p -64.69 116.78 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -178.16 -39.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.0 t -113.18 152.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.091 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.423 ' HB3' HG11 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 18' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 32' ' ' TYR . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG12 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.4 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.452 ' CH2' ' HE2' ' A' ' 85' ' ' LYS . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -58.25 -39.26 78.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 p -59.36 -26.49 65.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.086 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -22.87 4.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.664 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.29 129.13 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.215 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.97 118.78 10.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -137.28 149.81 47.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -101.35 147.83 25.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.287 -179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.428 HD13 ' CZ3' ' A' ' 39' ' ' TRP . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 HG11 ' CE3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 ' N ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.416 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.423 HG11 ' HB3' ' A' ' 27' ' ' PHE . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.439 ' N ' ' O ' ' A' ' 28' ' ' GLU . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.438 ' CD1' HG22 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.438 HG22 ' CD1' ' A' ' 75' ' ' PHE . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 112' ' ' ALA . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.444 ' N ' ' CG2' ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.422 ' CB ' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.422 ' CD1' ' CB ' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.401 ' CE ' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.403 ' O ' ' CE1' ' A' ' 108' ' ' PHE . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.404 ' HG2' ' O ' ' A' ' 148' ' ' LYS . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.404 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.425 HD13 HG21 ' A' ' 167' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.66 112.41 21.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -141.2 142.53 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 169.22 9.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.434 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.405 ' CB ' ' HA2' ' A' ' 183' ' ' GLY . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.405 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.434 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' HB ' ' CG2' ' A' ' 209' ' ' VAL . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.405 ' HB3' ' HG3' ' A' ' 207' ' ' GLU . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.481 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.481 ' CB ' ' HB3' ' A' ' 202' ' ' TYR . 1.4 mt-30 -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.405 ' HG3' ' HB3' ' A' ' 201' ' ' ASP . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 226' ' ' LYS . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . 0.463 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -103.42 -66.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.75 146.56 45.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -144.19 143.12 30.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.78 103.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 135.6 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.35 59.46 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.817 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -152.24 34.02 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.09 176.89 14.6 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.0 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.35 174.81 10.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -75.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -122.66 -43.5 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.849 0.357 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.75 35.5 3.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 pt -82.83 -29.09 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.26 14.37 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.292 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.5 m 53.16 80.74 0.28 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.223 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.16 83.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.656 2.237 . . . . 0.0 112.119 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.05 -168.57 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -98.24 30.33 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 -27.23 11.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.5 pp -118.68 -179.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -152.44 56.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.061 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.431 HD22 ' HB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -65.4 -13.83 59.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.543 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.1 m 165.35 -56.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.239 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 75.23 -59.67 0.53 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -52.3 178.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 29' ' ' ILE . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 HD11 ' HB ' ' A' ' 87' ' ' ILE . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.434 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.478 ' CE3' ' HB2' ' A' ' 45' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.56 -44.1 84.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -26.54 67.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.06 5.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.153 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.7 m -101.49 27.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 111.367 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 59.2 103.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.33 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.478 ' HB2' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -124.78 125.73 44.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.31 119.62 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.411 ' CD2' ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.421 ' CD1' ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.501 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.487 ' HB2' ' O ' ' A' ' 53' ' ' THR . 90.8 m-70 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.413 ' CG2' HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CE1' ' CG2' ' A' ' 53' ' ' THR . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD21 ' CG2' ' A' ' 56' ' ' VAL . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.404 ' O ' ' N ' ' A' ' 76' ' ' GLY . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CD1' HG22 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.413 HG22 ' CD1' ' A' ' 75' ' ' PHE . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.487 ' O ' HD23 ' A' ' 88' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.502 ' HA ' HD23 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.432 ' HB ' HD11 ' A' ' 29' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 112' ' ' ALA . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' N ' ' CG2' ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.408 HD13 HG22 ' A' ' 114' ' ' ILE . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.403 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.403 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 133' ' ' ILE . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 167' ' ' ILE . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -106.21 128.6 54.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -130.72 136.9 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -136.43 146.94 46.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . . . . . . . . . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.428 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . 0.414 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.414 ' CB ' ' HB3' ' A' ' 201' ' ' ASP . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.422 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 233' ' ' SER . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -73.87 -179.67 3.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.33 153.43 25.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.3 tttt -105.91 123.99 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -98.9 116.39 31.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 9.7 p -150.51 109.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.051 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -161.02 167.2 26.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.52 -47.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -73.42 -8.64 76.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.922 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.98 -36.48 11.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.765 0.316 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.13 154.87 21.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 -46.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -60.8 123.69 18.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.956 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.755 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -143.65 98.89 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.5 pt -138.06 36.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -50.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.509 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 7.6 p 54.56 55.69 11.61 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 5' ' ' THR . 74.8 Cg_endo -91.83 72.87 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.939 2.426 . . . . 0.0 112.362 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m 69.97 -65.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -112.81 -83.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -176.56 101.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.756 0.312 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -53.4 106.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.8 mtt-85 -53.54 -24.93 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 66.61 98.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -13.82 62.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.033 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' O ' HG13 ' A' ' 15' ' ' VAL . 0.2 OUTLIER 78.24 -61.89 0.36 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.475 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER 48.44 179.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.488 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.422 ' CB ' ' HB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' CD1' ' CG2' ' A' ' 15' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.402 ' HD3' ' HB2' ' A' ' 32' ' ' TYR . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.439 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.59 -37.1 80.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -59.49 -24.55 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.82 24.51 4.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.427 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.08 132.46 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 111.134 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.5 122.84 15.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.0 150.58 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.42 130.23 34.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.462 ' CD2' ' CH2' ' A' ' 39' ' ' TRP . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 47' ' ' LEU . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.491 ' CD1' ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.534 ' CG2' ' CE1' ' A' ' 57' ' ' PHE . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . 0.491 ' HA ' ' CD1' ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.431 ' O ' HG21 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.534 ' CE1' ' CG2' ' A' ' 53' ' ' THR . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.443 ' CD2' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 75' ' ' PHE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' CB ' HD12 ' A' ' 51' ' ' LEU . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.436 ' HG2' ' HA ' ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.04 142.81 54.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -105.14 136.77 44.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.028 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 -107.2 155.54 19.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.078 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.454 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.412 ' CD1' ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.401 ' HA ' ' CD2' ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' HA2' ' CD1' ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.448 ' CG2' ' CD1' ' A' ' 217' ' ' PHE . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 198' ' ' GLU . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . 0.408 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 174' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.411 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . 0.427 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.448 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . 0.403 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.454 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . 0.425 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -89.28 -169.81 2.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.47 170.74 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.086 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -91.1 110.55 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -102.64 121.31 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.37 -37.14 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.49 86.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -88.78 -65.44 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -143.56 80.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.41 -68.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.759 0.314 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.61 -30.1 67.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 100.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -75.08 -34.0 61.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.934 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -138.07 -54.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.91 -73.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.202 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.35 74.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -138.16 99.2 9.05 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.86 -46.08 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.454 2.103 . . . . 0.0 112.284 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -152.44 -65.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.81 -62.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -157.7 -64.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.086 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 HG13 HD11 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -168.88 146.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.446 ' N ' HG13 ' A' ' 10' ' ' ILE . 3.1 mmt85 -109.46 14.44 23.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.622 ' CD1' ' N ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -161.74 -71.67 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' H ' ' CD2' ' A' ' 12' ' ' LEU . 8.9 t 39.81 -157.98 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.592 0.234 . . . . 0.0 111.537 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 13' ' ' THR . 9.2 m-20 68.74 7.96 6.45 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER 177.72 174.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' O ' ' N ' ' A' ' 57' ' ' PHE . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.47 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.407 ' O ' HG13 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.454 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.47 ' CG2' ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.449 HG12 ' N ' ' A' ' 38' ' ' GLY . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.449 ' N ' HG12 ' A' ' 37' ' ' VAL . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.426 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -34.31 74.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -59.25 -25.53 64.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.41 24.79 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.78 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.17 152.97 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.968 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.44 119.55 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.93 117.02 17.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.777 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.25 122.95 15.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 ' HA ' HG13 ' A' ' 50' ' ' VAL . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG13 ' HA ' ' A' ' 47' ' ' LEU . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' A' ' 51' ' ' LEU . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.436 HG23 ' CE1' ' A' ' 57' ' ' PHE . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.41 ' CG2' HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' N ' ' O ' ' A' ' 28' ' ' GLU . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.41 HD21 ' CG2' ' A' ' 56' ' ' VAL . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.418 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.418 ' CG2' ' CE2' ' A' ' 75' ' ' PHE . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.426 ' HE2' ' CZ2' ' A' ' 39' ' ' TRP . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 35.8 t30 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.418 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.418 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ILE . . . . . . . . . . . . . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -71.05 118.69 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -161.54 146.11 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.041 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 -175.0 131.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.461 ' O ' ' N ' ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.445 ' HB2' ' CA ' ' A' ' 183' ' ' GLY . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.445 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.404 ' O ' ' CZ ' ' A' ' 217' ' ' PHE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . 0.42 HG21 HD12 ' A' ' 194' ' ' ILE . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . 0.461 ' N ' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.465 HD13 HG22 ' A' ' 212' ' ' ILE . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -56.93 3.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.38 125.38 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.54 115.53 24.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.17 106.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 16.4 t -117.45 30.5 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -106.72 52.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.997 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.27 34.29 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 68.82 117.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -57.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -158.06 142.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -96.42 -47.9 5.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.27 31.69 19.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 16' ' ' ALA . 70.4 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.705 0.288 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 60' ' ' VAL . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' C ' ' A' ' 92' ' ' GLU . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.887 ' HB2' HG23 ' A' ' 87' ' ' ILE . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 88' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' CB ' HG23 ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 38' ' ' GLY . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.763 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 71' ' ' LEU . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.745 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.112 HD22 HD13 ' A' ' 83' ' ' ILE . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 78' ' ' ASP . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 72' ' ' ILE . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.693 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.112 HD13 HD22 ' A' ' 71' ' ' LEU . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 51' ' ' LEU . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.887 HG23 ' HB2' ' A' ' 20' ' ' MET . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 31' ' ' CYS . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 103' ' ' GLN . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.451 ' HG2' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 111' ' ' ILE . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.73 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 215' ' ' GLY . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 115' ' ' VAL . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 136' ' ' ALA . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 157' ' ' VAL . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 107' ' ' MET . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 158' ' ' ILE . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 158' ' ' ILE . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 154' ' ' ALA . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 161' ' ' LEU . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 119' ' ' CYS . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.671 0.272 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 212' ' ' ILE . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 208' ' ' ILE . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.786 HD23 HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.926 HD13 HD21 ' A' ' 211' ' ' LEU . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HA ' HG21 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 191' ' ' LYS . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.612 HD11 HD11 ' A' ' 212' ' ' ILE . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.51 ' HB2' HD12 ' A' ' 197' ' ' ILE . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.421 ' HB3' HG13 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.631 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.42 ' HG2' ' CB ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 177' ' ' ILE . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.565 HG11 ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.469 ' C ' HD22 ' A' ' 211' ' ' LEU . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.948 ' HB3' HD11 ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 173' ' ' ARG . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 174' ' ' LEU . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.526 ' O ' HG11 ' A' ' 120' ' ' VAL . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.72 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 28' ' ' GLU . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' SG ' ' A' ' 31' ' ' CYS . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.843 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 33' ' ' LYS . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.789 0.328 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.66 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.736 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.705 HG21 HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.612 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.976 HD22 HD13 ' A' ' 83' ' ' ILE . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.577 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 HD22 ' A' ' 71' ' ' LEU . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.736 ' SG ' HD11 ' A' ' 51' ' ' LEU . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HG2' HD21 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 29' ' ' ILE . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 18' ' ' VAL . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 33' ' ' LYS . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 98' ' ' LYS . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.869 ' HA ' HD12 ' A' ' 114' ' ' ILE . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.572 HG22 ' OD2' ' A' ' 117' ' ' ASP . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.896 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' HG22 ' A' ' 113' ' ' THR . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.768 ' HA ' HD12 ' A' ' 133' ' ' ILE . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 116' ' ' ALA . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB1' ' CE ' ' A' ' 164' ' ' LYS . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.548 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 145' ' ' LYS . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 144' ' ' VAL . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 161' ' ' LEU . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.638 ' HA ' HD11 ' A' ' 167' ' ' ILE . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 158' ' ' ILE . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.66 HD22 ' HZ1' ' A' ' 164' ' ' LYS . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.66 ' HZ1' HD22 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 158' ' ' ILE . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 3.2 m-70 . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.62 0.247 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.681 ' C ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.681 HD22 ' C ' ' A' ' 173' ' ' ARG . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 206' ' ' LEU . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' HD2' ' A' ' 229' ' ' LYS . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 205' ' ' GLN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.489 ' N ' HG13 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 190' ' ' LEU . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 196' ' ' VAL . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 224' ' ' ILE . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.658 ' CD1' HD23 ' A' ' 211' ' ' LEU . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 209' ' ' VAL . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HB2' HG12 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.507 HD12 HD11 ' A' ' 177' ' ' ILE . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 206' ' ' LEU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.815 HG23 HG13 ' A' ' 196' ' ' VAL . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.658 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.461 HD12 HH11 ' A' ' 173' ' ' ARG . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HB3' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 220' ' ' ILE . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.41 ' OG1' HD13 ' A' ' 186' ' ' LEU . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HD2' HD23 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.687 ' O ' HD12 ' A' ' 234' ' ' LEU . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 233' ' ' SER . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG21 ' A' ' 60' ' ' VAL . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 29' ' ' ILE . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.891 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.801 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.977 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.87 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HB3' HG23 ' A' ' 50' ' ' VAL . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 34' ' ' ASN . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 81' ' ' THR . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 35' ' ' LYS . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.977 HG22 ' HB3' ' A' ' 30' ' ' ALA . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.136 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 17' ' ' VAL . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.136 HD21 HG21 ' A' ' 56' ' ' VAL . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 83' ' ' ILE . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.919 HD13 HD22 ' A' ' 71' ' ' LEU . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.801 ' SG ' HG21 ' A' ' 29' ' ' ILE . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.891 HG23 ' HB2' ' A' ' 20' ' ' MET . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD1' HD13 ' A' ' 29' ' ' ILE . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 93' ' ' VAL . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.434 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 111' ' ' ILE . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 111' ' ' ILE . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 133' ' ' ILE . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 216' ' ' CYS . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' HG12 ' A' ' 120' ' ' VAL . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' HD12 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.545 HD12 ' OG1' ' A' ' 129' ' ' THR . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' A' ' 116' ' ' ALA . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 53.7 m80 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.475 HG13 ' OE1' ' A' ' 153' ' ' GLN . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.475 ' OE1' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.659 HG22 HD12 ' A' ' 161' ' ' LEU . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 154' ' ' ALA . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 157' ' ' VAL . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.671 HG21 HG13 ' A' ' 115' ' ' VAL . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 16.8 m80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.863 0.363 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 238' ' ' ASN . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 234' ' ' LEU . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' HD12 ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.612 HD21 HG22 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 211' ' ' LEU . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 197' ' ' ILE . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.436 ' N ' HG12 ' A' ' 196' ' ' VAL . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.755 ' HA ' HG22 ' A' ' 180' ' ' VAL . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 206' ' ' LEU . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 194' ' ' ILE . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 212' ' ' ILE . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 120' ' ' VAL . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.751 HD13 ' CD1' ' A' ' 217' ' ' PHE . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 220' ' ' ILE . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.452 ' HA ' HD21 ' A' ' 186' ' ' LEU . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.512 ' CG2' HD22 ' A' ' 186' ' ' LEU . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.603 ' HB3' HD12 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 173' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 52' ' ' GLN . 13.3 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 29' ' ' ILE . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG3' ' HE3' ' A' ' 20' ' ' MET . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.949 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.836 ' HB3' HG23 ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' CH2' ' HE3' ' A' ' 85' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.702 0.286 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.896 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.874 HG22 ' SG ' ' A' ' 31' ' ' CYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.62 HG21 ' CE1' ' A' ' 57' ' ' PHE . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 51' ' ' LEU . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' HA ' HG23 ' A' ' 29' ' ' ILE . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 53' ' ' THR . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG22 ' CE2' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.859 HD22 HD13 ' A' ' 83' ' ' ILE . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.816 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 71' ' ' LEU . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' HG21 ' A' ' 29' ' ' ILE . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.896 ' HE3' HD21 ' A' ' 47' ' ' LEU . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' NH1' ' A' ' 100' ' ' ARG . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.702 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.1 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG21 ' A' ' 150' ' ' THR . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 133' ' ' ILE . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG23 ' NZ ' ' A' ' 118' ' ' LYS . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 111' ' ' ILE . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' NZ ' HG23 ' A' ' 114' ' ' ILE . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 ' HB2' ' A' ' 216' ' ' CYS . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.648 HD13 ' CD1' ' A' ' 128' ' ' TYR . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 130' ' ' VAL . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 161' ' ' LEU . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.651 HG13 ' OE1' ' A' ' 153' ' ' GLN . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 103' ' ' GLN . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.645 HG21 ' OD2' ' A' ' 110' ' ' ASP . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 157' ' ' VAL . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.591 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.812 ' HA ' HG21 ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 1.018 HD21 ' HB1' ' A' ' 136' ' ' ALA . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 57.9 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.612 0.244 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 217' ' ' PHE . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 172' ' ' MET . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.794 HD11 ' CD2' ' A' ' 186' ' ' LEU . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 205' ' ' GLN . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 180' ' ' VAL . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 228' ' ' THR . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.794 ' CD2' HD11 ' A' ' 178' ' ' LEU . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.532 HD21 ' OD1' ' A' ' 221' ' ' ASP . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 196' ' ' VAL . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 1.12 HD23 HG23 ' A' ' 194' ' ' ILE . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 1.12 HG23 HD23 ' A' ' 193' ' ' LEU . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 191' ' ' LYS . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 208' ' ' ILE . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.653 ' HA ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.736 HD11 ' OD2' ' A' ' 221' ' ' ASP . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 211' ' ' LEU . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 120' ' ' VAL . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.502 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.736 ' OD2' HD11 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 225' ' ' LYS . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.611 HG21 ' CD1' ' A' ' 193' ' ' LEU . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 185' ' ' LYS . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.412 ' CD ' HD22 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 52' ' ' GLN . 21.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' SG ' ' A' ' 31' ' ' CYS . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.005 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.752 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 33' ' ' LYS . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.59 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.891 0.377 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' HG21 ' A' ' 15' ' ' VAL . 24.4 tp60 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.005 HG22 ' HB3' ' A' ' 30' ' ' ALA . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.982 HG21 HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.982 HD21 HG21 ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.704 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.981 HD13 HD22 ' A' ' 71' ' ' LEU . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HG2' HD21 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 36' ' ' VAL . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 93' ' ' VAL . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.52 ' HE1' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.609 ' HA ' HD12 ' A' ' 111' ' ' ILE . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 108' ' ' PHE . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.489 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 111' ' ' ILE . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 111' ' ' ILE . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 216' ' ' CYS . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 120' ' ' VAL . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.537 ' HD1' HD13 ' A' ' 132' ' ' LEU . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD13 ' HD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.49 HG22 ' HE2' ' A' ' 137' ' ' MET . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.49 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 111' ' ' ILE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.52 HG22 ' HE1' ' A' ' 107' ' ' MET . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.2 tp60 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 158' ' ' ILE . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 155' ' ' LEU . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.618 ' CG2' HG23 ' A' ' 158' ' ' ILE . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.688 0.28 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.712 ' HE3' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 212' ' ' ILE . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD11 ' HE3' ' A' ' 172' ' ' MET . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 207' ' ' GLU . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 205' ' ' GLN . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.454 ' HZ2' ' HA ' ' A' ' 228' ' ' THR . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 229' ' ' LYS . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HG2' HD11 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 225' ' ' LYS . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.615 HG23 HD23 ' A' ' 193' ' ' LEU . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.627 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.676 ' HB3' HD11 ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 176' ' ' PHE . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 173' ' ' ARG . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.752 ' HB3' HG21 ' A' ' 120' ' ' VAL . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.664 ' HB2' ' HE2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 220' ' ' ILE . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.492 ' HG2' HD21 ' A' ' 190' ' ' LEU . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 185' ' ' LYS . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' NE2' ' A' ' 52' ' ' GLN . 22.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.345 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 87' ' ' ILE . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.869 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.88 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.884 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HG3' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 37' ' ' VAL . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 50' ' ' VAL . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 34' ' ' ASN . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.869 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.884 HG22 ' SG ' ' A' ' 31' ' ' CYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.82 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' NE2' HG22 ' A' ' 15' ' ' VAL . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.538 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 60' ' ' VAL . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 83' ' ' ILE . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.466 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 71' ' ' LEU . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.88 ' SG ' HG21 ' A' ' 29' ' ' ILE . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.869 ' HE3' HD21 ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 20' ' ' MET . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.75 HD21 ' SG ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 33' ' ' LYS . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.85 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 111' ' ' ILE . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' CYS . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.764 HG11 ' CD1' ' A' ' 111' ' ' ILE . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HD11 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 157' ' ' VAL . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 153' ' ' GLN . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.603 HD12 HG12 ' A' ' 157' ' ' VAL . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 8.0 p80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.96 0.41 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 212' ' ' ILE . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 238' ' ' ASN . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.623 ' CG ' HD23 ' A' ' 237' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.693 ' HD3' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.839 ' HB2' HD11 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 206' ' ' LEU . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.859 ' CD2' HD13 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' GLN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.44 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.859 HD13 ' CD2' ' A' ' 178' ' ' LEU . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.528 ' HG2' HD11 ' A' ' 224' ' ' ILE . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.991 HD23 HG23 ' A' ' 194' ' ' ILE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.991 HG23 HD23 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 191' ' ' LYS . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 212' ' ' ILE . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' A' ' 208' ' ' ILE . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 177' ' ' ILE . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.839 HD11 ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 197' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 193' ' ' LEU . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' A' ' 151' ' ' LYS . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.583 ' OD2' HD23 ' A' ' 211' ' ' LEU . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.767 HD13 HD13 ' A' ' 193' ' ' LEU . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 HD12 ' A' ' 186' ' ' LEU . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.623 HD23 ' CG ' ' A' ' 174' ' ' LEU . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 54.4 t30 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.595 0.236 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 15' ' ' VAL . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD12 ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.898 ' HB2' HG23 ' A' ' 87' ' ' ILE . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.682 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.827 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.843 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.82 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 103' ' ' GLN . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.757 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.827 HG22 ' SG ' ' A' ' 31' ' ' CYS . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' HG23 ' A' ' 29' ' ' ILE . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 83' ' ' ILE . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.855 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 71' ' ' LEU . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.714 ' CB ' HD11 ' A' ' 51' ' ' LEU . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 20' ' ' MET . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 36' ' ' VAL . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' NE2' HG11 ' A' ' 37' ' ' VAL . 1.2 tt0 -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 113' ' ' THR . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 110' ' ' ASP . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.601 HD21 ' HE2' ' A' ' 128' ' ' TYR . 9.9 t-20 -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.601 ' HE2' HD21 ' A' ' 121' ' ' ASN . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 136' ' ' ALA . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.677 ' CD2' HG22 ' A' ' 144' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 ' CD2' ' A' ' 142' ' ' TYR . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 157' ' ' VAL . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 158' ' ' ILE . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 157' ' ' VAL . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.629 HD12 HD11 ' A' ' 167' ' ' ILE . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 161' ' ' LEU . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.405 ' NE2' HG22 ' A' ' 212' ' ' ILE . 9.3 t-160 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.421 ' HE3' ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 218' ' ' ARG . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' HD1' HD13 ' A' ' 211' ' ' LEU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.559 HG12 HG22 ' A' ' 208' ' ' ILE . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 181' ' ' ASN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.496 ' N ' HG13 ' A' ' 180' ' ' VAL . 27.8 m120 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.851 ' HE2' HG23 ' A' ' 228' ' ' THR . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.638 ' HB3' HD23 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 211' ' ' LEU . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.905 ' HB ' HD23 ' A' ' 211' ' ' LEU . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.558 HG12 ' HG ' ' A' ' 211' ' ' LEU . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 196' ' ' VAL . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.559 ' OG ' HG22 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.727 ' O ' HD12 ' A' ' 178' ' ' LEU . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 177' ' ' ILE . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.559 HG22 ' OG ' ' A' ' 199' ' ' SER . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.79 ' C ' HD12 ' A' ' 211' ' ' LEU . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.905 HD23 ' HB ' ' A' ' 194' ' ' ILE . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.401 ' CB ' ' HD2' ' A' ' 214' ' ' PRO . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 213' ' ' ASP . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 194' ' ' ILE . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HA ' HD21 ' A' ' 186' ' ' LEU . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 231' ' ' LYS . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.851 HG23 ' HE2' ' A' ' 185' ' ' LYS . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 226' ' ' LYS . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.1 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 16' ' ' ALA . 25.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 60' ' ' VAL . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 31' ' ' CYS . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.783 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.92 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.622 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.949 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.62 ' HB3' HG23 ' A' ' 50' ' ' VAL . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG21 HE22 ' A' ' 103' ' ' GLN . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.822 0.344 . . . . 0.0 111.142 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD21 ' HD2' ' A' ' 85' ' ' LYS . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 35' ' ' LYS . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 30' ' ' ALA . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 71' ' ' LEU . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.648 HG23 ' N ' ' A' ' 66' ' ' ALA . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 58' ' ' VAL . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 83' ' ' ILE . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.836 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.422 HG22 ' HG ' ' A' ' 47' ' ' LEU . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 80' ' ' GLN . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HD2' HD21 ' A' ' 47' ' ' LEU . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.783 HG23 ' HB2' ' A' ' 20' ' ' MET . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.612 HD11 ' SG ' ' A' ' 31' ' ' CYS . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 98' ' ' LYS . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.577 HE22 HG21 ' A' ' 37' ' ' VAL . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.687 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 137' ' ' MET . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 111' ' ' ILE . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 127' ' ' PRO . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 126' ' ' ARG . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . 0.603 ' C ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.738 ' N ' HG12 ' A' ' 120' ' ' VAL . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 133' ' ' ILE . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 130' ' ' VAL . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HE2' HG22 ' A' ' 144' ' ' VAL . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.678 HG22 ' HE2' ' A' ' 142' ' ' TYR . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 158' ' ' ILE . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 158' ' ' ILE . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG13 ' A' ' 157' ' ' VAL . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.563 HD23 ' NZ ' ' A' ' 164' ' ' LYS . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.563 ' NZ ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.479 ' CD1' HD13 ' A' ' 158' ' ' ILE . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.647 0.26 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.432 ' HG2' HD12 ' A' ' 212' ' ' ILE . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.412 HG23 HG22 ' A' ' 208' ' ' ILE . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.846 ' CD2' HD22 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 205' ' ' GLN . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.846 HD22 ' CD2' ' A' ' 178' ' ' LEU . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.826 HD23 HD11 ' A' ' 194' ' ' ILE . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.826 HD11 HD23 ' A' ' 193' ' ' LEU . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 197' ' ' ILE . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 196' ' ' VAL . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.444 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.714 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 177' ' ' ILE . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' HG2' ' A' ' 173' ' ' ARG . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HB2' ' CB ' ' A' ' 118' ' ' LYS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.628 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 193' ' ' LEU . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 224' ' ' ILE . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' OE2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 29' ' ' ILE . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG2' HG23 ' A' ' 87' ' ' ILE . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' OE2' HG11 ' A' ' 17' ' ' VAL . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.76 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.69 ' SG ' HD11 ' A' ' 88' ' ' LEU . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.826 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 33' ' ' LYS . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.562 HD21 ' HE2' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 30' ' ' ALA . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 51' ' ' LEU . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.082 HG21 HD21 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG21 ' HG2' ' A' ' 28' ' ' GLU . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 66' ' ' ALA . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.098 HD22 HD13 ' A' ' 83' ' ' ILE . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.77 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.098 HD13 HD22 ' A' ' 71' ' ' LEU . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.814 ' HB3' HD21 ' A' ' 51' ' ' LEU . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HE2' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 83' ' ' ILE . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 93' ' ' VAL . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 93' ' ' VAL . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 95' ' ' VAL . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 111' ' ' ILE . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB2' HG13 ' A' ' 115' ' ' VAL . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.671 HG21 ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HB3' ' HG ' ' A' ' 216' ' ' CYS . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.505 ' CG2' HG22 ' A' ' 131' ' ' ILE . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.505 HG22 ' CG2' ' A' ' 129' ' ' THR . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 116' ' ' ALA . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.434 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 137' ' ' MET . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.7 mm-40 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.788 HG22 HD12 ' A' ' 167' ' ' ILE . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 158' ' ' ILE . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 157' ' ' VAL . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.788 HD12 HG22 ' A' ' 158' ' ' ILE . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.718 0.294 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.428 HD12 ' CG ' ' A' ' 213' ' ' ASP . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 190' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 234' ' ' LEU . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.818 HD11 HG12 ' A' ' 209' ' ' VAL . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 205' ' ' GLN . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 190' ' ' LEU . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.583 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.838 HD22 ' CD2' ' A' ' 211' ' ' LEU . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 221' ' ' ASP . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 193' ' ' LEU . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.561 ' CG1' HG21 ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.417 ' HB2' HG23 ' A' ' 209' ' ' VAL . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 205' ' ' GLN . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.585 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 208' ' ' ILE . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.818 HG12 HD11 ' A' ' 178' ' ' LEU . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.509 ' C ' HD12 ' A' ' 211' ' ' LEU . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.838 ' CD2' HD22 ' A' ' 190' ' ' LEU . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 213' ' ' ASP . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 218' ' ' ARG . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 193' ' ' LEU . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.731 ' N ' HD12 ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.583 HG21 ' HD2' ' A' ' 189' ' ' LYS . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 177' ' ' ILE . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.545 HG22 ' NE2' ' A' ' 52' ' ' GLN . 23.1 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 31' ' ' CYS . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.863 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' HE ' ' A' ' 22' ' ' ARG . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.702 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' HG23 ' A' ' 50' ' ' VAL . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 33' ' ' LYS . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 54' ' ' HIS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.545 ' NE2' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 66' ' ' ALA . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 83' ' ' ILE . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.444 HD11 ' OD1' ' A' ' 78' ' ' ASP . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 72' ' ' ILE . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.999 HD13 HD22 ' A' ' 71' ' ' LEU . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 29' ' ' ILE . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HG2' HD21 ' A' ' 47' ' ' LEU . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CD2' HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.727 ' HA ' HD12 ' A' ' 114' ' ' ILE . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.921 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 111' ' ' ILE . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 133' ' ' ILE . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 215' ' ' GLY . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.921 HG21 ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.646 ' HE1' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.491 ' CG ' ' HE3' ' A' ' 137' ' ' MET . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 108' ' ' PHE . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 153' ' ' GLN . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.821 ' HA ' HD13 ' A' ' 167' ' ' ILE . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 157' ' ' VAL . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.821 HD13 ' HA ' ' A' ' 158' ' ' ILE . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.737 0.304 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.557 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.748 ' CG2' HD12 ' A' ' 206' ' ' LEU . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.883 HD22 ' HB2' ' A' ' 186' ' ' LEU . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 178' ' ' LEU . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.581 ' HB3' HD23 ' A' ' 178' ' ' LEU . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.883 ' HB2' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.841 ' CG ' HG21 ' A' ' 209' ' ' VAL . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.879 ' HD3' HD11 ' A' ' 224' ' ' ILE . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 211' ' ' LEU . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 ' OD1' ' A' ' 221' ' ' ASP . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 211' ' ' LEU . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.416 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 211' ' ' LEU . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 187' ' ' LYS . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.776 HD22 HD12 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 120' ' ' VAL . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.879 HD11 ' HD3' ' A' ' 189' ' ' LYS . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.748 ' HE3' HD11 ' A' ' 211' ' ' LEU . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' HD12 ' A' ' 178' ' ' LEU . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.852 0.358 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 60' ' ' VAL . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG22 HG23 ' A' ' 93' ' ' VAL . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.905 ' HB2' HG23 ' A' ' 87' ' ' ILE . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.843 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' CB ' HG23 ' A' ' 50' ' ' VAL . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 32' ' ' TYR . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 33' ' ' LYS . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CH2' ' HE2' ' A' ' 85' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.683 HD21 ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.868 HG22 ' HB3' ' A' ' 30' ' ' ALA . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 66' ' ' ALA . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 HG13 ' A' ' 17' ' ' VAL . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.953 HD22 HD13 ' A' ' 83' ' ' ILE . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.745 ' CE2' HG23 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 83' ' ' ILE . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.953 HD13 HD22 ' A' ' 71' ' ' LEU . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 29' ' ' ILE . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.683 ' HE2' HD21 ' A' ' 47' ' ' LEU . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 20' ' ' MET . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 84' ' ' CYS . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.641 ' C ' HG13 ' A' ' 18' ' ' VAL . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 HG22 ' A' ' 18' ' ' VAL . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 113' ' ' THR . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' OD1' HD11 ' A' ' 114' ' ' ILE . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.839 ' O ' HG23 ' A' ' 115' ' ' VAL . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 109' ' ' ARG . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.64 HD11 ' OD1' ' A' ' 110' ' ' ASP . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 216' ' ' CYS . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.526 ' CD1' HD13 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 131' ' ' ILE . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.448 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG22 ' CG2' ' A' ' 129' ' ' THR . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 157' ' ' VAL . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 153' ' ' GLN . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.664 ' HA ' HD12 ' A' ' 167' ' ' ILE . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 167' ' ' ILE . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 158' ' ' ILE . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 167' ' ' ILE . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.743 ' HG3' HG23 ' A' ' 212' ' ' ILE . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 237' ' ' LEU . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.791 ' C ' HD13 ' A' ' 178' ' ' LEU . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 182' ' ' GLU . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 205' ' ' GLN . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 211' ' ' LEU . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 194' ' ' ILE . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 191' ' ' LYS . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.716 ' C ' HG12 ' A' ' 180' ' ' VAL . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 205' ' ' GLN . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 190' ' ' LEU . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.743 HG23 ' HG3' ' A' ' 173' ' ' ARG . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.496 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HG3' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 52' ' ' GLN . 22.1 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 60' ' ' VAL . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG22 HG23 ' A' ' 93' ' ' VAL . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.885 ' HB2' HG23 ' A' ' 87' ' ' ILE . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.567 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.675 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.718 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.693 ' HB2' HG23 ' A' ' 50' ' ' VAL . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' ASN . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.645 ' HA ' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 0.0 111.086 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 35' ' ' LYS . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HG2' HG21 ' A' ' 15' ' ' VAL . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.607 HG21 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.567 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.082 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.553 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.553 ' OD1' HD11 ' A' ' 72' ' ' ILE . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.87 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.082 HD13 HD22 ' A' ' 71' ' ' LEU . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.71 ' O ' HD13 ' A' ' 88' ' ' LEU . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB2' ' A' ' 20' ' ' MET . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 40' ' ' ARG . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.599 HG23 HG22 ' A' ' 18' ' ' VAL . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' O ' HG22 ' A' ' 102' ' ' THR . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 98' ' ' LYS . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 102' ' ' THR . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.779 ' HB3' HG21 ' A' ' 150' ' ' THR . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.817 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 111' ' ' ILE . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 128' ' ' TYR . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.454 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' CYS . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 140' ' ' ILE . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.77 HG13 ' HG2' ' A' ' 153' ' ' GLN . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.421 ' HA ' HG23 ' A' ' 37' ' ' VAL . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.779 HG21 ' HB3' ' A' ' 110' ' ' ASP . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.903 ' O ' HG23 ' A' ' 157' ' ' VAL . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.461 HG22 HG21 ' A' ' 167' ' ' ILE . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 168' ' ' GLU . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 211' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.618 HD12 ' CA ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.54 ' N ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.618 ' CA ' HD12 ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 187' ' ' LYS . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.726 ' N ' HD12 ' A' ' 186' ' ' LEU . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.711 ' HD3' HG21 ' A' ' 228' ' ' THR . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 186' ' ' LEU . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.56 HD13 ' OD1' ' A' ' 221' ' ' ASP . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 194' ' ' ILE . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.675 ' C ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 195' ' ' LYS . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.404 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 193' ' ' LEU . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' OD1' HD13 ' A' ' 194' ' ' ILE . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.702 HG21 HD22 ' A' ' 193' ' ' LEU . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.711 HG21 ' HD3' ' A' ' 189' ' ' LYS . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' LEU . . . . . 0.527 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 52' ' ' GLN . 61.0 t . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.557 ' HB ' HD12 ' A' ' 29' ' ' ILE . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.877 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 17' ' ' VAL . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.893 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.608 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 38' ' ' GLY . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.775 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.842 0.353 . . . . 0.0 111.422 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.659 HD11 ' SG ' ' A' ' 84' ' ' CYS . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 15' ' ' VAL . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.041 HG21 HD21 ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 60' ' ' VAL . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 66' ' ' ALA . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 72' ' ' ILE . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.118 HD22 HD13 ' A' ' 83' ' ' ILE . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 68' ' ' LYS . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.118 HD13 HD22 ' A' ' 71' ' ' LEU . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.893 ' SG ' HG21 ' A' ' 29' ' ' ILE . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HE3' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 20' ' ' MET . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.582 HD11 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.566 ' CE ' HG22 ' A' ' 150' ' ' THR . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.636 ' HD1' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 107' ' ' MET . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.591 HG23 ' HD2' ' A' ' 118' ' ' LYS . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 133' ' ' ILE . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 114' ' ' ILE . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 116' ' ' ALA . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.418 ' SD ' HG13 ' A' ' 157' ' ' VAL . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 140' ' ' ILE . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.636 HG21 ' HD1' ' A' ' 108' ' ' PHE . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.566 HG22 ' CE ' ' A' ' 107' ' ' MET . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.871 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 154' ' ' ALA . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 158' ' ' ILE . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 140' ' ' ILE . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.601 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 168' ' ' GLU . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 167' ' ' ILE . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.0 ttp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD22 HD13 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 177' ' ' ILE . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 182' ' ' GLU . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 205' ' ' GLN . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.62 HD13 HD21 ' A' ' 211' ' ' LEU . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 194' ' ' ILE . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.942 HG23 HD23 ' A' ' 193' ' ' LEU . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.538 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.721 ' HA ' HG22 ' A' ' 180' ' ' VAL . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.642 HD13 HD22 ' A' ' 174' ' ' LEU . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 197' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.583 HG22 HD21 ' A' ' 193' ' ' LEU . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.487 ' OD1' HD22 ' A' ' 211' ' ' LEU . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.472 ' HZ1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 224' ' ' ILE . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 234' ' ' LEU . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.571 0.224 . . . . 0.0 110.51 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG21 ' A' ' 60' ' ' VAL . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 93' ' ' VAL . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.944 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HG ' ' A' ' 88' ' ' LEU . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 147' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.481 ' CD1' ' C ' ' A' ' 39' ' ' TRP . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.943 HD12 HD12 ' A' ' 51' ' ' LEU . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 51' ' ' LEU . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . 1.001 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 71' ' ' LEU . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.613 HG21 HG13 ' A' ' 17' ' ' VAL . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 83' ' ' ILE . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.715 ' CE2' HG23 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 71' ' ' LEU . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 29' ' ' ILE . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.686 ' CE ' HD21 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 18' ' ' VAL . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CB ' HG21 ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 130' ' ' VAL . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' ILE . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HD3' ' ND1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.752 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 216' ' ' CYS . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.708 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 132' ' ' LEU . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.661 HG13 ' HB1' ' A' ' 112' ' ' ALA . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.708 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 140' ' ' ILE . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 157' ' ' VAL . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 111' ' ' ILE . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 37' ' ' VAL . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.414 HG21 ' CB ' ' A' ' 110' ' ' ASP . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 153' ' ' GLN . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 167' ' ' ILE . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 140' ' ' ILE . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 158' ' ' ILE . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.404 ' ND1' ' HD3' ' A' ' 118' ' ' LYS . 8.1 t60 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 225' ' ' LYS . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 236' ' ' VAL . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 178' ' ' LEU . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.574 HG13 ' C ' ' A' ' 204' ' ' GLN . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.581 ' O ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 178' ' ' LEU . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 190' ' ' LEU . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 178' ' ' LEU . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 228' ' ' THR . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 186' ' ' LEU . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.715 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' SER . . . . . 0.598 ' CB ' HG22 ' A' ' 209' ' ' VAL . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.574 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 199' ' ' SER . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.523 ' H ' HG22 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.723 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.706 HG21 ' HG3' ' A' ' 189' ' ' LYS . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 234' ' ' LEU . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 233' ' ' SER . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 16' ' ' ALA . 22.2 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.924 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.622 HG12 ' HG2' ' A' ' 28' ' ' GLU . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 93' ' ' VAL . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.797 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.924 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 33' ' ' LYS . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.733 ' CH2' HD23 ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.2 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.393 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG21 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.688 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.019 HD21 HG21 ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.625 HD11 ' OD1' ' A' ' 78' ' ' ASP . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' HD11 ' A' ' 72' ' ' ILE . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 71' ' ' LEU . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.686 ' O ' HD13 ' A' ' 88' ' ' LEU . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' MET . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 18' ' ' VAL . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' O ' HD13 ' A' ' 104' ' ' LEU . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 100' ' ' ARG . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 113' ' ' THR . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.593 ' O ' HG12 ' A' ' 115' ' ' VAL . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 133' ' ' ILE . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 110' ' ' ASP . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.645 HG13 HG21 ' A' ' 133' ' ' ILE . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 115' ' ' VAL . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 167' ' ' ILE . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 127' ' ' PRO . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.801 ' HA ' HG12 ' A' ' 120' ' ' VAL . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.511 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 133' ' ' ILE . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 132' ' ' LEU . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 129' ' ' THR . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.697 HG21 ' HB3' ' A' ' 103' ' ' GLN . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 153' ' ' GLN . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 167' ' ' ILE . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.683 HD11 ' CE ' ' A' ' 137' ' ' MET . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.653 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.477 ' HG2' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.563 0.22 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.681 HD21 ' OE1' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.687 HD21 ' HG2' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HG3' HG21 ' A' ' 228' ' ' THR . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.646 ' CD1' HD23 ' A' ' 186' ' ' LEU . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 224' ' ' ILE . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.807 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.73 HG21 ' CD1' ' A' ' 212' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.695 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.681 ' OE1' HD21 ' A' ' 178' ' ' LEU . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 197' ' ' ILE . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.807 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 197' ' ' ILE . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 120' ' ' VAL . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' CG ' HD11 ' A' ' 194' ' ' ILE . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 193' ' ' LEU . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.687 ' HG2' HD21 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.594 HG21 ' HG3' ' A' ' 189' ' ' LYS . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.409 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 230' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 182' ' ' GLU . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.416 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 52' ' ' GLN . 48.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.791 0.329 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.678 HG22 ' HA ' ' A' ' 93' ' ' VAL . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.709 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.639 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.723 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' SG ' ' A' ' 31' ' ' CYS . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 38' ' ' GLY . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.819 ' CE3' HG11 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 81' ' ' THR . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CE3' ' A' ' 39' ' ' TRP . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.684 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.698 ' HG2' HG21 ' A' ' 15' ' ' VAL . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.598 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.666 ' CB ' HD21 ' A' ' 71' ' ' LEU . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.493 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 83' ' ' ILE . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.77 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 71' ' ' LEU . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.709 ' SG ' HG21 ' A' ' 29' ' ' ILE . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD1' HD11 ' A' ' 29' ' ' ILE . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 18' ' ' VAL . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 93' ' ' VAL . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' MET . . . . . 0.693 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HD1' HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.91 HG23 ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' ILE . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.91 ' HD2' HG23 ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.682 ' O ' HD12 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 129' ' ' THR . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.474 ' SD ' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 107' ' ' MET . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.427 HG22 ' SD ' ' A' ' 107' ' ' MET . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 167' ' ' ILE . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 157' ' ' VAL . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.855 ' HB ' HG23 ' A' ' 158' ' ' ILE . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.876 0.37 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.584 HD13 ' H ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.584 ' H ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.693 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.822 ' HA ' HD23 ' A' ' 206' ' ' LEU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.582 HG22 ' C ' ' A' ' 205' ' ' GLN . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.693 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LYS . . . . . 0.475 ' HE2' HG23 ' A' ' 228' ' ' THR . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' ' 225' ' ' LYS . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 211' ' ' LEU . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.582 ' C ' HG22 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.758 HD22 HD11 ' A' ' 194' ' ' ILE . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 193' ' ' LEU . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.57 HD12 HD21 ' A' ' 186' ' ' LEU . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.852 ' HA ' HD11 ' A' ' 186' ' ' LEU . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.475 HG23 ' HE2' ' A' ' 185' ' ' LYS . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' CYS . 21.0 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.748 0.308 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 28' ' ' GLU . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.888 HG22 HG12 ' A' ' 93' ' ' VAL . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CB ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.823 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.82 ' SG ' HG21 ' A' ' 36' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ALA . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 93' ' ' VAL . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.749 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 111.287 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.862 ' HG ' HG22 ' A' ' 81' ' ' THR . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.749 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.821 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 1.026 HG21 HD21 ' A' ' 71' ' ' LEU . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 56' ' ' VAL . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.665 ' HA ' HD12 ' A' ' 83' ' ' ILE . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 71' ' ' LEU . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.823 ' SG ' HG21 ' A' ' 29' ' ' ILE . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' HG11 ' A' ' 18' ' ' VAL . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 18' ' ' VAL . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.591 HG12 ' HD3' ' A' ' 33' ' ' LYS . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.627 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 114' ' ' ILE . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 111' ' ' ILE . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.406 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.62 HG11 ' H ' ' A' ' 216' ' ' CYS . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 132' ' ' LEU . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.424 HG12 ' HG3' ' A' ' 134' ' ' GLU . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 132' ' ' LEU . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.857 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HG3' HG12 ' A' ' 130' ' ' VAL . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 137' ' ' MET . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 146' ' ' THR . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HD2' HG23 ' A' ' 150' ' ' THR . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.764 ' HA ' HD11 ' A' ' 167' ' ' ILE . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 157' ' ' VAL . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.764 HD11 ' HA ' ' A' ' 158' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.648 0.261 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.625 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 236' ' ' VAL . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 186' ' ' LEU . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 206' ' ' LEU . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.686 ' HB3' HD23 ' A' ' 178' ' ' LEU . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 197' ' ' ILE . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 198' ' ' GLU . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.642 ' HB2' HD12 ' A' ' 197' ' ' ILE . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.515 ' HD2' HE21 ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.48 ' C ' HG13 ' A' ' 180' ' ' VAL . 4.7 mm-40 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' HD12 ' A' ' 178' ' ' LEU . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 212' ' ' ILE . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.62 ' H ' HG11 ' A' ' 120' ' ' VAL . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 217' ' ' PHE . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.566 ' OD1' HD21 ' A' ' 190' ' ' LEU . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 193' ' ' LEU . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.58 ' N ' HD12 ' A' ' 224' ' ' ILE . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LYS . . . . . 0.482 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 177' ' ' ILE . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.764 0.316 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 88' ' ' LEU . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE1' ' HG3' ' A' ' 86' ' ' GLN . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 60' ' ' VAL . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.951 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 38' ' ' GLY . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' CZ2' ' HG2' ' A' ' 85' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.823 0.344 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD21 ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 35' ' ' LYS . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 30' ' ' ALA . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.747 ' HA ' HD13 ' A' ' 51' ' ' LEU . 48.5 m80 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.013 HD22 HD13 ' A' ' 83' ' ' ILE . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 ' OD1' ' A' ' 78' ' ' ASP . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CE2' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.505 ' CB ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 1.013 HD13 HD22 ' A' ' 71' ' ' LEU . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.947 ' CB ' HD11 ' A' ' 51' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HD2' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HG3' ' HE1' ' A' ' 20' ' ' MET . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 83' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' ARG . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.741 ' HA ' HG22 ' A' ' 18' ' ' VAL . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 144' ' ' VAL . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 118' ' ' LYS . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.883 HG13 HG21 ' A' ' 167' ' ' ILE . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.782 ' HD3' HG23 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 216' ' ' CYS . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.419 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 131' ' ' ILE . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.462 ' H ' HG22 ' A' ' 129' ' ' THR . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 157' ' ' VAL . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 108' ' ' PHE . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 167' ' ' ILE . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' VAL . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.883 HG21 HG13 ' A' ' 115' ' ' VAL . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.852 0.358 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 211' ' ' LEU . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.945 HD12 HG22 ' A' ' 208' ' ' ILE . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 207' ' ' GLU . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 182' ' ' GLU . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 205' ' ' GLN . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 179' ' ' PRO . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 229' ' ' LYS . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 194' ' ' ILE . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.799 HD13 ' HB3' ' A' ' 211' ' ' LEU . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 1.093 HG12 HD22 ' A' ' 211' ' ' LEU . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' GLU . . . . . 0.432 ' HG3' HD11 ' A' ' 208' ' ' ILE . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.459 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.735 ' HA ' HG22 ' A' ' 180' ' ' VAL . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 178' ' ' LEU . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.945 HG22 HD12 ' A' ' 177' ' ' ILE . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.411 ' O ' HD23 ' A' ' 211' ' ' LEU . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 1.093 HD22 HG12 ' A' ' 196' ' ' VAL . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.799 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 223' ' ' LEU . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.658 ' HG3' HD21 ' A' ' 186' ' ' LEU . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HG22 ' A' ' 87' ' ' ILE . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.59 ' HB3' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.773 HG22 ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.856 ' SG ' HG22 ' A' ' 50' ' ' VAL . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.774 ' CB ' HG23 ' A' ' 50' ' ' VAL . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 147' ' ' ASN . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.392 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.856 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.843 ' CB ' ' HB3' ' A' ' 30' ' ' ALA . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.879 ' HA ' HD13 ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' A' ' 29' ' ' ILE . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD22 HD13 ' A' ' 83' ' ' ILE . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.667 HD11 ' OD1' ' A' ' 78' ' ' ASP . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.667 ' OD1' HD11 ' A' ' 72' ' ' ILE . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.459 HG22 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 87' ' ' ILE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 29' ' ' ILE . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.674 ' CE ' HD21 ' A' ' 47' ' ' LEU . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.792 HD11 HG22 ' A' ' 83' ' ' ILE . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' OE2' ' A' ' 99' ' ' GLU . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.554 ' OE2' HG11 ' A' ' 95' ' ' VAL . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 144' ' ' VAL . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 130' ' ' VAL . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 111' ' ' ILE . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 169' ' ' ARG . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.471 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 128' ' ' TYR . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.413 ' HE3' HG21 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 142' ' ' TYR . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 140' ' ' ILE . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 111' ' ' ILE . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.683 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 153' ' ' GLN . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 157' ' ' VAL . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 167' ' ' ILE . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.932 0.396 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.816 ' HG2' HD12 ' A' ' 212' ' ' ILE . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.843 HD12 ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.802 ' HA ' HD23 ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 205' ' ' GLN . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.843 ' HA2' HD12 ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 211' ' ' LEU . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 211' ' ' LEU . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 212' ' ' ILE . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' GLU . . . . . 0.411 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.626 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 197' ' ' ILE . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 190' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.816 HD12 ' HG2' ' A' ' 173' ' ' ARG . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' CYS . . . . . 0.421 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HA ' HD12 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' PHE . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.493 ' OD2' HD13 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLU . . . . . 0.415 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' LYS . . . . . 0.635 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 186' ' ' LEU . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.407 ' HB2' ' CB ' ' A' ' 233' ' ' SER . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 229' ' ' LYS . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 12.3 m-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 15' ' ' VAL . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 60' ' ' VAL . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 88' ' ' LEU . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.853 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' OE2' HG23 ' A' ' 60' ' ' VAL . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.87 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.902 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.791 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HB2' HG11 ' A' ' 95' ' ' VAL . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.596 ' O ' HG12 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.78 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 147' ' ' ASN . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.813 0.34 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.611 HD21 ' CE ' ' A' ' 85' ' ' LYS . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.902 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.702 HD11 ' CB ' ' A' ' 84' ' ' CYS . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.949 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.63 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.612 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.995 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.751 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.751 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.995 HD13 HD22 ' A' ' 71' ' ' LEU . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.87 ' SG ' HG21 ' A' ' 29' ' ' ILE . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.611 ' CE ' HD21 ' A' ' 47' ' ' LEU . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.853 HG23 ' HB2' ' A' ' 20' ' ' MET . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 18' ' ' VAL . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG21 HG11 ' A' ' 36' ' ' VAL . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 33' ' ' LYS . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' O ' HG22 ' A' ' 102' ' ' THR . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 144' ' ' VAL . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB1' HG12 ' A' ' 130' ' ' VAL . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 114' ' ' ILE . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 113' ' ' THR . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 111' ' ' ILE . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' CYS . . . . . 0.792 ' SG ' HD13 ' A' ' 167' ' ' ILE . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.709 HG21 ' HE2' ' A' ' 125' ' ' LYS . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.9 t-20 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HE2' HG21 ' A' ' 120' ' ' VAL . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' THR . . . . . 0.58 ' OG1' HD23 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.747 HG12 ' HB1' ' A' ' 112' ' ' ALA . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 129' ' ' THR . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 161' ' ' LEU . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.445 ' CE ' HG22 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 136' ' ' ALA . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 108' ' ' PHE . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASN . . . . . 0.769 ' HA ' HG23 ' A' ' 37' ' ' VAL . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLN . . . . . 0.913 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 153' ' ' GLN . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 167' ' ' ILE . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 157' ' ' VAL . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ILE . . . . . 0.792 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' HG23 ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 186' ' ' LEU . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 205' ' ' GLN . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.853 HD11 ' HB3' ' A' ' 178' ' ' LEU . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.699 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.454 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.559 HD11 HG22 ' A' ' 220' ' ' ILE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . 0.812 HG13 HD22 ' A' ' 211' ' ' LEU . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 209' ' ' VAL . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 196' ' ' VAL . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 178' ' ' LEU . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 196' ' ' VAL . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LEU . . . . . 0.812 HD22 HG13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 173' ' ' ARG . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 224' ' ' ILE . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 193' ' ' LEU . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 220' ' ' ILE . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 186' ' ' LEU . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.649 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -71.48 -171.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 2' ' ' SER . 1.3 mp 77.74 -54.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.471 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 12' ' ' LEU . 56.7 t80 64.34 102.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -131.26 119.87 17.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.24 52.73 4.4 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.459 2.106 . . . . 0.0 112.67 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 7' ' ' THR . 25.0 m -165.32 31.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.21 -61.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.987 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -76.59 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.068 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.23 150.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -91.01 -45.83 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 13' ' ' THR . 3.8 tt 59.91 92.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.452 ' O ' HD23 ' A' ' 12' ' ' LEU . 2.1 p -59.0 169.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.755 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.02 23.8 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 16' ' ' ALA . 70.4 t -59.05 159.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.839 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 60' ' ' VAL . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' C ' ' A' ' 92' ' ' GLU . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.887 ' HB2' HG23 ' A' ' 87' ' ' ILE . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 88' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' CB ' HG23 ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 38' ' ' GLY . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -59.94 -35.33 74.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -59.54 -26.38 65.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.95 28.84 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.646 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 t -104.74 125.42 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.761 0.315 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.67 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -106.24 156.59 18.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.63 136.44 34.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.763 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 71' ' ' LEU . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.745 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.112 HD22 HD13 ' A' ' 83' ' ' ILE . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 78' ' ' ASP . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 72' ' ' ILE . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.693 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.112 HD13 HD22 ' A' ' 71' ' ' LEU . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 51' ' ' LEU . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.887 HG23 ' HB2' ' A' ' 20' ' ' MET . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 31' ' ' CYS . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 103' ' ' GLN . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.451 ' HG2' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 111' ' ' ILE . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.73 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 215' ' ' GLY . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 115' ' ' VAL . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 136' ' ' ALA . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 157' ' ' VAL . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 107' ' ' MET . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 158' ' ' ILE . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 158' ' ' ILE . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 154' ' ' ALA . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 161' ' ' LEU . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 119' ' ' CYS . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -109.16 136.51 48.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -151.7 136.87 17.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.35 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -110.62 175.25 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.563 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 212' ' ' ILE . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 208' ' ' ILE . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.786 HD23 HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.926 HD13 HD21 ' A' ' 211' ' ' LEU . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HA ' HG21 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 191' ' ' LYS . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.612 HD11 HD11 ' A' ' 212' ' ' ILE . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.51 ' HB2' HD12 ' A' ' 197' ' ' ILE . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.421 ' HB3' HG13 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.631 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.559 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.42 ' HG2' ' CB ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 177' ' ' ILE . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.565 HG11 ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.469 ' C ' HD22 ' A' ' 211' ' ' LEU . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.948 ' HB3' HD11 ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 173' ' ' ARG . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 174' ' ' LEU . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.526 ' O ' HG11 ' A' ' 120' ' ' VAL . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.72 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.84 -69.16 0.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.59 159.59 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -133.46 137.72 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -60.96 103.16 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.98 139.13 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.73 84.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.74 -57.8 1.79 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.78 -42.5 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.7 138.8 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -103.86 -46.31 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -153.24 37.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.895 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.368 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -123.94 -45.97 1.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 mt 63.27 105.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.89 144.62 26.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 80.29 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 91.66 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -163.4 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.58 45.2 1.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -161.06 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.724 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.33 131.02 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -105.24 -66.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.503 ' O ' HD23 ' A' ' 12' ' ' LEU . 8.4 tt -166.55 92.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.3 p -146.56 116.72 7.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -176.78 -52.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -112.31 151.53 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 28' ' ' GLU . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' SG ' ' A' ' 31' ' ' CYS . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.843 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 33' ' ' LYS . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -41.62 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -59.38 -23.45 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.19 -21.19 3.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -55.9 148.3 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -78.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.22 146.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.94 143.27 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.66 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.736 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG21 HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.612 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.976 HD22 HD13 ' A' ' 83' ' ' ILE . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.577 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 HD22 ' A' ' 71' ' ' LEU . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.736 ' SG ' HD11 ' A' ' 51' ' ' LEU . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HG2' HD21 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 29' ' ' ILE . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 18' ' ' VAL . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 33' ' ' LYS . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 98' ' ' LYS . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.869 ' HA ' HD12 ' A' ' 114' ' ' ILE . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.572 HG22 ' OD2' ' A' ' 117' ' ' ASP . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.896 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' HG22 ' A' ' 113' ' ' THR . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 170' ' ' ALA . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.768 ' HA ' HD12 ' A' ' 133' ' ' ILE . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 116' ' ' ALA . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB1' ' CE ' ' A' ' 164' ' ' LYS . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.548 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 145' ' ' LYS . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 144' ' ' VAL . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 161' ' ' LEU . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.638 ' HA ' HD11 ' A' ' 167' ' ' ILE . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 158' ' ' ILE . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.66 HD22 ' HZ1' ' A' ' 164' ' ' LYS . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.66 ' HZ1' HD22 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 158' ' ' ILE . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -69.52 149.99 47.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -105.13 138.14 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 111.587 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 3.2 m-70 -109.57 146.69 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.404 ' CG ' ' HA ' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.681 ' C ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.681 HD22 ' C ' ' A' ' 173' ' ' ARG . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 206' ' ' LEU . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' HD2' ' A' ' 229' ' ' LYS . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 205' ' ' GLN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.489 ' N ' HG13 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 190' ' ' LEU . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 196' ' ' VAL . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 224' ' ' ILE . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.658 ' CD1' HD23 ' A' ' 211' ' ' LEU . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 209' ' ' VAL . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HB2' HG12 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.507 HD12 HD11 ' A' ' 177' ' ' ILE . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 206' ' ' LEU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.815 HG23 HG13 ' A' ' 196' ' ' VAL . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.658 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.461 HD12 HH11 ' A' ' 173' ' ' ARG . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HB3' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 220' ' ' ILE . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.41 ' OG1' HD13 ' A' ' 186' ' ' LEU . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HD2' HD23 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.687 ' O ' HD12 ' A' ' 234' ' ' LEU . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 233' ' ' SER . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -88.89 -68.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.54 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 172' ' ' MET . 4.0 ptpp? -145.4 138.07 26.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.63 105.61 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.6 m -122.11 -42.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.017 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -71.23 172.67 8.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.045 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.43 -67.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.95 55.68 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.53 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -63.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 249' ' ' PHE . 0.8 OUTLIER -174.26 -168.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 50.53 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 247' ' ' GLU . 3.3 p90 -97.37 28.83 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.003 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.738 0.304 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -129.08 -61.28 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 mt -135.92 -50.79 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.42 127.22 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -72.93 -61.98 1.42 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.871 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 37.9 Cg_endo -67.97 -55.61 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.239 1.96 . . . . 0.0 112.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m 54.24 24.28 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 t30 179.46 51.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -169.29 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pt -99.5 173.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.74 82.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.555 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.0 tt -60.62 100.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.6 p -65.48 179.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -79.32 60.79 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.023 0.44 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.77 151.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.989 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG21 ' A' ' 60' ' ' VAL . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 29' ' ' ILE . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.891 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.801 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.977 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.87 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HB3' HG23 ' A' ' 50' ' ' VAL . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 34' ' ' ASN . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -34.91 72.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -63.26 -27.38 69.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.45 -23.69 3.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.605 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.38 128.11 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.09 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -59.2 145.8 41.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -171.69 164.76 6.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.927 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -115.4 152.64 32.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 81' ' ' THR . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 35' ' ' LYS . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.977 HG22 ' HB3' ' A' ' 30' ' ' ALA . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.136 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 17' ' ' VAL . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.136 HD21 HG21 ' A' ' 56' ' ' VAL . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 83' ' ' ILE . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.919 HD13 HD22 ' A' ' 71' ' ' LEU . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.801 ' SG ' HG21 ' A' ' 29' ' ' ILE . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.891 HG23 ' HB2' ' A' ' 20' ' ' MET . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD1' HD13 ' A' ' 29' ' ' ILE . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 93' ' ' VAL . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.434 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 111' ' ' ILE . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 111' ' ' ILE . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 133' ' ' ILE . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 216' ' ' CYS . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' HG12 ' A' ' 120' ' ' VAL . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' HD12 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.545 HD12 ' OG1' ' A' ' 129' ' ' THR . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' A' ' 116' ' ' ALA . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 53.7 m80 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.475 HG13 ' OE1' ' A' ' 153' ' ' GLN . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.475 ' OE1' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.659 HG22 HD12 ' A' ' 161' ' ' LEU . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 154' ' ' ALA . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 157' ' ' VAL . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.671 HG21 HG13 ' A' ' 115' ' ' VAL . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 -108.17 109.27 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -128.6 136.86 51.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 16.8 m80 -115.82 164.68 14.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 238' ' ' ASN . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 234' ' ' LEU . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' HD12 ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.612 HD21 HG22 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 211' ' ' LEU . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 197' ' ' ILE . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.436 ' N ' HG12 ' A' ' 196' ' ' VAL . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.755 ' HA ' HG22 ' A' ' 180' ' ' VAL . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 206' ' ' LEU . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 194' ' ' ILE . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.43 ' O ' HG23 ' A' ' 212' ' ' ILE . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 120' ' ' VAL . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.751 HD13 ' CD1' ' A' ' 217' ' ' PHE . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 220' ' ' ILE . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.452 ' HA ' HD21 ' A' ' 186' ' ' LEU . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.512 ' CG2' HD22 ' A' ' 186' ' ' LEU . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.603 ' HB3' HD12 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.48 ' O ' HD12 ' A' ' 239' ' ' LEU . 1.3 m-20 -85.98 -82.3 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 238' ' ' ASN . 1.5 mp -154.39 174.52 14.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.996 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 111.05 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.98 132.75 35.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 242' ' ' VAL . 31.1 t -127.53 52.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -63.51 -66.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.76 33.29 21.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.65 -135.03 12.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -123.05 114.13 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.05 -177.95 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.82 93.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -140.65 30.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.939 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.831 0.348 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 3' ' ' ILE . 48.9 m 59.9 95.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 2' ' ' SER . 8.2 pt -156.41 28.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.269 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 179.73 -62.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.51 63.93 2.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG3' HD11 ' A' ' 10' ' ' ILE . 52.8 Cg_exo -52.56 93.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.525 2.15 . . . . 0.0 112.376 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -61.89 -73.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.59 80.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.564 ' OE1' HG23 ' A' ' 10' ' ' ILE . 2.4 tm0? -177.09 -59.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.564 HG23 ' OE1' ' A' ' 9' ' ' GLN . 1.9 pp -85.88 168.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.171 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -135.23 28.77 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.43 169.79 16.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.436 HG23 ' OD1' ' A' ' 14' ' ' ASN . 11.4 t -165.61 -167.86 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.026 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 13' ' ' THR . 12.5 m-20 75.71 -59.61 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 52' ' ' GLN . 13.3 t -105.36 152.87 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 29' ' ' ILE . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG3' ' HE3' ' A' ' 20' ' ' MET . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.949 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.836 ' HB3' HG23 ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.467 ' HE3' ' HG3' ' A' ' 45' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -55.93 -30.7 62.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.8 p -83.16 -25.5 31.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.24 68.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.602 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p -158.88 88.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.02 119.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -179.06 -174.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 0.0 111.061 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -162.54 127.44 3.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.671 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.896 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.874 HG22 ' SG ' ' A' ' 31' ' ' CYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.62 HG21 ' CE1' ' A' ' 57' ' ' PHE . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 51' ' ' LEU . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' HA ' HG23 ' A' ' 29' ' ' ILE . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 53' ' ' THR . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG22 ' CE2' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.859 HD22 HD13 ' A' ' 83' ' ' ILE . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.816 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 71' ' ' LEU . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' HG21 ' A' ' 29' ' ' ILE . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.896 ' HE3' HD21 ' A' ' 47' ' ' LEU . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' NH1' ' A' ' 100' ' ' ARG . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.702 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.1 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG21 ' A' ' 150' ' ' THR . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 133' ' ' ILE . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG23 ' NZ ' ' A' ' 118' ' ' LYS . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 111' ' ' ILE . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' NZ ' HG23 ' A' ' 114' ' ' ILE . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 ' HB2' ' A' ' 216' ' ' CYS . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.648 HD13 ' CD1' ' A' ' 128' ' ' TYR . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 130' ' ' VAL . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 161' ' ' LEU . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.651 HG13 ' OE1' ' A' ' 153' ' ' GLN . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 103' ' ' GLN . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.645 HG21 ' OD2' ' A' ' 110' ' ' ASP . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 157' ' ' VAL . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.591 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.812 ' HA ' HG21 ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 1.018 HD21 ' HB1' ' A' ' 136' ' ' ALA . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -101.91 126.39 48.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -170.02 145.06 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 57.9 m-70 -99.2 176.87 5.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.554 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 217' ' ' PHE . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 172' ' ' MET . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.794 HD11 ' CD2' ' A' ' 186' ' ' LEU . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 205' ' ' GLN . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 180' ' ' VAL . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 228' ' ' THR . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.794 ' CD2' HD11 ' A' ' 178' ' ' LEU . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.532 HD21 ' OD1' ' A' ' 221' ' ' ASP . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 196' ' ' VAL . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 1.12 HD23 HG23 ' A' ' 194' ' ' ILE . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 1.12 HG23 HD23 ' A' ' 193' ' ' LEU . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 191' ' ' LYS . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 208' ' ' ILE . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.653 ' HA ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.736 HD11 ' OD2' ' A' ' 221' ' ' ASP . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 211' ' ' LEU . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 120' ' ' VAL . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.502 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.736 ' OD2' HD11 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 225' ' ' LYS . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.611 HG21 ' CD1' ' A' ' 193' ' ' LEU . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 185' ' ' LYS . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.412 ' CD ' HD22 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.93 -66.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 tp -106.02 117.34 33.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 128.52 43.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.97 111.36 23.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.87 -51.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.45 125.9 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -111.34 -61.83 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.44 73.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.91 -61.52 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -145.47 176.37 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 31.16 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 85.37 2.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.816 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -97.79 150.44 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -179.15 -35.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CD2' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -105.36 -52.44 2.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.934 0.397 . . . . 0.0 110.243 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.491 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 1.3 m -177.1 -62.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.277 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 67.9 Cg_endo -72.47 116.7 4.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.212 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -64.32 -66.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.98 104.96 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -176.59 -45.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.801 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.1 pt -110.36 -25.19 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.251 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.03 -59.97 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -162.94 151.35 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -149.05 -164.5 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.85 -59.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 52' ' ' GLN . 21.6 t -121.7 134.33 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.171 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' SG ' ' A' ' 31' ' ' CYS . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.005 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.752 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 33' ' ' LYS . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.59 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -39.51 76.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.695 ' OG ' HG13 ' A' ' 43' ' ' VAL . 11.2 p -64.35 -27.08 68.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.82 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.34 49.11 3.56 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 38' ' ' GLY . 34.0 m -97.9 29.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 111.255 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 56.44 72.18 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.04 162.47 14.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -121.68 148.89 44.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.013 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' HG21 ' A' ' 15' ' ' VAL . 24.4 tp60 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.005 HG22 ' HB3' ' A' ' 30' ' ' ALA . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.982 HG21 HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.485 ' HA ' HD13 ' A' ' 12' ' ' LEU . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.982 HD21 HG21 ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.704 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.981 HD13 HD22 ' A' ' 71' ' ' LEU . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HG2' HD21 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 36' ' ' VAL . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 93' ' ' VAL . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.52 ' HE1' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.609 ' HA ' HD12 ' A' ' 111' ' ' ILE . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 108' ' ' PHE . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.489 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 111' ' ' ILE . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 111' ' ' ILE . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 216' ' ' CYS . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 120' ' ' VAL . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.537 ' HD1' HD13 ' A' ' 132' ' ' LEU . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD13 ' HD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.49 HG22 ' HE2' ' A' ' 137' ' ' MET . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.49 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 111' ' ' ILE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.52 HG22 ' HE1' ' A' ' 107' ' ' MET . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.2 tp60 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 158' ' ' ILE . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 155' ' ' LEU . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.618 ' CG2' HG23 ' A' ' 158' ' ' ILE . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.38 127.3 52.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.608 ' HB1' ' OD1' ' A' ' 241' ' ' ASP . . . -169.38 136.79 1.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -99.66 -176.21 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.671 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.712 ' HE3' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 212' ' ' ILE . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD11 ' HE3' ' A' ' 172' ' ' MET . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 207' ' ' GLU . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 205' ' ' GLN . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.454 ' HZ2' ' HA ' ' A' ' 228' ' ' THR . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 229' ' ' LYS . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HG2' HD11 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 225' ' ' LYS . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.615 HG23 HD23 ' A' ' 193' ' ' LEU . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.627 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.676 ' HB3' HD11 ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 176' ' ' PHE . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 173' ' ' ARG . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.752 ' HB3' HG21 ' A' ' 120' ' ' VAL . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.664 ' HB2' ' HE2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.506 HD12 ' H ' ' A' ' 220' ' ' ILE . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.492 ' HG2' HD21 ' A' ' 190' ' ' LEU . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 185' ' ' LYS . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.77 -73.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -105.01 120.86 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASP . . . . . 0.608 ' OD1' ' HB1' ' A' ' 170' ' ' ALA . 70.5 m-20 -69.0 123.19 20.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 m -94.67 -23.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.01 40.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 101.3 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.97 -107.42 3.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -116.22 113.08 22.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -76.69 -174.88 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER -126.11 -55.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.702 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 250' ' ' GLU . 29.1 p90 -179.7 -43.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 249' ' ' PHE . 16.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.911 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -73.25 147.49 44.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.36 -41.63 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -110.83 -32.83 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m 64.1 121.41 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.66 91.08 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.395 2.063 . . . . 0.0 112.276 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.73 160.51 31.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -59.46 107.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -169.07 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.66 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -129.44 174.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.121 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 41.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.69 30.86 5.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -122.66 114.59 20.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -176.88 -40.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' NE2' ' A' ' 52' ' ' GLN . 22.0 t -122.57 156.85 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 87' ' ' ILE . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.869 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.88 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.884 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HG3' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 37' ' ' VAL . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 50' ' ' VAL . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 34' ' ' ASN . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -39.51 67.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.78 -18.54 40.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.142 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.87 67.59 1.98 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.645 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 44' ' ' GLU . 10.7 p -124.87 -44.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -177.82 125.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.416 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -174.42 -166.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.17 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -168.98 135.88 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.869 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.884 HG22 ' SG ' ' A' ' 31' ' ' CYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.82 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' NE2' HG22 ' A' ' 15' ' ' VAL . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.538 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 60' ' ' VAL . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 83' ' ' ILE . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.466 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 71' ' ' LEU . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.88 ' SG ' HG21 ' A' ' 29' ' ' ILE . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.869 ' HE3' HD21 ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 20' ' ' MET . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.75 HD21 ' SG ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 33' ' ' LYS . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.85 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 111' ' ' ILE . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 170' ' ' ALA . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.764 HG11 ' CD1' ' A' ' 111' ' ' ILE . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HD11 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 157' ' ' VAL . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 153' ' ' GLN . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.603 HD12 HG12 ' A' ' 157' ' ' VAL . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -66.64 150.07 49.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.725 ' HB1' ' CE ' ' A' ' 172' ' ' MET . . . -104.73 137.44 42.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 111.089 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 37.9 p-80 -109.82 141.04 43.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.161 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.725 ' CE ' ' HB1' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 238' ' ' ASN . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.623 ' CG ' HD23 ' A' ' 237' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.693 ' HD3' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.839 ' HB2' HD11 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 206' ' ' LEU . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.859 ' CD2' HD13 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' GLN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.44 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.859 HD13 ' CD2' ' A' ' 178' ' ' LEU . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.528 ' HG2' HD11 ' A' ' 224' ' ' ILE . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.991 HD23 HG23 ' A' ' 194' ' ' ILE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.991 HG23 HD23 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 191' ' ' LYS . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 212' ' ' ILE . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' A' ' 208' ' ' ILE . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 177' ' ' ILE . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.839 HD11 ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 197' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 193' ' ' LEU . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' A' ' 151' ' ' LYS . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.583 ' OD2' HD23 ' A' ' 211' ' ' LEU . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.767 HD13 HD13 ' A' ' 193' ' ' LEU . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 HD12 ' A' ' 186' ' ' LEU . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.623 HD23 ' CG ' ' A' ' 174' ' ' LEU . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 54.4 t30 -90.56 -67.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.11 126.48 18.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 110.71 18.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.26 101.57 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.77 179.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.67 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -30.16 71.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -111.57 72.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.555 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.21 113.24 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.345 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.05 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.87 -69.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -151.99 -50.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -113.95 -47.06 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' PHE . 8.5 tt -176.27 -43.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' ILE . 25.9 p90 -65.64 166.58 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 t -93.9 137.95 22.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.68 -25.2 15.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -113.58 102.7 10.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -49.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -46.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.53 175.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -109.3 -36.41 6.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 61' ' ' SER . 2.0 tt -177.13 97.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.66 161.27 32.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.89 -63.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.713 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -123.65 -179.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.689 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 15' ' ' VAL . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD12 ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.898 ' HB2' HG23 ' A' ' 87' ' ' ILE . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.682 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.827 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.843 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.82 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 103' ' ' GLN . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.757 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -45.33 76.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -26.93 65.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.02 -17.22 6.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.571 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.43 138.74 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 151.44 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -176.78 154.23 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.9 139.31 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.827 HG22 ' SG ' ' A' ' 31' ' ' CYS . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' HG23 ' A' ' 29' ' ' ILE . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.7 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 83' ' ' ILE . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.855 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 71' ' ' LEU . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.714 ' CB ' HD11 ' A' ' 51' ' ' LEU . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 20' ' ' MET . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 36' ' ' VAL . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.498 ' NE2' HG11 ' A' ' 37' ' ' VAL . 1.2 tt0 -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 113' ' ' THR . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 110' ' ' ASP . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.601 HD21 ' HE2' ' A' ' 128' ' ' TYR . 9.9 t-20 -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.601 ' HE2' HD21 ' A' ' 121' ' ' ASN . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 136' ' ' ALA . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.677 ' CD2' HG22 ' A' ' 144' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 ' CD2' ' A' ' 142' ' ' TYR . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 157' ' ' VAL . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 158' ' ' ILE . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 157' ' ' VAL . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.629 HD12 HD11 ' A' ' 167' ' ' ILE . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 161' ' ' LEU . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 142.26 36.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -143.69 136.89 27.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.405 ' NE2' HG22 ' A' ' 212' ' ' ILE . 9.3 t-160 -123.32 119.73 30.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 218' ' ' ARG . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' HD1' HD13 ' A' ' 211' ' ' LEU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.559 HG12 HG22 ' A' ' 208' ' ' ILE . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 181' ' ' ASN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.496 ' N ' HG13 ' A' ' 180' ' ' VAL . 27.8 m120 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.851 ' HE2' HG23 ' A' ' 228' ' ' THR . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.638 ' HB3' HD23 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 211' ' ' LEU . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.905 ' HB ' HD23 ' A' ' 211' ' ' LEU . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.558 HG12 ' HG ' ' A' ' 211' ' ' LEU . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 196' ' ' VAL . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.559 ' OG ' HG22 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.593 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.727 ' O ' HD12 ' A' ' 178' ' ' LEU . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 177' ' ' ILE . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.559 HG22 ' OG ' ' A' ' 199' ' ' SER . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.79 ' C ' HD12 ' A' ' 211' ' ' LEU . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.905 HD23 ' HB ' ' A' ' 194' ' ' ILE . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.401 ' CB ' ' HD2' ' A' ' 214' ' ' PRO . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 213' ' ' ASP . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 194' ' ' ILE . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HA ' HD21 ' A' ' 186' ' ' LEU . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 231' ' ' LYS . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.851 HG23 ' HE2' ' A' ' 185' ' ' LYS . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 226' ' ' LYS . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.1 t-20 -69.1 -39.59 78.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.69 151.12 41.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.56 131.03 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.38 116.57 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.47 -30.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.72 50.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -97.76 40.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.93 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.25 2.7 4.42 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.88 143.14 5.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.741 0.305 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.64 83.87 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -111.57 -34.23 6.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HA ' HG21 ' A' ' 10' ' ' ILE . 34.2 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.851 0.357 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -35.58 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.04 36.2 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 t80 60.43 108.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.008 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.06 149.85 60.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.42 -27.99 27.44 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.571 2.181 . . . . 0.0 112.383 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 156.43 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -61.74 111.55 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -48.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 1' ' ' MET . 4.1 pt -102.15 -179.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -133.12 84.11 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.644 ' C ' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -73.49 -5.61 41.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.634 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.466 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -65.07 140.51 58.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -176.65 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 16' ' ' ALA . 25.8 t -73.66 155.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 60' ' ' VAL . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.471 HG23 ' SG ' ' A' ' 31' ' ' CYS . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.783 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.92 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.622 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.949 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.62 ' HB3' HG23 ' A' ' 50' ' ' VAL . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG21 HE22 ' A' ' 103' ' ' GLN . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -56.54 -41.96 77.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.7 p -59.67 -27.28 66.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.18 44.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.34 139.93 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.81 126.68 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.52 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -97.52 138.67 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.142 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD21 ' HD2' ' A' ' 85' ' ' LYS . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 35' ' ' LYS . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 30' ' ' ALA . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 71' ' ' LEU . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.648 HG23 ' N ' ' A' ' 66' ' ' ALA . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 58' ' ' VAL . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 83' ' ' ILE . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.836 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.422 HG22 ' HG ' ' A' ' 47' ' ' LEU . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 80' ' ' GLN . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HD2' HD21 ' A' ' 47' ' ' LEU . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.783 HG23 ' HB2' ' A' ' 20' ' ' MET . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.612 HD11 ' SG ' ' A' ' 31' ' ' CYS . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 98' ' ' LYS . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.577 HE22 HG21 ' A' ' 37' ' ' VAL . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.687 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 137' ' ' MET . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 111' ' ' ILE . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 127' ' ' PRO . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 126' ' ' ARG . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . 0.603 ' C ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.738 ' N ' HG12 ' A' ' 120' ' ' VAL . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 133' ' ' ILE . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 130' ' ' VAL . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.741 HD13 ' O ' ' A' ' 140' ' ' ILE . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HE2' HG22 ' A' ' 144' ' ' VAL . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.678 HG22 ' HE2' ' A' ' 142' ' ' TYR . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 158' ' ' ILE . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 158' ' ' ILE . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG13 ' A' ' 157' ' ' VAL . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.563 HD23 ' NZ ' ' A' ' 164' ' ' LYS . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.563 ' NZ ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.479 ' CD1' HD13 ' A' ' 158' ' ' ILE . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -82.21 116.05 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 215' ' ' GLY . . . -148.51 140.93 24.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.156 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 -152.93 122.74 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.682 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.432 ' HG2' HD12 ' A' ' 212' ' ' ILE . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.412 HG23 HG22 ' A' ' 208' ' ' ILE . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.846 ' CD2' HD22 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 205' ' ' GLN . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.846 HD22 ' CD2' ' A' ' 178' ' ' LEU . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.826 HD23 HD11 ' A' ' 194' ' ' ILE . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.826 HD11 HD23 ' A' ' 193' ' ' LEU . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 197' ' ' ILE . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 196' ' ' VAL . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.444 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.714 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 177' ' ' ILE . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' HG2' ' A' ' 173' ' ' ARG . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HB2' ' CB ' ' A' ' 118' ' ' LYS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.628 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 193' ' ' LEU . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 224' ' ' ILE . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -49.97 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.36 174.59 11.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -141.23 134.81 29.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.985 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -104.95 105.23 15.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 243' ' ' GLU . 9.4 m -144.52 -47.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 242' ' ' VAL . 2.8 mt-10 -82.59 166.6 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.18 78.63 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.17 -53.63 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.52 127.01 39.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 -171.75 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.81 90.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.12 -31.43 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.836 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 tpp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 116.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.2 tt -178.96 106.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.9 144.95 55.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.936 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.458 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -78.9 -52.3 1.26 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.514 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 5' ' ' THR . 74.4 Cg_endo -76.55 -29.52 5.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.446 2.097 . . . . 0.0 112.676 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 9' ' ' GLN . 4.9 m -103.01 131.51 49.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.998 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -114.44 29.43 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 7' ' ' THR . 4.9 tt0 -120.88 -43.77 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.32 176.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -105.39 -29.27 10.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.87 177.52 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.06 -27.97 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 65.55 18.59 11.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.459 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -107.36 177.61 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' OE2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 29' ' ' ILE . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG2' HG23 ' A' ' 87' ' ' ILE . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' OE2' HG11 ' A' ' 17' ' ' VAL . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.76 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.69 ' SG ' HD11 ' A' ' 88' ' ' LEU . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.826 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 33' ' ' LYS . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -58.94 -31.27 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -61.04 -31.84 71.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.85 -8.83 4.53 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.447 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 38' ' ' GLY . 14.3 p -86.72 145.57 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.237 0.518 . . . . 0.0 111.119 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.19 130.79 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.78 171.22 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.08 132.66 43.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.562 HD21 ' HE2' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 30' ' ' ALA . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 51' ' ' LEU . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.082 HG21 HD21 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG21 ' HG2' ' A' ' 28' ' ' GLU . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 66' ' ' ALA . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.098 HD22 HD13 ' A' ' 83' ' ' ILE . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.77 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.098 HD13 HD22 ' A' ' 71' ' ' LEU . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.814 ' HB3' HD21 ' A' ' 51' ' ' LEU . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HE2' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 83' ' ' ILE . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 93' ' ' VAL . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 93' ' ' VAL . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 95' ' ' VAL . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 111' ' ' ILE . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB2' HG13 ' A' ' 115' ' ' VAL . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.671 HG21 ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HB3' ' HG ' ' A' ' 216' ' ' CYS . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.505 ' CG2' HG22 ' A' ' 131' ' ' ILE . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.505 HG22 ' CG2' ' A' ' 129' ' ' THR . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 116' ' ' ALA . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.434 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 137' ' ' MET . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.7 mm-40 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.788 HG22 HD12 ' A' ' 167' ' ' ILE . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 158' ' ' ILE . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 157' ' ' VAL . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.788 HD12 HG22 ' A' ' 158' ' ' ILE . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 -102.86 116.03 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.32 136.99 52.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.165 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -120.76 140.35 51.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.428 HD12 ' CG ' ' A' ' 213' ' ' ASP . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 190' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 234' ' ' LEU . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.818 HD11 HG12 ' A' ' 209' ' ' VAL . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 205' ' ' GLN . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 190' ' ' LEU . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.583 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.838 HD22 ' CD2' ' A' ' 211' ' ' LEU . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 221' ' ' ASP . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 193' ' ' LEU . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.561 ' CG1' HG21 ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.417 ' HB2' HG23 ' A' ' 209' ' ' VAL . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 205' ' ' GLN . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.585 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 208' ' ' ILE . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.818 HG12 HD11 ' A' ' 178' ' ' LEU . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.509 ' C ' HD12 ' A' ' 211' ' ' LEU . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.838 ' CD2' HD22 ' A' ' 190' ' ' LEU . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 213' ' ' ASP . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 218' ' ' ARG . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 193' ' ' LEU . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.731 ' N ' HD12 ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.583 HG21 ' HD2' ' A' ' 189' ' ' LYS . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 177' ' ' ILE . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -112.22 -177.65 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.87 123.42 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.42 110.41 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.52 157.57 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 243' ' ' GLU . 8.6 m -58.53 -37.02 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 242' ' ' VAL . 9.4 pt-20 -178.11 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.47 -71.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.72 34.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 247' ' ' GLU . 2.1 m-20 -136.04 -174.52 3.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.716 0.293 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 246' ' ' ASP . 4.7 mt-10 82.2 -13.37 0.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -96.67 -47.91 5.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 55.41 94.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.711 0.291 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.62 177.43 11.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 4' ' ' PHE . 14.6 tt -148.42 -46.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 3' ' ' ILE . 3.1 m-85 -134.97 144.04 47.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.411 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -87.02 -52.34 0.42 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 5' ' ' THR . 49.5 Cg_exo -55.84 106.46 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.541 2.16 . . . . 0.0 112.233 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 43.25 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -153.5 29.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -178.82 -63.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.844 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 tp -143.0 118.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.89 42.23 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.988 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.85 HD13 HG21 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -158.79 -53.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.004 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p 55.09 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.174 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 73.92 -60.58 0.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.545 HG22 ' NE2' ' A' ' 52' ' ' GLN . 23.1 t -119.78 147.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.948 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.85 HG21 HD13 ' A' ' 12' ' ' LEU . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 31' ' ' CYS . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.863 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' HE ' ' A' ' 22' ' ' ARG . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.702 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' HG23 ' A' ' 50' ' ' VAL . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 33' ' ' LYS . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.503 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -59.07 -34.21 71.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -60.25 -28.11 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.808 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.53 24.46 3.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.818 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t -107.64 145.65 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.34 142.61 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -167.43 147.9 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.94 132.62 39.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 54' ' ' HIS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.545 ' NE2' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 66' ' ' ALA . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 83' ' ' ILE . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.444 HD11 ' OD1' ' A' ' 78' ' ' ASP . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 72' ' ' ILE . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.999 HD13 HD22 ' A' ' 71' ' ' LEU . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 29' ' ' ILE . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HG2' HD21 ' A' ' 47' ' ' LEU . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CD2' HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.727 ' HA ' HD12 ' A' ' 114' ' ' ILE . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.921 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 111' ' ' ILE . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 133' ' ' ILE . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 215' ' ' GLY . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.921 HG21 ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.646 ' HE1' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.491 ' CG ' ' HE3' ' A' ' 137' ' ' MET . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 108' ' ' PHE . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.6 OUTLIER -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 153' ' ' GLN . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.821 ' HA ' HD13 ' A' ' 167' ' ' ILE . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 157' ' ' VAL . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.821 HD13 ' HA ' ' A' ' 158' ' ' ILE . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.1 131.68 39.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.9 136.84 49.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.319 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -127.21 164.2 22.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.557 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.748 ' CG2' HD12 ' A' ' 206' ' ' LEU . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.883 HD22 ' HB2' ' A' ' 186' ' ' LEU . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 178' ' ' LEU . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' HB3' HD23 ' A' ' 178' ' ' LEU . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.883 ' HB2' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.841 ' CG ' HG21 ' A' ' 209' ' ' VAL . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.879 ' HD3' HD11 ' A' ' 224' ' ' ILE . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 211' ' ' LEU . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 ' OD1' ' A' ' 221' ' ' ASP . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 211' ' ' LEU . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.416 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 211' ' ' LEU . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 187' ' ' LYS . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.776 HD22 HD12 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 120' ' ' VAL . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.879 HD11 ' HD3' ' A' ' 189' ' ' LYS . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.748 ' HE3' HD11 ' A' ' 211' ' ' LEU . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' HD12 ' A' ' 178' ' ' LEU . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -103.62 -176.9 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.64 168.92 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 142.42 28.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 134.51 54.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.42 -33.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.306 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.54 99.62 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.41 37.13 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 113.69 29.31 2.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -99.41 -175.56 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 45.84 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.372 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.97 89.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -133.19 -50.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -59.66 -177.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.26 -47.09 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.995 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -167.3 -51.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m 61.34 118.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' HG3' HG21 ' A' ' 13' ' ' THR . 37.0 Cg_endo -65.42 100.07 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.382 2.055 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -132.18 -46.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -171.36 -39.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' ILE . 18.0 pt20 -57.0 -49.3 76.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 9' ' ' GLN . 2.7 pt -161.57 109.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -95.58 65.36 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.94 -83.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 6' ' ' PRO . 14.2 p 48.85 -161.88 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.136 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 t30 78.11 -60.33 0.41 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.14 138.11 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 60' ' ' VAL . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG22 HG23 ' A' ' 93' ' ' VAL . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.905 ' HB2' HG23 ' A' ' 87' ' ' ILE . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.843 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' CB ' HG23 ' A' ' 50' ' ' VAL . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 32' ' ' TYR . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 33' ' ' LYS . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.84 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.51 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.61 -36.35 71.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t -60.6 -31.94 71.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.67 25.36 4.3 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 38' ' ' GLY . 12.0 p -93.74 151.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.12 98.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -107.58 157.25 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD21 ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.868 HG22 ' HB3' ' A' ' 30' ' ' ALA . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 66' ' ' ALA . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 HG13 ' A' ' 17' ' ' VAL . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.953 HD22 HD13 ' A' ' 83' ' ' ILE . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.745 ' CE2' HG23 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 83' ' ' ILE . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.953 HD13 HD22 ' A' ' 71' ' ' LEU . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 29' ' ' ILE . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.683 ' HE2' HD21 ' A' ' 47' ' ' LEU . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 20' ' ' MET . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 84' ' ' CYS . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.641 ' C ' HG13 ' A' ' 18' ' ' VAL . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 HG22 ' A' ' 18' ' ' VAL . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 113' ' ' THR . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' OD1' HD11 ' A' ' 114' ' ' ILE . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.839 ' O ' HG23 ' A' ' 115' ' ' VAL . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 109' ' ' ARG . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.64 HD11 ' OD1' ' A' ' 110' ' ' ASP . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 216' ' ' CYS . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.526 ' CD1' HD13 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 131' ' ' ILE . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.448 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG22 ' CG2' ' A' ' 129' ' ' THR . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 157' ' ' VAL . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 153' ' ' GLN . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.664 ' HA ' HD12 ' A' ' 167' ' ' ILE . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 167' ' ' ILE . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 158' ' ' ILE . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 167' ' ' ILE . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -111.04 117.08 32.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -156.26 152.6 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -99.09 170.95 8.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.639 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.743 ' HG3' HG23 ' A' ' 212' ' ' ILE . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 237' ' ' LEU . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.791 ' C ' HD13 ' A' ' 178' ' ' LEU . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 182' ' ' GLU . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 205' ' ' GLN . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 211' ' ' LEU . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 194' ' ' ILE . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 191' ' ' LYS . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.716 ' C ' HG12 ' A' ' 180' ' ' VAL . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 205' ' ' GLN . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 190' ' ' LEU . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG23 ' HG3' ' A' ' 173' ' ' ARG . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.496 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HG3' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -83.85 -78.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.35 174.6 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.437 ' HD3' HG13 ' A' ' 242' ' ' VAL . 8.5 tmtt? -122.38 110.38 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.33 123.25 23.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.437 HG13 ' HD3' ' A' ' 240' ' ' LYS . 15.3 m -140.98 165.17 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.3 78.2 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -78.06 -35.3 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -162.2 -56.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -119.37 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -70.24 -24.9 63.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.91 87.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -37.87 69.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -106.52 167.36 9.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 mt 73.31 -59.78 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -74.94 126.6 31.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.413 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -91.1 -52.35 0.3 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 5' ' ' THR . 32.0 Cg_exo -58.38 97.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.572 2.181 . . . . 0.0 112.132 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m 63.64 136.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.024 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -107.56 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -137.59 -58.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 14' ' ' ASN . 3.9 pt -88.35 147.38 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -74.26 -49.83 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.9 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -61.03 122.59 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' HB2' HD13 ' A' ' 10' ' ' ILE . 1.0 OUTLIER -177.73 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 52' ' ' GLN . 22.1 t -107.86 159.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.039 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 60' ' ' VAL . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG22 HG23 ' A' ' 93' ' ' VAL . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.885 ' HB2' HG23 ' A' ' 87' ' ' ILE . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.567 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.675 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.718 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.693 ' HB2' HG23 ' A' ' 50' ' ' VAL . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' ASN . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.645 ' HA ' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -55.36 -44.3 75.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.401 ' OG ' HG23 ' A' ' 43' ' ' VAL . 27.9 p -59.44 -27.51 66.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.85 -19.33 4.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.763 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG23 ' OG ' ' A' ' 41' ' ' SER . 22.6 t -53.85 141.98 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 111.329 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.14 131.98 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -157.53 173.01 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -115.44 137.57 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.086 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 35' ' ' LYS . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HG2' HG21 ' A' ' 15' ' ' VAL . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.607 HG21 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.567 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.082 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.553 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.553 ' OD1' HD11 ' A' ' 72' ' ' ILE . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.87 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.082 HD13 HD22 ' A' ' 71' ' ' LEU . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.71 ' O ' HD13 ' A' ' 88' ' ' LEU . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB2' ' A' ' 20' ' ' MET . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 40' ' ' ARG . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.599 HG23 HG22 ' A' ' 18' ' ' VAL . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' O ' HG22 ' A' ' 102' ' ' THR . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 98' ' ' LYS . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 102' ' ' THR . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.779 ' HB3' HG21 ' A' ' 150' ' ' THR . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.817 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 111' ' ' ILE . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 128' ' ' TYR . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.454 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' CYS . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 140' ' ' ILE . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.77 HG13 ' HG2' ' A' ' 153' ' ' GLN . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.421 ' HA ' HG23 ' A' ' 37' ' ' VAL . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.779 HG21 ' HB3' ' A' ' 110' ' ' ASP . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.903 ' O ' HG23 ' A' ' 157' ' ' VAL . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.461 HG22 HG21 ' A' ' 167' ' ' ILE . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 168' ' ' GLU . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.04 112.86 21.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.73 164.54 23.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.222 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -130.05 -177.7 4.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 239' ' ' LEU . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 211' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.618 HD12 ' CA ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.54 ' N ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.618 ' CA ' HD12 ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 187' ' ' LYS . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.726 ' N ' HD12 ' A' ' 186' ' ' LEU . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.711 ' HD3' HG21 ' A' ' 228' ' ' THR . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 186' ' ' LEU . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.56 HD13 ' OD1' ' A' ' 221' ' ' ASP . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 194' ' ' ILE . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.675 ' C ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 195' ' ' LYS . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.404 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 193' ' ' LEU . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' OD1' HD13 ' A' ' 194' ' ' ILE . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.702 HG21 HD22 ' A' ' 193' ' ' LEU . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.711 HG21 ' HD3' ' A' ' 189' ' ' LYS . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.527 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -177.39 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 2.7 mm? -80.23 112.65 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 111.198 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -121.42 148.57 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.98 153.86 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.2 t 68.62 -68.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.255 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.55 71.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.824 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.25 31.26 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 130.34 -93.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.423 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.77 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 0.0 111.004 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 62.61 148.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -157.82 42.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -92.53 146.35 23.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.923 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.875 0.369 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 174.98 7.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 4' ' ' PHE . 23.0 pt -110.73 -40.34 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' N ' HG13 ' A' ' 3' ' ' ILE . 23.1 p90 -112.21 -28.31 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m 64.12 125.76 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.812 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 118.81 5.9 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.383 2.055 . . . . 0.0 112.316 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -89.99 -49.92 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -114.8 -51.9 2.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.672 ' C ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -165.54 65.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.972 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER 57.96 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.06 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.468 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -134.54 -49.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.019 HD13 HG12 ' A' ' 60' ' ' VAL . 8.7 tt -166.23 123.53 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 -56.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -138.7 29.88 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 52' ' ' GLN . 61.0 t -74.49 155.09 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.557 ' HB ' HD12 ' A' ' 29' ' ' ILE . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.877 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 17' ' ' VAL . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.893 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.608 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 38' ' ' GLY . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.775 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -26.08 67.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.45 25.46 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.84 -82.19 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.991 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 44' ' ' GLU . 8.4 p -166.58 160.62 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 43' ' ' VAL . 6.5 mt-10 -43.99 143.7 1.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.284 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -135.76 170.47 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.84 121.11 10.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.659 HD11 ' SG ' ' A' ' 84' ' ' CYS . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 15' ' ' VAL . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.041 HG21 HD21 ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 60' ' ' VAL . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 1.019 HG12 HD13 ' A' ' 12' ' ' LEU . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 66' ' ' ALA . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 72' ' ' ILE . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.118 HD22 HD13 ' A' ' 83' ' ' ILE . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 68' ' ' LYS . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.118 HD13 HD22 ' A' ' 71' ' ' LEU . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.893 ' SG ' HG21 ' A' ' 29' ' ' ILE . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HE3' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 20' ' ' MET . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.582 HD11 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.566 ' CE ' HG22 ' A' ' 150' ' ' THR . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.636 ' HD1' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 107' ' ' MET . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.591 HG23 ' HD2' ' A' ' 118' ' ' LYS . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 133' ' ' ILE . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 114' ' ' ILE . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 116' ' ' ALA . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.418 ' SD ' HG13 ' A' ' 157' ' ' VAL . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.608 ' O ' HG22 ' A' ' 140' ' ' ILE . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.636 HG21 ' HD1' ' A' ' 108' ' ' PHE . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.566 HG22 ' CE ' ' A' ' 107' ' ' MET . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.871 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 154' ' ' ALA . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 158' ' ' ILE . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 140' ' ' ILE . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.601 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 168' ' ' GLU . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 167' ' ' ILE . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.0 ttp180 -111.58 124.59 52.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.525 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -124.71 167.44 14.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD22 HD13 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.44 HD12 ' N ' ' A' ' 177' ' ' ILE . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 182' ' ' GLU . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 205' ' ' GLN . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.62 HD13 HD21 ' A' ' 211' ' ' LEU . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 194' ' ' ILE . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.942 HG23 HD23 ' A' ' 193' ' ' LEU . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.538 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.721 ' HA ' HG22 ' A' ' 180' ' ' VAL . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.568 HD13 ' H ' ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.642 HD13 HD22 ' A' ' 174' ' ' LEU . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 197' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.583 HG22 HD21 ' A' ' 193' ' ' LEU . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.487 ' OD1' HD22 ' A' ' 211' ' ' LEU . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.472 ' HZ1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 224' ' ' ILE . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 234' ' ' LEU . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.76 -75.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.478 HD13 ' H ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -105.41 135.77 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.478 ' H ' HD13 ' A' ' 239' ' ' LEU . 39.4 pttt -139.24 132.72 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -79.04 154.81 29.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.29 -31.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -105.49 133.15 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 30.78 4.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.08 -40.12 2.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -153.25 133.47 13.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -104.67 -77.59 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -111.09 -26.37 9.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.21 31.8 10.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.941 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t 61.09 112.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.5 tt -171.3 55.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' HA ' HD11 ' A' ' 10' ' ' ILE . 64.9 t80 66.32 -73.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.84 114.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.894 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.68 75.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.355 2.037 . . . . 0.0 112.217 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -157.31 160.14 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.445 ' ND2' ' O ' ' A' ' 8' ' ' ASN . 1.9 p-10 -67.02 79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.22 -51.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 4' ' ' PHE . 2.2 pp -142.77 167.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -156.18 93.15 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.71 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 60' ' ' VAL . 1.9 pt? -111.45 -20.76 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.334 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.496 ' OG1' HG12 ' A' ' 60' ' ' VAL . 3.3 m -124.76 -68.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.43 29.63 7.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -157.4 -177.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG21 ' A' ' 60' ' ' VAL . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 93' ' ' VAL . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.944 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HG ' ' A' ' 88' ' ' LEU . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 147' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -59.3 -40.81 87.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -59.27 -22.61 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.14 17.54 5.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.707 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.58 127.62 42.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.771 0.32 . . . . 0.0 110.992 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.12 135.53 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -159.42 171.75 19.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.167 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.1 t0 -119.92 145.03 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.943 HD12 HD12 ' A' ' 51' ' ' LEU . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 51' ' ' LEU . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.944 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . 1.001 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 71' ' ' LEU . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' HD11 ' A' ' 12' ' ' LEU . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.518 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 83' ' ' ILE . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.715 ' CE2' HG23 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 71' ' ' LEU . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 29' ' ' ILE . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.686 ' CE ' HD21 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 18' ' ' VAL . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CB ' HG21 ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 130' ' ' VAL . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' ILE . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HD3' ' ND1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.752 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 216' ' ' CYS . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.708 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 132' ' ' LEU . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.661 HG13 ' HB1' ' A' ' 112' ' ' ALA . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.708 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 140' ' ' ILE . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 157' ' ' VAL . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 111' ' ' ILE . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 37' ' ' VAL . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.414 HG21 ' CB ' ' A' ' 110' ' ' ASP . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.1 mm100 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 153' ' ' GLN . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 167' ' ' ILE . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 140' ' ' ILE . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 158' ' ' ILE . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -107.08 113.38 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 215' ' ' GLY . . . -153.36 154.5 34.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.404 ' ND1' ' HD3' ' A' ' 118' ' ' LYS . 8.1 t60 -173.17 129.81 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 225' ' ' LYS . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 236' ' ' VAL . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 178' ' ' LEU . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.574 HG13 ' C ' ' A' ' 204' ' ' GLN . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' O ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 178' ' ' LEU . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 190' ' ' LEU . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 178' ' ' LEU . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 228' ' ' THR . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 186' ' ' LEU . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.715 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' SER . . . . . 0.598 ' CB ' HG22 ' A' ' 209' ' ' VAL . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.574 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 199' ' ' SER . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.771 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.523 ' H ' HG22 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.723 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.706 HG21 ' HG3' ' A' ' 189' ' ' LYS . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 234' ' ' LEU . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 233' ' ' SER . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -100.46 -30.42 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.8 132.45 36.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -143.66 119.25 10.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.87 101.74 9.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.0 -61.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -109.34 -28.21 9.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.36 121.52 10.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.49 29.88 3.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.429 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -143.41 -48.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.87 0.367 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.06 147.21 30.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 -66.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 59.57 33.96 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.748 0.309 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -160.25 -169.29 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 mt 66.61 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -161.68 96.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -147.97 115.1 4.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.63 18.91 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.604 2.203 . . . . 0.0 112.988 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m 64.54 37.63 7.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -146.23 -70.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -179.44 50.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mt 71.94 -61.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 67.9 37.92 2.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tt -156.4 74.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.77 141.21 30.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.6 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 16' ' ' ALA . 22.2 t -106.17 155.88 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.924 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.622 HG12 ' HG2' ' A' ' 28' ' ' GLU . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 93' ' ' VAL . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.797 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.924 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 33' ' ' LYS . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.733 ' CH2' HD23 ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -56.96 -39.88 75.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 t -64.38 -26.49 68.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.84 31.41 2.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 38' ' ' GLY . 21.6 t -98.73 135.75 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.99 103.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.05 158.42 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.2 m-20 -99.64 137.07 38.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.268 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG21 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.688 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.019 HD21 HG21 ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.625 HD11 ' OD1' ' A' ' 78' ' ' ASP . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' HD11 ' A' ' 72' ' ' ILE . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 71' ' ' LEU . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.686 ' O ' HD13 ' A' ' 88' ' ' LEU . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' MET . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 18' ' ' VAL . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' O ' HD13 ' A' ' 104' ' ' LEU . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 100' ' ' ARG . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 113' ' ' THR . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.593 ' O ' HG12 ' A' ' 115' ' ' VAL . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 133' ' ' ILE . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 110' ' ' ASP . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.645 HG13 HG21 ' A' ' 133' ' ' ILE . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 115' ' ' VAL . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 167' ' ' ILE . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 127' ' ' PRO . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.801 ' HA ' HG12 ' A' ' 120' ' ' VAL . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.511 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 133' ' ' ILE . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 132' ' ' LEU . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 129' ' ' THR . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.697 HG21 ' HB3' ' A' ' 103' ' ' GLN . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 153' ' ' GLN . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 167' ' ' ILE . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.683 HD11 ' CE ' ' A' ' 137' ' ' MET . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.653 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.477 ' HG2' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -93.81 114.25 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.868 ' HB3' ' C ' ' A' ' 215' ' ' GLY . . . -170.22 175.01 5.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 -175.8 119.56 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.681 HD21 ' OE1' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.687 HD21 ' HG2' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HG3' HG21 ' A' ' 228' ' ' THR . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.646 ' CD1' HD23 ' A' ' 186' ' ' LEU . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 224' ' ' ILE . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.807 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.73 HG21 ' CD1' ' A' ' 212' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.695 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.681 ' OE1' HD21 ' A' ' 178' ' ' LEU . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 197' ' ' ILE . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.807 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 197' ' ' ILE . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.868 ' C ' ' HB3' ' A' ' 170' ' ' ALA . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.488 ' N ' ' HB3' ' A' ' 170' ' ' ALA . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' CG ' HD11 ' A' ' 194' ' ' ILE . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 193' ' ' LEU . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.687 ' HG2' HD21 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.594 HG21 ' HG3' ' A' ' 189' ' ' LYS . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.409 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 230' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 182' ' ' GLU . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.416 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.0 OUTLIER -70.41 -74.2 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.37 141.31 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -97.89 121.13 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.49 136.05 38.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.99 127.15 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.87 81.38 1.76 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -98.72 -63.53 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.66 -65.42 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.13 -55.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -171.4 -46.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -177.38 105.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.97 30.81 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.68 150.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.78 -75.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -179.42 66.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -63.62 111.07 4.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.745 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.37 111.64 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.439 2.093 . . . . 0.0 112.233 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 9' ' ' GLN . 8.8 t -174.49 -178.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -97.9 37.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' H ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -106.68 -33.03 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 pt -128.56 -179.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -119.06 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -162.2 117.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -99.81 -169.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 60.34 80.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 52' ' ' GLN . 48.5 t 65.07 153.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.603 HG21 HD22 ' A' ' 12' ' ' LEU . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.678 HG22 ' HA ' ' A' ' 93' ' ' VAL . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.709 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.639 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.723 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' SG ' ' A' ' 31' ' ' CYS . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 38' ' ' GLY . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.819 ' CE3' HG11 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -58.81 -37.84 77.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -59.57 -27.22 66.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.2 3.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -96.87 140.33 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.54 117.24 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.61 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -135.15 179.91 6.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.616 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.16 150.02 40.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 81' ' ' THR . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CE3' ' A' ' 39' ' ' TRP . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.684 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.698 ' HG2' HG21 ' A' ' 15' ' ' VAL . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.598 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.666 ' CB ' HD21 ' A' ' 71' ' ' LEU . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.493 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 83' ' ' ILE . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.77 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 71' ' ' LEU . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.709 ' SG ' HG21 ' A' ' 29' ' ' ILE . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD1' HD11 ' A' ' 29' ' ' ILE . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 18' ' ' VAL . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 93' ' ' VAL . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' MET . . . . . 0.693 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HD1' HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.91 HG23 ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' ILE . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.91 ' HD2' HG23 ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 170' ' ' ALA . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.682 ' O ' HD12 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 129' ' ' THR . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.474 ' SD ' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 107' ' ' MET . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.427 HG22 ' SD ' ' A' ' 107' ' ' MET . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 167' ' ' ILE . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 157' ' ' VAL . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.855 ' HB ' HG23 ' A' ' 158' ' ' ILE . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -72.13 144.22 48.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.879 ' HB2' HG13 ' A' ' 120' ' ' VAL . . . -105.16 162.4 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 -162.64 177.09 9.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.584 HD13 ' H ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.584 ' H ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.693 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.822 ' HA ' HD23 ' A' ' 206' ' ' LEU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.582 HG22 ' C ' ' A' ' 205' ' ' GLN . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.693 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LYS . . . . . 0.475 ' HE2' HG23 ' A' ' 228' ' ' THR . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' ' 225' ' ' LYS . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 211' ' ' LEU . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.582 ' C ' HG22 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.758 HD22 HD11 ' A' ' 194' ' ' ILE . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 193' ' ' LEU . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.57 HD12 HD21 ' A' ' 186' ' ' LEU . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.852 ' HA ' HD11 ' A' ' 186' ' ' LEU . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.475 HG23 ' HE2' ' A' ' 185' ' ' LYS . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.92 -167.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 239' ' ' LEU . 3.7 mp -92.62 170.17 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -106.1 145.42 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -60.33 116.49 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 243' ' ' GLU . 15.3 m -137.15 -46.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -103.91 48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.15 -33.52 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.26 -43.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.577 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -176.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -68.65 -73.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.32 85.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.21 133.13 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.821 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.88 128.81 31.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.52 -78.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' HD1' HG23 ' A' ' 13' ' ' THR . 0.4 OUTLIER -164.93 -171.1 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.861 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.66 -67.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.457 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 57.7 Cg_endo -71.8 -47.15 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.225 1.95 . . . . 0.0 112.507 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -105.61 -179.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -156.79 76.35 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -45.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 pt -104.9 179.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.77 80.17 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 4.9 tt -83.29 -36.62 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 HG23 ' HD1' ' A' ' 4' ' ' PHE . 72.6 p -64.69 116.78 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -178.16 -39.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' CYS . 21.0 t -113.18 152.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 28' ' ' GLU . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.888 HG22 HG12 ' A' ' 93' ' ' VAL . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CB ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.823 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.82 ' SG ' HG21 ' A' ' 36' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ALA . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 93' ' ' VAL . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.749 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -58.25 -39.26 78.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 p -59.36 -26.49 65.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.086 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -22.87 4.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.664 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.29 129.13 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.215 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.97 118.78 10.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -137.28 149.81 47.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -101.35 147.83 25.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.287 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.862 ' HG ' HG22 ' A' ' 81' ' ' THR . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.749 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.821 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 1.026 HG21 HD21 ' A' ' 71' ' ' LEU . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 56' ' ' VAL . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.665 ' HA ' HD12 ' A' ' 83' ' ' ILE . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 71' ' ' LEU . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.823 ' SG ' HG21 ' A' ' 29' ' ' ILE . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' HG11 ' A' ' 18' ' ' VAL . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 18' ' ' VAL . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.591 HG12 ' HD3' ' A' ' 33' ' ' LYS . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.627 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 114' ' ' ILE . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 111' ' ' ILE . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.406 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.62 HG11 ' H ' ' A' ' 216' ' ' CYS . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 132' ' ' LEU . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.424 HG12 ' HG3' ' A' ' 134' ' ' GLU . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 132' ' ' LEU . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.857 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HG3' HG12 ' A' ' 130' ' ' VAL . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 137' ' ' MET . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 146' ' ' THR . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HD2' HG23 ' A' ' 150' ' ' THR . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.764 ' HA ' HD11 ' A' ' 167' ' ' ILE . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 157' ' ' VAL . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.764 HD11 ' HA ' ' A' ' 158' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.66 112.41 21.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -141.2 142.53 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 169.22 9.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.625 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 236' ' ' VAL . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 186' ' ' LEU . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 206' ' ' LEU . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.686 ' HB3' HD23 ' A' ' 178' ' ' LEU . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 197' ' ' ILE . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 198' ' ' GLU . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.642 ' HB2' HD12 ' A' ' 197' ' ' ILE . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.515 ' HD2' HE21 ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.48 ' C ' HG13 ' A' ' 180' ' ' VAL . 4.7 mm-40 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.58 ' H ' HD12 ' A' ' 206' ' ' LEU . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' HD12 ' A' ' 178' ' ' LEU . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.422 ' O ' HG23 ' A' ' 212' ' ' ILE . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.62 ' H ' HG11 ' A' ' 120' ' ' VAL . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 217' ' ' PHE . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.566 ' OD1' HD21 ' A' ' 190' ' ' LEU . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 193' ' ' LEU . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.58 ' N ' HD12 ' A' ' 224' ' ' ILE . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LYS . . . . . 0.482 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 177' ' ' ILE . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 240' ' ' LYS . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -103.42 -66.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.75 146.56 45.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.587 ' HD2' HD22 ' A' ' 237' ' ' LEU . 20.8 mtpp -144.19 143.12 30.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.78 103.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 135.6 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.35 59.46 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.817 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -152.24 34.02 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.09 176.89 14.6 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.0 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.35 174.81 10.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -75.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -122.66 -43.5 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.849 0.357 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.75 35.5 3.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 pt -82.83 -29.09 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.26 14.37 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.292 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.458 HG22 ' OG1' ' A' ' 7' ' ' THR . 3.5 m 53.16 80.74 0.28 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.223 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.16 83.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.656 2.237 . . . . 0.0 112.119 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.458 ' OG1' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -130.05 -168.57 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 7' ' ' THR . 23.7 m-80 -98.24 30.33 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 -27.23 11.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 12' ' ' LEU . 2.5 pp -118.68 -179.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -152.44 56.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.061 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.776 HD22 ' HB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -65.4 -13.83 59.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.543 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.776 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.1 m 165.35 -56.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.239 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 75.23 -59.67 0.53 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 13' ' ' THR . 0.5 OUTLIER -52.3 178.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 88' ' ' LEU . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE1' ' HG3' ' A' ' 86' ' ' GLN . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 60' ' ' VAL . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.951 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 38' ' ' GLY . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.492 ' CE3' ' HB2' ' A' ' 45' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -57.56 -44.1 84.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -26.54 67.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.06 5.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.153 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 38' ' ' GLY . 3.7 m -101.49 27.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 111.367 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 59.2 103.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.33 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' CE ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -124.78 125.73 44.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.31 119.62 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD21 ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 35' ' ' LYS . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 30' ' ' ALA . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.747 ' HA ' HD13 ' A' ' 51' ' ' LEU . 48.5 m80 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.013 HD22 HD13 ' A' ' 83' ' ' ILE . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 ' OD1' ' A' ' 78' ' ' ASP . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CE2' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.505 ' CB ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 1.013 HD13 HD22 ' A' ' 71' ' ' LEU . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.947 ' CB ' HD11 ' A' ' 51' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HD2' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HG3' ' HE1' ' A' ' 20' ' ' MET . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 83' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' ARG . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.741 ' HA ' HG22 ' A' ' 18' ' ' VAL . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 144' ' ' VAL . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 118' ' ' LYS . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.883 HG13 HG21 ' A' ' 167' ' ' ILE . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.782 ' HD3' HG23 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 216' ' ' CYS . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.419 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 131' ' ' ILE . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.462 ' H ' HG22 ' A' ' 129' ' ' THR . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 157' ' ' VAL . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 108' ' ' PHE . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 167' ' ' ILE . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' VAL . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.883 HG21 HG13 ' A' ' 115' ' ' VAL . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -106.21 128.6 54.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 240' ' ' LYS . . . -130.72 136.9 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -136.43 146.94 46.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 211' ' ' LEU . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.945 HD12 HG22 ' A' ' 208' ' ' ILE . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 207' ' ' GLU . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 182' ' ' GLU . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 205' ' ' GLN . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 179' ' ' PRO . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 229' ' ' LYS . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 194' ' ' ILE . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.799 HD13 ' HB3' ' A' ' 211' ' ' LEU . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 1.093 HG12 HD22 ' A' ' 211' ' ' LEU . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' GLU . . . . . 0.432 ' HG3' HD11 ' A' ' 208' ' ' ILE . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.459 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.735 ' HA ' HG22 ' A' ' 180' ' ' VAL . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 178' ' ' LEU . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.945 HG22 HD12 ' A' ' 177' ' ' ILE . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.411 ' O ' HD23 ' A' ' 211' ' ' LEU . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 1.093 HD22 HG12 ' A' ' 196' ' ' VAL . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.799 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 223' ' ' LEU . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.658 ' HG3' HD21 ' A' ' 186' ' ' LEU . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -73.87 -179.67 3.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.33 153.43 25.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.661 ' HE2' ' HB1' ' A' ' 170' ' ' ALA . 11.3 tttt -105.91 123.99 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -98.9 116.39 31.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 242' ' ' VAL . 9.7 p -150.51 109.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -161.02 167.2 26.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.52 -47.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -73.42 -8.64 76.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.922 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.98 -36.48 11.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.765 0.316 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.13 154.87 21.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 -46.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -60.8 123.69 18.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.956 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.755 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -143.65 98.89 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.5 pt -138.06 36.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -50.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.525 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 7.6 p 54.56 55.69 11.61 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.732 ' CG ' HG23 ' A' ' 10' ' ' ILE . 74.8 Cg_endo -91.83 72.87 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.939 2.426 . . . . 0.0 112.362 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m 69.97 -65.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -112.81 -83.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -176.56 101.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.756 0.312 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.732 HG23 ' CG ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -53.4 106.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.8 mtt-85 -53.54 -24.93 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER 66.61 98.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -13.82 62.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.033 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER 78.24 -61.89 0.36 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER 48.44 179.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.488 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HG22 ' A' ' 87' ' ' ILE . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.59 ' HB3' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.773 HG22 ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.856 ' SG ' HG22 ' A' ' 50' ' ' VAL . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.774 ' CB ' HG23 ' A' ' 50' ' ' VAL . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 147' ' ' ASN . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.59 -37.1 80.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -59.49 -24.55 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.82 24.51 4.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.427 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.08 132.46 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 111.134 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.5 122.84 15.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -141.0 150.58 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.42 130.23 34.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.856 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.843 ' CB ' ' HB3' ' A' ' 30' ' ' ALA . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.879 ' HA ' HD13 ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' A' ' 29' ' ' ILE . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD22 HD13 ' A' ' 83' ' ' ILE . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.667 HD11 ' OD1' ' A' ' 78' ' ' ASP . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.667 ' OD1' HD11 ' A' ' 72' ' ' ILE . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.459 HG22 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 87' ' ' ILE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 29' ' ' ILE . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.674 ' CE ' HD21 ' A' ' 47' ' ' LEU . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.792 HD11 HG22 ' A' ' 83' ' ' ILE . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' OE2' ' A' ' 99' ' ' GLU . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.554 ' OE2' HG11 ' A' ' 95' ' ' VAL . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 144' ' ' VAL . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 130' ' ' VAL . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 111' ' ' ILE . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 169' ' ' ARG . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG2' ' HB2' ' A' ' 170' ' ' ALA . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.471 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 128' ' ' TYR . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.413 ' HE3' HG21 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 142' ' ' TYR . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 140' ' ' ILE . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 111' ' ' ILE . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.683 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 153' ' ' GLN . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 157' ' ' VAL . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 167' ' ' ILE . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.2 OUTLIER -69.04 142.81 54.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.657 ' HB2' ' CG2' ' A' ' 120' ' ' VAL . . . -105.14 136.77 44.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.028 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 -107.2 155.54 19.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.078 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.816 ' HG2' HD12 ' A' ' 212' ' ' ILE . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.843 HD12 ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.802 ' HA ' HD23 ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 205' ' ' GLN . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.843 ' HA2' HD12 ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 211' ' ' LEU . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 211' ' ' LEU . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 212' ' ' ILE . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLU . . . . . 0.411 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.626 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 197' ' ' ILE . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 190' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.816 HD12 ' HG2' ' A' ' 173' ' ' ARG . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' CYS . . . . . 0.421 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HA ' HD12 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' PHE . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.493 ' OD2' HD13 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLU . . . . . 0.415 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.635 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 186' ' ' LEU . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.407 ' HB2' ' CB ' ' A' ' 233' ' ' SER . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 229' ' ' LYS . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 12.3 m-80 -89.28 -169.81 2.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.47 170.74 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.086 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -91.1 110.55 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -102.64 121.31 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.37 -37.14 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.49 86.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -88.78 -65.44 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -143.56 80.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.41 -68.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.759 0.314 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.61 -30.1 67.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 100.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -75.08 -34.0 61.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.934 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -138.07 -54.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.91 -73.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.202 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.35 74.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -138.16 99.2 9.05 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.86 -46.08 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.454 2.103 . . . . 0.0 112.284 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -152.44 -65.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.81 -62.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.428 ' HA ' HG23 ' A' ' 5' ' ' THR . 1.6 tp60 -157.7 -64.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.086 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 ' HB ' ' A' ' 13' ' ' THR . 0.6 OUTLIER -168.88 146.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 10' ' ' ILE . 3.1 mmt85 -109.46 14.44 23.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.77 HD22 ' H ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -161.74 -71.67 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.77 ' H ' HD22 ' A' ' 12' ' ' LEU . 8.9 t 39.81 -157.98 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.592 0.234 . . . . 0.0 111.537 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' THR . 9.2 m-20 68.74 7.96 6.45 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.3 OUTLIER 177.72 174.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 15' ' ' VAL . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 60' ' ' VAL . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 88' ' ' LEU . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.853 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' OE2' HG23 ' A' ' 60' ' ' VAL . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.87 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.902 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.791 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HB2' HG11 ' A' ' 95' ' ' VAL . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.596 ' O ' HG12 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.78 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 147' ' ' ASN . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -34.31 74.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -59.25 -25.53 64.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.41 24.79 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.78 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG12 ' HE3' ' A' ' 45' ' ' LYS . 2.7 t -112.17 152.97 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.44 119.55 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HE3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -131.93 117.02 17.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.777 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.25 122.95 15.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.611 HD21 ' CE ' ' A' ' 85' ' ' LYS . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.902 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.702 HD11 ' CB ' ' A' ' 84' ' ' CYS . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.949 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.63 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.995 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.751 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.751 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.995 HD13 HD22 ' A' ' 71' ' ' LEU . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.87 ' SG ' HG21 ' A' ' 29' ' ' ILE . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.611 ' CE ' HD21 ' A' ' 47' ' ' LEU . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.853 HG23 ' HB2' ' A' ' 20' ' ' MET . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 18' ' ' VAL . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG21 HG11 ' A' ' 36' ' ' VAL . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 33' ' ' LYS . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' O ' HG22 ' A' ' 102' ' ' THR . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 144' ' ' VAL . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB1' HG12 ' A' ' 130' ' ' VAL . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 114' ' ' ILE . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 113' ' ' THR . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 111' ' ' ILE . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' CYS . . . . . 0.792 ' SG ' HD13 ' A' ' 167' ' ' ILE . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.709 HG21 ' HE2' ' A' ' 125' ' ' LYS . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 1.9 t-20 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HE2' HG21 ' A' ' 120' ' ' VAL . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.58 ' OG1' HD23 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.747 HG12 ' HB1' ' A' ' 112' ' ' ALA . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 129' ' ' THR . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 161' ' ' LEU . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.445 ' CE ' HG22 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 136' ' ' ALA . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 108' ' ' PHE . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . 0.769 ' HA ' HG23 ' A' ' 37' ' ' VAL . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.913 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 153' ' ' GLN . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 167' ' ' ILE . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 157' ' ' VAL . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ILE . . . . . 0.792 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -71.05 118.69 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 215' ' ' GLY . . . -161.54 146.11 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.041 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 -175.0 131.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' HG23 ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 186' ' ' LEU . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 205' ' ' GLN . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.853 HD11 ' HB3' ' A' ' 178' ' ' LEU . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.699 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.454 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.559 HD11 HG22 ' A' ' 220' ' ' ILE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . 0.812 HG13 HD22 ' A' ' 211' ' ' LEU . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 209' ' ' VAL . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 196' ' ' VAL . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.589 ' H ' HD23 ' A' ' 206' ' ' LEU . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 178' ' ' LEU . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 196' ' ' VAL . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LEU . . . . . 0.812 HD22 HG13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 173' ' ' ARG . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 170' ' ' ALA . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 224' ' ' ILE . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 193' ' ' LEU . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 220' ' ' ILE . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 186' ' ' LEU . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -56.93 3.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.38 125.38 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -119.54 115.53 24.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.17 106.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 242' ' ' VAL . 16.4 t -117.45 30.5 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -106.72 52.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.997 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.27 34.29 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 68.82 117.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -57.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -158.06 142.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -96.42 -47.9 5.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.27 31.69 19.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 16' ' ' ALA . 70.4 t . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.705 0.288 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 60' ' ' VAL . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' C ' ' A' ' 92' ' ' GLU . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.887 ' HB2' HG23 ' A' ' 87' ' ' ILE . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 88' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' CB ' HG23 ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 38' ' ' GLY . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.763 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 71' ' ' LEU . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.529 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.745 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.112 HD22 HD13 ' A' ' 83' ' ' ILE . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 78' ' ' ASP . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 72' ' ' ILE . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.693 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.112 HD13 HD22 ' A' ' 71' ' ' LEU . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 51' ' ' LEU . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.887 HG23 ' HB2' ' A' ' 20' ' ' MET . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 31' ' ' CYS . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 103' ' ' GLN . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.451 ' HG2' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 111' ' ' ILE . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.73 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 215' ' ' GLY . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 115' ' ' VAL . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 136' ' ' ALA . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 157' ' ' VAL . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 107' ' ' MET . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 158' ' ' ILE . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 158' ' ' ILE . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 154' ' ' ALA . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 161' ' ' LEU . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 119' ' ' CYS . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.671 0.272 . . . . 0.0 110.563 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 212' ' ' ILE . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 208' ' ' ILE . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.786 HD23 HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.926 HD13 HD21 ' A' ' 211' ' ' LEU . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HA ' HG21 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 191' ' ' LYS . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.612 HD11 HD11 ' A' ' 212' ' ' ILE . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.51 ' HB2' HD12 ' A' ' 197' ' ' ILE . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.421 ' HB3' HG13 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.631 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.42 ' HG2' ' CB ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 177' ' ' ILE . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.565 HG11 ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.469 ' C ' HD22 ' A' ' 211' ' ' LEU . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.948 ' HB3' HD11 ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 173' ' ' ARG . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 174' ' ' LEU . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.526 ' O ' HG11 ' A' ' 120' ' ' VAL . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.72 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.766 0.317 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 28' ' ' GLU . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' SG ' ' A' ' 31' ' ' CYS . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.843 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 33' ' ' LYS . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.789 0.328 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.66 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.736 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.705 HG21 HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.612 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.976 HD22 HD13 ' A' ' 83' ' ' ILE . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.577 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 HD22 ' A' ' 71' ' ' LEU . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.736 ' SG ' HD11 ' A' ' 51' ' ' LEU . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HG2' HD21 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 29' ' ' ILE . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 18' ' ' VAL . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 33' ' ' LYS . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 98' ' ' LYS . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.869 ' HA ' HD12 ' A' ' 114' ' ' ILE . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.572 HG22 ' OD2' ' A' ' 117' ' ' ASP . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.896 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' HG22 ' A' ' 113' ' ' THR . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.768 ' HA ' HD12 ' A' ' 133' ' ' ILE . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 116' ' ' ALA . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB1' ' CE ' ' A' ' 164' ' ' LYS . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.548 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 145' ' ' LYS . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 144' ' ' VAL . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 161' ' ' LEU . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.638 ' HA ' HD11 ' A' ' 167' ' ' ILE . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 158' ' ' ILE . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.66 HD22 ' HZ1' ' A' ' 164' ' ' LYS . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.66 ' HZ1' HD22 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 158' ' ' ILE . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 . . . . . 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 3.2 m-70 . . . . . 0 CA--C 1.526 0.042 0 CA-C-O 120.62 0.247 . . . . 0.0 110.533 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.681 ' C ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.681 HD22 ' C ' ' A' ' 173' ' ' ARG . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 206' ' ' LEU . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' HD2' ' A' ' 229' ' ' LYS . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 205' ' ' GLN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.489 ' N ' HG13 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 190' ' ' LEU . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 196' ' ' VAL . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 224' ' ' ILE . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.658 ' CD1' HD23 ' A' ' 211' ' ' LEU . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 209' ' ' VAL . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HB2' HG12 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.507 HD12 HD11 ' A' ' 177' ' ' ILE . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 206' ' ' LEU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.815 HG23 HG13 ' A' ' 196' ' ' VAL . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.658 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.461 HD12 HH11 ' A' ' 173' ' ' ARG . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HB3' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 220' ' ' ILE . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.41 ' OG1' HD13 ' A' ' 186' ' ' LEU . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HD2' HD23 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.687 ' O ' HD12 ' A' ' 234' ' ' LEU . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 233' ' ' SER . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.81 0.338 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG21 ' A' ' 60' ' ' VAL . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 29' ' ' ILE . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.891 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.801 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.977 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.87 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HB3' HG23 ' A' ' 50' ' ' VAL . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 34' ' ' ASN . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 81' ' ' THR . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 35' ' ' LYS . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.977 HG22 ' HB3' ' A' ' 30' ' ' ALA . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.136 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 17' ' ' VAL . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.136 HD21 HG21 ' A' ' 56' ' ' VAL . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 83' ' ' ILE . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.919 HD13 HD22 ' A' ' 71' ' ' LEU . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.801 ' SG ' HG21 ' A' ' 29' ' ' ILE . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.891 HG23 ' HB2' ' A' ' 20' ' ' MET . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD1' HD13 ' A' ' 29' ' ' ILE . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 93' ' ' VAL . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 HE22 ' A' ' 103' ' ' GLN . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.424 HE22 HG11 ' A' ' 95' ' ' VAL . 34.2 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.434 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 111' ' ' ILE . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 111' ' ' ILE . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 133' ' ' ILE . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 216' ' ' CYS . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' HG12 ' A' ' 120' ' ' VAL . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' HD12 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.545 HD12 ' OG1' ' A' ' 129' ' ' THR . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' A' ' 116' ' ' ALA . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.475 HG13 ' OE1' ' A' ' 153' ' ' GLN . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.475 ' OE1' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.659 HG22 HD12 ' A' ' 161' ' ' LEU . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 154' ' ' ALA . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 157' ' ' VAL . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.671 HG21 HG13 ' A' ' 115' ' ' VAL . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 16.8 m80 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.863 0.363 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 238' ' ' ASN . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 234' ' ' LEU . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' HD12 ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.612 HD21 HG22 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 211' ' ' LEU . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 197' ' ' ILE . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.436 ' N ' HG12 ' A' ' 196' ' ' VAL . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.755 ' HA ' HG22 ' A' ' 180' ' ' VAL . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 206' ' ' LEU . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 194' ' ' ILE . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 212' ' ' ILE . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 120' ' ' VAL . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.751 HD13 ' CD1' ' A' ' 217' ' ' PHE . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 220' ' ' ILE . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.452 ' HA ' HD21 ' A' ' 186' ' ' LEU . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.512 ' CG2' HD22 ' A' ' 186' ' ' LEU . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.603 ' HB3' HD12 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 173' ' ' ARG . 1.3 m-20 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 52' ' ' GLN . 13.3 t . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.791 0.329 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 29' ' ' ILE . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG3' ' HE3' ' A' ' 20' ' ' MET . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.525 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.949 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.836 ' HB3' HG23 ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.45 ' CH2' ' HE3' ' A' ' 85' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.702 0.286 . . . . 0.0 110.671 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.896 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.874 HG22 ' SG ' ' A' ' 31' ' ' CYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.62 HG21 ' CE1' ' A' ' 57' ' ' PHE . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 51' ' ' LEU . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.86 ' HA ' HG23 ' A' ' 29' ' ' ILE . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 53' ' ' THR . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.539 HG22 ' CE2' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.411 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.859 HD22 HD13 ' A' ' 83' ' ' ILE . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.816 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 71' ' ' LEU . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' HG21 ' A' ' 29' ' ' ILE . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.896 ' HE3' HD21 ' A' ' 47' ' ' LEU . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.799 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' NH1' ' A' ' 100' ' ' ARG . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.702 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG21 ' A' ' 150' ' ' THR . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 133' ' ' ILE . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.418 HG23 ' NZ ' ' A' ' 118' ' ' LYS . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 111' ' ' ILE . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' NZ ' HG23 ' A' ' 114' ' ' ILE . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 ' HB2' ' A' ' 216' ' ' CYS . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.648 HD13 ' CD1' ' A' ' 128' ' ' TYR . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 130' ' ' VAL . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 161' ' ' LEU . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.651 HG13 ' OE1' ' A' ' 153' ' ' GLN . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 103' ' ' GLN . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.645 HG21 ' OD2' ' A' ' 110' ' ' ASP . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 157' ' ' VAL . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.591 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.812 ' HA ' HG21 ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 1.018 HD21 ' HB1' ' A' ' 136' ' ' ALA . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 57.9 m-70 . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.612 0.244 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 217' ' ' PHE . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 172' ' ' MET . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.794 HD11 ' CD2' ' A' ' 186' ' ' LEU . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 205' ' ' GLN . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 180' ' ' VAL . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 228' ' ' THR . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.794 ' CD2' HD11 ' A' ' 178' ' ' LEU . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.532 HD21 ' OD1' ' A' ' 221' ' ' ASP . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 196' ' ' VAL . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 1.12 HD23 HG23 ' A' ' 194' ' ' ILE . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 1.12 HG23 HD23 ' A' ' 193' ' ' LEU . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 191' ' ' LYS . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 208' ' ' ILE . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.653 ' HA ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.736 HD11 ' OD2' ' A' ' 221' ' ' ASP . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 211' ' ' LEU . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 120' ' ' VAL . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.502 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.736 ' OD2' HD11 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 225' ' ' LYS . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.611 HG21 ' CD1' ' A' ' 193' ' ' LEU . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 185' ' ' LYS . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.412 ' CD ' HD22 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 52' ' ' GLN . 21.6 t . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.815 0.34 . . . . 0.0 111.171 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' SG ' ' A' ' 31' ' ' CYS . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.005 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.752 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 33' ' ' LYS . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.471 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.59 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.891 0.377 . . . . 0.0 111.013 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.9 tp-100 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.005 HG22 ' HB3' ' A' ' 30' ' ' ALA . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.982 HG21 HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.982 HD21 HG21 ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.704 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.981 HD13 HD22 ' A' ' 71' ' ' LEU . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HG2' HD21 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 36' ' ' VAL . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 93' ' ' VAL . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.52 ' HE1' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.609 ' HA ' HD12 ' A' ' 111' ' ' ILE . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 108' ' ' PHE . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.489 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 111' ' ' ILE . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 111' ' ' ILE . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 216' ' ' CYS . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 120' ' ' VAL . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.537 ' HD1' HD13 ' A' ' 132' ' ' LEU . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.537 HD13 ' HD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.49 HG22 ' HE2' ' A' ' 137' ' ' MET . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.49 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 111' ' ' ILE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.52 HG22 ' HE1' ' A' ' 107' ' ' MET . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.9 tp-100 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 158' ' ' ILE . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 155' ' ' LEU . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.618 ' CG2' HG23 ' A' ' 158' ' ' ILE . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.688 0.28 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.712 ' HE3' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 212' ' ' ILE . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.712 HD11 ' HE3' ' A' ' 172' ' ' MET . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 207' ' ' GLU . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 205' ' ' GLN . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.454 ' HZ2' ' HA ' ' A' ' 228' ' ' THR . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 229' ' ' LYS . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HG2' HD11 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 225' ' ' LYS . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.615 HG23 HD23 ' A' ' 193' ' ' LEU . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.627 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.676 ' HB3' HD11 ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 176' ' ' PHE . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 173' ' ' ARG . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.752 ' HB3' HG21 ' A' ' 120' ' ' VAL . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.664 ' HB2' ' HE2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 220' ' ' ILE . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.492 ' HG2' HD21 ' A' ' 190' ' ' LEU . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 185' ' ' LYS . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' NE2' ' A' ' 52' ' ' GLN . 22.0 t . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.826 0.345 . . . . 0.0 111.16 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 87' ' ' ILE . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.869 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.88 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.884 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HG3' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 37' ' ' VAL . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 50' ' ' VAL . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 34' ' ' ASN . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.102 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.869 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.884 HG22 ' SG ' ' A' ' 31' ' ' CYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.82 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.605 ' NE2' HG22 ' A' ' 15' ' ' VAL . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.538 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 60' ' ' VAL . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 83' ' ' ILE . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.466 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 71' ' ' LEU . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.88 ' SG ' HG21 ' A' ' 29' ' ' ILE . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.869 ' HE3' HD21 ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 20' ' ' MET . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.75 HD21 ' SG ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 33' ' ' LYS . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.85 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 111' ' ' ILE . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 119' ' ' CYS . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.764 HG11 ' CD1' ' A' ' 111' ' ' ILE . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HD11 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 157' ' ' VAL . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 153' ' ' GLN . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.603 HD12 HG12 ' A' ' 157' ' ' VAL . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 8.0 p80 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.96 0.41 . . . . 0.0 111.161 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.417 ' O ' ' HA ' ' A' ' 212' ' ' ILE . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 238' ' ' ASN . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.623 ' CG ' HD23 ' A' ' 237' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.693 ' HD3' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.839 ' HB2' HD11 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 206' ' ' LEU . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.859 ' CD2' HD13 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' GLN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.44 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.859 HD13 ' CD2' ' A' ' 178' ' ' LEU . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.528 ' HG2' HD11 ' A' ' 224' ' ' ILE . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.991 HD23 HG23 ' A' ' 194' ' ' ILE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.991 HG23 HD23 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 191' ' ' LYS . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 212' ' ' ILE . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' A' ' 208' ' ' ILE . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 177' ' ' ILE . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.839 HD11 ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 197' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 193' ' ' LEU . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' A' ' 151' ' ' LYS . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.583 ' OD2' HD23 ' A' ' 211' ' ' LEU . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.767 HD13 HD13 ' A' ' 193' ' ' LEU . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 HD12 ' A' ' 186' ' ' LEU . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.623 HD23 ' CG ' ' A' ' 174' ' ' LEU . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 10.3 t-20 . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.595 0.236 . . . . 0.0 110.689 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 15' ' ' VAL . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD12 ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.898 ' HB2' HG23 ' A' ' 87' ' ' ILE . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.682 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.827 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.843 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.82 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.757 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.827 HG22 ' SG ' ' A' ' 31' ' ' CYS . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' HG23 ' A' ' 29' ' ' ILE . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 83' ' ' ILE . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.855 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 71' ' ' LEU . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.714 ' CB ' HD11 ' A' ' 51' ' ' LEU . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 20' ' ' MET . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 36' ' ' VAL . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 113' ' ' THR . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 110' ' ' ASP . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 136' ' ' ALA . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.677 ' CD2' HG22 ' A' ' 144' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 ' CD2' ' A' ' 142' ' ' TYR . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 157' ' ' VAL . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 158' ' ' ILE . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 157' ' ' VAL . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.629 HD12 HD11 ' A' ' 167' ' ' ILE . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 161' ' ' LEU . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.405 ' NE2' HG22 ' A' ' 212' ' ' ILE . 9.3 t-160 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.753 0.311 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.421 ' HE3' ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 218' ' ' ARG . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.588 ' HD1' HD13 ' A' ' 211' ' ' LEU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.559 HG12 HG22 ' A' ' 208' ' ' ILE . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 181' ' ' ASN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.496 ' N ' HG13 ' A' ' 180' ' ' VAL . 64.0 m-80 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.851 ' HE2' HG23 ' A' ' 228' ' ' THR . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.638 ' HB3' HD23 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 211' ' ' LEU . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.905 ' HB ' HD23 ' A' ' 211' ' ' LEU . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.558 HG12 ' HG ' ' A' ' 211' ' ' LEU . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 196' ' ' VAL . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.559 ' OG ' HG22 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.727 ' O ' HD12 ' A' ' 178' ' ' LEU . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 177' ' ' ILE . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.559 HG22 ' OG ' ' A' ' 199' ' ' SER . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.79 ' C ' HD12 ' A' ' 211' ' ' LEU . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.905 HD23 ' HB ' ' A' ' 194' ' ' ILE . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.401 ' CB ' ' HD2' ' A' ' 214' ' ' PRO . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 213' ' ' ASP . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 194' ' ' ILE . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HA ' HD21 ' A' ' 186' ' ' LEU . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 231' ' ' LYS . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.851 HG23 ' HE2' ' A' ' 185' ' ' LYS . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 226' ' ' LYS . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.1 t-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 16' ' ' ALA . 25.8 t . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 120.8 0.333 . . . . 0.0 111.09 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 60' ' ' VAL . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.783 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.92 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.622 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.949 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.62 ' HB3' HG23 ' A' ' 50' ' ' VAL . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.577 HG21 HE22 ' A' ' 103' ' ' GLN . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.822 0.344 . . . . 0.0 111.142 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.61 HD21 ' HD2' ' A' ' 85' ' ' LYS . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 35' ' ' LYS . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 30' ' ' ALA . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 71' ' ' LEU . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.648 HG23 ' N ' ' A' ' 66' ' ' ALA . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 58' ' ' VAL . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 83' ' ' ILE . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.836 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.422 HG22 ' HG ' ' A' ' 47' ' ' LEU . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 80' ' ' GLN . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HD2' HD21 ' A' ' 47' ' ' LEU . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.783 HG23 ' HB2' ' A' ' 20' ' ' MET . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.612 HD11 ' SG ' ' A' ' 31' ' ' CYS . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 98' ' ' LYS . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.577 HE22 HG21 ' A' ' 37' ' ' VAL . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.687 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 137' ' ' MET . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 111' ' ' ILE . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 127' ' ' PRO . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 126' ' ' ARG . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . 0.603 ' C ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.738 ' N ' HG12 ' A' ' 120' ' ' VAL . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 133' ' ' ILE . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 130' ' ' VAL . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.741 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HE2' HG22 ' A' ' 144' ' ' VAL . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.678 HG22 ' HE2' ' A' ' 142' ' ' TYR . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 158' ' ' ILE . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 158' ' ' ILE . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG13 ' A' ' 157' ' ' VAL . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.563 HD23 ' NZ ' ' A' ' 164' ' ' LYS . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.563 ' NZ ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.479 ' CD1' HD13 ' A' ' 158' ' ' ILE . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.647 0.26 . . . . 0.0 110.682 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.432 ' HG2' HD12 ' A' ' 212' ' ' ILE . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.412 HG23 HG22 ' A' ' 208' ' ' ILE . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.846 ' CD2' HD22 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 205' ' ' GLN . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.846 HD22 ' CD2' ' A' ' 178' ' ' LEU . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.826 HD23 HD11 ' A' ' 194' ' ' ILE . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.826 HD11 HD23 ' A' ' 193' ' ' LEU . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 197' ' ' ILE . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 196' ' ' VAL . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.444 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.714 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 177' ' ' ILE . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' HG2' ' A' ' 173' ' ' ARG . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HB2' ' CB ' ' A' ' 118' ' ' LYS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.628 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 193' ' ' LEU . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 224' ' ' ILE . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' OE2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 29' ' ' ILE . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG2' HG23 ' A' ' 87' ' ' ILE . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.548 ' OE2' HG11 ' A' ' 17' ' ' VAL . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.76 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.69 ' SG ' HD11 ' A' ' 88' ' ' LEU . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.826 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 33' ' ' LYS . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.562 HD21 ' HE2' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 30' ' ' ALA . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 51' ' ' LEU . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.082 HG21 HD21 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.528 HG21 ' HG2' ' A' ' 28' ' ' GLU . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 66' ' ' ALA . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.098 HD22 HD13 ' A' ' 83' ' ' ILE . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.77 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.098 HD13 HD22 ' A' ' 71' ' ' LEU . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.814 ' HB3' HD21 ' A' ' 51' ' ' LEU . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HE2' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 83' ' ' ILE . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 93' ' ' VAL . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 93' ' ' VAL . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 95' ' ' VAL . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 111' ' ' ILE . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB2' HG13 ' A' ' 115' ' ' VAL . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.671 HG21 ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HB3' ' HG ' ' A' ' 216' ' ' CYS . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.505 ' CG2' HG22 ' A' ' 131' ' ' ILE . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.505 HG22 ' CG2' ' A' ' 129' ' ' THR . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 116' ' ' ALA . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.434 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 137' ' ' MET . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.4 mm100 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.788 HG22 HD12 ' A' ' 167' ' ' ILE . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 158' ' ' ILE . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 157' ' ' VAL . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.788 HD12 HG22 ' A' ' 158' ' ' ILE . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.718 0.294 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.428 HD12 ' CG ' ' A' ' 213' ' ' ASP . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 190' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 234' ' ' LEU . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.818 HD11 HG12 ' A' ' 209' ' ' VAL . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 205' ' ' GLN . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 190' ' ' LEU . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.583 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.838 HD22 ' CD2' ' A' ' 211' ' ' LEU . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 221' ' ' ASP . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 193' ' ' LEU . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.561 ' CG1' HG21 ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.417 ' HB2' HG23 ' A' ' 209' ' ' VAL . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 205' ' ' GLN . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.585 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 208' ' ' ILE . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.818 HG12 HD11 ' A' ' 178' ' ' LEU . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.509 ' C ' HD12 ' A' ' 211' ' ' LEU . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.838 ' CD2' HD22 ' A' ' 190' ' ' LEU . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 213' ' ' ASP . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 218' ' ' ARG . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 193' ' ' LEU . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.731 ' N ' HD12 ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.583 HG21 ' HD2' ' A' ' 189' ' ' LYS . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 177' ' ' ILE . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.545 HG22 ' NE2' ' A' ' 52' ' ' GLN . 23.1 t . . . . . 0 C--O 1.232 0.166 0 CA-C-O 120.723 0.297 . . . . 0.0 110.948 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 31' ' ' CYS . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.863 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' HE ' ' A' ' 22' ' ' ARG . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.702 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' HG23 ' A' ' 50' ' ' VAL . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 33' ' ' LYS . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 54' ' ' HIS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.545 ' NE2' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 66' ' ' ALA . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 83' ' ' ILE . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.444 HD11 ' OD1' ' A' ' 78' ' ' ASP . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 72' ' ' ILE . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.999 HD13 HD22 ' A' ' 71' ' ' LEU . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 29' ' ' ILE . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HG2' HD21 ' A' ' 47' ' ' LEU . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CD2' HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.727 ' HA ' HD12 ' A' ' 114' ' ' ILE . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.921 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 111' ' ' ILE . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 133' ' ' ILE . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 215' ' ' GLY . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.921 HG21 ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.646 ' HE1' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.491 ' CG ' ' HE3' ' A' ' 137' ' ' MET . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.535 HG13 HE22 ' A' ' 153' ' ' GLN . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.4 tt0 -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 153' ' ' GLN . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.821 ' HA ' HD13 ' A' ' 167' ' ' ILE . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 157' ' ' VAL . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.821 HD13 ' HA ' ' A' ' 158' ' ' ILE . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.737 0.304 . . . . 0.0 110.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.557 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.748 ' CG2' HD12 ' A' ' 206' ' ' LEU . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.883 HD22 ' HB2' ' A' ' 186' ' ' LEU . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 178' ' ' LEU . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.581 ' HB3' HD23 ' A' ' 178' ' ' LEU . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.883 ' HB2' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.841 ' CG ' HG21 ' A' ' 209' ' ' VAL . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.879 ' HD3' HD11 ' A' ' 224' ' ' ILE . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 211' ' ' LEU . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 ' OD1' ' A' ' 221' ' ' ASP . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 211' ' ' LEU . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.416 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 211' ' ' LEU . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 187' ' ' LYS . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.776 HD22 HD12 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 120' ' ' VAL . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.879 HD11 ' HD3' ' A' ' 189' ' ' LYS . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.748 ' HE3' HD11 ' A' ' 211' ' ' LEU . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' HD12 ' A' ' 178' ' ' LEU . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.852 0.358 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 60' ' ' VAL . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG22 HG23 ' A' ' 93' ' ' VAL . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.405 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.905 ' HB2' HG23 ' A' ' 87' ' ' ILE . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.843 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.489 ' CB ' HG23 ' A' ' 50' ' ' VAL . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 32' ' ' TYR . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 33' ' ' LYS . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.488 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.48 ' CH2' ' HE2' ' A' ' 85' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.683 HD21 ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.868 HG22 ' HB3' ' A' ' 30' ' ' ALA . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.549 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 66' ' ' ALA . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 HG13 ' A' ' 17' ' ' VAL . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.953 HD22 HD13 ' A' ' 83' ' ' ILE . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.745 ' CE2' HG23 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 83' ' ' ILE . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.953 HD13 HD22 ' A' ' 71' ' ' LEU . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 29' ' ' ILE . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.683 ' HE2' HD21 ' A' ' 47' ' ' LEU . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 20' ' ' MET . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 84' ' ' CYS . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.641 ' C ' HG13 ' A' ' 18' ' ' VAL . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 HG22 ' A' ' 18' ' ' VAL . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 113' ' ' THR . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.64 ' OD1' HD11 ' A' ' 114' ' ' ILE . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.839 ' O ' HG23 ' A' ' 115' ' ' VAL . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 109' ' ' ARG . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.64 HD11 ' OD1' ' A' ' 110' ' ' ASP . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 216' ' ' CYS . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.526 ' CD1' HD13 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 131' ' ' ILE . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.448 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG22 ' CG2' ' A' ' 129' ' ' THR . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 157' ' ' VAL . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 153' ' ' GLN . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.664 ' HA ' HD12 ' A' ' 167' ' ' ILE . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 167' ' ' ILE . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 158' ' ' ILE . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 167' ' ' ILE . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.654 0.264 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.743 ' HG3' HG23 ' A' ' 212' ' ' ILE . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 237' ' ' LEU . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.791 ' C ' HD13 ' A' ' 178' ' ' LEU . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 182' ' ' GLU . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 205' ' ' GLN . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 211' ' ' LEU . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 194' ' ' ILE . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 191' ' ' LYS . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.716 ' C ' HG12 ' A' ' 180' ' ' VAL . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 205' ' ' GLN . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 190' ' ' LEU . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.743 HG23 ' HG3' ' A' ' 173' ' ' ARG . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.496 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HG3' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 52' ' ' GLN . 22.1 t . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.767 0.318 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 60' ' ' VAL . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG22 HG23 ' A' ' 93' ' ' VAL . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.885 ' HB2' HG23 ' A' ' 87' ' ' ILE . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.567 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.675 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.718 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.693 ' HB2' HG23 ' A' ' 50' ' ' VAL . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' ASN . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.645 ' HA ' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.894 0.378 . . . . 0.0 111.086 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 35' ' ' LYS . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HG2' HG21 ' A' ' 15' ' ' VAL . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.607 HG21 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.567 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.082 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.553 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.553 ' OD1' HD11 ' A' ' 72' ' ' ILE . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.87 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.082 HD13 HD22 ' A' ' 71' ' ' LEU . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.71 ' O ' HD13 ' A' ' 88' ' ' LEU . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB2' ' A' ' 20' ' ' MET . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 40' ' ' ARG . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.599 HG23 HG22 ' A' ' 18' ' ' VAL . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.551 ' O ' HG22 ' A' ' 102' ' ' THR . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 98' ' ' LYS . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 102' ' ' THR . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.779 ' HB3' HG21 ' A' ' 150' ' ' THR . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.817 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 111' ' ' ILE . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 128' ' ' TYR . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.454 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' CYS . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 140' ' ' ILE . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.77 HG13 ' HG2' ' A' ' 153' ' ' GLN . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.421 ' HA ' HG23 ' A' ' 37' ' ' VAL . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.779 HG21 ' HB3' ' A' ' 110' ' ' ASP . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.903 ' O ' HG23 ' A' ' 157' ' ' VAL . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.461 HG22 HG21 ' A' ' 167' ' ' ILE . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 168' ' ' GLU . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 . . . . . 0 N--CA 1.458 -0.04 0 CA-C-O 120.848 0.356 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 211' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.618 HD12 ' CA ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.54 ' N ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.618 ' CA ' HD12 ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 187' ' ' LYS . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.726 ' N ' HD12 ' A' ' 186' ' ' LEU . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.711 ' HD3' HG21 ' A' ' 228' ' ' THR . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 186' ' ' LEU . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.56 HD13 ' OD1' ' A' ' 221' ' ' ASP . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 194' ' ' ILE . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.675 ' C ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 195' ' ' LYS . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.404 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 193' ' ' LEU . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.56 ' OD1' HD13 ' A' ' 194' ' ' ILE . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.702 HG21 HD22 ' A' ' 193' ' ' LEU . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.711 HG21 ' HD3' ' A' ' 189' ' ' LYS . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . 0.527 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 52' ' ' GLN . 61.0 t . . . . . 0 N--CA 1.457 -0.107 0 CA-C-O 120.893 0.378 . . . . 0.0 111.124 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.557 ' HB ' HD12 ' A' ' 29' ' ' ILE . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.877 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 17' ' ' VAL . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.893 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.608 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 38' ' ' GLY . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.775 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.842 0.353 . . . . 0.0 111.422 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.659 HD11 ' SG ' ' A' ' 84' ' ' CYS . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 15' ' ' VAL . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.041 HG21 HD21 ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 60' ' ' VAL . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.517 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 66' ' ' ALA . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 72' ' ' ILE . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.118 HD22 HD13 ' A' ' 83' ' ' ILE . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 68' ' ' LYS . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.118 HD13 HD22 ' A' ' 71' ' ' LEU . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.893 ' SG ' HG21 ' A' ' 29' ' ' ILE . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HE3' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 20' ' ' MET . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.582 HD11 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.566 ' CE ' HG22 ' A' ' 150' ' ' THR . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.636 ' HD1' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 107' ' ' MET . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.591 HG23 ' HD2' ' A' ' 118' ' ' LYS . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 133' ' ' ILE . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 114' ' ' ILE . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 116' ' ' ALA . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.418 ' SD ' HG13 ' A' ' 157' ' ' VAL . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 140' ' ' ILE . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.636 HG21 ' HD1' ' A' ' 108' ' ' PHE . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.566 HG22 ' CE ' ' A' ' 107' ' ' MET . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.871 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 154' ' ' ALA . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 158' ' ' ILE . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 140' ' ' ILE . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.601 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 168' ' ' GLU . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 167' ' ' ILE . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.0 ttp180 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 . . . . . 0 N--CA 1.457 -0.099 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.642 HD22 HD13 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 177' ' ' ILE . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 182' ' ' GLU . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 205' ' ' GLN . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.62 HD13 HD21 ' A' ' 211' ' ' LEU . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 194' ' ' ILE . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.942 HG23 HD23 ' A' ' 193' ' ' LEU . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.538 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.721 ' HA ' HG22 ' A' ' 180' ' ' VAL . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.568 ' H ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.642 HD13 HD22 ' A' ' 174' ' ' LEU . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 197' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.583 HG22 HD21 ' A' ' 193' ' ' LEU . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.487 ' OD1' HD22 ' A' ' 211' ' ' LEU . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.472 ' HZ1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 224' ' ' ILE . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 234' ' ' LEU . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.208 0 CA-C-O 120.571 0.224 . . . . 0.0 110.51 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG21 ' A' ' 60' ' ' VAL . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 93' ' ' VAL . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.944 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.665 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.4 ' CB ' HG23 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HG ' ' A' ' 88' ' ' LEU . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 147' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.481 ' C ' ' CD1' ' A' ' 39' ' ' TRP . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.1 t0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.89 0.376 . . . . 0.0 111.052 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.943 HD12 HD12 ' A' ' 51' ' ' LEU . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 51' ' ' LEU . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.944 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 1.001 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 71' ' ' LEU . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.613 HG21 HG13 ' A' ' 17' ' ' VAL . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 83' ' ' ILE . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.715 ' CE2' HG23 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 71' ' ' LEU . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 29' ' ' ILE . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.686 ' CE ' HD21 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 18' ' ' VAL . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CB ' HG21 ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 130' ' ' VAL . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' ILE . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HD3' ' ND1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.752 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 216' ' ' CYS . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.708 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 132' ' ' LEU . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.661 HG13 ' HB1' ' A' ' 112' ' ' ALA . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.708 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 140' ' ' ILE . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 157' ' ' VAL . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 111' ' ' ILE . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 37' ' ' VAL . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.414 HG21 ' CB ' ' A' ' 110' ' ' ASP . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 153' ' ' GLN . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 167' ' ' ILE . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 140' ' ' ILE . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 158' ' ' ILE . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.404 ' ND1' ' HD3' ' A' ' 118' ' ' LYS . 8.1 t60 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.793 0.33 . . . . 0.0 111.093 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 225' ' ' LYS . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 236' ' ' VAL . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 178' ' ' LEU . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.574 HG13 ' C ' ' A' ' 204' ' ' GLN . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.581 ' O ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 178' ' ' LEU . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 190' ' ' LEU . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 178' ' ' LEU . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 228' ' ' THR . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 186' ' ' LEU . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.715 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . 0.598 ' CB ' HG22 ' A' ' 209' ' ' VAL . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.574 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 199' ' ' SER . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.523 ' H ' HG22 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.723 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.706 HG21 ' HG3' ' A' ' 189' ' ' LYS . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 234' ' ' LEU . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 233' ' ' SER . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 16' ' ' ALA . 22.2 t . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.848 0.356 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.924 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.622 HG12 ' HG2' ' A' ' 28' ' ' GLU . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 93' ' ' VAL . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.797 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.924 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 33' ' ' LYS . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.733 ' CH2' HD23 ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.2 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.924 0.393 . . . . 0.0 111.268 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.019 HG21 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.688 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.019 HD21 HG21 ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.625 HD11 ' OD1' ' A' ' 78' ' ' ASP . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' HD11 ' A' ' 72' ' ' ILE . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 71' ' ' LEU . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.686 ' O ' HD13 ' A' ' 88' ' ' LEU . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' MET . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 18' ' ' VAL . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.552 ' O ' HD13 ' A' ' 104' ' ' LEU . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 100' ' ' ARG . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 113' ' ' THR . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.593 ' O ' HG12 ' A' ' 115' ' ' VAL . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 133' ' ' ILE . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 110' ' ' ASP . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.645 HG13 HG21 ' A' ' 133' ' ' ILE . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 115' ' ' VAL . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 167' ' ' ILE . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 127' ' ' PRO . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.801 ' HA ' HG12 ' A' ' 120' ' ' VAL . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.511 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 133' ' ' ILE . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 132' ' ' LEU . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 129' ' ' THR . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.697 HG21 ' HB3' ' A' ' 103' ' ' GLN . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 153' ' ' GLN . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 167' ' ' ILE . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.683 HD11 ' CE ' ' A' ' 137' ' ' MET . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.653 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.477 ' HG2' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 . . . . . 0 N--CA 1.461 0.094 0 CA-C-O 120.563 0.22 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.681 HD21 ' OE1' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.687 HD21 ' HG2' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HG3' HG21 ' A' ' 228' ' ' THR . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.646 ' CD1' HD23 ' A' ' 186' ' ' LEU . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 224' ' ' ILE . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.807 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.73 HG21 ' CD1' ' A' ' 212' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.695 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.681 ' OE1' HD21 ' A' ' 178' ' ' LEU . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 197' ' ' ILE . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.807 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 197' ' ' ILE . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . 0.576 ' HA3' HG22 ' A' ' 120' ' ' VAL . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.549 ' CG ' HD11 ' A' ' 194' ' ' ILE . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 193' ' ' LEU . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.687 ' HG2' HD21 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.594 HG21 ' HG3' ' A' ' 189' ' ' LYS . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.409 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 182' ' ' GLU . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.416 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 52' ' ' GLN . 48.5 t . . . . . 0 N--CA 1.457 -0.091 0 CA-C-O 120.791 0.329 . . . . 0.0 110.996 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.678 HG22 ' HA ' ' A' ' 93' ' ' VAL . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.709 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.639 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.723 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' SG ' ' A' ' 31' ' ' CYS . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 38' ' ' GLY . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.819 ' CE3' HG11 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 81' ' ' THR . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CE3' ' A' ' 39' ' ' TRP . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.684 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.698 ' HG2' HG21 ' A' ' 15' ' ' VAL . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.598 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.666 ' CB ' HD21 ' A' ' 71' ' ' LEU . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.463 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.493 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 83' ' ' ILE . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.497 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.77 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 71' ' ' LEU . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.709 ' SG ' HG21 ' A' ' 29' ' ' ILE . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD1' HD11 ' A' ' 29' ' ' ILE . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 18' ' ' VAL . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 93' ' ' VAL . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . 0.693 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HD1' HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.91 HG23 ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' ILE . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.91 ' HD2' HG23 ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.682 ' O ' HD12 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 129' ' ' THR . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.474 ' SD ' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 107' ' ' MET . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.427 HG22 ' SD ' ' A' ' 107' ' ' MET . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 167' ' ' ILE . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 157' ' ' VAL . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.855 ' HB ' HG23 ' A' ' 158' ' ' ILE . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.876 0.37 . . . . 0.0 111.133 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.584 HD13 ' H ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.584 ' H ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.693 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.822 ' HA ' HD23 ' A' ' 206' ' ' LEU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.582 HG22 ' C ' ' A' ' 205' ' ' GLN . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.693 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . 0.475 ' HE2' HG23 ' A' ' 228' ' ' THR . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' ' 225' ' ' LYS . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 211' ' ' LEU . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.582 ' C ' HG22 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.758 HD22 HD11 ' A' ' 194' ' ' ILE . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 193' ' ' LEU . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.57 HD12 HD21 ' A' ' 186' ' ' LEU . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.852 ' HA ' HD11 ' A' ' 186' ' ' LEU . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.475 HG23 ' HE2' ' A' ' 185' ' ' LYS . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' CYS . 21.0 t . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.748 0.308 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 28' ' ' GLU . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.888 HG22 HG12 ' A' ' 93' ' ' VAL . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CB ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.823 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.82 ' SG ' HG21 ' A' ' 36' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ALA . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 93' ' ' VAL . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.749 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.799 0.333 . . . . 0.0 111.287 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.862 ' HG ' HG22 ' A' ' 81' ' ' THR . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.749 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.821 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 1.026 HG21 HD21 ' A' ' 71' ' ' LEU . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 56' ' ' VAL . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.665 ' HA ' HD12 ' A' ' 83' ' ' ILE . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 71' ' ' LEU . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.823 ' SG ' HG21 ' A' ' 29' ' ' ILE . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' HG11 ' A' ' 18' ' ' VAL . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 18' ' ' VAL . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.591 HG12 ' HD3' ' A' ' 33' ' ' LYS . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.627 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 114' ' ' ILE . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 111' ' ' ILE . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.406 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.62 HG11 ' H ' ' A' ' 216' ' ' CYS . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 132' ' ' LEU . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.424 HG12 ' HG3' ' A' ' 134' ' ' GLU . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 132' ' ' LEU . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.857 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HG3' HG12 ' A' ' 130' ' ' VAL . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 137' ' ' MET . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 146' ' ' THR . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HD2' HG23 ' A' ' 150' ' ' THR . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.764 ' HA ' HD11 ' A' ' 167' ' ' ILE . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 157' ' ' VAL . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.764 HD11 ' HA ' ' A' ' 158' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.648 0.261 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.625 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 236' ' ' VAL . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 186' ' ' LEU . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 206' ' ' LEU . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.686 ' HB3' HD23 ' A' ' 178' ' ' LEU . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 197' ' ' ILE . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 198' ' ' GLU . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.642 ' HB2' HD12 ' A' ' 197' ' ' ILE . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.484 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.48 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.0 OUTLIER 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 180' ' ' VAL . 1.4 mt-30 -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.58 HD12 ' H ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' HD12 ' A' ' 178' ' ' LEU . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 212' ' ' ILE . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.62 ' H ' HG11 ' A' ' 120' ' ' VAL . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 217' ' ' PHE . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.566 ' OD1' HD21 ' A' ' 190' ' ' LEU . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 193' ' ' LEU . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.58 ' N ' HD12 ' A' ' 224' ' ' ILE . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . 0.482 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 177' ' ' ILE . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.502 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.764 0.316 . . . . 0.0 110.954 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 88' ' ' LEU . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE1' ' HG3' ' A' ' 86' ' ' GLN . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 60' ' ' VAL . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.951 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 38' ' ' GLY . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.41 ' CZ2' ' HG2' ' A' ' 85' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.823 0.344 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.71 HD21 ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 35' ' ' LYS . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 30' ' ' ALA . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.747 ' HA ' HD13 ' A' ' 51' ' ' LEU . 90.8 m-70 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.013 HD22 HD13 ' A' ' 83' ' ' ILE . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 ' OD1' ' A' ' 78' ' ' ASP . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CE2' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.589 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.505 ' CB ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 1.013 HD13 HD22 ' A' ' 71' ' ' LEU . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.947 ' CB ' HD11 ' A' ' 51' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HD2' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HG3' ' HE1' ' A' ' 20' ' ' MET . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 83' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' ARG . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.741 ' HA ' HG22 ' A' ' 18' ' ' VAL . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 144' ' ' VAL . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 118' ' ' LYS . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.883 HG13 HG21 ' A' ' 167' ' ' ILE . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.782 ' HD3' HG23 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 216' ' ' CYS . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.419 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 131' ' ' ILE . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.462 ' H ' HG22 ' A' ' 129' ' ' THR . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 157' ' ' VAL . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 108' ' ' PHE . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 167' ' ' ILE . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' VAL . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.883 HG21 HG13 ' A' ' 115' ' ' VAL . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.852 0.358 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 211' ' ' LEU . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.945 HD12 HG22 ' A' ' 208' ' ' ILE . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 207' ' ' GLU . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 182' ' ' GLU . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 205' ' ' GLN . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 179' ' ' PRO . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 229' ' ' LYS . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 194' ' ' ILE . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.799 HD13 ' HB3' ' A' ' 211' ' ' LEU . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 1.093 HG12 HD22 ' A' ' 211' ' ' LEU . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . 0.432 ' HG3' HD11 ' A' ' 208' ' ' ILE . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.459 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.735 ' HA ' HG22 ' A' ' 180' ' ' VAL . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 178' ' ' LEU . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.945 HG22 HD12 ' A' ' 177' ' ' ILE . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.411 ' O ' HD23 ' A' ' 211' ' ' LEU . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 1.093 HD22 HG12 ' A' ' 196' ' ' VAL . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.799 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 223' ' ' LEU . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.658 ' HG3' HD21 ' A' ' 186' ' ' LEU . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER . . . . . 0 CA--C 1.533 0.289 0 CA-C-O 120.788 0.328 . . . . 0.0 111.488 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HG22 ' A' ' 87' ' ' ILE . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.59 ' HB3' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.773 HG22 ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.856 ' SG ' HG22 ' A' ' 50' ' ' VAL . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.774 ' CB ' HG23 ' A' ' 50' ' ' VAL . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 147' ' ' ASN . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.922 0.392 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.856 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.843 ' CB ' ' HB3' ' A' ' 30' ' ' ALA . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.879 ' HA ' HD13 ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' A' ' 29' ' ' ILE . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.735 HD22 HD13 ' A' ' 83' ' ' ILE . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.667 HD11 ' OD1' ' A' ' 78' ' ' ASP . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.667 ' OD1' HD11 ' A' ' 72' ' ' ILE . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.459 HG22 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 87' ' ' ILE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 29' ' ' ILE . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.674 ' CE ' HD21 ' A' ' 47' ' ' LEU . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.792 HD11 HG22 ' A' ' 83' ' ' ILE . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' OE2' ' A' ' 99' ' ' GLU . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.554 ' OE2' HG11 ' A' ' 95' ' ' VAL . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 144' ' ' VAL . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 130' ' ' VAL . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 111' ' ' ILE . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 169' ' ' ARG . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.514 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.471 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 128' ' ' TYR . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.413 ' HE3' HG21 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 142' ' ' TYR . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 140' ' ' ILE . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 111' ' ' ILE . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.683 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 153' ' ' GLN . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 157' ' ' VAL . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 167' ' ' ILE . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.932 0.396 . . . . 0.0 111.078 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.816 ' HG2' HD12 ' A' ' 212' ' ' ILE . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.843 HD12 ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.802 ' HA ' HD23 ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 205' ' ' GLN . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.843 ' HA2' HD12 ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 211' ' ' LEU . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 211' ' ' LEU . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 212' ' ' ILE . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . 0.411 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.626 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 197' ' ' ILE . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 190' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.816 HD12 ' HG2' ' A' ' 173' ' ' ARG . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . 0.421 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HA ' HD12 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' PHE . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.493 ' OD2' HD13 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . 0.415 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . 0.635 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 186' ' ' LEU . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.407 ' HB2' ' CB ' ' A' ' 233' ' ' SER . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 229' ' ' LYS . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 12.3 m-80 . . . . . 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.3 OUTLIER . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 15' ' ' VAL . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 60' ' ' VAL . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 88' ' ' LEU . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.853 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.612 ' OE2' HG23 ' A' ' 60' ' ' VAL . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.87 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.902 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.791 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HB2' HG11 ' A' ' 95' ' ' VAL . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.596 ' O ' HG12 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.78 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 147' ' ' ASN . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.813 0.34 . . . . 0.0 110.811 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.611 HD21 ' CE ' ' A' ' 85' ' ' LYS . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.902 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.702 HD11 ' CB ' ' A' ' 84' ' ' CYS . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.949 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.63 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.612 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.995 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.751 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.751 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.995 HD13 HD22 ' A' ' 71' ' ' LEU . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.87 ' SG ' HG21 ' A' ' 29' ' ' ILE . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.611 ' CE ' HD21 ' A' ' 47' ' ' LEU . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.853 HG23 ' HB2' ' A' ' 20' ' ' MET . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 18' ' ' VAL . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG21 HG11 ' A' ' 36' ' ' VAL . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 33' ' ' LYS . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.498 ' O ' HG22 ' A' ' 102' ' ' THR . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 144' ' ' VAL . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB1' HG12 ' A' ' 130' ' ' VAL . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 114' ' ' ILE . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 113' ' ' THR . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 111' ' ' ILE . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' CYS . . . . . 0.792 ' SG ' HD13 ' A' ' 167' ' ' ILE . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.709 HG21 ' HE2' ' A' ' 125' ' ' LYS . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 35.8 t30 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HE2' HG21 ' A' ' 120' ' ' VAL . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' THR . . . . . 0.58 ' OG1' HD23 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.747 HG12 ' HB1' ' A' ' 112' ' ' ALA . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 129' ' ' THR . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 161' ' ' LEU . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.445 ' CE ' HG22 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 136' ' ' ALA . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 108' ' ' PHE . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASN . . . . . 0.769 ' HA ' HG23 ' A' ' 37' ' ' VAL . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLN . . . . . 0.913 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 153' ' ' GLN . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 167' ' ' ILE . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 157' ' ' VAL . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ILE . . . . . 0.792 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 . . . . . 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.761 0.315 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' HG23 ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 186' ' ' LEU . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 205' ' ' GLN . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.853 HD11 ' HB3' ' A' ' 178' ' ' LEU . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.699 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.454 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.559 HD11 HG22 ' A' ' 220' ' ' ILE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . 0.812 HG13 HD22 ' A' ' 211' ' ' LEU . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 209' ' ' VAL . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 196' ' ' VAL . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.589 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 178' ' ' LEU . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 196' ' ' VAL . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . 0.812 HD22 HG13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 173' ' ' ARG . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 224' ' ' ILE . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 193' ' ' LEU . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 220' ' ' ILE . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 186' ' ' LEU . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.835 0.35 . . . . 0.0 111.199 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.649 ' O ' HD12 ' A' ' 3' ' ' ILE . 0.6 OUTLIER -71.48 -171.28 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.794 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.649 HD12 ' O ' ' A' ' 2' ' ' SER . 1.3 mp 77.74 -54.66 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.471 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 12' ' ' LEU . 56.7 t80 64.34 102.11 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.882 0.372 . . . . 0.0 110.786 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.1 p -131.26 119.87 17.82 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.61 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.24 52.73 4.4 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.459 2.106 . . . . 0.0 112.67 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.547 HG22 ' O ' ' A' ' 7' ' ' THR . 25.0 m -165.32 31.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.837 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -153.21 -61.42 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.987 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.08 -76.59 0.61 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.068 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 pt -119.23 150.52 21.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.22 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.1 mtt-85 -91.01 -45.83 8.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.887 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 13' ' ' THR . 3.8 tt 59.91 92.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.452 ' O ' HD23 ' A' ' 12' ' ' LEU . 2.1 p -59.0 169.63 1.0 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.755 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -96.02 23.8 6.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.502 HG12 ' N ' ' A' ' 16' ' ' ALA . 70.4 t -59.05 159.93 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.839 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.624 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.24 134.68 41.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.512 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.529 HG13 HG21 ' A' ' 60' ' ' VAL . 21.1 t -112.59 124.05 68.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.989 0.423 . . . . 0.0 111.565 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG13 ' C ' ' A' ' 92' ' ' GLU . 21.2 t -113.22 136.04 50.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.734 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -120.25 154.26 35.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.351 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.887 ' HB2' HG23 ' A' ' 87' ' ' ILE . 6.0 tmm? -153.64 133.64 13.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.827 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 129.89 37.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' HD3' ' CD1' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -164.22 138.01 5.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.944 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 62.11 17.63 9.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.488 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -36.64 3.62 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.743 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -85.24 147.73 26.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.845 0.355 . . . . 0.0 111.123 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.14 128.78 46.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.763 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 78.0 m-85 -113.63 154.78 26.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.488 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.1 OUTLIER -145.21 150.4 36.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.875 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.574 HD11 HD12 ' A' ' 88' ' ' LEU . 0.3 OUTLIER -140.42 148.32 22.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-O 120.86 0.362 . . . . 0.0 111.3 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.13 107.41 19.22 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.145 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.782 ' SG ' HD11 ' A' ' 88' ' ' LEU . 1.4 p -134.61 177.62 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.118 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.738 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.0 m-85 -90.17 133.41 34.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.055 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.438 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -61.11 -36.39 79.59 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.003 179.804 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -74.36 -46.18 42.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.455 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' CB ' HG23 ' A' ' 50' ' ' VAL . 5.2 mptt -69.52 -35.91 75.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.967 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 32' ' ' TYR . 70.9 t -68.34 -50.37 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.697 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.459 HG13 ' N ' ' A' ' 38' ' ' GLY . 13.5 p -59.46 -43.97 91.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.811 0.339 . . . . 0.0 110.682 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.25 -35.36 82.6 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.072 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.738 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.9 t-105 -64.72 -55.97 16.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.859 0.362 . . . . 0.0 110.397 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -59.94 -35.33 74.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.774 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 47.5 t -59.54 -26.38 65.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.897 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.95 28.84 2.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.646 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.4 t -104.74 125.42 59.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.761 0.315 . . . . 0.0 111.108 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.67 88.28 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.929 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -106.24 156.59 18.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.78 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -94.63 136.44 34.93 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.004 0.43 . . . . 0.0 111.424 -179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.763 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -64.09 -29.12 70.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.157 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -65.63 -12.74 55.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.481 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -115.21 -46.23 2.9 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.699 0.285 . . . . 0.0 111.39 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG12 ' HA ' ' A' ' 47' ' ' LEU . 10.7 p -66.9 -28.92 44.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.742 0.306 . . . . 0.0 111.433 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.763 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -103.3 107.36 18.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.915 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -74.59 -32.3 62.31 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.08 0.467 . . . . 0.0 110.063 179.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.518 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.2 m -123.51 110.56 15.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.606 179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.4 m80 -80.23 59.16 3.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.858 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -165.14 131.29 2.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.791 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 71' ' ' LEU . 21.9 t -69.6 108.14 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.985 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.745 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.6 m-85 -86.62 -175.19 5.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.331 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.3 t -132.41 -54.14 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.341 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 34.4 t30 -126.58 71.42 1.29 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.199 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.529 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.71 -37.29 39.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.357 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.8 t -55.67 -27.95 52.85 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.224 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -112.14 -26.06 9.01 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.143 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.49 52.01 1.01 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.546 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -117.45 119.55 35.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.84 0.352 . . . . 0.0 110.785 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.745 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 17.2 t -95.01 152.76 3.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.251 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.467 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.66 -169.58 2.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.037 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.9 151.86 40.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -65.12 -43.41 92.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -57.17 -55.02 40.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.886 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.42 -33.31 74.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.704 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.112 HD22 HD13 ' A' ' 83' ' ' ILE . 5.5 mt -59.64 -45.11 92.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.769 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.455 HD11 ' HB3' ' A' ' 78' ' ' ASP . 4.2 mt -76.08 -29.43 19.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.277 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.3 -15.14 56.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.517 -179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.38 -33.94 9.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.655 0.264 . . . . 0.0 111.675 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.466 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 74.3 m-85 -112.79 -26.94 8.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.55 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 99.84 12.0 41.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.634 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.05 157.64 43.09 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.943 0.401 . . . . 0.0 110.875 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.455 ' HB3' HD11 ' A' ' 72' ' ' ILE . 9.5 p-10 -97.96 -17.21 19.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.017 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.83 94.14 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.879 0.371 . . . . 0.0 110.981 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.693 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -57.41 -34.19 68.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.81 179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.0 -48.41 80.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.322 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.0 -51.29 70.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.343 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.112 HD13 HD22 ' A' ' 71' ' ' LEU . 5.5 mt -55.9 -38.59 52.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.56 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.682 ' SG ' HD11 ' A' ' 51' ' ' LEU . 66.6 m -59.79 -45.94 90.75 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.232 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.607 ' HG2' HD21 ' A' ' 47' ' ' LEU . 31.8 mttt -58.02 -44.53 87.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.095 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.94 -50.49 70.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.869 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.887 HG23 ' HB2' ' A' ' 20' ' ' MET . 56.1 mt -65.17 -29.65 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.059 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.782 HD11 ' SG ' ' A' ' 31' ' ' CYS . 3.1 mp -72.95 -29.58 63.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.037 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.4 p -95.51 -38.36 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.275 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -44.28 7.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.104 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.38 175.25 11.94 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.625 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.591 ' C ' HG13 ' A' ' 18' ' ' VAL . 0.0 OUTLIER -109.46 136.23 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.84 0.353 . . . . 0.0 110.821 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -88.94 135.7 25.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.121 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -97.23 108.07 20.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.897 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 m -130.75 145.59 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.217 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.4 m -69.75 175.97 3.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.879 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -62.34 -37.86 87.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -60.73 -47.37 86.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.936 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.92 -30.71 69.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.958 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.7 ttp180 -83.05 -38.17 22.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.982 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.66 -42.67 77.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.944 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.411 HG23 ' N ' ' A' ' 103' ' ' GLN . 9.7 t -59.75 -45.06 93.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.839 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.411 ' N ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -66.72 -34.96 78.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.872 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.73 -48.98 64.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.843 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -60.64 -43.97 96.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.83 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -62.15 -48.97 77.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.832 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.451 ' HG2' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -62.7 -46.98 85.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.86 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.9 OUTLIER -60.05 -43.28 95.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.2 ttt85 -60.49 -43.9 96.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.789 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.31 -52.03 66.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.807 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.1 mt -55.05 -44.43 74.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.171 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -65.68 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.152 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 60.5 m -71.06 -47.84 56.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.5 mm -65.25 -33.22 62.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.199 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 111' ' ' ILE . 45.6 t -81.1 -27.65 10.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.293 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -90.1 -26.26 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.374 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.26 -27.02 12.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.263 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -123.93 54.59 1.32 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.88 0.371 . . . . 0.0 111.065 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.73 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.8 OUTLIER 178.29 155.08 0.38 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 215' ' ' GLY . 2.8 m -136.17 179.06 4.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.169 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -129.63 155.34 80.46 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.817 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.54 63.86 1.18 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.567 2.178 . . . . 0.0 112.224 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.77 76.88 0.88 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.896 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 59.95 25.4 14.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.099 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.07 31.77 16.89 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.904 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.88 113.59 26.15 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.878 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -55.93 125.97 20.85 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.408 2.072 . . . . 0.0 112.231 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.52 165.37 25.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.835 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.55 149.26 24.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.975 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.6 m -54.15 -37.98 37.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 8.9 tp -66.34 -31.3 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -71.53 -47.4 55.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.746 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.516 HD13 ' HB ' ' A' ' 115' ' ' VAL . 6.2 mt -64.43 -38.18 81.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.05 -45.04 78.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.79 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -49.67 76.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.836 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.474 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -61.66 -41.17 97.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.2 ttt -59.92 -40.31 88.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.838 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 5.4 ttpt -77.96 -39.33 42.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.872 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -29.88 70.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.021 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.474 HG22 ' O ' ' A' ' 136' ' ' ALA . 0.8 OUTLIER -93.0 17.07 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.499 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 53.76 50.06 17.83 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.897 0.379 . . . . 0.0 111.067 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.424 ' CE2' ' HA ' ' A' ' 157' ' ' VAL . 3.2 t80 -94.8 122.04 37.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.46 116.61 32.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.896 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.451 HG11 ' HG2' ' A' ' 107' ' ' MET . 21.4 t -65.79 154.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.16 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.413 ' N ' HG12 ' A' ' 144' ' ' VAL . 0.1 OUTLIER -104.51 85.47 2.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 22.1 p -60.81 -18.08 53.37 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.364 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -92.41 18.41 8.49 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.42 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -148.17 -179.25 6.79 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.826 0.346 . . . . 0.0 110.915 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.2 p -86.18 146.64 26.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.924 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 33.4 p -65.25 -42.47 93.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.954 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -50.85 25.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.18 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -61.15 -32.02 71.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.771 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 27.9 mm100 -74.68 -22.75 58.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.239 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.7 ' O ' HG23 ' A' ' 158' ' ' ILE . . . -52.44 -42.69 64.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.499 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.419 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.0 mt -63.54 -47.42 81.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.194 -179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -63.93 -40.42 96.4 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.418 -179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 158' ' ' ILE . 14.4 p -74.28 -45.49 46.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.853 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.7 HG23 ' O ' ' A' ' 154' ' ' ALA . 1.1 pp -64.64 -30.77 51.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.628 0.251 . . . . 0.0 111.261 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 15.2 tttt -78.72 -49.5 13.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.802 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -64.3 -39.06 93.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.941 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.435 ' HA ' HD23 ' A' ' 161' ' ' LEU . 11.8 mt -57.9 -24.46 57.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.132 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 38.7 mttm -55.01 -29.96 58.47 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.058 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.74 -45.25 90.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -88.73 -62.18 1.54 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.853 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -134.86 121.64 20.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -61.69 108.58 1.01 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.73 HD11 ' HB3' ' A' ' 119' ' ' CYS . 4.7 tp -116.11 125.26 73.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.073 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -134.23 156.38 48.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.006 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 15.4 ttp-105 -109.16 136.51 48.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.88 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -151.7 136.87 17.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.921 0.391 . . . . 0.0 111.35 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -110.62 175.25 5.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.563 179.727 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.09 139.09 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.438 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.636 ' HG2' HD12 ' A' ' 212' ' ' ILE . 13.3 mtt85 -101.13 142.21 32.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.34 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.438 ' N ' ' O ' ' A' ' 211' ' ' LEU . 30.7 mt -121.05 149.92 41.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.081 0.467 . . . . 0.0 111.916 -179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -133.91 121.47 21.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.88 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 235' ' ' GLU . 4.7 m-85 -126.93 134.28 50.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.101 0.477 . . . . 0.0 111.717 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.409 HG23 HG22 ' A' ' 208' ' ' ILE . 3.8 mp -117.48 103.77 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.042 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.772 HD11 HD22 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -102.24 147.73 34.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.425 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 34.3 Cg_exo -57.38 -162.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.53 2.153 . . . . 0.0 111.993 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.6 t -75.95 -49.3 26.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.346 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -81.75 -57.8 3.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.357 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.43 -26.08 11.73 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.651 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -67.49 -24.12 73.73 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.948 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.06 -25.51 58.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.712 0.291 . . . . 0.0 111.325 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 20.0 tttp -85.93 -41.23 15.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.333 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.786 HD23 HD11 ' A' ' 190' ' ' LEU . 0.1 OUTLIER -68.67 -56.05 9.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.398 -179.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 20.8 ttpt -43.5 -53.67 5.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.814 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -59.93 -26.08 65.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.364 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.5 -43.09 21.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.528 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.926 HD13 HD21 ' A' ' 211' ' ' LEU . 21.8 mt -69.42 -35.82 76.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.557 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.589 ' HA ' HG21 ' A' ' 196' ' ' VAL . 0.1 OUTLIER -46.36 -61.21 2.79 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.67 -179.487 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 72.8 Cg_endo -75.21 -32.15 5.38 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.569 2.179 . . . . 0.0 112.962 -179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 194' ' ' ILE . 2.0 tp -52.98 -56.8 13.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.482 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.948 HD11 ' HB3' ' A' ' 211' ' ' LEU . 2.8 pp -159.42 -175.29 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.924 0.392 . . . . 0.0 111.524 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.89 121.31 10.84 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.813 -179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 191' ' ' LYS . 39.8 t -106.72 118.26 54.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.707 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.612 HD11 HD11 ' A' ' 212' ' ' ILE . 2.9 pp -131.66 160.37 42.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.922 0.391 . . . . 0.0 111.498 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.51 ' HB2' HD12 ' A' ' 197' ' ' ILE . 7.6 mm-40 57.49 62.35 2.18 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.421 ' HB3' HG13 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -106.17 122.91 47.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.025 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -133.66 118.46 18.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.693 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.42 ' CB ' ' HG2' ' A' ' 207' ' ' GLU . 2.8 p30 -129.81 144.76 51.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.153 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.64 149.55 32.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.735 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.09 110.0 0.88 Allowed Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.399 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 30.3 tp60 62.27 39.68 12.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.947 0.404 . . . . 0.0 110.396 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.631 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.57 178.26 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.164 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.82 149.02 43.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.969 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.42 ' HG2' ' CB ' ' A' ' 201' ' ' ASP . 0.1 OUTLIER -111.81 134.62 53.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.241 -179.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.409 HG22 HG23 ' A' ' 177' ' ' ILE . 2.9 pt -112.03 104.09 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.49 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.565 HG11 ' CG1' ' A' ' 196' ' ' VAL . 21.2 t -125.09 145.12 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.635 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.469 ' C ' HD22 ' A' ' 211' ' ' LEU . 22.2 m -109.5 145.54 36.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.124 179.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.948 ' HB3' HD11 ' A' ' 194' ' ' ILE . 2.6 mm? -119.86 128.94 54.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 111.751 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.636 HD12 ' HG2' ' A' ' 173' ' ' ARG . 8.4 mm -104.52 125.52 59.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.672 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.425 ' OD1' HD11 ' A' ' 174' ' ' LEU . 14.7 p-10 -154.48 152.62 26.46 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 120.861 0.362 . . . . 0.0 111.419 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 43.7 Cg_endo -67.73 -166.59 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.711 2.274 . . . . 0.0 112.179 179.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.526 ' O ' HG11 ' A' ' 120' ' ' VAL . . . -87.95 11.3 67.37 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.986 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 3.6 p -114.53 -40.62 3.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.839 0.352 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.24 -21.02 61.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.224 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -28.19 7.54 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.26 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -60.87 2.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.875 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.45 -28.21 39.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.93 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 0.7 OUTLIER -69.48 -63.15 1.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.759 179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -52.74 -33.47 48.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.102 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.87 -63.37 1.08 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.389 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.72 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -61.24 -43.59 96.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.722 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.72 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -58.47 -54.41 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.077 -179.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -57.76 -38.88 76.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.129 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -74.6 -26.25 59.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.298 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.9 p -85.98 -31.54 22.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.171 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.98 -32.29 30.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.063 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 48.9 58.06 8.07 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.744 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.3 pttp 45.43 31.17 0.83 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.803 0.335 . . . . 0.0 111.365 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.71 -26.64 4.39 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.571 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 39.5 p -112.3 173.02 6.57 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.797 0.332 . . . . 0.0 110.983 -179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.9 tp -112.28 151.56 29.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 176' ' ' PHE . 5.9 pm0 -138.04 115.24 11.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.193 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 26.9 t -106.78 148.0 11.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.043 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.4 tp -89.36 137.51 32.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.809 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.84 -69.16 0.77 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.002 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 3.1 tp -107.59 159.59 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.969 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.5 mtpp -133.46 137.72 45.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.875 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -60.96 103.16 0.24 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.926 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 29.1 m -145.98 139.13 20.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.128 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -67.73 84.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.916 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.58 33.47 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.883 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -88.74 -57.8 1.79 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.506 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -119.78 -42.5 2.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.815 0.341 . . . . 0.0 110.841 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.7 138.8 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.858 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.1 pttm -103.86 -46.31 4.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -153.24 37.75 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.895 179.965 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 mtt . . . . . 0 N--CA 1.486 1.337 0 CA-C-O 120.872 0.368 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.3 m -123.94 -45.97 1.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 31.0 mt 63.27 105.22 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.158 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.89 144.62 26.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 80.29 0.69 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.874 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.1 91.66 0.45 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.564 2.176 . . . . 0.0 112.363 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.88 -163.4 1.03 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.721 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.58 45.2 1.18 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.883 0.373 . . . . 0.0 110.88 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -161.06 -45.13 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.724 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.3 tp -124.33 131.02 73.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.929 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.4 mtm-85 -105.24 -66.54 0.97 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.945 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.503 HD23 ' O ' ' A' ' 12' ' ' LEU . 8.4 tt -166.55 92.63 0.47 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.95 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 73.3 p -146.56 116.72 7.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -176.78 -52.09 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.875 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.7 t -112.31 151.53 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.084 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.4 136.06 40.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.046 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.614 HG12 ' HG2' ' A' ' 28' ' ' GLU . 21.9 t -117.31 120.71 65.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.073 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 HG23 ' SG ' ' A' ' 31' ' ' CYS . 25.9 t -111.52 140.09 32.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.72 154.29 41.08 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.202 -179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.843 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.7 tmm? -144.8 168.05 21.13 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 22.4 tttt -117.65 115.99 26.18 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -151.79 129.62 11.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.842 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.24 37.96 28.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.196 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 57.26 24.94 53.38 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.602 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.66 136.94 54.77 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.825 0.345 . . . . 0.0 110.84 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.5 mtp85 -90.63 105.52 17.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.04 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -103.31 147.45 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.729 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -144.53 150.69 37.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.108 -179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.638 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -139.98 150.63 21.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.129 179.517 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.1 113.68 25.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.024 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.617 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.6 p -136.01 177.72 7.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.019 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.748 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.8 m-85 -89.8 125.85 35.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.864 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.24 -34.49 64.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' VAL . 3.7 m-80 -75.6 -51.43 12.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.041 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.0 mptt -66.28 -26.34 67.29 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.004 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 HG23 ' O ' ' A' ' 32' ' ' TYR . 76.5 t -76.52 -49.3 24.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.766 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.658 HG13 ' O ' ' A' ' 33' ' ' LYS . 31.6 m -60.38 -38.83 79.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.82 0.343 . . . . 0.0 110.568 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.06 -46.27 52.22 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.007 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.645 ' CH2' HD23 ' A' ' 47' ' ' LEU . 1.9 t-105 -59.61 -51.2 70.84 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.264 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -58.79 -41.62 87.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.791 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 15.7 t -59.38 -23.45 62.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.004 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.19 -21.19 3.51 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.652 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.5 t -55.9 148.3 3.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.82 0.343 . . . . 0.0 111.18 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.92 -78.19 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.914 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.22 146.71 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.826 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -96.94 143.27 27.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.908 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.66 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -65.15 -27.04 68.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 -179.907 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.1 -10.13 56.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.3 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -116.75 -40.16 3.2 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.632 0.253 . . . . 0.0 111.445 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -74.86 -28.95 21.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.636 0.255 . . . . 0.0 111.565 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.736 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.94 114.07 26.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.803 0.335 . . . . 0.0 110.759 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -77.21 -33.27 56.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.04 0.448 . . . . 0.0 110.225 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.597 HG21 ' CE1' ' A' ' 57' ' ' PHE . 52.7 m -125.78 118.86 26.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -84.71 55.9 3.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.968 0.413 . . . . 0.0 110.808 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.87 132.33 4.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.702 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.705 HG21 HD21 ' A' ' 71' ' ' LEU . 24.4 t -72.93 109.72 5.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.076 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.612 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.8 m-85 -84.82 -174.54 5.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.172 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.1 t -131.81 -53.24 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.322 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -129.39 74.65 1.6 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.201 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.502 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -56.6 -31.48 34.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.062 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.2 t -56.93 -29.92 63.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.001 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -113.17 -25.98 8.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.37 51.38 1.06 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.559 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.4 116.18 28.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.9 0.381 . . . . 0.0 110.8 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.612 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -89.61 151.72 3.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.274 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.518 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -86.12 166.37 15.84 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -100.68 150.02 23.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.982 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.76 -37.05 80.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.924 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -58.16 -45.83 86.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.951 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.26 -31.36 64.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.824 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.976 HD22 HD13 ' A' ' 83' ' ' ILE . 4.9 mt -63.41 -42.26 98.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.895 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.577 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -78.1 -42.43 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.21 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 65.4 p -71.31 -17.37 62.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.392 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.29 -35.83 9.48 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.675 0.274 . . . . 0.0 111.507 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 83' ' ' ILE . 95.6 m-85 -108.29 -45.3 3.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.303 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 84.73 53.9 3.07 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.334 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.7 p -148.88 -42.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.767 0.318 . . . . 0.0 110.947 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.577 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.6 t0 76.14 22.83 1.32 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.858 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -125.6 94.48 4.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.579 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.519 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.5 pm0 -51.75 -31.2 25.64 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.039 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -64.19 -54.94 25.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.467 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -60.57 -43.75 96.95 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.341 179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.976 HD13 HD22 ' A' ' 71' ' ' LEU . 24.7 mt -59.07 -41.29 82.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.353 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.736 ' SG ' HD11 ' A' ' 51' ' ' LEU . 50.7 m -61.57 -42.34 98.71 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.079 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.628 ' HG2' HD21 ' A' ' 47' ' ' LEU . 50.5 mttt -56.56 -50.04 73.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.275 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -55.54 -49.52 72.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.817 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.843 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.1 mt -61.25 -28.35 43.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.997 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.638 HD12 HD11 ' A' ' 29' ' ' ILE . 5.0 mp -74.55 -35.98 63.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.213 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 15.9 m -91.3 -31.17 16.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.472 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.01 -44.34 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.83 0.348 . . . . 0.0 111.147 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -67.56 158.38 51.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.644 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.64 129.4 36.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.774 0.321 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.477 ' HA ' HG22 ' A' ' 18' ' ' VAL . 11.3 p -87.72 143.48 11.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.286 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -109.13 105.7 15.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.783 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 33' ' ' LYS . 21.0 m -108.04 146.08 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.66 160.33 29.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.791 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -59.92 -33.84 72.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.906 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -59.84 -57.47 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -62.21 -31.01 71.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.87 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.76 -30.83 59.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.884 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -70.95 -52.78 17.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.891 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.482 HG22 ' O ' ' A' ' 98' ' ' LYS . 1.7 t -59.51 -39.01 82.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.84 -44.97 75.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tp -61.01 -42.0 97.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 50.3 mm-40 -65.94 -45.31 82.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.762 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -64.66 -45.33 87.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.804 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -46.91 86.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.437 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.41 -50.12 74.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.639 179.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -60.99 -33.43 73.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.638 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -52.56 58.88 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.6 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.869 ' HA ' HD12 ' A' ' 114' ' ' ILE . 4.8 mt -58.87 -37.26 65.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.621 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.836 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -64.35 -48.19 76.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.646 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.572 HG22 ' OD2' ' A' ' 117' ' ' ASP . 59.7 m -55.86 -43.32 76.99 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.491 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.869 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.6 mt -58.94 -61.44 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.541 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.439 ' O ' ' HB3' ' A' ' 119' ' ' CYS . 61.5 t -55.72 -22.18 12.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.12 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.896 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -94.69 -12.88 26.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.219 179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.572 ' OD2' HG22 ' A' ' 113' ' ' THR . 6.0 m-20 -101.62 -68.93 0.8 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.592 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -73.65 -52.9 11.79 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 115' ' ' VAL . 9.1 t -62.56 155.18 26.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.835 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.616 HG22 ' HB2' ' A' ' 170' ' ' ALA . 2.1 m -138.37 153.49 26.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.044 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 50.9 t30 -81.72 119.52 75.58 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.78 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.88 -15.51 47.31 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.415 2.077 . . . . 0.0 112.447 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.7 -48.0 82.63 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.7 m -138.79 21.81 2.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.4 mttp 53.4 29.17 8.4 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.087 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.9 mpt_? -100.91 164.46 16.06 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.66 145.67 58.44 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.563 2.175 . . . . 0.0 112.294 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 155.48 37.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 35.5 p -109.83 145.34 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.768 ' HA ' HD12 ' A' ' 133' ' ' ILE . 11.8 t -51.65 -35.99 17.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.391 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.4 pp -66.88 -35.78 75.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.051 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.05 -39.92 75.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.836 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.896 HD11 ' HB2' ' A' ' 116' ' ' ALA . 4.2 mt -68.13 -47.76 77.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.985 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -58.94 -52.07 67.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.849 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -58.57 -44.38 89.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.96 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.542 ' HB1' ' CE ' ' A' ' 164' ' ' LYS . . . -64.87 -43.75 91.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.268 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.548 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.0 tpp -58.94 -41.45 87.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.092 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.22 -40.28 59.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -56.04 -42.29 76.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.078 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.1 tt -89.65 -4.11 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.708 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 60.39 75.07 0.42 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.865 0.364 . . . . 0.0 110.813 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -93.93 167.22 11.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.978 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 71.1 m -143.27 142.25 31.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.782 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 145' ' ' LYS . 21.4 t -112.07 158.2 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.143 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 144' ' ' VAL . 30.4 mttt -138.76 113.01 8.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 67.0 p -59.56 -30.23 68.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.009 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.98 -29.67 68.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.04 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.7 mttt -96.6 179.02 5.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.012 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.5 m -103.49 158.31 16.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.943 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 10.9 p -65.4 -52.82 50.77 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.021 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -49.06 -49.96 38.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.203 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -60.83 -31.13 70.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.825 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.68 -25.54 60.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.179 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.466 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.22 -35.5 62.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.355 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.9 tp -72.61 -40.6 66.37 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.039 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.54 -42.46 74.6 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.013 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.609 HG22 HD12 ' A' ' 161' ' ' LEU . 12.8 p -68.13 -45.5 83.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.493 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.638 ' HA ' HD11 ' A' ' 167' ' ' ILE . 0.5 OUTLIER -62.55 -45.29 99.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.247 -179.888 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 158' ' ' ILE . 2.9 mttm -64.37 -46.65 82.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.933 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 31.3 tp60 -63.48 -56.08 18.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.091 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.66 HD22 ' HZ1' ' A' ' 164' ' ' LYS . 54.2 mt -54.74 -28.94 52.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.223 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 8.2 tmtm? -57.16 -21.96 36.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.376 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -58.16 -33.25 69.01 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.302 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.66 ' HZ1' HD22 ' A' ' 161' ' ' LEU . 0.2 OUTLIER -118.2 -37.13 3.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.25 -179.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.4 tpt -130.53 113.87 14.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.854 0.359 . . . . 0.0 110.948 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -72.08 101.5 2.77 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.638 HD11 ' HA ' ' A' ' 158' ' ' ILE . 6.4 pt -107.36 145.55 14.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.919 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -150.22 170.37 19.13 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.939 0.399 . . . . 0.0 111.381 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 57.8 mmt-85 -69.52 149.99 47.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.678 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.616 ' HB2' HG22 ' A' ' 120' ' ' VAL . . . -105.13 138.14 41.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.054 0.454 . . . . 0.0 111.587 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 3.2 m-70 -109.57 146.69 34.27 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.533 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.404 ' CG ' ' HA ' ' A' ' 240' ' ' LYS . 0.0 OUTLIER -174.31 170.09 3.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.894 0.378 . . . . 0.0 111.06 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.681 ' C ' HD22 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -101.31 141.64 33.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.407 179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.681 HD22 ' C ' ' A' ' 173' ' ' ARG . 4.0 mm? -128.68 151.08 49.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.943 0.402 . . . . 0.0 111.872 -179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.1 110.53 15.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.158 179.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.628 ' HD2' HD11 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -110.89 137.89 47.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.05 0.452 . . . . 0.0 111.655 -179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 206' ' ' LEU . 17.6 tt -121.86 119.57 59.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.24 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.863 HD23 ' HD2' ' A' ' 229' ' ' LYS . 1.3 mp -122.64 149.91 56.92 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.273 -179.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -58.83 -178.93 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.655 2.237 . . . . 0.0 112.066 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 205' ' ' GLN . 8.5 p -76.21 -47.37 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.656 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.489 ' N ' HG13 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -81.82 -57.9 3.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.806 0.336 . . . . 0.0 111.458 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -22.45 67.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.478 -179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -70.01 -24.82 76.26 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.902 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.79 -20.2 46.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.639 0.257 . . . . 0.0 111.528 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 15.3 tttp -74.75 -58.67 3.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.771 0.32 . . . . 0.0 111.385 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 1.023 HD11 HD23 ' A' ' 190' ' ' LEU . 32.8 tp -67.71 -36.64 81.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.582 -179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.05 -39.18 4.01 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.666 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -76.67 -44.35 34.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.313 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.13 -5.83 48.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.918 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.023 HD23 HD11 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -102.63 -29.3 11.62 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.826 0.346 . . . . 0.0 111.262 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.442 ' HA ' HG21 ' A' ' 196' ' ' VAL . 3.7 mtpp -52.56 -61.37 4.71 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.48 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.8 Cg_endo -73.39 -31.63 8.9 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.525 2.15 . . . . 0.0 112.744 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.45 HD22 HG21 ' A' ' 224' ' ' ILE . 5.0 tp -55.66 -54.83 39.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.399 -179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.658 ' CD1' HD23 ' A' ' 211' ' ' LEU . 2.4 pp -132.16 -179.13 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.922 0.392 . . . . 0.0 111.511 -179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 85.8 mttt -82.64 106.3 14.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.872 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.815 HG13 HG23 ' A' ' 209' ' ' VAL . 85.9 t -85.43 148.37 4.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.192 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.8 pt -155.57 151.91 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 52.81 81.91 0.08 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.13 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 11.3 p -100.11 130.75 46.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.938 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.431 ' HB2' HG12 ' A' ' 208' ' ' ILE . 0.7 OUTLIER -129.0 122.63 30.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -158.41 125.22 4.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.705 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.2 OUTLIER -117.36 100.69 7.85 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.046 -179.84 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 43.15 -95.82 0.01 OUTLIER Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.925 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.48 53.28 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.074 0.464 . . . . 0.0 110.662 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.4 tt0 -121.51 178.28 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.867 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.507 HD12 HD11 ' A' ' 177' ' ' ILE . 1.8 pt? -72.62 148.95 44.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.894 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -98.8 130.14 45.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.416 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HG ' ' A' ' 206' ' ' LEU . 8.1 mm -111.55 112.01 38.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.571 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.815 HG23 HG13 ' A' ' 196' ' ' VAL . 10.4 p -124.15 132.97 70.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.327 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 65.8 m -109.86 147.11 33.94 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.367 179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.658 HD23 ' CD1' ' A' ' 194' ' ' ILE . 1.8 mp -113.47 128.95 56.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.023 0.439 . . . . 0.0 111.648 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.461 HD12 HH11 ' A' ' 173' ' ' ARG . 4.3 tt -109.39 131.33 60.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.645 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.425 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 48.3 t0 64.29 80.75 0.23 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.612 -179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 22.0 Cg_endo -61.6 -50.96 4.62 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.515 2.143 . . . . 0.0 112.381 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 48.88 -159.49 0.82 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.451 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 31.4 p -63.23 -24.76 68.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.769 0.319 . . . . 0.0 111.049 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.449 ' HB3' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -62.26 -21.08 64.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.356 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -53.85 -46.1 71.13 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.207 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -57.56 -60.17 4.07 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.902 0.382 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.6 mp -57.85 -24.13 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.215 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.86 -47.53 37.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.138 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 225' ' ' LYS . 7.5 pt-20 -66.24 -34.72 78.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.865 0.364 . . . . 0.0 111.022 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.82 -52.96 17.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.982 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 220' ' ' ILE . 2.6 tt -63.32 -41.62 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.618 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.428 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -67.3 -40.29 86.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.145 -179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.409 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -68.75 -32.17 71.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.843 0.354 . . . . 0.0 110.933 179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -82.72 -27.45 31.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.164 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.41 ' OG1' HD13 ' A' ' 186' ' ' LEU . 40.6 p -92.29 -26.91 17.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.391 -179.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HD2' HD23 ' A' ' 178' ' ' LEU . 0.1 OUTLIER -106.77 -16.0 14.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.413 -179.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.87 39.21 87.84 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.512 -0.851 . . . . 0.0 112.257 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.97 24.72 9.51 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.776 0.322 . . . . 0.0 110.975 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -88.96 10.68 71.8 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.723 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.687 ' O ' HD12 ' A' ' 234' ' ' LEU . 34.7 p -137.92 173.07 12.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.705 0.288 . . . . 0.0 110.789 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 233' ' ' SER . 3.7 mp -134.99 149.81 50.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.861 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.43 ' HB2' ' CE2' ' A' ' 176' ' ' PHE . 21.7 tt0 -135.85 115.22 12.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 145.09 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.088 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 8.0 tp -71.45 135.37 47.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.761 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 29.4 t30 -88.89 -68.32 0.78 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.082 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -154.33 171.54 19.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.861 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.404 ' HA ' ' CG ' ' A' ' 172' ' ' MET . 4.0 ptpp? -145.4 138.07 26.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.927 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.63 105.61 5.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 5.6 m -122.11 -42.74 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.017 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -71.23 172.67 8.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.045 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -176.43 -67.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 168.95 55.68 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.53 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -112.52 -63.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.803 0.335 . . . . 0.0 110.912 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.435 ' HB3' ' CD2' ' A' ' 249' ' ' PHE . 0.8 OUTLIER -174.26 -168.71 0.41 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.933 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.68 50.53 2.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.91 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.435 ' CD2' ' HB3' ' A' ' 247' ' ' GLU . 3.3 p90 -97.37 28.83 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.003 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.276 -0.868 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.738 0.304 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 m -129.08 -61.28 1.05 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.978 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 33.2 mt -135.92 -50.79 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.187 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -73.42 127.22 32.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.866 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.411 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -72.93 -61.98 1.42 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.871 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 37.9 Cg_endo -67.97 -55.61 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.239 1.96 . . . . 0.0 112.3 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m 54.24 24.28 4.87 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.154 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.5 t30 179.46 51.01 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.856 0.36 . . . . 0.0 110.888 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -169.29 -66.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.004 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pt -99.5 173.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.141 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.74 82.77 1.86 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.849 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.555 HD23 ' O ' ' A' ' 12' ' ' LEU . 6.0 tt -60.62 100.99 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.961 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 49.6 p -65.48 179.3 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.715 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -79.32 60.79 3.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.023 0.44 . . . . 0.0 110.912 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -70.77 151.1 9.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.989 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.58 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.6 136.69 40.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.595 HG13 HG21 ' A' ' 60' ' ' VAL . 26.4 t -117.9 116.67 52.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.99 0.424 . . . . 0.0 111.162 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.556 ' HB ' HD12 ' A' ' 29' ' ' ILE . 22.7 t -100.28 115.76 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.904 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 11.0 mtp180 -100.29 158.29 15.98 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.055 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.891 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -163.77 129.66 3.08 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.796 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 tttt -86.95 135.87 33.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.976 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' HD3' ' CE1' ' A' ' 75' ' ' PHE . 12.6 ttt85 -162.08 133.99 5.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.45 21.55 11.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.31 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.65 -44.11 2.59 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.62 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.54 173.18 6.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.792 0.329 . . . . 0.0 111.002 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.75 140.29 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.778 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -135.4 155.88 49.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.091 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.6 pt-20 -153.64 146.15 24.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.801 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -123.72 149.22 27.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.908 0.385 . . . . 0.0 111.147 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.977 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.99 107.16 19.01 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.792 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.87 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -135.31 177.77 7.56 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.27 -179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.762 ' O ' HG23 ' A' ' 36' ' ' VAL . 10.4 m-85 -82.35 129.72 34.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.032 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.58 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.4 OUTLIER -60.0 -35.32 74.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.003 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' O ' HG12 ' A' ' 37' ' ' VAL . 9.5 m-80 -77.87 -47.23 19.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.0 0.429 . . . . 0.0 110.895 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.772 ' HB3' HG23 ' A' ' 50' ' ' VAL . 3.6 tptt -65.24 -33.08 75.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.763 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.762 HG23 ' O ' ' A' ' 32' ' ' TYR . 81.6 t -73.69 -51.83 23.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.756 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 34' ' ' ASN . 12.0 p -55.3 -37.86 45.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-O 120.934 0.397 . . . . 0.0 110.561 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.43 -44.82 57.43 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.086 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.466 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.2 t-105 -60.16 -58.5 8.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.958 0.409 . . . . 0.0 110.26 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.02 -34.91 72.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.826 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.6 m -63.26 -27.38 69.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.951 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 133.45 -23.69 3.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.605 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -59.38 128.11 19.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.863 0.363 . . . . 0.0 111.09 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -59.2 145.8 41.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.815 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -171.69 164.76 6.68 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.927 -179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.5 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -115.4 152.64 32.49 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.784 ' HG ' HG22 ' A' ' 81' ' ' THR . 3.3 mm? -62.67 -30.03 71.08 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.319 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -68.02 -8.84 40.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.1 -179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -122.41 -28.27 4.31 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.772 HG23 ' HB3' ' A' ' 35' ' ' LYS . 9.1 p -88.4 -29.51 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.87 HD23 ' HB3' ' A' ' 31' ' ' CYS . 10.5 mt -93.09 132.22 37.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.803 0.335 . . . . 0.0 111.18 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -41.21 20.46 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.977 HG22 ' HB3' ' A' ' 30' ' ' ALA . 9.0 t -130.93 115.44 16.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.263 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 24.3 m170 -72.94 67.51 0.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.357 -179.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.6 m -166.98 141.64 3.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.136 HG21 HD21 ' A' ' 71' ' ' LEU . 17.3 t -77.38 106.26 7.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.69 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.666 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.1 m-85 -81.94 179.86 7.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.262 0.553 . . . . 0.0 111.647 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 79.4 t -130.71 -46.02 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.041 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -135.04 66.72 1.52 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.952 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.595 HG21 HG13 ' A' ' 17' ' ' VAL . 2.5 t -49.72 -40.96 16.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.472 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 p -55.92 -26.08 45.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.281 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -110.93 -25.77 9.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.204 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.19 43.95 1.96 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.447 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 tt0 -109.36 125.14 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.836 0.35 . . . . 0.0 110.733 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.2 t -106.84 148.41 11.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.205 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.55 157.87 22.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.972 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 37.7 mttt -90.42 152.8 20.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.94 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 5.8 mmtp -58.94 -31.92 69.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.846 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -52.13 66.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.792 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -66.32 -34.04 77.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.745 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.136 HD21 HG21 ' A' ' 56' ' ' VAL . 4.8 mt -61.27 -47.76 84.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.903 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.1 mt -79.71 -28.54 12.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.313 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -77.32 -20.51 54.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.33 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.45 -30.63 10.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.669 0.271 . . . . 0.0 111.478 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.435 ' CE1' ' HD3' ' A' ' 22' ' ' ARG . 81.5 m-85 -107.98 -33.45 7.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.16 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.29 -11.76 51.44 Favored Glycine 0 CA--C 1.517 0.189 0 C-N-CA 120.566 -0.826 . . . . 0.0 112.622 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.1 t -132.34 171.04 14.23 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.748 0.309 . . . . 0.0 110.815 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -105.73 -14.34 15.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.379 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.12 86.07 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.759 0.314 . . . . 0.0 111.004 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 83' ' ' ILE . 5.4 pm0 -57.26 -33.52 67.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -59.77 -54.33 47.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.503 179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -57.88 -42.85 85.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.455 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.919 HD13 HD22 ' A' ' 71' ' ' LEU . 53.8 mt -59.22 -41.67 84.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.45 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.801 ' SG ' HG21 ' A' ' 29' ' ' ILE . 86.3 m -62.57 -39.35 93.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.163 179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.424 ' HE3' ' CD2' ' A' ' 47' ' ' LEU . 48.6 mttt -58.17 -54.42 47.17 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.459 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -57.26 -43.62 83.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.992 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.891 HG23 ' HB2' ' A' ' 20' ' ' MET . 20.4 mt -68.59 -29.17 42.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.121 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.452 ' CD1' HD13 ' A' ' 29' ' ' ILE . 2.0 mp -76.78 -28.83 55.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.048 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.9 m -96.05 -31.13 13.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 12.3 mmtt -101.52 -44.23 5.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.993 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.7 179.23 6.54 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.424 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.4 pm0 -113.89 135.53 53.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.86 0.362 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.58 ' O ' HG13 ' A' ' 93' ' ' VAL . 12.5 p -90.17 112.73 25.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.086 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 35.6 mm-40 -80.63 107.34 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.424 HG11 HE22 ' A' ' 103' ' ' GLN . 9.3 m -106.39 146.69 12.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.134 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.5 175.96 7.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -58.05 -43.37 86.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.971 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -64.95 -44.63 88.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -68.27 -31.81 71.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.812 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -44.97 63.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.781 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -41.58 96.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.9 p -60.31 -36.94 79.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.881 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.424 HE22 HG11 ' A' ' 95' ' ' VAL . 34.2 mt-30 -62.1 -48.89 78.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.824 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.84 -48.28 82.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.896 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.59 -45.54 92.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.769 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -61.35 -43.43 98.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.847 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.434 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.76 -47.86 76.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.34 -53.42 57.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.776 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.7 mtt85 -59.95 -32.27 70.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.771 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.99 -52.2 60.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.703 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 115' ' ' VAL . 6.7 mt -60.85 -38.54 79.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.917 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.26 -37.97 81.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.972 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -66.47 -37.82 85.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.798 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.543 HD12 ' HA ' ' A' ' 111' ' ' ILE . 8.1 mt -71.6 -42.02 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.149 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 111' ' ' ILE . 36.0 t -73.92 -22.52 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.328 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.592 ' HB2' HD12 ' A' ' 133' ' ' ILE . . . -93.28 -36.9 12.33 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.315 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.89 -48.7 5.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.126 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -92.71 46.11 1.22 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.433 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -177.04 155.68 1.21 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.89 179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.461 HG13 ' SG ' ' A' ' 216' ' ' CYS . 16.2 m -142.73 169.44 12.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.143 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -88.14 129.74 48.77 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.884 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.97 63.16 6.77 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.432 2.088 . . . . 0.0 112.375 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -142.34 -56.13 0.44 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.953 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.8 t -134.73 22.71 3.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 54.27 36.57 25.46 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.118 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 12.6 mmt-85 -100.95 136.43 19.77 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.922 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.457 ' HA ' HG12 ' A' ' 120' ' ' VAL . 52.0 Cg_exo -54.37 159.51 8.1 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.519 2.146 . . . . 0.0 112.211 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 163.62 12.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.857 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.545 ' OG1' HD12 ' A' ' 132' ' ' LEU . 0.7 OUTLIER -109.37 129.77 55.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.033 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.1 m -54.04 -33.57 24.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.226 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 11.7 pt -62.81 -36.17 74.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.031 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.545 HD12 ' OG1' ' A' ' 129' ' ' THR . 29.9 mt -75.92 -39.22 56.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.592 HD12 ' HB2' ' A' ' 116' ' ' ALA . 22.2 mt -68.54 -37.62 77.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.68 -47.37 54.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.764 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -48.86 79.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.843 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.34 -40.88 96.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.056 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 1.7 ttt -65.77 -30.49 71.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.2 mttp -77.41 -46.24 23.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.891 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.0 -40.97 91.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.826 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 tp -71.61 -10.24 13.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.53 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 65.58 51.56 1.47 Allowed 'General case' 0 C--O 1.232 0.172 0 CA-C-O 120.917 0.389 . . . . 0.0 110.822 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 77.0 t80 -82.5 133.9 35.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -106.54 154.45 20.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.006 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.475 HG13 ' OE1' ' A' ' 153' ' ' GLN . 21.7 t -133.31 132.41 58.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.148 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 7.1 mmtm -90.69 118.06 29.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.962 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.6 p -56.84 -29.01 62.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.133 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -98.13 31.0 2.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.983 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 mmtt -126.09 158.3 35.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.868 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.25 142.71 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 56.7 p -59.99 -53.47 57.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.92 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.3 49.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.141 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.08 -32.59 74.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.732 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.475 ' OE1' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -71.1 -22.87 62.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.114 -179.995 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.501 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -52.52 -34.97 52.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.312 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 10.6 tp -65.94 -42.65 89.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.97 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -70.39 -52.43 22.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.316 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.659 HG22 HD12 ' A' ' 161' ' ' LEU . 13.3 p -54.75 -45.66 73.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.5 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 154' ' ' ALA . 41.9 mt -66.66 -45.36 88.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.81 0.338 . . . . 0.0 111.016 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 1.6 tttt -61.45 -30.04 70.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.038 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -87.65 -37.87 16.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.141 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.659 HD12 HG22 ' A' ' 157' ' ' VAL . 19.4 mt -73.09 -31.1 64.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.356 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.13 -26.13 15.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.137 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.45 -33.96 73.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.862 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -98.41 -66.98 0.87 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.958 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.7 mtt -118.33 -178.95 3.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.67 121.15 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.845 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.671 HG21 HG13 ' A' ' 115' ' ' VAL . 26.2 mm -101.04 130.4 50.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.126 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 18.8 tt0 -100.98 110.26 22.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.849 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.419 ' HG2' ' CE1' ' A' ' 171' ' ' HIS . 31.6 ttp180 -108.17 109.27 20.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.028 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -128.6 136.86 51.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.944 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 16.8 m80 -115.82 164.68 14.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.08 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 6.3 mtp -152.49 154.92 36.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 238' ' ' ASN . 0.0 OUTLIER -91.61 116.06 28.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.5 179.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.476 ' O ' ' N ' ' A' ' 211' ' ' LEU . 4.7 mp -101.35 113.32 26.3 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.91 0.386 . . . . 0.0 111.535 -179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -97.97 133.77 41.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.402 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -131.79 130.38 41.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.038 0.447 . . . . 0.0 111.482 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.603 HD12 ' HB3' ' A' ' 234' ' ' LEU . 26.5 mt -107.96 100.14 10.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.108 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.541 ' HB2' ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -94.63 150.02 37.38 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.615 -179.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.434 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 89.5 Cg_endo -77.2 -162.72 0.18 Allowed 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.866 2.377 . . . . 0.0 112.115 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.755 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.8 t -76.06 -59.66 3.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.722 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -81.69 -57.9 3.24 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.434 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.1 OUTLIER -55.33 -20.62 12.14 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -66.04 -51.78 42.33 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.212 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.52 -25.02 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.676 0.274 . . . . 0.0 111.604 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.4 tttp -78.94 -32.2 45.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.552 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.65 HD23 ' CD ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -89.17 -56.02 3.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.798 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 7.8 pttm -44.15 -50.03 8.8 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.952 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.65 -63.88 0.99 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.494 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.75 -25.35 65.59 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.643 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.524 ' HG ' HD12 ' A' ' 186' ' ' LEU . 11.2 mt -64.86 -32.47 74.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.691 0.281 . . . . 0.0 111.594 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.439 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -49.18 -63.6 1.57 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.591 -179.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.439 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 65.2 Cg_endo -73.66 -32.02 8.04 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.549 2.166 . . . . 0.0 112.924 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.612 HD21 HG22 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -53.87 -55.85 23.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.524 -179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 211' ' ' LEU . 18.7 mt -138.99 160.08 29.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.461 -179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.502 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.41 109.13 1.83 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.679 179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 197' ' ' ILE . 11.7 t -82.96 158.06 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.402 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.436 ' N ' HG12 ' A' ' 196' ' ' VAL . 7.4 tp -178.55 142.91 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.066 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 60.28 80.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.907 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -122.7 131.27 53.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.004 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -133.53 136.36 44.96 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -158.27 156.69 31.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.815 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -122.21 100.62 7.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.054 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.44 -99.94 0.01 OUTLIER Glycine 0 C--N 1.333 0.402 0 C-N-CA 121.099 -0.572 . . . . 0.0 112.916 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -104.26 65.23 0.78 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.17 0.509 . . . . 0.0 110.221 179.56 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.755 ' HA ' HG22 ' A' ' 180' ' ' VAL . 3.0 mt-30 -142.14 178.66 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.036 -179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 206' ' ' LEU . 2.6 pt? -72.39 144.19 48.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.494 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -112.53 130.31 56.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.002 0.43 . . . . 0.0 111.837 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -102.06 106.23 19.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.836 178.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.417 ' CG2' HG13 ' A' ' 196' ' ' VAL . 14.9 p -120.03 144.79 27.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.96 0.41 . . . . 0.0 111.988 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 27.7 m -109.95 151.2 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.351 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 194' ' ' ILE . 2.7 mt -131.46 161.05 33.39 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.94 0.4 . . . . 0.0 111.259 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 212' ' ' ILE . 12.8 tt -149.22 125.01 2.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.798 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.428 ' CB ' ' CD ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -177.78 177.51 0.43 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.924 -179.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 81.2 Cg_exo -47.55 168.77 0.07 OUTLIER 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.677 2.251 . . . . 0.0 112.422 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -93.81 29.45 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.723 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 120' ' ' VAL . 15.2 m -121.5 -37.32 2.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.788 0.328 . . . . 0.0 111.077 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 220' ' ' ILE . 0.1 OUTLIER -56.95 -21.68 32.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.285 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -49.61 -28.27 5.55 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.774 0.321 . . . . 0.0 111.251 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -62.78 -47.76 82.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.901 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.751 HD13 ' CD1' ' A' ' 217' ' ' PHE . 3.6 mp -70.84 -36.03 62.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.966 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -62.24 -43.99 97.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -71.29 -41.17 70.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.03 -57.51 12.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 220' ' ' ILE . 14.7 tt -62.63 -39.35 84.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.984 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.452 ' HA ' HD21 ' A' ' 186' ' ' LEU . 2.1 tttp -59.48 -38.17 80.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.42 -38.7 29.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.027 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -80.13 -6.56 57.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.494 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.512 ' CG2' HD22 ' A' ' 186' ' ' LEU . 88.3 m -119.62 -31.54 4.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.63 0.253 . . . . 0.0 111.538 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.65 ' CD ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -115.72 -12.88 11.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.655 0.243 . . . . 0.0 111.655 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.51 -80.06 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.384 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 13.9 pttm -161.5 29.69 0.13 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.809 0.338 . . . . 0.0 110.817 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -99.51 2.99 57.61 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.987 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 15.2 p -121.61 173.0 7.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.783 0.325 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.603 ' HB3' HD12 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -136.5 115.31 12.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.957 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -105.39 115.33 30.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.996 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.77 144.4 15.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.163 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.5 mt -94.65 130.78 40.98 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.752 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.48 ' O ' HD12 ' A' ' 239' ' ' LEU . 1.3 m-20 -85.98 -82.3 0.2 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.123 -179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 238' ' ' ASN . 1.5 mp -154.39 174.52 14.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.996 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.42 111.05 10.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.85 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.98 132.75 35.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.886 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 242' ' ' VAL . 31.1 t -127.53 52.72 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.075 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -63.51 -66.75 0.5 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 59.76 33.29 21.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.972 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 87.65 -135.03 12.85 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.495 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.1 p30 -123.05 114.13 19.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.769 0.319 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -110.05 -177.95 3.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.853 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -153.82 93.94 1.71 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -140.65 30.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.936 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.259 -0.877 . . . . 0.0 110.939 179.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mtp . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.831 0.348 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' O ' HG23 ' A' ' 3' ' ' ILE . 48.9 m 59.9 95.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.942 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.458 HG23 ' O ' ' A' ' 2' ' ' SER . 8.2 pt -156.41 28.51 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.269 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 13' ' ' THR . 0.5 OUTLIER 179.73 -62.81 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.917 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 61.51 63.93 2.18 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.912 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG3' HD11 ' A' ' 10' ' ' ILE . 52.8 Cg_exo -52.56 93.48 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.525 2.15 . . . . 0.0 112.376 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 65.0 p -61.89 -73.44 0.1 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.966 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -169.59 80.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.871 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.564 ' OE1' HG23 ' A' ' 10' ' ' ILE . 2.4 tm0? -177.09 -59.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.564 HG23 ' OE1' ' A' ' 9' ' ' GLN . 1.9 pp -85.88 168.58 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.171 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.2 ttt-85 -135.23 28.77 3.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.43 169.79 16.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.823 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.436 HG23 ' OD1' ' A' ' 14' ' ' ASN . 11.4 t -165.61 -167.86 1.21 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.026 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.436 ' OD1' HG23 ' A' ' 13' ' ' THR . 12.5 m-20 75.71 -59.61 0.52 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.06 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.471 HG21 ' HG2' ' A' ' 52' ' ' GLN . 13.3 t -105.36 152.87 7.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.139 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -87.64 145.81 26.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.864 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 23.9 t -117.19 122.32 69.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.293 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' HB ' HD12 ' A' ' 29' ' ' ILE . 3.3 t -105.13 120.22 55.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.692 179.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -104.18 158.22 16.59 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.39 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 4.1 ttp -141.87 168.02 20.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.757 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.84 101.45 4.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.911 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.481 ' HG3' ' HE3' ' A' ' 20' ' ' MET . 10.9 mtt-85 -149.13 145.83 27.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.864 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.79 29.52 18.83 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.209 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.1 27.28 59.75 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.59 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.77 152.01 47.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.811 0.339 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.0 ptp85 -97.51 125.73 42.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -131.92 140.52 49.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.525 ' OE2' HG23 ' A' ' 60' ' ' VAL . 5.9 pt-20 -150.39 143.01 24.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.974 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.86 HG23 ' HA ' ' A' ' 56' ' ' VAL . 0.5 OUTLIER -128.29 155.45 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.949 179.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.11 106.79 18.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.874 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -130.26 177.09 7.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.035 -179.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.949 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -104.41 114.09 28.08 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.362 179.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -43.35 -47.75 6.83 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.9 OUTLIER -59.27 -55.03 40.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.901 0.381 . . . . 0.0 111.06 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.836 ' HB3' HG23 ' A' ' 50' ' ' VAL . 1.1 tpmp? -70.16 -18.97 63.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.292 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.949 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.9 t -70.48 -46.28 71.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.427 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.6 p -70.93 -40.24 76.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.118 179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -65.71 -30.79 78.07 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.947 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.467 ' HE3' ' HG3' ' A' ' 45' ' ' LYS . 4.1 t-105 -76.46 -55.83 5.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.398 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.8 ptt180 -55.93 -30.7 62.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 92.8 p -83.16 -25.5 31.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.772 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.24 68.39 1.52 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.602 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.639 ' O ' HG13 ' A' ' 43' ' ' VAL . 7.2 p -158.88 88.57 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.905 0.383 . . . . 0.0 111.249 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.02 119.07 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.973 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.467 ' HG3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -179.06 -174.64 0.34 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.009 0.433 . . . . 0.0 111.061 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.427 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -162.54 127.44 3.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.671 179.841 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.896 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -57.12 -44.43 83.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.221 -179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -72.63 -9.48 58.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -109.5 -23.16 11.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.681 0.277 . . . . 0.0 111.343 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.874 HG22 ' SG ' ' A' ' 31' ' ' CYS . 10.7 p -87.34 -47.29 15.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.296 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -83.14 102.42 11.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.159 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.471 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.1 tp-100 -60.97 -33.01 72.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.007 0.432 . . . . 0.0 109.967 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.62 HG21 ' CE1' ' A' ' 57' ' ' PHE . 92.7 m -130.98 122.62 27.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.609 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.468 ' HA ' HD13 ' A' ' 51' ' ' LEU . 23.2 m80 -84.9 55.46 3.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.003 0.43 . . . . 0.0 110.935 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.75 132.85 3.9 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.86 ' HA ' HG23 ' A' ' 29' ' ' ILE . 19.5 t -71.53 112.91 7.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.808 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CE1' HG21 ' A' ' 53' ' ' THR . 5.3 m-85 -88.93 -176.65 5.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.438 -179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.3 t -129.75 -46.98 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.2 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -135.9 64.94 1.55 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.942 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.525 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.8 t -47.81 -41.91 9.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.62 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.8 t -57.26 -24.81 57.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.227 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp -109.78 -25.91 10.11 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.073 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.48 40.03 2.46 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.568 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -108.69 131.93 54.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.831 0.348 . . . . 0.0 110.833 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.539 HG22 ' CE2' ' A' ' 57' ' ' PHE . 25.6 t -112.07 153.87 13.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.208 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.411 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -89.33 -177.93 5.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.033 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -116.74 158.8 23.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.968 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.575 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.2 OUTLIER -66.3 -36.63 83.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.901 179.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -57.95 -48.91 78.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.841 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -70.91 -34.52 71.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.866 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.859 HD22 HD13 ' A' ' 83' ' ' ILE . 8.2 mt -60.88 -49.55 76.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.9 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.575 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.9 mt -70.31 -43.67 78.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.125 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.8 t -64.58 -23.41 67.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.309 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.34 -54.11 3.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.465 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' HG23 ' A' ' 83' ' ' ILE . 88.8 m-85 -86.92 -46.08 10.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.272 -179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 119.69 1.23 13.5 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.764 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.78 162.26 32.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.822 0.344 . . . . 0.0 110.83 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -100.12 -13.68 18.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.133 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -75.98 98.44 4.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.886 0.374 . . . . 0.0 110.833 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.816 ' HA ' HD12 ' A' ' 83' ' ' ILE . 1.1 pt20 -53.82 -44.71 70.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.941 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.94 -55.43 11.86 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.778 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -55.53 -47.9 75.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.348 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.859 HD13 HD22 ' A' ' 71' ' ' LEU . 9.4 mt -57.25 -39.53 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.561 179.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.848 ' SG ' HG21 ' A' ' 29' ' ' ILE . 75.4 m -59.08 -46.21 88.86 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.084 179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.896 ' HE3' HD21 ' A' ' 47' ' ' LEU . 5.2 mtpt -58.84 -41.84 87.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.935 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -55.86 -47.75 76.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.393 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 17.5 mt -66.54 -28.99 45.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.775 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.799 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.6 mp -67.95 -37.91 82.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.93 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 58.6 m -92.31 -45.84 8.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.224 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.0 mmtp -82.0 -44.18 17.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.173 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.83 173.08 48.26 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.549 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.22 134.12 52.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.856 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -87.42 130.67 36.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.036 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -72.21 105.63 4.08 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' NH1' ' A' ' 100' ' ' ARG . 22.9 m -137.66 142.98 35.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.151 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 7.6 t -70.57 169.86 13.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.856 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.94 -32.56 70.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.862 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -41.62 81.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.885 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -59.79 -30.03 68.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.452 ' NH1' HG23 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -87.53 -31.29 20.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.81 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.75 -44.76 80.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.855 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.2 t -59.53 -38.69 81.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.702 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.0 OUTLIER -64.06 -47.79 78.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.817 179.865 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.96 -37.04 84.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.745 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.5 tt0 -60.31 -50.13 74.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -63.62 -42.02 98.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -46.34 86.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.875 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.3 OUTLIER -60.92 -43.73 98.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -44.42 95.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.706 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG21 ' A' ' 150' ' ' THR . 17.4 t0 -59.52 -49.62 77.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.769 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.835 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.1 mt -60.19 -38.08 75.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.871 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.463 ' HA ' HD13 ' A' ' 133' ' ' ILE . . . -64.81 -37.08 86.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.8 m -67.76 -47.4 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.908 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.418 HG23 ' NZ ' ' A' ' 118' ' ' LYS . 37.1 mm -61.77 -37.98 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.044 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.835 HG23 ' O ' ' A' ' 111' ' ' ILE . 33.8 t -75.64 -29.37 20.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.074 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -85.55 -23.98 27.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.282 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.3 -58.41 2.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.159 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' NZ ' HG23 ' A' ' 114' ' ' ILE . 1.6 mtmp? -121.49 73.32 1.05 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.173 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.402 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.1 OUTLIER -179.39 130.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.91 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.751 HG21 ' HB2' ' A' ' 216' ' ' CYS . 28.3 m -115.58 -179.27 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.128 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -109.67 118.28 50.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.966 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -72.98 61.89 3.93 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.427 2.085 . . . . 0.0 112.32 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -137.24 -47.74 0.58 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.789 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -147.95 24.3 1.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.027 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 6.1 mmpt? 55.67 38.18 29.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.103 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 148.78 35.47 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.87 126.81 13.67 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.593 2.195 . . . . 0.0 112.23 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.648 ' CD1' HD13 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -64.19 147.68 51.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.544 HG22 HD12 ' A' ' 132' ' ' LEU . 0.9 OUTLIER -120.18 158.24 27.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.903 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.862 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.5 t -51.96 -47.77 41.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.248 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.5 pp -59.3 -29.92 42.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.994 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.648 HD13 ' CD1' ' A' ' 128' ' ' TYR . 1.1 mt -71.95 -45.71 60.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.862 HD12 ' HA ' ' A' ' 130' ' ' VAL . 4.0 mt -60.19 -42.32 89.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.883 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.53 -51.13 62.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.651 179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.96 -38.75 83.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.711 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 1.018 ' HB1' HD21 ' A' ' 161' ' ' LEU . . . -62.41 -50.46 71.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.09 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.06 -38.92 80.54 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.801 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 15.0 mttt -71.97 -39.7 69.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.758 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -59.74 -43.3 94.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.943 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.7 tt -88.9 8.27 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.515 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 58.71 80.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.907 0.384 . . . . 0.0 110.936 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -109.86 134.25 52.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.834 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 67.8 m -106.95 -26.21 11.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.651 HG13 ' OE1' ' A' ' 153' ' ' GLN . 45.6 t 64.05 136.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.025 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.96 100.57 8.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.988 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.702 HG21 ' HB3' ' A' ' 103' ' ' GLN . 69.9 p -59.51 -28.37 67.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.0 p30 -57.07 -30.27 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.1 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -94.72 167.56 11.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.92 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 3.4 m -80.43 157.43 26.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.965 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.645 HG21 ' OD2' ' A' ' 110' ' ' ASP . 71.1 p -62.42 -56.22 20.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.986 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.62 -46.4 49.32 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.115 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -61.45 -33.52 73.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.822 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.774 ' O ' HG23 ' A' ' 157' ' ' VAL . 57.4 mt-30 -71.06 -27.44 63.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.076 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.03 -44.45 67.38 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.358 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.591 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -56.6 -50.66 71.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.974 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.11 -44.13 95.08 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.959 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.774 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.9 t -58.6 -46.89 89.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.129 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.812 ' HA ' HG21 ' A' ' 167' ' ' ILE . 7.1 mt -59.38 -46.39 92.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.177 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.4 -44.34 83.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.105 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.5 tp-100 -61.54 -59.87 4.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.175 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 1.018 HD21 ' HB1' ' A' ' 136' ' ' ALA . 2.4 mt -60.43 -26.59 66.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.091 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -55.28 -31.33 61.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.976 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.26 -40.49 96.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.753 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -92.96 -8.22 43.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.391 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 13.5 mtm 64.82 93.05 0.07 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.909 0.385 . . . . 0.0 110.708 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.8 mtmt -160.47 -35.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.202 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.812 HG21 ' HA ' ' A' ' 158' ' ' ILE . 3.5 tt -89.87 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.392 . . . . 0.0 111.325 -179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -161.5 102.59 1.21 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.596 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.0 ttt180 -101.91 126.39 48.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.085 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -170.02 145.06 2.81 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 57.9 m-70 -99.2 176.87 5.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.554 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.502 ' HE1' ' HB3' ' A' ' 217' ' ' PHE . 1.9 ttm -138.0 106.83 5.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.993 0.425 . . . . 0.0 111.571 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.457 ' C ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -124.32 110.69 14.91 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.064 179.059 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.501 HD11 ' HG2' ' A' ' 172' ' ' MET . 4.8 mp -140.69 179.73 6.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.276 0.56 . . . . 0.0 112.444 -179.358 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -149.87 115.76 5.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.534 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -105.01 148.29 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.094 0.473 . . . . 0.0 111.931 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 32.5 mt -126.21 104.39 12.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.241 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.794 HD11 ' CD2' ' A' ' 186' ' ' LEU . 2.9 mm? -93.12 152.95 41.7 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.517 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.435 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 80.8 Cg_endo -76.07 -166.47 0.37 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.681 2.254 . . . . 0.0 112.081 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 205' ' ' GLN . 33.3 m -76.13 -48.28 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.921 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.515 ' N ' HG23 ' A' ' 180' ' ' VAL . 3.0 m120 -81.98 -57.95 3.19 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.435 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -58.98 -18.44 34.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.786 -179.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.498 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -51.78 -60.44 7.47 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.937 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.67 -19.87 43.23 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.538 0.208 . . . . 0.0 111.558 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.635 ' HD3' HG23 ' A' ' 228' ' ' THR . 5.4 tttp -76.11 -45.83 31.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.679 0.276 . . . . 0.0 111.521 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.794 ' CD2' HD11 ' A' ' 178' ' ' LEU . 23.3 tp -88.07 -24.13 23.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.619 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -50.87 -62.92 1.31 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.73 0.3 . . . . 0.0 111.286 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -71.62 -14.57 62.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.472 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -87.93 -21.91 24.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.609 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.532 HD21 ' OD1' ' A' ' 221' ' ' ASP . 1.2 mt -102.36 -28.32 12.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.647 0.26 . . . . 0.0 111.352 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.486 ' HD2' HG21 ' A' ' 196' ' ' VAL . 4.5 tptt -56.2 -56.01 35.85 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.377 -179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 71.8 Cg_endo -77.0 -35.28 1.86 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.539 2.16 . . . . 0.0 112.723 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 1.12 HD23 HG23 ' A' ' 194' ' ' ILE . 3.0 tt -55.75 -52.53 63.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.226 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 1.12 HG23 HD23 ' A' ' 193' ' ' LEU . 2.3 pp -139.92 179.71 2.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.231 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 212' ' ' ILE . 1.3 tttt -87.39 110.94 20.62 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.137 0.494 . . . . 0.0 110.825 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 191' ' ' LYS . 26.9 m -113.32 162.69 11.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.079 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.46 HG23 ' O ' ' A' ' 196' ' ' VAL . 1.5 pp -157.32 172.88 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.189 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 61.88 31.17 18.31 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.061 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.0 m -71.2 105.79 3.55 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.682 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 208' ' ' ILE . 3.7 mt-10 -126.99 133.26 50.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.213 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -158.42 156.45 30.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.405 ' O ' ' HB2' ' A' ' 205' ' ' GLN . 0.6 OUTLIER -122.86 100.55 6.96 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.783 0.325 . . . . 0.0 111.22 -179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 42.01 -98.03 0.01 OUTLIER Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.15 -0.547 . . . . 0.0 113.049 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -105.25 56.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.369 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.653 ' HA ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.85 178.09 7.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.798 179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -72.64 148.84 44.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.396 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -115.2 133.88 55.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.001 0.429 . . . . 0.0 111.757 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.564 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.6 pt -102.37 125.01 56.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.307 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.444 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 38.6 t -128.5 144.89 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.83 0.348 . . . . 0.0 111.352 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 1.3 m -109.9 145.55 36.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.426 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.736 HD11 ' OD2' ' A' ' 221' ' ' ASP . 0.7 OUTLIER -108.56 128.85 55.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.258 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.687 HD13 ' O ' ' A' ' 211' ' ' LEU . 23.6 mm -145.88 124.86 5.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.757 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 177.83 133.29 0.22 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.197 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.455 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 97.6 Cg_endo -84.98 115.47 1.72 Allowed 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.657 2.238 . . . . 0.0 112.358 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 148.71 -152.31 24.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.728 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.751 ' HB2' HG21 ' A' ' 120' ' ' VAL . 21.9 m -124.38 29.02 6.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.745 0.307 . . . . 0.0 111.05 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.502 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 0.4 OUTLIER -60.75 -20.82 62.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.112 179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -42.21 -31.7 0.41 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.737 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -56.94 -64.09 0.99 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.904 0.383 . . . . 0.0 110.758 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.415 HD13 ' CE1' ' A' ' 217' ' ' PHE . 3.0 mt -59.55 -31.77 47.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.695 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.736 ' OD2' HD11 ' A' ' 211' ' ' LEU . 0.4 OUTLIER -67.0 -40.29 87.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.606 179.705 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.432 ' HA ' ' HG2' ' A' ' 225' ' ' LYS . 15.9 mt-10 -67.67 -40.65 84.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.879 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -50.55 61.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.283 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.611 HG21 ' CD1' ' A' ' 193' ' ' LEU . 2.1 pp -66.8 -39.45 83.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.732 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.432 ' HG2' ' HA ' ' A' ' 222' ' ' GLU . 0.0 OUTLIER -71.78 -29.44 64.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.728 0.299 . . . . 0.0 111.002 -179.637 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -79.04 -31.63 44.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.791 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -81.75 -28.86 33.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.197 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.635 HG23 ' HD3' ' A' ' 185' ' ' LYS . 59.7 m -89.09 -31.49 18.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.293 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.412 ' CD ' HD22 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -97.21 -20.99 17.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.157 -179.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 60.73 -86.6 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.465 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.42 30.29 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.861 0.363 . . . . 0.0 110.906 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -122.13 10.66 9.39 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.848 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -119.29 173.06 7.17 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.323 . . . . 0.0 111.013 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.05 136.92 52.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.934 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -122.82 115.32 21.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.921 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.77 147.95 11.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.108 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.8 mp -117.15 146.89 42.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -112.93 -66.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 tp -106.02 117.34 33.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.9 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.36 128.52 43.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.97 111.36 23.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -134.87 -51.42 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.113 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -62.45 125.9 25.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.963 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -111.34 -61.83 1.64 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.937 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -158.44 73.83 0.22 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.532 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -115.91 -61.52 1.72 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.842 0.353 . . . . 0.0 110.912 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -145.47 176.37 9.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.768 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.71 31.16 2.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -110.73 85.37 2.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.807 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.816 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.831 0.348 . . . . 0.0 111.186 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 t -97.79 150.44 21.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.007 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.593 HG23 ' CD2' ' A' ' 4' ' ' PHE . 0.6 OUTLIER -179.15 -35.85 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.171 179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.593 ' CD2' HG23 ' A' ' 3' ' ' ILE . 0.0 OUTLIER -105.36 -52.44 2.83 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.934 0.397 . . . . 0.0 110.243 179.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.491 ' HB ' ' HD3' ' A' ' 6' ' ' PRO . 1.3 m -177.1 -62.63 0.0 OUTLIER Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.277 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.491 ' HD3' ' HB ' ' A' ' 5' ' ' THR . 67.9 Cg_endo -72.47 116.7 4.81 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.567 2.178 . . . . 0.0 112.212 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -64.32 -66.54 0.53 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.987 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -136.98 104.96 5.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.476 HE21 HG23 ' A' ' 10' ' ' ILE . 0.5 OUTLIER -176.59 -45.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.801 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.476 HG23 HE21 ' A' ' 9' ' ' GLN . 3.1 pt -110.36 -25.19 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.251 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 74.03 -59.97 0.54 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.905 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -162.94 151.35 14.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 179.901 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.0 t -149.05 -164.5 2.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.799 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 76.85 -59.72 0.48 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.124 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.495 HG21 ' HG2' ' A' ' 52' ' ' GLN . 21.6 t -121.7 134.33 65.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.171 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.48 147.88 39.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.001 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.4 t -121.22 121.79 65.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.293 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.555 HG23 ' SG ' ' A' ' 31' ' ' CYS . 23.9 t -105.78 128.27 60.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.754 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -106.38 158.27 17.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.888 0.375 . . . . 0.0 111.368 -179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.745 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -148.68 154.41 39.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.704 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttt -121.27 113.38 19.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.34 129.69 13.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.92 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.14 36.49 24.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.065 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.79 28.12 65.22 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.469 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.92 144.29 48.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.57 105.54 17.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.99 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -112.62 140.56 47.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.747 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 18' ' ' VAL . 4.3 pt-20 -147.16 154.04 40.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.001 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.69 149.74 31.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.842 0.354 . . . . 0.0 111.222 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.005 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.44 108.05 19.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.649 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.716 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.3 p -131.18 177.86 7.14 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.273 -179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.9 m-85 -88.67 138.81 31.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.348 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.752 ' O ' HG22 ' A' ' 37' ' ' VAL . 4.8 ptpt -65.23 -42.8 93.05 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.5 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m-20 -73.51 -37.98 65.47 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.125 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.545 ' CB ' HG23 ' A' ' 50' ' ' VAL . 4.7 mmpt? -72.78 -38.77 67.16 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.089 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -67.27 -51.53 52.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.481 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.752 HG22 ' O ' ' A' ' 33' ' ' LYS . 17.6 m -58.92 -46.92 91.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.949 0.404 . . . . 0.0 110.565 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.774 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -62.98 -31.57 81.14 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.684 -0.769 . . . . 0.0 111.857 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.59 ' CH2' HD23 ' A' ' 47' ' ' LEU . 6.0 t-105 -63.8 -54.66 31.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.897 0.38 . . . . 0.0 110.246 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.39 -39.51 76.25 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.471 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.695 ' OG ' HG13 ' A' ' 43' ' ' VAL . 11.2 p -64.35 -27.08 68.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.82 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.34 49.11 3.56 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.532 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.774 HG22 ' O ' ' A' ' 38' ' ' GLY . 34.0 m -97.9 29.28 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.766 0.317 . . . . 0.0 111.255 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 56.44 72.18 0.52 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HD2' ' HB3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -110.04 162.47 14.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.021 -179.67 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.467 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -121.68 148.89 44.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.013 -179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.704 ' HG ' HG22 ' A' ' 81' ' ' THR . 0.3 OUTLIER -63.55 -33.02 74.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.062 -179.89 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -72.37 -7.2 48.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.624 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -120.2 -17.99 8.15 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.3 p -98.27 -30.16 3.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.716 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.7 mt -90.72 125.91 35.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.807 0.337 . . . . 0.0 110.948 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' HG2' HG21 ' A' ' 15' ' ' VAL . 6.9 tp-100 -77.54 -45.41 25.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.149 0.5 . . . . 0.0 109.771 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.005 HG22 ' HB3' ' A' ' 30' ' ' ALA . 13.6 t -129.94 112.64 13.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.338 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -72.03 71.07 0.81 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.291 -179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -167.0 135.02 2.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.385 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.982 HG21 HD21 ' A' ' 71' ' ' LEU . 18.1 t -75.89 97.98 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.857 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.672 ' CE1' HG21 ' A' ' 53' ' ' THR . 8.9 m-85 -69.8 -179.22 1.74 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.47 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 97.5 t -132.59 -45.84 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.928 179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -138.69 67.3 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.066 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.439 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.6 t -50.98 -37.95 17.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.284 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.485 ' HA ' HD13 ' A' ' 12' ' ' LEU . 8.4 t -54.03 -27.41 31.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.159 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -113.65 -26.0 8.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.129 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.34 46.17 1.26 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.386 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.96 128.58 55.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.664 0.269 . . . . 0.0 110.715 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 7.2 t -111.19 143.83 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.186 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -77.83 178.09 7.67 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.04 151.73 27.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.72 -34.22 75.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.24 -51.29 70.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -66.16 -35.17 79.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.778 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.982 HD21 HG21 ' A' ' 56' ' ' VAL . 9.3 mt -58.22 -47.15 84.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.86 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.6 mt -75.91 -43.59 39.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.5 p -59.15 -26.17 64.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.348 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -95.84 -63.04 1.19 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.813 0.339 . . . . 0.0 111.529 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.8 m-85 -72.73 -43.92 62.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.187 -179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.12 11.79 17.42 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.662 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -157.68 150.02 22.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.835 0.35 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.5 t0 -85.56 -11.85 53.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.232 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.28 83.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.876 0.37 . . . . 0.0 110.893 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.555 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.1 OUTLIER -55.51 -31.9 62.44 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.74 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.704 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.36 -54.56 45.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.403 179.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -58.62 -43.0 89.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.181 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.981 HD13 HD22 ' A' ' 71' ' ' LEU . 67.2 mt -58.91 -41.03 81.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.58 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 99.2 m -62.74 -42.6 99.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.483 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HG2' HD21 ' A' ' 47' ' ' LEU . 59.2 mttt -57.97 -50.42 73.46 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.47 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -58.37 -40.84 83.37 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.918 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.745 HG23 ' HB2' ' A' ' 20' ' ' MET . 27.0 mt -67.8 -30.6 48.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 36' ' ' VAL . 3.6 mp -76.67 -29.32 56.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.083 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.9 p -94.27 -33.18 13.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.145 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.02 -44.12 5.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.161 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -61.82 173.24 7.75 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.572 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -98.82 115.19 28.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.322 . . . . 0.0 110.907 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.581 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.7 p -79.55 111.43 16.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.025 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -84.32 105.63 15.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.845 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.54 HG13 HG22 ' A' ' 93' ' ' VAL . 16.4 m -137.62 136.26 46.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.14 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -69.36 175.99 3.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -73.77 -13.89 61.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.3 -52.67 60.72 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.819 0.342 . . . . 0.0 111.066 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.71 -36.82 77.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.891 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -65.61 -45.48 82.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.77 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.42 -47.87 71.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.758 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.3 m -64.02 -45.64 88.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 19.8 mm100 -60.92 -42.5 98.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.763 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 mt -59.61 -51.94 67.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.735 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.9 -43.12 99.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.633 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.72 -38.68 91.82 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.52 ' HE1' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -60.87 -51.62 68.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.676 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.609 ' HA ' HD12 ' A' ' 111' ' ' ILE . 34.9 m-85 -61.21 -37.66 83.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.692 179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.44 -41.52 89.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.748 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.18 -45.24 94.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.708 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' A' ' 108' ' ' PHE . 7.3 mt -61.82 -47.57 92.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.833 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.489 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -63.62 -35.39 80.35 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.967 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 67.2 m -65.63 -45.31 83.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.812 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 111' ' ' ILE . 5.5 mt -63.34 -42.98 98.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.069 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 111' ' ' ILE . 31.2 t -71.83 -29.56 34.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -84.0 -28.87 27.41 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.22 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.05 -57.82 3.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.076 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.25 73.47 1.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.094 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.441 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.1 OUTLIER 178.28 131.39 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.939 179.829 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.752 HG21 ' HB3' ' A' ' 216' ' ' CYS . 15.6 m -141.33 164.29 20.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.069 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 -82.02 133.99 50.4 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.878 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.69 60.06 5.82 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.519 2.146 . . . . 0.0 112.408 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -161.04 -49.9 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.861 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.1 t -98.63 -25.68 14.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 tttm 64.73 32.49 11.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.95 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -119.44 136.04 24.38 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.59 ' HA ' HG12 ' A' ' 120' ' ' VAL . 70.0 Cg_endo -74.34 107.32 2.42 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.513 2.142 . . . . 0.0 112.385 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.537 ' HD1' HD13 ' A' ' 132' ' ' LEU . 15.8 m-85 -60.36 164.44 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.891 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 17.9 p -99.24 159.79 14.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.949 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.403 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.1 m -53.39 -30.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.237 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.1 mt -70.16 -36.45 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.898 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.537 HD13 ' HD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -69.98 -51.11 35.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.66 179.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.49 HG22 ' HE2' ' A' ' 137' ' ' MET . 3.7 mt -60.95 -43.15 95.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.858 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -62.84 -42.06 99.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.691 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -59.58 -48.44 81.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.69 -40.81 96.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.966 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.49 ' HE2' HG22 ' A' ' 133' ' ' ILE . 2.4 tpp -64.72 -32.01 73.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.811 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp -78.05 -42.37 32.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.89 -40.06 91.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.77 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.4 tt -75.45 -7.02 9.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.47 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 68.03 47.1 1.1 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.015 0.436 . . . . 0.0 110.938 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -69.6 155.97 39.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.811 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -146.81 88.43 1.75 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.039 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.504 HG11 HD11 ' A' ' 111' ' ' ILE . 5.5 m -78.77 140.01 17.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.961 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.06 130.54 51.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.002 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.52 HG22 ' HE1' ' A' ' 107' ' ' MET . 27.3 p -58.98 -20.15 49.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.209 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -93.64 23.17 4.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.247 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -126.61 139.34 53.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.793 0.33 . . . . 0.0 110.813 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 50.6 m -66.64 140.34 57.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.937 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 2.9 p -61.93 -61.59 2.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.909 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.34 -45.71 35.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.101 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -61.37 -36.1 79.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.75 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.9 tp-100 -75.09 -25.22 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.083 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.52 -43.97 62.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.37 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.725 ' HA ' HD12 ' A' ' 158' ' ' ILE . 7.9 tp -58.26 -50.52 73.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.55 -39.4 83.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.6 t -61.4 -43.98 97.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.725 HD12 ' HA ' ' A' ' 155' ' ' LEU . 7.1 mt -62.14 -52.74 56.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.06 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -60.19 -48.07 83.28 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -61.19 -56.65 18.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.98 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 161' ' ' LEU . 21.6 mt -60.35 -26.11 66.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.077 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -29.44 52.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.011 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -71.19 -30.68 66.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.869 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 36.3 mmtt -104.16 -69.85 0.79 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.93 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mmt -115.92 129.87 56.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.16 146.66 43.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.823 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.618 ' CG2' HG23 ' A' ' 158' ' ' ILE . 10.4 tp -140.19 150.62 21.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.217 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -141.16 123.23 15.55 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 3.2 ttm180 -105.38 127.3 52.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.608 ' HB1' ' OD1' ' A' ' 241' ' ' ASP . . . -169.38 136.79 1.78 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.228 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -99.66 -176.21 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.671 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.712 ' HE3' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -174.03 107.18 0.13 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.958 0.408 . . . . 0.0 111.339 179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.506 ' HG2' HG23 ' A' ' 212' ' ' ILE . 47.4 mtp180 -108.57 107.28 17.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.098 179.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.712 HD11 ' HE3' ' A' ' 172' ' ' MET . 0.3 OUTLIER -108.81 178.2 4.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.256 0.55 . . . . 0.0 112.051 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.27 147.45 31.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.44 ' CZ ' ' HB2' ' A' ' 233' ' ' SER . 41.0 t80 -147.34 147.87 30.78 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.222 0.534 . . . . 0.0 112.107 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 16.2 mt -132.55 120.43 42.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.558 179.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.676 HD11 ' HB3' ' A' ' 207' ' ' GLU . 0.8 OUTLIER -109.24 151.46 42.05 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.922 0.392 . . . . 0.0 111.94 -178.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 60.3 Cg_endo -71.81 -166.09 0.24 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.882 2.388 . . . . 0.0 112.474 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.627 HG22 ' HA ' ' A' ' 205' ' ' GLN . 3.2 t -75.99 -63.52 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.804 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -68.37 -57.95 5.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 112.018 -178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.41 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -65.67 -16.31 63.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.759 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 178' ' ' LEU . . . -75.59 -22.83 74.48 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 120.577 -0.821 . . . . 0.0 113.128 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 23.4 mttt -53.72 -52.47 60.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.708 0.29 . . . . 0.0 111.512 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.454 ' HZ2' ' HA ' ' A' ' 228' ' ' THR . 0.0 OUTLIER -85.74 -36.77 19.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.667 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.552 HD11 ' HA ' ' A' ' 229' ' ' LYS . 2.2 mt -53.51 -26.62 21.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.535 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -83.16 -63.0 1.44 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.791 0.329 . . . . 0.0 111.354 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -57.35 -23.78 51.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.58 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.451 ' HG2' HD11 ' A' ' 224' ' ' ILE . 0.7 OUTLIER -83.99 -22.98 31.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.607 -0.269 . . . . 0.0 111.679 -179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.492 HD21 ' HG2' ' A' ' 225' ' ' LYS . 33.9 mt -99.16 -27.09 13.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.711 0.291 . . . . 0.0 111.458 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.428 ' N ' ' HD2' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -54.35 -52.02 72.83 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.488 -179.751 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.428 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 95.3 Cg_endo -80.19 -33.16 1.13 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.531 2.154 . . . . 0.0 112.776 -179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.615 HD23 HG23 ' A' ' 194' ' ' ILE . 0.3 OUTLIER -57.02 -53.55 56.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.381 -179.664 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.615 HG23 HD23 ' A' ' 193' ' ' LEU . 2.6 pp -137.61 179.36 3.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.432 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.18 118.54 23.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.863 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.97 151.42 21.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.185 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 1.6 pp -152.13 163.13 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 62.26 52.79 3.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.844 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.3 m -91.05 113.64 25.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -129.02 114.39 16.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.011 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -111.72 146.75 36.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -108.03 150.42 27.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.613 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.07 101.54 0.04 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.579 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 61.48 39.97 14.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.95 0.405 . . . . 0.0 110.458 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.627 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.84 178.2 7.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.148 -179.708 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 3.8 pp -72.71 148.95 44.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.933 -179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.676 ' HB3' HD11 ' A' ' 178' ' ' LEU . 1.4 tt0 -117.68 140.59 49.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.123 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -95.33 129.08 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.698 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 176' ' ' PHE . 10.9 p -130.95 145.36 35.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.057 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 42.2 t -109.3 145.53 35.82 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.45 ' HB2' ' HB2' ' A' ' 174' ' ' LEU . 4.3 mp -118.77 140.5 49.84 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.131 0.491 . . . . 0.0 112.159 -178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.506 HG23 ' HG2' ' A' ' 173' ' ' ARG . 36.0 mt -146.77 124.82 3.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.473 179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.416 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 2.5 p30 -177.05 157.42 1.33 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.947 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 213' ' ' ASP . 10.6 Cg_endo -53.8 177.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.563 2.175 . . . . 0.0 112.1 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -79.21 -3.49 88.45 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.639 -0.791 . . . . 0.0 113.163 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.752 ' HB3' HG21 ' A' ' 120' ' ' VAL . 29.0 p -83.24 -40.75 19.2 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.841 0.32 . . . . 0.0 111.187 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.53 ' CD1' HG22 ' A' ' 194' ' ' ILE . 0.2 OUTLIER -66.05 -20.92 66.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.308 -179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.664 ' HB2' ' HE2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -46.1 -31.94 2.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.771 0.319 . . . . 0.0 111.545 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 31.7 mm-40 -66.77 -64.22 0.9 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.138 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.506 ' H ' HD12 ' A' ' 220' ' ' ILE . 3.3 mp -60.24 -38.42 77.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.359 -179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -58.83 -56.79 17.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.178 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -58.48 -38.08 76.88 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.078 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 6.7 mt -63.2 -63.7 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.947 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.529 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -56.92 -42.92 79.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.13 -179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.492 ' HG2' HD21 ' A' ' 190' ' ' LEU . 11.2 mtmt -56.94 -55.43 34.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.955 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.38 -36.71 71.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.209 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -76.83 -25.25 53.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.239 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.454 ' HA ' ' HZ2' ' A' ' 185' ' ' LYS . 30.7 p -92.62 -22.19 19.62 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.432 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -96.21 -27.57 14.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.725 0.298 . . . . 0.0 111.228 -179.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.402 ' N ' ' HG3' ' A' ' 229' ' ' LYS . . . 49.74 37.08 27.01 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.619 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 14.2 tttt 61.07 36.19 18.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 110.895 -179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -133.9 25.68 3.51 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.608 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 176' ' ' PHE . 1.2 m -143.08 173.08 11.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.752 0.31 . . . . 0.0 110.917 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.9 mt -106.36 147.12 29.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.877 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.5 115.72 6.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.03 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 25.9 t -106.67 148.04 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.1 mp -123.36 132.81 54.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.939 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -94.77 -73.41 0.58 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.3 mt -105.01 120.86 42.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.947 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.96 136.4 52.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . 0.608 ' OD1' ' HB1' ' A' ' 170' ' ' ALA . 70.5 m-20 -69.0 123.19 20.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.949 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 7.9 m -94.67 -23.12 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.28 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -95.01 40.67 1.1 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.048 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.48 101.3 10.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.899 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 101.97 -107.42 3.17 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.536 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -116.22 113.08 22.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -76.69 -174.88 3.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.796 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . 0.428 ' HB2' ' CD2' ' A' ' 249' ' ' PHE . 0.0 OUTLIER -126.11 -55.36 1.47 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.702 179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 250' ' ' GLU . 29.1 p90 -179.7 -43.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . 0.438 ' N ' ' CD1' ' A' ' 249' ' ' PHE . 16.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.911 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 mtt . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.82 0.343 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -73.25 147.49 44.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.4 mp -120.36 -41.63 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.026 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 29.3 p90 -110.83 -32.83 6.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.919 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m 64.1 121.41 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.725 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.66 91.08 0.35 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.395 2.063 . . . . 0.0 112.276 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -160.73 160.51 31.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.888 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -59.46 107.14 0.54 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.819 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -169.07 -41.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.66 HD13 ' H ' ' A' ' 10' ' ' ILE . 0.2 OUTLIER -129.44 174.19 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.121 179.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 41.22 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.01 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.69 30.86 5.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.895 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.6 p -122.66 114.59 20.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -176.88 -40.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.925 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.605 HG22 ' NE2' ' A' ' 52' ' ' GLN . 22.0 t -122.57 156.85 27.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.16 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' N ' HG12 ' A' ' 15' ' ' VAL . . . -87.77 133.15 33.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.943 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t -106.65 118.14 53.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.032 0.444 . . . . 0.0 111.324 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.476 HG12 HG22 ' A' ' 87' ' ' ILE . 11.0 t -106.3 125.56 61.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.64 158.21 20.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.25 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.869 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.0 tmm? -154.66 161.5 41.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.753 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.01 124.88 50.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 10.4 ttm-85 -160.32 137.95 9.63 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.817 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.12 30.83 19.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.084 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.49 29.0 70.54 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.558 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.04 167.04 20.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.797 0.332 . . . . 0.0 110.958 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 8.8 mtp180 -109.75 117.53 34.13 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.916 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -123.98 134.52 53.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.794 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -147.04 147.83 31.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.951 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.88 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.8 OUTLIER -132.24 156.66 42.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.13 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.08 106.77 18.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.705 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.884 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -120.65 174.12 6.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.22 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.904 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -96.97 114.05 25.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.595 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.781 ' HG3' HG11 ' A' ' 95' ' ' VAL . 0.2 OUTLIER -43.53 -46.33 6.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.781 -179.59 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 37' ' ' VAL . 62.8 m-80 -61.66 -54.9 36.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.321 -179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.582 ' CB ' HG23 ' A' ' 50' ' ' VAL . 10.1 mtpp -68.14 -21.7 64.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.35 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.904 HG23 ' O ' ' A' ' 32' ' ' TYR . 92.1 t -71.55 -44.49 70.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.908 0.385 . . . . 0.0 110.242 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 34' ' ' ASN . 14.5 m -70.29 -40.56 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.374 179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.24 -33.18 84.36 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.781 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.464 ' CZ3' ' CD2' ' A' ' 47' ' ' LEU . 7.3 t-105 -71.58 -52.08 19.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.873 0.368 . . . . 0.0 110.083 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.41 -39.51 67.39 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.678 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -82.78 -18.54 40.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.142 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 64.87 67.59 1.98 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.645 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.484 HG13 ' N ' ' A' ' 44' ' ' GLU . 10.7 p -124.87 -44.69 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.887 0.375 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' N ' HG13 ' A' ' 43' ' ' VAL . 1.0 OUTLIER -177.82 125.62 0.13 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.416 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HE2' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -174.42 -166.24 0.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.17 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -168.98 135.88 1.81 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.869 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -57.29 -48.19 79.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.48 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -70.32 -8.66 52.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.93 -179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -115.73 -14.96 11.38 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 -179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.884 HG22 ' SG ' ' A' ' 31' ' ' CYS . 14.9 p -96.02 -44.27 12.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.663 0.268 . . . . 0.0 111.54 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.82 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -82.56 101.94 11.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.905 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.605 ' NE2' HG22 ' A' ' 15' ' ' VAL . 4.1 mt-30 -64.57 -31.03 72.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.934 0.397 . . . . 0.0 110.319 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.538 HG21 ' CE1' ' A' ' 57' ' ' PHE . 70.3 m -130.56 114.87 16.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.622 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -82.44 57.77 3.83 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.957 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.4 m -165.34 127.49 2.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.541 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.837 ' HA ' HG23 ' A' ' 29' ' ' ILE . 3.4 t -69.64 110.91 3.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.947 0.403 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.538 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.1 m-85 -83.98 -179.69 7.32 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.341 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.9 t -126.9 -45.82 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.285 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -136.88 66.91 1.46 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.251 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.406 HG23 ' H ' ' A' ' 60' ' ' VAL . 2.2 t -53.01 -30.49 16.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.137 -179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -58.47 -30.55 67.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.895 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -112.02 -25.96 9.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.034 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.67 47.1 0.99 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.586 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 131.67 55.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.785 0.326 . . . . 0.0 110.575 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.537 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 28.7 t -108.51 154.25 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.297 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.61 -169.79 2.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.047 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 28.1 mttt -127.68 147.83 50.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -59.87 -41.67 92.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -56.61 -50.56 71.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.884 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -70.11 -31.56 69.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.784 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.033 HD22 HD13 ' A' ' 83' ' ' ILE . 4.0 mt -62.12 -36.56 82.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 8.2 mt -79.86 -48.84 20.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.2 p -67.88 -16.01 63.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.403 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.19 -44.69 7.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.673 0.273 . . . . 0.0 111.428 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.475 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 57.3 m-85 -102.64 -45.72 4.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.327 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 90.59 44.66 4.52 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.331 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.423 ' O ' ' CB ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -138.91 -45.62 0.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.782 0.325 . . . . 0.0 110.925 -179.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.423 ' CB ' ' O ' ' A' ' 77' ' ' THR . 17.8 t0 82.68 -7.3 1.26 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.353 -179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -99.34 96.63 7.85 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.698 0.285 . . . . 0.0 110.377 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.726 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -47.17 -44.78 22.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.256 -179.569 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.466 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -51.11 -52.69 41.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.906 0.384 . . . . 0.0 110.647 179.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -57.59 -52.14 66.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.296 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.033 HD13 HD22 ' A' ' 71' ' ' LEU . 6.9 mt -53.7 -39.37 38.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.405 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.88 ' SG ' HG21 ' A' ' 29' ' ' ILE . 80.8 m -59.66 -44.58 93.51 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.973 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.869 ' HE3' HD21 ' A' ' 47' ' ' LEU . 7.2 mttt -57.83 -44.54 86.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.864 179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.94 -47.71 74.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.493 179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.869 HG23 ' HB2' ' A' ' 20' ' ' MET . 5.5 mt -68.92 -28.49 39.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.75 HD21 ' SG ' ' A' ' 31' ' ' CYS . 1.0 OUTLIER -71.26 -31.75 67.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.121 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 37.2 p -98.32 -44.84 6.39 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.28 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.56 -35.57 20.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.182 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -76.96 168.59 54.81 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.512 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.35 137.25 39.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.797 0.332 . . . . 0.0 110.894 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 93' ' ' VAL . 11.3 p -86.27 120.87 36.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.988 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -105.32 109.35 21.3 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.781 HG11 ' HG3' ' A' ' 33' ' ' LYS . 27.4 m -132.84 159.71 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.139 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.2 m -81.3 173.67 12.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.896 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -59.95 -37.92 80.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.905 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mtmm -59.82 -44.8 93.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.75 -41.32 97.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.777 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.74 -37.72 79.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.839 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -64.79 -44.86 88.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.7 m -60.07 -34.3 73.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.891 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.7 tp60 -68.49 -44.35 74.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 mt -60.47 -48.85 79.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.716 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -60.47 -46.9 88.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.773 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -62.96 -38.72 92.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 24.9 tpp -64.22 -46.86 82.01 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.737 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -60.21 -42.0 94.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.71 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.58 -37.5 86.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.826 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -63.28 -59.95 4.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.778 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.85 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -56.06 -37.4 48.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.094 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -67.01 -42.17 85.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.016 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 70.4 m -61.47 -41.76 97.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 33.0 mm -68.19 -39.18 80.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 111' ' ' ILE . 34.8 t -75.78 -19.17 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.416 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -94.02 -40.83 9.88 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.59 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -101.56 -39.93 7.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.355 -179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 41.76 1.09 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.981 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.427 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.8 OUTLIER -176.75 179.47 1.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.927 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.615 HG13 ' HB2' ' A' ' 170' ' ' ALA . 16.1 m -156.75 169.73 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.072 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -111.11 117.05 50.67 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.841 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.88 -21.79 21.86 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.459 2.106 . . . . 0.0 112.475 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -51.63 -58.0 7.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.189 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 72.4 p -136.29 19.36 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.172 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 52.07 31.32 8.66 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.158 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.5 mtm-85 -110.07 141.58 24.12 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -76.31 127.25 9.68 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.599 2.199 . . . . 0.0 112.344 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -71.08 172.69 8.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.19 148.14 27.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.794 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.3 m -51.65 -30.31 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.293 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 30.7 mm -73.7 -36.37 46.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.06 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 11.9 mt -72.75 -43.63 62.64 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.796 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.538 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 12.5 mt -67.77 -39.27 81.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -67.08 -44.9 78.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.818 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.7 ttt-85 -60.47 -49.17 78.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.467 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -64.76 -50.64 66.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.12 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 17.6 ttp -59.48 -31.51 69.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.941 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -81.4 -40.81 22.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.93 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -60.49 -42.16 95.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG22 ' O ' ' A' ' 136' ' ' ALA . 1.6 tt -77.85 -4.56 6.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.525 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 51.7 m-70 63.21 66.48 0.72 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.884 0.373 . . . . 0.0 110.909 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CE2' HG12 ' A' ' 144' ' ' VAL . 27.5 t80 -72.34 -54.64 8.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.93 96.7 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.959 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.764 HG11 ' CD1' ' A' ' 111' ' ' ILE . 10.9 m -81.74 160.34 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.139 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 27.7 mttp -106.49 118.28 36.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.969 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 62.0 p -57.07 -27.37 61.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.119 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -96.58 29.86 2.8 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.956 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.6 tptp -131.27 144.02 50.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.932 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 43.2 t -74.45 143.18 44.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.787 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 71.5 p -61.34 -50.94 70.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.045 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HD11 ' A' ' 220' ' ' ILE . 0.0 OUTLIER -49.36 -46.77 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.088 -179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.69 -30.74 71.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.848 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.837 ' O ' HG23 ' A' ' 157' ' ' VAL . 72.9 mm-40 -70.32 -25.65 63.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.087 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.59 -37.43 49.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.37 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.67 -54.38 46.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -61.36 -38.51 87.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.0 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.837 HG23 ' O ' ' A' ' 153' ' ' GLN . 31.2 t -58.68 -48.61 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.209 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 10.5 mt -63.34 -47.71 90.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.163 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.34 -47.42 86.0 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -64.59 -57.22 9.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.133 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.603 HD12 HG12 ' A' ' 157' ' ' VAL . 21.5 mt -58.71 -20.42 48.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.333 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.408 ' HA ' ' CB ' ' A' ' 166' ' ' LYS . 0.6 OUTLIER -54.16 -32.17 54.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.825 0.345 . . . . 0.0 111.052 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -73.73 -27.04 60.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.06 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.02 -72.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.105 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -130.64 -35.15 1.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.368 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.408 ' CB ' ' HA ' ' A' ' 162' ' ' LYS . 11.7 tttt 76.62 135.31 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.853 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.707 HD13 ' H ' ' A' ' 167' ' ' ILE . 0.2 OUTLIER -130.23 147.9 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.816 179.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -121.68 157.64 30.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.214 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 6.0 mmm-85 -66.64 150.07 49.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.722 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.725 ' HB1' ' CE ' ' A' ' 172' ' ' MET . . . -104.73 137.44 42.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 111.089 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 8.0 p80 -109.82 141.04 43.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.161 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.725 ' CE ' ' HB1' ' A' ' 170' ' ' ALA . 0.0 OUTLIER -154.75 170.16 22.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.416 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.417 ' HB3' ' HB3' ' A' ' 238' ' ' ASN . 13.6 ttt180 -108.08 142.49 38.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.996 0.426 . . . . 0.0 111.124 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.623 ' CG ' HD23 ' A' ' 237' ' ' LEU . 1.2 mp -140.79 154.58 46.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.093 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.693 ' HD3' HG13 ' A' ' 236' ' ' VAL . 0.0 OUTLIER -124.57 133.28 53.34 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.899 179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.839 ' HB2' HD11 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -129.17 129.69 45.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.414 -179.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.598 ' CG2' HD12 ' A' ' 206' ' ' LEU . 4.2 mp -113.63 114.19 46.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.241 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.859 ' CD2' HD13 ' A' ' 186' ' ' LEU . 0.3 OUTLIER -114.25 152.64 46.13 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.262 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.44 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 30.1 Cg_endo -62.63 -177.0 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.611 2.207 . . . . 0.0 112.268 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 205' ' ' GLN . 6.5 p -76.15 -44.78 36.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.869 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 180' ' ' VAL . 21.5 m-20 -81.64 -57.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.727 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.44 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.3 OUTLIER -68.57 -20.71 64.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.459 -179.491 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -58.05 -38.8 90.66 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.847 -179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.5 pttt -74.7 -25.02 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.711 0.291 . . . . 0.0 111.277 -179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -30.27 60.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.328 -179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.859 HD13 ' CD2' ' A' ' 178' ' ' LEU . 10.1 tt -89.13 -59.92 2.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.263 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -49.0 -28.36 3.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.459 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.37 -58.27 5.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.321 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.528 ' HG2' HD11 ' A' ' 224' ' ' ILE . 3.6 tttt -80.29 -5.74 56.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.222 -0.445 . . . . 0.0 112.002 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.33 -28.83 13.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.783 0.325 . . . . 0.0 111.529 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.441 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.5 OUTLIER -57.31 -52.06 77.08 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.296 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.441 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.74 -34.65 1.26 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.782 2.322 . . . . 0.0 112.524 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.991 HD23 HG23 ' A' ' 194' ' ' ILE . 3.5 tt -57.37 -53.15 61.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.356 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.991 HG23 HD23 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -129.72 172.47 15.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.94 0.4 . . . . 0.0 111.454 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.46 126.59 31.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.719 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.435 HG21 ' HG2' ' A' ' 191' ' ' LYS . 3.3 m -134.23 159.01 42.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.288 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 212' ' ' ILE . 13.7 pt -156.35 173.73 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.139 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 58.97 28.05 17.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 100.0 p -74.95 107.04 6.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.802 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.707 ' HB2' HD11 ' A' ' 208' ' ' ILE . 16.0 mt-10 -129.96 154.16 47.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.245 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -158.38 146.75 18.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.561 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -113.29 100.63 8.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.126 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 40.79 -97.08 0.01 OUTLIER Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.055 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.66 52.1 0.72 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.112 0.482 . . . . 0.0 110.483 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.494 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -121.56 178.23 4.9 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.051 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.598 HD12 ' CG2' ' A' ' 177' ' ' ILE . 2.3 pt? -72.62 149.07 44.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.027 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -94.76 128.94 41.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -179.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.707 HD11 ' HB2' ' A' ' 200' ' ' GLU . 1.0 OUTLIER -111.53 105.65 19.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.866 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.43 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 11.5 p -127.81 144.46 37.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.968 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 19.4 m -109.98 145.63 36.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.932 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.839 HD11 ' HB2' ' A' ' 176' ' ' PHE . 1.4 mp -101.24 154.27 18.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.827 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.573 HD11 ' CD1' ' A' ' 197' ' ' ILE . 32.7 mt -148.04 144.71 19.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.018 0.437 . . . . 0.0 111.593 -179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.3 t0 75.19 77.28 0.18 Allowed Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.661 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 171' ' ' HIS . 73.5 Cg_endo -77.17 -14.99 16.42 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.617 2.211 . . . . 0.0 112.464 179.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -43.35 93.34 0.01 OUTLIER Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.113 -0.565 . . . . 0.0 113.414 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 214' ' ' PRO . 0.5 OUTLIER 75.79 -58.17 0.55 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.652 0.263 . . . . 0.0 111.581 179.553 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.409 ' CE1' ' O ' ' A' ' 193' ' ' LEU . 0.1 OUTLIER -46.75 -27.69 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.847 -179.409 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.04 -34.0 67.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.792 0.329 . . . . 0.0 111.174 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -64.15 1.05 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.822 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.62 HD11 ' HG2' ' A' ' 151' ' ' LYS . 41.0 mt -62.14 -30.12 48.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.737 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.583 ' OD2' HD23 ' A' ' 211' ' ' LEU . 46.9 t0 -65.33 -52.96 50.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.676 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.425 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.4 OUTLIER -61.54 -37.51 84.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.73 -54.05 32.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.305 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.767 HD13 HD13 ' A' ' 193' ' ' LEU . 13.1 tt -67.08 -46.79 83.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.785 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.519 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.62 -38.74 82.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.677 0.275 . . . . 0.0 111.039 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.456 ' HA ' ' HG2' ' A' ' 229' ' ' LYS . 3.2 tttt -72.39 -36.27 68.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.826 0.346 . . . . 0.0 111.08 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -73.02 -28.02 62.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.355 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.682 HG23 HD12 ' A' ' 186' ' ' LEU . 10.5 t -90.49 -29.09 18.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.301 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.456 ' HG2' ' HA ' ' A' ' 226' ' ' LYS . 0.0 OUTLIER -83.64 -26.92 29.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.778 0.323 . . . . 0.0 110.93 179.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 54.98 41.62 77.82 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.544 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 58.99 29.13 18.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.769 0.319 . . . . 0.0 110.927 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -116.92 20.78 11.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.733 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.6 m -141.1 170.38 15.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.776 0.322 . . . . 0.0 110.862 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.421 ' O ' ' CD1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -122.9 154.39 38.4 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.944 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.406 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 3.1 tt0 -159.42 115.36 2.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.964 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.693 HG13 ' HD3' ' A' ' 175' ' ' ARG . 12.2 p -106.87 148.07 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.623 HD23 ' CG ' ' A' ' 174' ' ' LEU . 3.5 mt -88.66 145.76 25.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.935 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 173' ' ' ARG . 10.3 t-20 -90.56 -67.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.843 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.2 mp -141.11 126.48 18.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.746 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.69 110.71 18.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.26 101.57 0.74 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.717 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 10.0 m -140.77 179.62 2.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -170.67 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.89 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.89 -30.16 71.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.917 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -111.57 72.29 0.21 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.555 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -75.21 113.24 12.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.826 0.345 . . . . 0.0 110.816 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.53 -90.39 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.05 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 177.87 -69.08 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.8 0.333 . . . . 0.0 110.886 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -151.99 -50.91 0.11 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.881 179.958 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.6 mtt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.778 0.323 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -113.95 -47.06 2.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.982 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.431 HG23 ' N ' ' A' ' 4' ' ' PHE . 8.5 tt -176.27 -43.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.34 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' N ' HG23 ' A' ' 3' ' ' ILE . 25.9 p90 -65.64 166.58 10.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.4 t -93.9 137.95 22.9 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.831 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -73.68 -25.2 15.01 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.527 2.151 . . . . 0.0 112.428 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -113.58 102.7 10.53 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -179.06 -49.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.91 -46.15 0.07 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.771 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.4 pp -117.53 175.84 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -109.3 -36.41 6.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 61' ' ' SER . 2.0 tt -177.13 97.06 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.878 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.66 161.27 32.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.967 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -177.89 -63.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.713 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -123.65 -179.66 2.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.689 179.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.559 ' H ' HG22 ' A' ' 15' ' ' VAL . . . -79.13 135.65 36.9 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.847 0.356 . . . . 0.0 111.21 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.2 t -104.57 120.34 54.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.488 ' HB ' HD12 ' A' ' 29' ' ' ILE . 15.5 t -106.99 126.31 63.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.19 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 17.3 ttp180 -115.52 158.29 22.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.017 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.898 ' HB2' HG23 ' A' ' 87' ' ' ILE . 8.4 tmm? -162.82 159.93 24.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.745 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -112.11 122.29 47.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.958 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.418 ' HG2' ' CD1' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.84 124.02 17.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.998 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.85 40.13 19.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.153 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.22 27.58 71.74 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.548 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -126.52 157.26 39.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.815 0.341 . . . . 0.0 110.881 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.01 106.31 16.2 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.961 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 61.2 m-85 -108.27 151.55 25.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.838 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 57' ' ' PHE . 2.8 tt0 -148.84 152.47 36.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.812 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.682 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.01 155.05 13.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.884 0.373 . . . . 0.0 111.037 179.798 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.13 112.74 23.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.928 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.827 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -134.2 160.23 38.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.065 -179.534 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.843 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.9 m-85 -80.24 131.5 35.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.286 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.469 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -56.76 -44.2 81.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.195 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' O ' HG12 ' A' ' 37' ' ' VAL . 12.2 t-20 -72.12 -45.1 61.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.363 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.82 ' HB2' HG23 ' A' ' 50' ' ' VAL . 10.3 mmtt -66.13 -33.87 76.77 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.066 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.843 HG23 ' O ' ' A' ' 32' ' ' TYR . 98.6 t -73.24 -44.44 55.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.085 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 34' ' ' ASN . 7.3 p -61.94 -41.38 90.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.864 0.364 . . . . 0.0 110.35 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.65 -43.36 60.41 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.019 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.757 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -63.51 -53.32 53.79 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.914 0.388 . . . . 0.0 110.282 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -55.44 -45.33 76.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.844 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.23 -26.93 65.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.943 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 126.02 -17.22 6.75 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.571 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.3 t -58.43 138.74 19.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.858 0.361 . . . . 0.0 111.15 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 151.44 16.55 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.997 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.484 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -176.78 154.23 1.15 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.861 -179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.9 139.31 38.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.962 0.41 . . . . 0.0 111.13 -179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.769 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.96 -30.93 71.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.283 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -69.47 -8.27 45.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 112.059 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 30.3 mm-40 -118.27 -34.16 4.16 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.624 0.25 . . . . 0.0 111.664 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.827 HG22 ' SG ' ' A' ' 31' ' ' CYS . 11.0 p -80.95 -42.37 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.6 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.769 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -81.72 106.9 14.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.773 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -64.52 -33.46 75.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.162 179.35 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.551 HG21 ' CE1' ' A' ' 57' ' ' PHE . 50.3 m -134.63 114.12 12.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.7 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 16.8 m80 -81.14 59.32 3.83 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.004 0.43 . . . . 0.0 110.799 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -161.65 126.85 3.53 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.443 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' HG23 ' A' ' 29' ' ' ILE . 4.2 t -69.57 106.87 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.991 0.424 . . . . 0.0 110.957 -179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.551 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.4 m-85 -81.02 179.29 7.93 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.238 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.503 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 95.7 t -126.14 -44.55 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.384 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.434 ' HB3' ' CG ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -140.09 70.34 1.36 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.293 179.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 1.8 t -55.63 -29.75 25.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.106 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.4 ' O ' HD13 ' A' ' 12' ' ' LEU . 5.5 p -55.12 -33.81 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.079 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.434 ' CG ' ' HB3' ' A' ' 59' ' ' ASN . 9.5 ptmt -113.44 -26.1 8.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.066 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 112.1 47.99 0.68 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.694 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.49 138.17 46.24 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.598 0.237 . . . . 0.0 110.551 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.491 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 22.9 t -122.05 152.87 26.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.361 -0.382 . . . . 0.0 111.434 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -92.48 177.92 5.98 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.91 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 22.9 pttt -114.16 156.8 23.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.507 ' O ' HD12 ' A' ' 72' ' ' ILE . 0.4 OUTLIER -61.19 -36.55 80.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.946 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -57.48 -53.47 57.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.63 -34.06 77.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.741 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.992 HD22 HD13 ' A' ' 83' ' ' ILE . 13.5 mt -58.8 -46.09 88.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.821 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.507 HD12 ' O ' ' A' ' 68' ' ' LYS . 3.8 mt -74.06 -39.51 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.2 t -65.15 -23.79 67.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.28 -179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.35 -57.02 2.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 111.539 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.554 ' CD1' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -77.57 -36.89 51.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.284 -179.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 104.01 9.56 36.71 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.638 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.58 159.64 43.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 110.814 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -96.1 -19.9 19.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.956 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.1 92.52 0.08 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.915 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.855 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.3 OUTLIER -56.48 -36.5 69.18 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.751 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.76 -51.23 70.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.001 0.429 . . . . 0.0 110.523 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -58.85 -41.6 87.38 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.34 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.992 HD13 HD22 ' A' ' 71' ' ' LEU . 38.1 mt -59.23 -44.28 91.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.587 179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.714 ' CB ' HD11 ' A' ' 51' ' ' LEU . 59.3 m -61.09 -40.45 93.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.296 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 62.0 mttt -57.82 -52.56 64.99 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.508 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 12.2 mm-40 -55.0 -46.65 75.2 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.602 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.898 HG23 ' HB2' ' A' ' 20' ' ' MET . 26.7 mt -64.07 -25.8 38.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.654 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.689 ' HG ' HG13 ' A' ' 36' ' ' VAL . 1.4 tp -77.67 -30.59 52.11 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.833 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -93.12 -29.32 15.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.246 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.7 mmtt -104.85 -44.24 4.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.78 0.324 . . . . 0.0 111.245 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.32 173.84 8.2 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.495 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 8.7 tt0 -107.88 127.67 53.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.882 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.4 p -87.86 137.06 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.66 106.87 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.852 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 m -111.28 140.23 31.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.174 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.09 176.0 5.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -59.49 -54.55 45.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttm -59.41 -37.97 79.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -66.17 -39.43 89.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -76.04 -34.08 59.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.837 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -62.69 -54.74 34.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.7 m -59.62 -34.36 72.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.826 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.78 -40.51 83.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.821 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.84 -44.13 90.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.849 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -62.13 -47.43 84.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.809 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.74 -44.78 96.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.85 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.3 tpp -60.33 -44.28 95.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -53.34 59.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.791 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.6 mtp85 -57.47 -34.93 69.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.882 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.526 ' O ' HG22 ' A' ' 113' ' ' THR . 2.6 t70 -61.91 -59.45 5.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.827 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.758 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.7 mt -58.41 -29.31 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.07 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -68.28 -49.29 61.51 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.432 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 110' ' ' ASP . 5.4 t -64.12 -40.13 95.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.312 -179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 35.6 mm -65.17 -44.32 95.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.145 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.0 t -74.97 -25.05 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.361 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.21 -24.19 23.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.471 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -97.72 -24.03 15.66 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.32 -179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.7 tttm -109.7 -69.7 0.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.788 0.328 . . . . 0.0 111.216 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 20.5 m -59.55 146.0 42.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.029 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 5.2 m -132.74 169.64 21.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.062 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' O ' ' N ' ' A' ' 123' ' ' GLU . 0.6 OUTLIER -105.27 123.29 40.13 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.3 69.59 0.22 Allowed 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 121' ' ' ASN . 0.5 OUTLIER -132.2 -58.12 0.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.9 p -153.1 29.11 0.5 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 71.2 mttt 59.12 39.7 22.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.967 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.18 119.52 42.14 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -51.11 158.53 3.29 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.425 2.084 . . . . 0.0 112.377 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.75 139.62 30.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.922 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.3 141.48 52.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.965 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.4 p -53.77 -38.32 35.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.349 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 pt -67.84 -30.01 46.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.053 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -73.11 -42.56 62.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.553 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 36.8 mt -68.47 -37.0 77.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.943 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -69.09 -47.26 65.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.96 -44.84 96.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.665 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.13 -44.28 96.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.232 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.05 -47.69 84.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.062 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -72.55 -38.15 68.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.001 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -58.0 -46.59 85.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.985 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 136' ' ' ALA . 11.1 tt -88.54 7.61 3.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.504 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 55.61 78.58 0.19 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.904 0.383 . . . . 0.0 110.843 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.677 ' CD2' HG22 ' A' ' 144' ' ' VAL . 13.0 t80 -71.38 -26.18 62.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.149 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 t 76.08 -56.77 0.58 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.112 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.677 HG22 ' CD2' ' A' ' 142' ' ' TYR . 47.7 t 66.81 124.32 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.9 0.381 . . . . 0.0 111.119 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -96.17 100.12 11.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.873 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.0 p -56.18 -29.13 60.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.057 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -97.44 31.75 2.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.021 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -135.08 139.42 44.71 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.885 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.63 152.63 34.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 25.8 p -61.99 -54.83 36.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.068 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.47 -50.77 30.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.241 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.33 -31.06 70.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.792 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -23.79 62.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.086 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.418 ' HA ' HG12 ' A' ' 157' ' ' VAL . . . -53.47 -40.01 64.96 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.427 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.18 -44.4 92.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.942 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.91 -52.89 31.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.462 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 158' ' ' ILE . 9.1 p -53.71 -46.73 62.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.584 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.479 ' N ' HG13 ' A' ' 157' ' ' VAL . 26.0 mm -63.61 -49.62 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.969 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.93 -37.6 82.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.863 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 2.1 tp60 -65.49 -57.31 8.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.993 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.629 HD12 HD11 ' A' ' 167' ' ' ILE . 58.8 mt -58.89 -24.71 62.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.105 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.9 tptp -54.71 -28.14 45.68 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.1 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -59.68 -31.51 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.913 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -66.95 1.03 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.979 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -108.18 150.08 27.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.4 ttmt -102.53 97.85 8.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.629 HD11 HD12 ' A' ' 161' ' ' LEU . 34.9 pt -112.12 139.74 35.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.5 pm0 -153.22 156.28 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.933 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 142.26 36.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.908 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -143.69 136.89 27.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.097 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.405 ' NE2' HG22 ' A' ' 212' ' ' ILE . 9.3 t-160 -123.32 119.73 30.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.917 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.413 ' HE3' ' HB2' ' A' ' 172' ' ' MET . 0.0 OUTLIER -141.67 170.25 16.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.045 -179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.423 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 0.5 OUTLIER -94.62 128.52 41.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.533 179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.681 HD11 ' HD3' ' A' ' 218' ' ' ARG . 63.1 mt -99.64 113.37 25.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.758 -179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -97.88 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.494 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.588 ' HD1' HD13 ' A' ' 211' ' ' LEU . 69.4 m-85 -133.31 138.89 46.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.641 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.559 HG12 HG22 ' A' ' 208' ' ' ILE . 9.6 mt -120.68 128.94 76.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.973 179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.751 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -133.42 152.18 78.77 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.041 0.448 . . . . 0.0 111.904 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.6 -171.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.933 2.422 . . . . 0.0 112.476 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.496 HG13 ' N ' ' A' ' 181' ' ' ASN . 9.2 p -76.16 -47.33 31.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.258 -179.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.496 ' N ' HG13 ' A' ' 180' ' ' VAL . 64.0 m-80 -81.7 -58.05 3.18 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.119 0.414 . . . . 0.0 112.119 -179.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -16.48 60.48 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.82 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.751 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -71.17 -49.27 27.65 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.975 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 6.9 mttt -48.03 -26.24 1.72 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.822 0.304 . . . . 0.0 111.822 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.851 ' HE2' HG23 ' A' ' 228' ' ' THR . 41.8 tttt -81.64 -64.5 1.17 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.779 0.323 . . . . 0.0 111.63 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.638 ' HB3' HD23 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -56.45 -43.88 79.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.757 -179.217 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -46.69 -61.79 1.67 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.776 0.322 . . . . 0.0 111.515 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.3 -22.86 61.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.263 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.2 OUTLIER -76.52 -43.6 38.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.767 0.317 . . . . 0.0 111.364 -179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.629 ' HB3' HD21 ' A' ' 211' ' ' LEU . 64.6 mt -71.26 -22.33 61.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.483 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.415 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 2.4 mttt -56.08 -61.23 6.86 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.373 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 62.0 Cg_endo -73.27 -40.1 1.81 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.498 2.132 . . . . 0.0 112.825 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.613 ' HB3' HD12 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -54.69 -52.78 61.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.245 -179.719 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.905 ' HB ' HD23 ' A' ' 211' ' ' LEU . 3.0 mp -138.88 157.67 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.183 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.48 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.1 OUTLIER -65.61 119.64 11.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.669 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.558 HG12 ' HG ' ' A' ' 211' ' ' LEU . 30.7 m -102.67 155.89 5.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.325 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 196' ' ' VAL . 2.3 pp -158.24 160.96 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.04 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 58.16 36.33 25.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.559 ' OG ' HG22 ' A' ' 209' ' ' VAL . 0.3 OUTLIER -73.43 120.94 19.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.746 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -142.13 141.76 32.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.973 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.41 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 8.1 p-10 -158.39 152.66 24.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.75 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 5.0 t80 -109.9 150.45 28.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.866 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.04 122.38 13.95 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.694 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 59.71 32.57 21.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.445 ' O ' HG23 ' A' ' 180' ' ' VAL . 3.0 tp60 -131.78 176.12 8.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.068 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.5 pt? -72.98 149.2 43.52 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.77 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.727 ' O ' HD12 ' A' ' 178' ' ' LEU . 2.2 mp0 -110.35 144.01 39.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.981 0.42 . . . . 0.0 111.555 -179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.559 HG22 HG12 ' A' ' 177' ' ' ILE . 1.7 pt -123.57 119.89 58.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.461 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.559 HG22 ' OG ' ' A' ' 199' ' ' SER . 21.1 t -128.89 144.9 36.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.979 0.419 . . . . 0.0 111.606 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.79 ' C ' HD12 ' A' ' 211' ' ' LEU . 0.5 OUTLIER -109.78 156.25 20.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.307 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.905 HD23 ' HB ' ' A' ' 194' ' ' ILE . 8.7 mp -135.66 165.88 24.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.934 0.397 . . . . 0.0 111.462 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 173' ' ' ARG . 21.5 mt -142.59 124.97 13.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.838 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.401 ' CB ' ' HD2' ' A' ' 214' ' ' PRO . 0.6 OUTLIER 176.14 170.59 0.36 Allowed Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.936 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.401 ' HD2' ' CB ' ' A' ' 213' ' ' ASP . 72.5 Cg_endo -74.99 164.78 32.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.542 2.161 . . . . 0.0 112.326 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -63.75 -22.54 66.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.61 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 50.6 t -58.59 -51.39 70.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.978 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.12 -21.02 65.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.18 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.681 ' HD3' HD11 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -51.65 -27.8 12.58 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.286 -179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -61.65 1.93 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.927 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 2.5 mp -58.17 -34.46 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.141 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 194' ' ' ILE . 54.6 t0 -66.98 -42.32 85.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -66.59 -43.77 84.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.907 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 2.6 mt -60.12 -59.73 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.972 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.565 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -58.53 -33.89 49.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.274 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.559 ' HA ' HD21 ' A' ' 186' ' ' LEU . 3.4 ttpt -72.8 -27.08 61.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.117 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.412 ' HG3' ' HG2' ' A' ' 231' ' ' LYS . 1.6 tttt -80.28 -37.91 31.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.062 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -82.5 -23.6 34.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.446 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.851 HG23 ' HE2' ' A' ' 185' ' ' LYS . 69.1 m -96.38 -28.71 14.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.589 -179.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -111.7 -11.55 13.98 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.95 33.18 67.99 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.49 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . 0.412 ' HG2' ' HG3' ' A' ' 226' ' ' LYS . 2.8 mmmt 63.23 29.22 15.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.845 0.355 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -101.54 16.11 56.74 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.793 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 10.6 p -122.96 172.4 8.53 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.84 0.352 . . . . 0.0 111.01 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 5.4 mt -124.07 129.41 50.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.79 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 176' ' ' PHE . 9.1 pt-20 -115.08 115.25 26.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.093 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 29.5 t -106.82 135.85 43.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.109 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 5.3 mt -81.68 117.67 22.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.635 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.403 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.1 t-20 -69.1 -39.59 78.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.984 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -142.69 151.12 41.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.95 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -149.56 131.03 14.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.38 116.57 26.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -108.47 -30.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.121 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -91.72 50.6 1.72 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.874 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -97.76 40.78 1.15 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.914 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -152.93 -60.06 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.516 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.25 2.7 4.42 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 111.734 0.272 . . . . 0.0 111.734 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -165.88 143.14 5.46 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.741 0.305 . . . . 0.0 110.869 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.64 83.87 1.99 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.935 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 21.6 p90 -111.57 -34.23 6.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.952 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.911 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HA ' HG21 ' A' ' 10' ' ' ILE . 34.2 ttp . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.851 0.357 . . . . 0.0 111.218 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -35.58 8.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 27.4 pt -114.04 36.2 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.6 t80 60.43 108.93 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.008 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -83.06 149.85 60.01 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.877 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.42 -27.99 27.44 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.571 2.181 . . . . 0.0 112.383 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.62 156.43 17.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -61.74 111.55 1.91 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.838 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -147.95 -48.33 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.497 HG21 ' HA ' ' A' ' 1' ' ' MET . 4.1 pt -102.15 -179.87 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.113 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.7 mmp_? -133.12 84.11 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.807 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.644 ' C ' HD22 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -73.49 -5.61 41.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.634 -179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.466 ' N ' HD13 ' A' ' 12' ' ' LEU . 0.2 OUTLIER -65.07 140.51 58.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.866 0.365 . . . . 0.0 110.892 179.961 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -176.65 -63.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.981 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 16' ' ' ALA . 25.8 t -73.66 155.02 6.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.949 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.47 137.6 41.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.008 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG13 HG21 ' A' ' 60' ' ' VAL . 27.7 t -120.02 109.42 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.028 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 28' ' ' GLU . 10.9 t -95.91 130.37 44.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.764 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.41 ' CG ' ' HB3' ' A' ' 28' ' ' GLU . 10.8 mtm180 -118.69 149.43 41.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.301 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.783 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.0 OUTLIER -144.16 168.04 20.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.703 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -137.31 103.21 5.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.398 . . . . 0.0 111.406 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.445 ' CD ' ' CZ ' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -139.94 151.48 45.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.24 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 58.91 28.43 17.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.826 0.346 . . . . 0.0 111.204 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.88 27.04 67.91 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.27 179.11 5.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.904 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.407 ' O ' ' CD1' ' A' ' 27' ' ' PHE . 13.4 ttm180 -129.69 134.93 47.93 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.98 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.428 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 17.7 m-85 -144.14 152.11 40.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.766 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.0 pt-20 -149.23 154.34 38.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.876 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.84 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -137.48 148.95 25.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.934 0.397 . . . . 0.0 111.269 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.939 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -94.37 109.91 21.73 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.803 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.92 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.8 OUTLIER -137.44 177.83 7.57 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.12 -179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.622 ' O ' HG23 ' A' ' 36' ' ' VAL . 12.8 m-85 -83.59 147.78 27.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.237 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.949 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -72.43 -42.1 65.45 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.0 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -74.75 -40.1 61.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.609 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.62 ' HB3' HG23 ' A' ' 50' ' ' VAL . 5.0 mptp? -70.97 -38.62 72.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.613 -0.267 . . . . 0.0 111.146 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 32' ' ' TYR . 69.2 t -70.71 -46.86 67.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.678 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.577 HG21 HE22 ' A' ' 103' ' ' GLN . 14.8 p -61.27 -40.6 86.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 0.0 110.769 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.68 -41.51 74.5 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.19 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.487 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 1.9 t-105 -60.79 -59.01 6.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.847 0.356 . . . . 0.0 110.38 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -56.54 -41.96 77.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.947 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 83.7 p -59.67 -27.28 66.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.036 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 118.18 44.93 0.51 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.498 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 29.0 t -122.34 139.93 47.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.818 0.342 . . . . 0.0 111.092 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.81 126.68 28.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.23 152.52 30.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.772 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -97.52 138.67 34.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.142 -179.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.61 HD21 ' HD2' ' A' ' 85' ' ' LYS . 2.3 mm? -59.04 -41.83 88.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.001 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -58.29 -18.79 29.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.901 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -105.77 -55.29 2.35 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.62 HG23 ' HB3' ' A' ' 35' ' ' LYS . 8.8 p -54.73 -46.7 74.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.592 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.92 HD23 ' HB3' ' A' ' 31' ' ' CYS . 5.9 mt -81.63 131.82 35.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.882 0.372 . . . . 0.0 110.853 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -81.34 -46.44 14.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.813 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.939 HG22 ' HB3' ' A' ' 30' ' ' ALA . 8.8 t -128.23 113.21 15.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.395 179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -72.96 70.18 1.01 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.142 -179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -166.24 134.92 3.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.297 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.516 HG11 HD21 ' A' ' 71' ' ' LEU . 18.4 t -74.25 98.89 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.791 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.599 ' CE1' HG21 ' A' ' 53' ' ' THR . 7.0 m-85 -70.85 177.44 3.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.445 -179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.648 HG23 ' N ' ' A' ' 66' ' ' ALA . 98.8 t -130.24 -45.39 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.155 179.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -139.56 71.48 1.38 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.036 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.58 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -54.67 -34.7 30.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.2 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.2 p -55.3 -29.0 57.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.067 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.63 -25.99 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.082 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.06 52.09 0.91 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -117.82 136.03 53.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.689 0.28 . . . . 0.0 110.627 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.443 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 5.0 t -116.93 143.6 26.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.347 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.648 ' N ' HG23 ' A' ' 58' ' ' VAL . . . -72.73 -165.82 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -127.3 149.49 50.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.037 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -59.25 -34.89 72.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.968 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -56.98 -54.6 44.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.55 -33.25 75.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.68 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.833 HD22 HD13 ' A' ' 83' ' ' ILE . 13.7 mt -60.67 -50.39 73.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.952 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.5 mt -69.51 -33.39 56.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.162 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.9 t -72.13 -24.4 61.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.44 -25.61 13.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.617 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.51 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 78.8 m-85 -114.98 -43.88 3.07 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.318 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.46 28.03 58.36 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.484 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 4.1 p -114.7 -34.28 5.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.845 0.355 . . . . 0.0 110.774 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.7 t0 67.5 17.96 10.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.166 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.91 89.13 2.97 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.38 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.836 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.9 pm0 -45.02 -39.44 5.63 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.418 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.422 HG22 ' HG ' ' A' ' 47' ' ' LEU . 4.6 m -56.38 -54.57 44.04 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.914 0.388 . . . . 0.0 110.334 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -59.81 -37.15 78.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.122 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.836 HD12 ' HA ' ' A' ' 80' ' ' GLN . 62.7 mt -61.79 -43.91 98.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.379 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.84 ' SG ' HG21 ' A' ' 29' ' ' ILE . 60.2 m -60.7 -44.86 96.04 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.421 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.61 ' HD2' HD21 ' A' ' 47' ' ' LEU . 6.6 mtpm? -56.13 -50.19 71.79 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.723 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -58.23 -39.46 79.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.429 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.783 HG23 ' HB2' ' A' ' 20' ' ' MET . 30.4 mt -73.23 -31.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.761 179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.612 HD11 ' SG ' ' A' ' 31' ' ' CYS . 2.3 mp -70.33 -30.32 67.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.804 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.2 m -98.39 -28.58 13.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.362 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.41 9.78 25.5 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.718 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -121.86 177.34 16.45 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.541 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -107.71 122.99 47.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.96 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG23 HG22 ' A' ' 18' ' ' VAL . 11.9 p -87.9 131.53 35.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.118 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -82.66 105.71 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.5 m -123.26 152.41 28.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -72.29 154.97 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.882 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.06 -31.26 69.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.638 ' O ' HG23 ' A' ' 102' ' ' THR . 0.7 OUTLIER -61.51 -48.06 82.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.843 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.18 -43.41 95.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.4 mtm180 -64.81 -42.72 94.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.82 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.6 -43.94 97.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.842 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.638 HG23 ' O ' ' A' ' 98' ' ' LYS . 82.6 p -60.17 -47.22 86.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.781 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.577 HE22 HG21 ' A' ' 37' ' ' VAL . 36.8 mt-30 -66.16 -37.13 84.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.54 -46.79 86.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.705 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.08 -46.84 82.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -61.17 -44.37 97.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.686 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -55.58 31.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.694 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.687 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.6 OUTLIER -57.72 -34.94 70.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.57 179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.71 -41.85 95.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.69 -46.77 86.62 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.584 179.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.726 HD13 ' HE1' ' A' ' 137' ' ' MET . 5.1 mt -62.43 -41.2 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.83 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -69.3 -32.18 71.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.748 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 79.3 m -70.4 -56.91 5.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.78 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -56.65 -43.81 79.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.232 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 111' ' ' ILE . 62.1 t -69.14 -33.13 56.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 110.759 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -79.52 -21.7 44.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.028 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.37 -49.9 6.43 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.046 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' CB ' ' HB2' ' A' ' 214' ' ' PRO . 0.0 OUTLIER -131.75 81.63 1.98 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.911 0.386 . . . . 0.0 111.313 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.421 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.2 OUTLIER -176.48 94.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.576 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.738 HG12 ' N ' ' A' ' 127' ' ' PRO . 29.0 m -107.09 170.82 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.254 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -103.22 138.6 19.59 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.788 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.03 -41.98 70.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.44 2.093 . . . . 0.0 112.267 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -96.87 46.8 1.05 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 126' ' ' ARG . 46.7 m -163.65 -43.6 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 10.1 mtmm 63.66 32.96 13.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . 0.603 ' C ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -143.33 143.8 25.71 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.837 179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.738 ' N ' HG12 ' A' ' 120' ' ' VAL . 66.6 Cg_endo -74.05 121.77 7.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.577 2.184 . . . . 0.0 112.423 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -59.7 169.57 1.33 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.931 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 41.3 p -98.62 155.48 17.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.971 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.687 ' HA ' HD12 ' A' ' 133' ' ' ILE . 16.0 m -54.86 -32.54 26.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.226 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 17.7 pt -64.7 -34.99 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.006 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 mt -75.58 -43.37 48.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.786 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.687 HD12 ' HA ' ' A' ' 130' ' ' VAL . 5.7 mt -63.68 -39.12 84.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -71.02 -48.64 51.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.763 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -46.72 88.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.766 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.64 -52.53 64.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.1 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.726 ' HE1' HD13 ' A' ' 111' ' ' ILE . 0.4 OUTLIER -58.48 -30.65 67.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -48.25 28.67 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.804 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.48 -43.05 75.22 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.846 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.741 ' O ' HD13 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -73.9 -19.03 17.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.203 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 66.49 51.55 1.13 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.032 0.444 . . . . 0.0 110.734 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HE2' HG22 ' A' ' 144' ' ' VAL . 89.0 t80 -73.86 162.32 29.23 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.908 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -129.12 118.8 23.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.898 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.678 HG22 ' HE2' ' A' ' 142' ' ' TYR . 23.5 t -103.03 -31.18 2.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.059 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.89 119.5 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 58.3 p -64.24 -16.23 61.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.266 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -87.4 8.84 22.8 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.514 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.8 mttt -120.04 179.71 4.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.822 0.344 . . . . 0.0 110.871 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.1 145.35 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.859 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 76.7 p -70.73 -48.46 54.4 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 -61.37 1.67 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.415 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.16 -26.5 64.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.03 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.422 ' HG2' HG13 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -77.65 -23.95 49.57 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.174 -179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.402 ' O ' HG12 ' A' ' 158' ' ' ILE . . . -51.57 -42.48 61.91 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.85 0.357 . . . . 0.0 111.486 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.11 -46.24 88.25 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.87 -53.6 30.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.626 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.492 HG13 ' N ' ' A' ' 158' ' ' ILE . 10.3 p -52.83 -46.97 52.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.571 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.492 ' N ' HG13 ' A' ' 157' ' ' VAL . 31.1 mm -63.8 -48.4 86.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.696 0.284 . . . . 0.0 111.011 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.4 -42.3 95.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.956 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -65.81 -47.18 75.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.982 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.563 HD23 ' NZ ' ' A' ' 164' ' ' LYS . 8.8 mt -57.34 -22.2 40.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.244 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -63.75 -20.05 65.45 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.35 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -57.57 -52.67 64.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.757 0.313 . . . . 0.0 111.154 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.563 ' NZ ' HD23 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -105.06 -30.35 9.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.101 -179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 2.5 ttm -111.03 -168.41 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.952 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.08 82.49 0.85 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.479 ' CD1' HD13 ' A' ' 158' ' ' ILE . 22.3 pt -107.17 165.5 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.24 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -142.47 106.02 4.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 13.2 ttp85 -82.21 116.05 21.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.008 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.742 ' HB3' ' O ' ' A' ' 215' ' ' GLY . . . -148.51 140.93 24.27 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.156 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 13.1 t-80 -152.93 122.74 6.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.682 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 4.2 tmm? -174.15 170.24 3.78 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.301 0.572 . . . . 0.0 111.897 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.432 ' HG2' HD12 ' A' ' 212' ' ' ILE . 5.0 mtp180 -123.91 129.17 50.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.443 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.402 ' N ' ' O ' ' A' ' 211' ' ' LEU . 0.5 OUTLIER -108.64 179.54 4.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.213 -179.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.436 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.8 ttm180 -144.75 140.28 28.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.974 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.465 ' CD2' HD21 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -136.75 144.48 43.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.131 0.491 . . . . 0.0 111.727 -179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.412 HG23 HG22 ' A' ' 208' ' ' ILE . 26.9 mt -134.66 111.28 14.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.106 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.846 ' CD2' HD22 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -108.05 155.36 40.21 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.607 -178.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' CB ' ' A' ' 182' ' ' GLU . 69.6 Cg_endo -72.99 -161.32 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.778 2.318 . . . . 0.0 112.161 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.714 HG22 ' HA ' ' A' ' 205' ' ' GLN . 18.7 t -73.1 -65.24 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.943 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -76.18 -57.89 3.6 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.488 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -55.07 -22.22 15.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.63 -179.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.435 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -71.62 -43.11 53.18 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.937 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 21.5 mttm -57.01 -26.43 60.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.709 0.29 . . . . 0.0 111.474 -179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -85.9 -27.89 24.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.728 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.846 HD22 ' CD2' ' A' ' 178' ' ' LEU . 1.1 mp -89.11 -53.4 4.59 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.423 ' HG3' ' N ' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -46.4 -51.17 15.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.79 0.329 . . . . 0.0 111.772 -179.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.423 ' N ' ' HG3' ' A' ' 187' ' ' LYS . 59.4 mt-10 -64.12 -30.88 71.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.423 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.9 mmtm -80.85 -21.85 40.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.794 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.6 mt -102.51 -22.35 14.05 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.676 0.274 . . . . 0.0 111.704 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -54.96 -55.54 37.7 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.453 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.37 -39.4 0.19 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.63 2.22 . . . . 0.0 113.046 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.826 HD23 HD11 ' A' ' 194' ' ' ILE . 18.8 tp -55.47 -51.97 65.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.53 -179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.826 HD11 HD23 ' A' ' 193' ' ' LEU . 2.1 mp -124.65 161.26 28.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.872 0.368 . . . . 0.0 111.454 -179.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.461 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -75.15 109.76 8.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.702 179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.542 ' O ' HG23 ' A' ' 197' ' ' ILE . 20.2 m -109.12 161.19 7.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.276 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.542 HG23 ' O ' ' A' ' 196' ' ' VAL . 16.4 pt -159.33 163.28 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.083 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 59.48 37.76 22.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.92 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 30.3 t -73.08 113.89 10.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.036 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -123.82 118.62 27.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.415 ' CB ' ' CG ' ' A' ' 207' ' ' GLU . 6.5 p-10 -130.44 140.62 50.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.56 150.42 26.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.81 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -51.05 109.67 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.444 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.3 mp0 60.88 41.66 14.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.002 0.429 . . . . 0.0 110.457 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.714 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -139.68 178.28 7.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.05 -179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 4.2 pp -72.69 148.96 44.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.888 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' CG ' ' CB ' ' A' ' 201' ' ' ASP . 7.0 mp0 -116.97 137.74 52.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.302 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.412 HG22 HG23 ' A' ' 177' ' ' ILE . 1.5 pp -105.74 124.89 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.524 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 t -130.92 144.97 36.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.223 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -109.76 145.55 36.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.298 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.402 ' O ' ' N ' ' A' ' 174' ' ' LEU . 4.3 mm? -114.37 144.05 43.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.412 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' HG2' ' A' ' 173' ' ' ARG . 14.1 tt -158.74 124.91 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.467 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 176.01 150.46 0.31 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-O 120.965 0.412 . . . . 0.0 111.689 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.414 ' HB2' ' CB ' ' A' ' 118' ' ' LYS . 80.8 Cg_endo -88.16 -164.92 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.12 2.547 . . . . 0.0 112.331 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.742 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 65.17 -167.58 31.25 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.578 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -96.82 36.81 1.35 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.796 0.332 . . . . 0.0 110.985 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.628 ' CD1' HD11 ' A' ' 220' ' ' ILE . 0.2 OUTLIER -60.17 -25.81 65.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.986 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 45.4 mtp180 -56.56 -29.84 62.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.135 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.01 -64.21 1.03 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.877 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.628 HD11 ' CD1' ' A' ' 217' ' ' PHE . 22.0 pt -67.95 -36.41 75.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.931 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 62.5 t0 -60.92 -53.14 60.98 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.815 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 17.8 tt0 -64.52 -35.8 82.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.863 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.59 -63.64 1.17 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.925 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.66 HG21 HD22 ' A' ' 193' ' ' LEU . 3.0 tt -63.76 -33.73 63.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 176' ' ' PHE . 56.1 mttt -60.06 -52.9 63.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.85 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -66.76 -35.61 80.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.981 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.88 -19.81 59.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.404 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 224' ' ' ILE . 76.4 p -101.71 -28.9 12.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.678 0.275 . . . . 0.0 111.291 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.482 ' HB3' HD21 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -84.59 -28.92 26.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.778 0.323 . . . . 0.0 111.05 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.72 42.74 59.36 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.674 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 61.36 30.76 19.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.774 0.321 . . . . 0.0 110.867 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -127.47 28.92 4.39 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.546 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.1 m -139.04 157.56 45.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.871 0.367 . . . . 0.0 110.834 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -105.79 126.22 51.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.863 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 3.3 pt-20 -123.69 115.22 21.07 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.015 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 12.7 t -106.83 148.04 11.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.135 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 6.4 mp -101.23 134.49 44.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.818 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -49.97 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.98 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.36 174.59 11.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -141.23 134.81 29.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.985 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -104.95 105.23 15.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.842 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 243' ' ' GLU . 9.4 m -144.52 -47.34 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.13 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.442 ' N ' HG23 ' A' ' 242' ' ' VAL . 2.8 mt-10 -82.59 166.6 19.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.79 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.18 78.63 0.27 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.877 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 137.17 -53.63 0.73 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.546 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -129.52 127.01 39.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.771 0.319 . . . . 0.0 110.907 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -127.52 -171.75 2.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.007 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.81 90.57 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -96.12 -31.43 13.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.905 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.836 -179.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 tpp . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.764 0.316 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 62.24 116.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.959 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.598 HG23 ' O ' ' A' ' 3' ' ' ILE . 18.2 tt -178.96 106.29 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.962 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.9 144.95 55.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.936 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.458 ' N ' ' HD2' ' A' ' 6' ' ' PRO . 0.3 OUTLIER -78.9 -52.3 1.26 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.514 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 5' ' ' THR . 74.4 Cg_endo -76.55 -29.52 5.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.446 2.097 . . . . 0.0 112.676 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 9' ' ' GLN . 4.9 m -103.01 131.51 49.93 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.998 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -114.44 29.43 8.02 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.935 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' H ' HG22 ' A' ' 7' ' ' THR . 4.9 tt0 -120.88 -43.77 2.45 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.74 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.32 176.23 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.035 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 57.6 mtt-85 -105.39 -29.27 10.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -168.87 177.52 4.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.06 -27.97 35.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.942 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.8 t30 65.55 18.59 11.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.459 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER -107.36 177.61 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.681 0.277 . . . . 0.0 110.731 179.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -75.38 142.91 43.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.826 0.346 . . . . 0.0 111.002 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG11 ' OE2' ' A' ' 28' ' ' GLU . 21.7 t -114.89 132.35 64.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.269 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.621 ' HB ' HD12 ' A' ' 29' ' ' ILE . 24.5 t -126.44 137.49 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.999 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.23 158.22 44.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.224 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.472 ' HG2' HG23 ' A' ' 87' ' ' ILE . 1.1 ppp? -149.14 158.7 44.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.804 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.9 tttt -107.79 116.89 32.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.904 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.0 ttt85 -153.54 146.39 24.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.4 21.34 10.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.286 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.35 -47.56 3.09 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.662 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.31 155.45 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.08 144.7 30.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.735 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -128.6 151.9 48.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.928 0.394 . . . . 0.0 111.099 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.548 ' OE2' HG11 ' A' ' 17' ' ' VAL . 2.7 tt0 -135.04 168.27 19.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.76 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -160.45 143.9 4.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.909 0.385 . . . . 0.0 111.246 179.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.897 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -90.84 111.47 22.88 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.205 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.69 ' SG ' HD11 ' A' ' 88' ' ' LEU . 13.8 m -135.59 167.38 21.22 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.016 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.826 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.9 m-85 -79.65 131.32 35.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.057 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' O ' HG13 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -55.4 -42.18 73.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.526 -179.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -74.14 -44.34 54.08 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.552 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 1.1 mptt -66.92 -34.6 78.12 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.099 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.826 HG23 ' O ' ' A' ' 32' ' ' TYR . 90.4 t -73.06 -49.28 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.989 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 33' ' ' LYS . 34.4 m -58.15 -41.84 81.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.858 0.361 . . . . 0.0 110.836 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.886 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -68.27 -48.32 53.09 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.12 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.468 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -56.02 -60.51 3.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.852 0.358 . . . . 0.0 110.406 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.7 ttt-85 -58.94 -31.27 68.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.686 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.1 t -61.04 -31.84 71.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 134.85 -8.83 4.53 Favored Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.39 -0.91 . . . . 0.0 113.447 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.886 HG12 ' O ' ' A' ' 38' ' ' GLY . 14.3 p -86.72 145.57 7.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.237 0.518 . . . . 0.0 111.119 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -78.19 130.79 36.73 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -135.78 171.22 14.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.74 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.08 132.66 43.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.947 0.403 . . . . 0.0 111.43 -179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.562 HD21 ' HE2' ' A' ' 85' ' ' LYS . 1.0 OUTLIER -62.65 -33.0 74.15 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.987 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -62.32 -15.73 49.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.725 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 4.7 mm-40 -108.14 -55.25 2.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.444 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 47' ' ' LEU . 14.6 p -58.84 -44.61 90.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.457 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.814 HD21 ' HB3' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -79.22 93.53 5.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.852 -179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -60.54 -47.65 85.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.895 0.378 . . . . 0.0 110.41 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 30' ' ' ALA . 11.4 t -119.54 116.67 26.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.883 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.46 ' HA ' HD12 ' A' ' 51' ' ' LEU . 20.8 m80 -75.14 62.83 1.24 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -176.59 132.0 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.553 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.082 HG21 HD21 ' A' ' 71' ' ' LEU . 2.8 t -64.36 164.54 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.506 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.583 ' CE1' HG21 ' A' ' 53' ' ' THR . 16.3 m-85 -135.16 -174.62 3.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.307 0.575 . . . . 0.0 111.598 -179.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 76.2 t -136.35 -45.2 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.682 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -137.13 66.58 1.46 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.976 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.528 HG21 ' HG2' ' A' ' 28' ' ' GLU . 2.9 t -49.04 -41.35 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.333 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.4 t -49.91 -27.9 5.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.011 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -113.06 -25.93 8.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.896 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.91 41.09 2.18 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.576 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -101.04 100.79 11.43 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.932 0.396 . . . . 0.0 110.559 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.438 HG12 ' N ' ' A' ' 66' ' ' ALA . 17.4 t -74.17 157.33 6.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.33 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -81.88 -166.57 1.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.123 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 45.2 mttt -127.12 148.34 50.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.038 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 9.1 mttp -62.84 -46.65 86.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -56.96 -54.4 47.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.848 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.04 -30.08 70.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.742 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.098 HD22 HD13 ' A' ' 83' ' ' ILE . 6.5 mt -63.22 -52.81 60.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.969 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 6.2 mt -70.89 -32.78 49.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.432 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.7 p -80.97 -16.31 53.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.656 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -100.34 -33.18 10.5 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.735 0.302 . . . . 0.0 111.606 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 83' ' ' ILE . 50.7 m-85 -109.45 -33.89 6.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.182 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 105.14 14.04 23.51 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.632 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -156.42 158.79 37.92 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.934 0.397 . . . . 0.0 110.762 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -94.27 -16.47 23.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.173 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -60.57 91.96 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.82 0.343 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.77 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.8 OUTLIER -57.4 -40.84 79.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.041 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.416 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -58.04 -50.73 72.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.694 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -56.23 -46.03 79.73 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.995 0.426 . . . . 0.0 110.212 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.098 HD13 HD22 ' A' ' 71' ' ' LEU . 15.1 mt -58.15 -39.33 72.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.267 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.814 ' HB3' HD21 ' A' ' 51' ' ' LEU . 72.4 m -60.02 -44.16 94.79 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.065 179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.562 ' HE2' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -57.83 -48.61 79.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.362 179.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 13.9 mt-30 -56.66 -42.18 78.51 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.774 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.634 HD11 HG22 ' A' ' 83' ' ' ILE . 8.3 mt -71.08 -27.95 31.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.972 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.69 HD11 ' SG ' ' A' ' 31' ' ' CYS . 1.3 mp -77.46 -25.94 50.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.185 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.0 p -89.17 -38.03 14.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.272 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -102.68 -44.18 5.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.292 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.45 ' CA ' ' HB3' ' A' ' 20' ' ' MET . . . -60.58 152.81 37.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.791 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -86.38 142.61 28.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.796 0.331 . . . . 0.0 110.724 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.636 ' O ' HG13 ' A' ' 93' ' ' VAL . 8.1 p -98.63 99.58 8.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 56.6 mt-30 -70.4 105.66 3.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.797 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.577 HG13 HG22 ' A' ' 93' ' ' VAL . 4.0 m -124.73 161.55 28.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.324 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 71.2 m -105.71 176.13 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.822 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.47 -22.51 66.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.17 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.3 pttp -54.94 -54.95 36.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.302 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' CG ' ' HB ' ' A' ' 95' ' ' VAL . 1.2 pp20? -71.97 -30.66 65.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.82 0.343 . . . . 0.0 110.745 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.12 -40.67 86.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.558 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -78.19 -45.82 22.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.49 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 79.0 m -61.08 -39.01 88.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.652 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 42.2 tp60 -67.67 -38.96 84.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.652 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.8 tp -61.11 -49.16 78.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.717 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -66.22 -44.3 84.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.743 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -60.49 -49.3 78.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.75 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.9 tpp -61.83 -36.51 81.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -59.45 -56.51 21.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.704 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.4 mtt-85 -60.31 -35.23 75.12 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.97 -52.66 64.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.747 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.847 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.0 mt -58.4 -46.13 89.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.965 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -60.22 -33.32 72.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 31.1 m -68.72 -50.54 49.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.841 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 42.4 mm -59.76 -34.56 56.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.847 HG23 ' O ' ' A' ' 111' ' ' ILE . 28.9 t -72.33 -38.43 61.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 133' ' ' ILE . . . -83.27 -10.85 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.493 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -102.12 -29.24 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.714 0.292 . . . . 0.0 111.184 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 mttp -117.14 -59.84 1.9 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.095 -179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.41 ' HB2' HG13 ' A' ' 115' ' ' VAL . 33.8 m -65.07 159.26 23.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.769 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.671 HG21 ' HB2' ' A' ' 216' ' ' CYS . 5.2 m -153.9 168.15 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.286 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -101.94 135.71 19.65 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.713 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -77.34 -2.26 12.45 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.506 2.137 . . . . 0.0 112.764 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -80.39 -52.51 7.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.729 0.299 . . . . 0.0 111.042 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 13.6 m -107.77 -12.66 15.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.402 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.43 ' HB3' ' HG ' ' A' ' 216' ' ' CYS . 22.5 mttp 64.95 31.88 11.01 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 110.992 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 22.6 ttp-105 -144.65 138.0 14.15 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.758 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -52.02 143.56 40.2 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.432 2.088 . . . . 0.0 112.46 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -84.55 -176.72 6.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.505 ' CG2' HG22 ' A' ' 131' ' ' ILE . 6.1 m -90.15 142.01 28.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.908 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 12.6 t -53.12 -39.71 34.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.348 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.505 HG22 ' CG2' ' A' ' 129' ' ' THR . 2.4 tt -66.52 -30.92 51.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.896 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 7.8 mt -73.1 -38.92 66.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.874 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.401 HD11 ' HB2' ' A' ' 116' ' ' ALA . 16.7 mt -69.8 -38.21 75.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.002 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -68.98 -47.65 65.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.836 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.3 ttp180 -60.36 -46.5 89.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.42 -44.69 96.7 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.041 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.434 ' HG3' ' CG ' ' A' ' 142' ' ' TYR . 0.1 OUTLIER -57.54 -47.08 83.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.3 mttm -68.3 -38.36 81.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.75 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -62.31 -32.11 72.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.888 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.428 HG22 ' O ' ' A' ' 137' ' ' MET . 1.7 tt -90.71 11.32 2.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.528 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 58.36 48.08 12.91 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.931 0.396 . . . . 0.0 110.901 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.434 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 73.6 t80 -86.68 115.18 23.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.94 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -93.83 141.99 27.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.843 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 21.7 t -108.66 136.55 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.114 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -101.5 103.28 14.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.883 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 82.0 p -55.51 -26.15 41.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.214 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -97.72 31.5 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.99 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -130.93 147.98 52.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.39 146.99 54.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.966 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.3 p -62.62 -57.85 9.61 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.019 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -51.18 -39.78 57.19 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.014 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.79 -37.2 81.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.726 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.4 mm100 -72.42 -27.17 62.17 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.068 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.09 -40.04 60.65 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -50.63 72.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.748 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.57 -36.32 80.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.2 t -62.85 -57.78 10.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.155 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.788 HG22 HD12 ' A' ' 167' ' ' ILE . 33.9 pt -56.64 -38.12 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.213 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.411 ' N ' HG13 ' A' ' 158' ' ' ILE . 16.4 mmtt -69.0 -52.25 30.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.022 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.58 -53.91 49.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.194 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.428 HD12 HG12 ' A' ' 157' ' ' VAL . 8.4 mt -56.77 -22.29 34.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.325 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -51.6 -26.61 9.15 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.215 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -78.81 -42.3 28.12 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.908 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.09 -67.56 0.83 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.3 mtt -125.08 109.84 13.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.847 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.88 116.78 6.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.788 HD12 HG22 ' A' ' 158' ' ' ILE . 2.0 pp -139.33 147.21 24.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.158 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -153.17 169.56 22.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.959 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 14.5 mtm105 -102.86 116.03 31.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.788 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -115.32 136.99 52.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.165 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -120.76 140.35 51.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.668 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.0 153.98 25.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.166 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 5.0 mmm180 -84.57 147.66 26.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.49 179.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.428 HD12 ' CG ' ' A' ' 213' ' ' ASP . 0.5 OUTLIER -127.14 142.86 51.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.07 0.462 . . . . 0.0 111.675 -179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 145.96 50.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.856 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.483 ' CD2' HD11 ' A' ' 190' ' ' LEU . 0.2 OUTLIER -143.32 139.36 30.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.085 0.469 . . . . 0.0 111.942 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.405 ' HB ' ' CB ' ' A' ' 234' ' ' LEU . 22.5 mm -121.49 100.09 8.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.967 179.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.818 HD11 HG12 ' A' ' 209' ' ' VAL . 1.0 OUTLIER -91.46 128.15 47.93 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.543 -178.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 35.9 Cg_exo -57.56 -162.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.443 2.095 . . . . 0.0 112.099 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.585 HG22 ' HA ' ' A' ' 205' ' ' GLN . 23.4 t -76.1 -67.94 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.657 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 -81.62 -57.93 3.24 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.714 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -51.05 -24.83 4.16 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.628 -179.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 178' ' ' LEU . . . -67.65 -40.69 90.31 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.887 -179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -57.32 -21.7 37.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.695 0.283 . . . . 0.0 111.337 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -80.23 -66.51 0.87 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.829 0.347 . . . . 0.0 111.37 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.447 HD21 HD11 ' A' ' 190' ' ' LEU . 2.5 tp -57.16 -31.26 65.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.503 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 2.1 tptp -47.26 -57.61 5.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.336 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -69.58 -22.22 63.54 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.316 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.583 ' HD2' HG21 ' A' ' 228' ' ' THR . 0.5 OUTLIER -85.04 -17.44 37.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.688 -179.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.838 HD22 ' CD2' ' A' ' 211' ' ' LEU . 6.6 mt -89.45 -34.16 16.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.68 0.276 . . . . 0.0 111.432 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.464 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 1.0 OUTLIER -54.21 -47.87 96.06 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.334 -179.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.464 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 6.1 Cg_exo -78.87 -27.57 4.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.876 2.384 . . . . 0.0 112.275 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 221' ' ' ASP . 1.2 tp -61.99 -53.29 57.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.224 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 193' ' ' LEU . 4.4 pt -156.87 179.51 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -63.83 127.02 29.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.151 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.561 ' CG1' HG21 ' A' ' 209' ' ' VAL . 33.0 t -125.73 131.96 71.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.961 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 17.8 pt -152.77 170.17 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.958 0.408 . . . . 0.0 111.392 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 55.2 68.58 0.84 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.968 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.417 ' HB2' HG23 ' A' ' 209' ' ' VAL . 8.3 t -111.6 143.59 42.23 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.074 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -147.94 114.0 5.83 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.793 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -118.15 154.76 31.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.161 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.406 ' HB2' ' CB ' ' A' ' 205' ' ' GLN . 57.7 m-85 -115.79 150.47 36.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.642 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -46.86 106.32 0.14 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.777 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 61.1 42.86 11.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.948 0.404 . . . . 0.0 110.652 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.585 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -140.01 178.18 7.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.974 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.7 OUTLIER -73.01 147.54 45.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.091 -179.725 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -108.86 142.65 39.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.019 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.401 HD12 ' O ' ' A' ' 208' ' ' ILE . 1.6 pp -112.69 109.62 29.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.774 179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.818 HG12 HD11 ' A' ' 178' ' ' LEU . 14.5 p -131.03 144.91 36.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.31 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.509 ' C ' HD12 ' A' ' 211' ' ' LEU . 15.3 m -109.96 145.6 36.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.687 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.838 ' CD2' HD22 ' A' ' 190' ' ' LEU . 2.4 mp -125.7 174.44 8.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.097 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.473 HG22 ' N ' ' A' ' 213' ' ' ASP . 23.7 mm -105.59 158.76 5.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.473 ' N ' HG22 ' A' ' 212' ' ' ILE . 0.5 OUTLIER -119.5 80.13 22.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.12 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -68.91 79.56 0.69 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.719 2.279 . . . . 0.0 111.853 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.25 -110.57 3.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.178 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.671 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -126.61 42.64 3.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.904 0.383 . . . . 0.0 110.951 179.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -70.96 -20.85 62.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.101 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . 0.404 ' HB3' ' NH1' ' A' ' 218' ' ' ARG . 18.9 ttp-105 -47.14 -33.72 5.44 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.303 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -58.15 -56.85 16.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.856 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 59.0 mt -61.8 -32.08 52.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.795 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.509 ' HA ' HD21 ' A' ' 193' ' ' LEU . 5.5 t0 -70.99 -33.11 70.1 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.87 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -72.52 -42.41 64.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 4.3 tp -68.16 -46.37 70.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.081 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.731 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.8 pp -65.27 -42.76 94.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.596 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.731 ' N ' HD12 ' A' ' 224' ' ' ILE . 1.1 pttm -65.43 -40.41 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.05 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 17.0 mttt -68.11 -35.67 78.51 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 62.2 tt0 -82.79 -18.94 38.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.629 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.583 HG21 ' HD2' ' A' ' 189' ' ' LYS . 77.2 p -103.76 -21.85 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 111.644 0.239 . . . . 0.0 111.644 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.438 ' HE2' ' HA2' ' A' ' 183' ' ' GLY . 13.6 mmtp -125.02 -1.13 7.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.12 -82.52 0.04 OUTLIER Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.25 -0.976 . . . . 0.0 112.329 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -164.38 30.83 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 110.84 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -114.39 19.86 16.57 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.741 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 58.6 p -123.62 153.92 40.04 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.724 0.297 . . . . 0.0 110.747 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 177' ' ' ILE . 0.3 OUTLIER -110.56 148.59 31.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.956 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -150.45 122.55 8.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.3 t -105.97 140.11 25.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.195 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 22.8 tp -111.82 127.88 55.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.935 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -112.22 -177.65 3.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.945 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.87 123.42 20.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.42 110.41 4.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.809 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.52 157.57 18.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.952 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.495 HG23 ' HG2' ' A' ' 243' ' ' GLU . 8.6 m -58.53 -37.02 62.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 242' ' ' VAL . 9.4 pt-20 -178.11 -50.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.938 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 66.47 -71.52 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.003 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -174.72 34.77 0.11 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.449 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . 0.41 ' O ' ' CB ' ' A' ' 247' ' ' GLU . 2.1 m-20 -136.04 -174.52 3.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.716 0.293 . . . . 0.0 110.83 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.41 ' CB ' ' O ' ' A' ' 246' ' ' ASP . 4.7 mt-10 82.2 -13.37 0.86 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 48.4 pttt -96.67 -47.91 5.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.774 0.321 . . . . 0.0 110.869 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 55.41 94.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.028 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.883 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.711 0.291 . . . . 0.0 111.228 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -158.62 177.43 11.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.905 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 4' ' ' PHE . 14.6 tt -148.42 -46.34 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.138 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.51 ' N ' HG23 ' A' ' 3' ' ' ILE . 3.1 m-85 -134.97 144.04 47.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.745 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.411 ' N ' ' CD ' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -87.02 -52.34 0.42 Allowed Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.901 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 5' ' ' THR . 49.5 Cg_exo -55.84 106.46 0.2 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.541 2.16 . . . . 0.0 112.233 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 p -121.81 43.25 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -153.5 29.92 0.48 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.014 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -178.82 -63.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.844 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.51 ' O ' HG23 ' A' ' 10' ' ' ILE . 5.3 tp -143.0 118.87 4.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.891 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.89 42.23 3.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.988 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.85 HD13 HG21 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -158.79 -53.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.004 179.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.1 p 55.09 178.01 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.174 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.0 t30 73.92 -60.58 0.52 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.545 HG22 ' NE2' ' A' ' 52' ' ' GLN . 23.1 t -119.78 147.05 23.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.948 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.645 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -82.66 137.66 34.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.817 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.85 HG21 HD13 ' A' ' 12' ' ' LEU . 21.9 t -117.65 128.98 74.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.989 0.423 . . . . 0.0 111.342 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 31' ' ' CYS . 12.0 t -109.34 135.32 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.538 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -112.59 158.22 20.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.164 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.863 ' HB2' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -171.29 109.21 0.29 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.815 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -85.75 132.78 34.07 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.462 ' HE ' ' HB2' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -146.87 136.31 22.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.884 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.462 ' HB2' ' HE ' ' A' ' 22' ' ' ARG . . . 61.63 30.82 18.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.103 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.77 41.07 64.25 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.525 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.15 169.42 17.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.839 0.352 . . . . 0.0 110.834 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -116.72 121.3 41.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -122.06 142.34 50.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.02 0.438 . . . . 0.0 111.04 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' O ' ' N ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -139.42 154.66 47.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.258 179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.702 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -145.35 135.8 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.943 0.401 . . . . 0.0 111.484 -179.736 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.548 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.65 106.64 18.6 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.898 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.668 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.4 p -134.62 177.83 7.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.281 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.697 ' O ' HG23 ' A' ' 36' ' ' VAL . 19.1 m-85 -87.85 132.89 34.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.377 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.645 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -65.55 -32.13 73.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.546 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -75.68 -45.05 39.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.135 -179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.664 ' HB3' HG23 ' A' ' 50' ' ' VAL . 9.3 mptt -72.42 -36.73 68.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.831 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 32' ' ' TYR . 77.8 t -67.93 -49.42 68.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.712 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 33' ' ' LYS . 13.6 p -61.99 -43.28 97.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.878 0.37 . . . . 0.0 110.873 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.457 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -66.63 -34.32 87.17 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.283 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.503 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 2.5 t-105 -68.57 -55.88 10.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.795 0.331 . . . . 0.0 110.497 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.2 ttp85 -59.07 -34.21 71.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.02 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.3 p -60.25 -28.11 67.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.808 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.53 24.46 3.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.818 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 31.3 t -107.64 145.65 14.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.9 0.381 . . . . 0.0 111.101 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.34 142.61 47.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.865 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -167.43 147.9 5.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.841 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -94.94 132.62 39.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.911 0.386 . . . . 0.0 111.2 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.698 ' HA ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -58.37 -42.76 87.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.126 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -53.99 -20.15 5.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.009 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -105.59 -48.37 3.68 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 47' ' ' LEU . 11.8 p -52.77 -41.78 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 54' ' ' HIS . 8.5 mt -85.35 136.35 33.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.904 0.383 . . . . 0.0 111.083 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.545 ' NE2' HG22 ' A' ' 15' ' ' VAL . 0.3 OUTLIER -89.48 -52.88 4.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.7 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.572 HG21 ' CE1' ' A' ' 57' ' ' PHE . 6.7 t -103.66 -10.31 18.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.302 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 51' ' ' LEU . 38.2 m80 65.82 -81.52 0.03 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.893 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 2.5 m -40.85 139.89 0.8 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.782 0.325 . . . . 0.0 111.415 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.669 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 2.9 t -73.24 120.63 22.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.776 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.572 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.3 m-85 -90.54 -174.35 4.08 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.376 0.608 . . . . 0.0 111.577 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG23 ' HB2' ' A' ' 66' ' ' ALA . 53.0 t -130.21 -44.62 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.453 179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.46 67.88 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.714 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.6 t -50.62 -45.78 27.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.474 -179.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.8 t -49.93 -27.16 4.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -108.38 -25.94 10.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.814 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.6 45.9 2.05 Favored Glycine 0 C--N 1.331 0.256 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.485 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -112.0 111.17 21.9 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.866 0.365 . . . . 0.0 110.51 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.4 t -81.95 151.18 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.497 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.669 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -93.28 124.78 37.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.919 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.0 mtmm -61.56 143.64 55.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.02 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -60.21 -32.75 71.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.79 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -57.24 -41.08 78.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.731 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.93 -38.56 53.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.585 179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.999 HD22 HD13 ' A' ' 83' ' ' ILE . 7.5 mt -57.2 -35.99 70.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.829 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.444 HD11 ' OD1' ' A' ' 78' ' ' ASP . 6.3 mt -83.03 -48.49 17.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.156 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.11 -22.01 48.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.227 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.69 -49.0 5.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.798 0.332 . . . . 0.0 111.5 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -93.99 -50.57 5.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.216 -179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 90.64 35.38 7.35 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.524 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -122.37 -40.42 2.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.891 0.377 . . . . 0.0 110.886 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.444 ' OD1' HD11 ' A' ' 72' ' ' ILE . 36.9 t0 72.9 22.24 3.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.071 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -129.93 91.51 3.15 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.66 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.403 ' HA ' HD12 ' A' ' 83' ' ' ILE . 7.1 pm0 -47.91 -33.28 7.38 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.303 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.74 -58.66 6.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.503 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -57.55 -43.19 84.27 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.479 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.999 HD13 HD22 ' A' ' 71' ' ' LEU . 58.4 mt -58.55 -38.17 69.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.347 179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.702 ' SG ' HG21 ' A' ' 29' ' ' ILE . 57.2 m -65.76 -41.96 91.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.387 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HG2' HD21 ' A' ' 47' ' ' LEU . 37.9 mttt -56.91 -49.84 74.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.278 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -60.15 -40.5 90.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.287 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 20' ' ' MET . 49.7 mt -70.24 -25.7 27.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.731 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.479 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.5 mp -77.81 -32.41 52.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.018 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 p -96.59 -30.08 13.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.457 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -102.46 -36.61 8.35 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.705 0.288 . . . . 0.0 111.227 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -71.57 -178.96 30.58 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.617 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -113.23 123.64 50.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.787 0.327 . . . . 0.0 110.958 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.537 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.9 p -82.87 115.9 26.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -94.33 109.23 21.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.898 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.3 m -114.79 161.68 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -78.01 168.29 20.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.973 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -70.56 -39.55 73.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.956 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -56.71 -39.36 73.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -65.77 -50.06 66.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.827 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.41 -32.67 67.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.932 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -55.85 8.96 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.979 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.4 t -60.18 -35.14 74.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -68.91 -46.04 69.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.83 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.4 mt -62.09 -34.97 77.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.819 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -68.73 -51.58 39.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.853 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -65.63 -38.54 89.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 1.7 tpt -63.21 -51.56 65.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.789 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.493 ' CD2' HG21 ' A' ' 144' ' ' VAL . 0.8 OUTLIER -59.81 -42.4 93.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.819 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.7 -41.01 98.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.752 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -60.3 -57.62 12.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.747 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.727 ' HA ' HD12 ' A' ' 114' ' ' ILE . 47.1 mt -53.99 -41.15 48.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.842 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.921 ' HA ' HG21 ' A' ' 133' ' ' ILE . . . -65.12 -46.31 81.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.005 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 61.9 m -58.87 -32.71 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.848 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.727 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.1 mt -74.59 -41.19 48.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.173 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.596 HG23 ' O ' ' A' ' 111' ' ' ILE . 25.9 t -78.32 -24.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.654 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.64 ' HB2' ' CG1' ' A' ' 133' ' ' ILE . . . -96.73 -38.3 9.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.619 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -97.18 -33.05 11.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.756 0.312 . . . . 0.0 111.496 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.64 36.79 2.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.843 0.354 . . . . 0.0 111.048 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 1.2 m -168.5 156.45 8.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.773 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.541 HG13 ' HA3' ' A' ' 215' ' ' GLY . 19.5 m -130.59 171.78 17.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.252 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB2' ' CE2' ' A' ' 128' ' ' TYR . 63.6 t30 -99.75 117.85 62.88 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.858 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.39 -22.51 27.35 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.425 2.084 . . . . 0.0 112.453 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -54.66 -58.99 5.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.084 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.91 33.04 0.35 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.969 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.34 30.18 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 110.96 4.89 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.975 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -56.99 118.09 4.89 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.431 2.088 . . . . 0.0 112.363 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.518 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 19.8 m-85 -84.16 149.07 26.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 10.7 t -121.89 157.52 31.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.947 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 19.9 m -47.29 -29.44 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.488 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 6.9 mt -66.95 -45.8 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.496 HD22 ' CD1' ' A' ' 128' ' ' TYR . 0.3 OUTLIER -67.75 -36.87 81.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.775 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.921 HG21 ' HA ' ' A' ' 112' ' ' ALA . 18.5 mm -66.96 -52.62 42.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.891 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.65 -41.77 82.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.785 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -59.97 -52.23 66.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.876 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -63.82 -46.64 84.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.256 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.646 ' HE1' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -58.54 -38.27 77.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.017 -179.864 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.7 ttmt -76.87 -41.07 45.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.901 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -58.31 -41.48 84.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.869 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.554 HG22 ' O ' ' A' ' 136' ' ' ALA . 12.0 tt -85.6 -4.44 9.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.526 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER 61.69 74.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.833 0.349 . . . . 0.0 110.784 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.491 ' CG ' ' HE3' ' A' ' 137' ' ' MET . 31.1 t80 -89.07 154.8 19.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.907 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -116.13 116.48 27.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.992 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.535 HG13 HE22 ' A' ' 153' ' ' GLN . 21.6 t -92.99 130.45 42.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.168 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 100.33 11.54 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.941 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 38.4 p -56.22 -25.37 47.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -97.58 30.58 2.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.965 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -131.69 167.08 20.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.857 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 61.3 m -91.3 148.07 22.6 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 28.6 p -63.13 -55.1 28.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -48.99 -49.45 40.7 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.043 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -32.04 71.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.812 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.818 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.4 tt0 -72.85 -25.84 61.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.18 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -51.43 -43.26 61.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.354 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.62 ' HA ' HD12 ' A' ' 158' ' ' ILE . 0.3 OUTLIER -59.18 -51.51 69.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.41 88.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.818 HG23 ' O ' ' A' ' 153' ' ' GLN . 29.9 t -59.69 -46.4 93.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.067 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.821 ' HA ' HD13 ' A' ' 167' ' ' ILE . 6.1 mt -61.04 -50.52 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.034 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.21 -45.87 91.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.91 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.4 tp60 -63.37 -58.8 5.92 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.088 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.761 HD12 HG12 ' A' ' 157' ' ' VAL . 18.0 mt -57.04 -23.58 47.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -54.23 -29.15 45.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.882 0.373 . . . . 0.0 111.129 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.8 -31.53 71.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.891 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.51 -65.44 1.03 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.865 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 12.6 mtp -129.22 126.66 39.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -68.96 153.48 43.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.002 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.821 HD13 ' HA ' ' A' ' 158' ' ' ILE . 3.2 mp -129.32 147.07 33.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.107 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -148.18 133.61 18.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.032 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.1 131.68 39.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.725 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.9 136.84 49.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.319 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.4 m-70 -127.21 164.2 22.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.516 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.04 140.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 111.406 -179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.1 147.73 23.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.112 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 175' ' ' ARG . 0.3 OUTLIER -124.87 155.36 39.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.213 0.53 . . . . 0.0 112.004 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.557 ' H ' HD23 ' A' ' 174' ' ' LEU . 2.6 mtt180 -134.82 129.07 33.94 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.984 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.466 ' CE1' ' CB ' ' A' ' 235' ' ' GLU . 0.2 OUTLIER -132.33 140.92 48.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.044 0.45 . . . . 0.0 111.617 -179.443 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.748 ' CG2' HD12 ' A' ' 206' ' ' LEU . 3.2 mt -132.46 106.37 10.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.464 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.883 HD22 ' HB2' ' A' ' 186' ' ' LEU . 2.0 mp -110.26 160.2 29.22 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.029 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.426 ' HD2' ' HG ' ' A' ' 178' ' ' LEU . 22.5 Cg_endo -61.08 -174.24 0.11 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.561 2.174 . . . . 0.0 112.185 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 205' ' ' GLN . 4.6 p -75.99 -27.15 17.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.696 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -81.68 -57.89 3.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.375 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' HB3' HD23 ' A' ' 178' ' ' LEU . 1.3 mp0 -78.41 -22.14 48.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.485 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -53.01 -26.76 28.26 Favored Glycine 0 CA--C 1.517 0.209 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.004 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -79.98 -29.58 39.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.743 0.306 . . . . 0.0 111.404 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 2.9 ttpt -78.8 -31.04 45.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.233 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.883 ' HB2' HD22 ' A' ' 178' ' ' LEU . 0.4 OUTLIER -64.47 -59.98 3.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.318 -179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.841 ' CG ' HG21 ' A' ' 209' ' ' VAL . 5.0 mttt -50.12 -59.26 4.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.785 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -54.27 -41.06 68.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.727 -179.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.879 ' HD3' HD11 ' A' ' 224' ' ' ILE . 2.2 mttt -80.42 -5.73 56.96 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.776 HD12 HD22 ' A' ' 211' ' ' LEU . 2.7 mm? -115.61 -24.42 8.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 111.725 0.269 . . . . 0.0 111.725 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.453 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 7.5 mttp -57.39 -52.52 73.65 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.581 0.229 . . . . 0.0 111.071 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.453 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.9 Cg_exo -79.68 -33.37 1.27 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.832 2.355 . . . . 0.0 112.337 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.456 HD23 ' OD1' ' A' ' 221' ' ' ASP . 0.4 OUTLIER -67.6 -43.04 81.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.586 -179.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.627 HG21 HD13 ' A' ' 211' ' ' LEU . 9.5 tp -146.6 151.33 14.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.856 0.36 . . . . 0.0 111.629 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.416 ' N ' HG13 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -64.88 109.7 2.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.683 179.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.676 HG12 ' HB3' ' A' ' 211' ' ' LEU . 31.8 m -101.24 142.66 15.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.383 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 14.7 tt -135.17 159.1 41.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.887 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 59.9 70.06 0.66 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.23 104.02 16.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.973 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -112.39 116.65 30.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.782 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -146.92 123.07 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -98.04 150.52 21.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.66 115.99 3.88 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.611 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 60.77 33.09 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.898 0.38 . . . . 0.0 110.676 -179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.528 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.6 tt0 -123.81 177.96 5.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.879 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.748 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.4 pt? -73.01 149.04 43.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.94 137.9 36.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.984 0.421 . . . . 0.0 111.628 -179.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 4.8 mt -128.93 107.12 15.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.483 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.841 HG21 ' CG ' ' A' ' 187' ' ' LYS . 21.2 t -130.88 145.03 36.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.651 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 95.0 m -109.67 158.84 17.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.776 HD22 HD12 ' A' ' 190' ' ' LEU . 0.5 OUTLIER -151.21 136.19 17.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.99 0.424 . . . . 0.0 112.074 -179.56 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 13.6 mt -104.44 127.17 59.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.793 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 194' ' ' ILE . 42.3 p-10 -139.45 141.74 29.74 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.186 -179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -80.01 -170.07 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.611 2.208 . . . . 0.0 112.264 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.541 ' HA3' HG13 ' A' ' 120' ' ' VAL . . . -63.08 155.58 42.51 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.467 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 2.8 t 74.32 -58.4 0.59 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.671 0.272 . . . . 0.0 111.229 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -46.13 -29.25 1.47 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.308 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.9 mmt180 -50.84 -28.03 8.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.129 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -57.63 8.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.975 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 4.6 mt -62.84 -41.36 92.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.456 ' OD1' HD23 ' A' ' 193' ' ' LEU . 0.5 OUTLIER -60.63 -63.01 1.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -53.79 -34.87 60.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.153 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 3.9 tp -59.67 -63.59 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.972 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.879 HD11 ' HD3' ' A' ' 189' ' ' LYS . 1.0 OUTLIER -59.47 -37.28 69.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.126 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.748 ' HE3' HD11 ' A' ' 211' ' ' LEU . 2.0 mmmp? -62.32 -47.79 82.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.021 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.25 -31.47 72.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.961 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -75.1 -28.35 60.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.1 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 p -86.79 -31.49 20.86 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.134 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.32 -26.34 24.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.053 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.03 34.56 66.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.464 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 15.3 mttm 60.92 30.59 19.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.737 0.303 . . . . 0.0 110.838 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -134.47 33.44 2.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.578 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' HD12 ' A' ' 178' ' ' LEU . 13.4 m -138.57 172.87 12.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.784 0.326 . . . . 0.0 110.96 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 78.1 mt -114.7 123.68 49.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.847 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.466 ' CB ' ' CE1' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -133.31 125.83 30.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.183 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 17.7 t -106.71 141.34 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.951 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 9.3 mp -105.65 148.3 27.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -103.62 -176.9 3.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.974 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 8.8 mp -84.64 168.92 14.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.975 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.08 142.42 28.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.04 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -114.3 134.51 54.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.868 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 2.6 m -117.42 -33.99 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.306 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -86.54 99.62 11.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.913 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -132.41 37.13 3.54 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.914 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 113.69 29.31 2.93 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.517 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -99.41 -175.56 3.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.829 0.347 . . . . 0.0 110.84 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 45.84 -168.84 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.372 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 62.97 89.18 0.09 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.924 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -133.19 -50.66 0.87 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.938 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.214 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -59.66 -177.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.942 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.3 mp -101.26 -47.09 11.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.995 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -167.3 -51.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.03 179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.0 m 61.34 118.22 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.906 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.621 ' HG3' HG21 ' A' ' 13' ' ' THR . 37.0 Cg_endo -65.42 100.07 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.382 2.055 . . . . 0.0 112.243 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 t -132.18 -46.94 0.92 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.097 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -171.36 -39.92 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.138 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.606 ' O ' HG23 ' A' ' 10' ' ' ILE . 18.0 pt20 -57.0 -49.3 76.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.606 HG23 ' O ' ' A' ' 9' ' ' GLN . 2.7 pt -161.57 109.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.003 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.4 mtt180 -95.58 65.36 2.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.863 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.94 -83.85 0.06 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.621 HG21 ' HG3' ' A' ' 6' ' ' PRO . 14.2 p 48.85 -161.88 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.136 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.4 t30 78.11 -60.33 0.41 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.002 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -90.14 138.11 20.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.991 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.679 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.32 144.11 42.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.128 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 60' ' ' VAL . 24.3 t -126.75 117.28 47.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.055 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG22 HG23 ' A' ' 93' ' ' VAL . 11.7 t -110.78 133.76 55.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.013 -179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.405 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 6.7 ptt85 -119.1 157.4 27.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.281 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.905 ' HB2' HG23 ' A' ' 87' ' ' ILE . 9.5 tmm? -158.69 124.58 4.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.823 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.9 tttm -85.88 123.44 31.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.04 139.26 19.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.815 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.31 29.44 19.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.17 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.01 -53.94 4.53 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.527 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.32 166.91 15.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.769 0.318 . . . . 0.0 110.97 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -118.11 142.09 47.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.867 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -129.86 155.07 46.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.506 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.9 OUTLIER -147.61 150.34 34.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.941 -179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.622 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -134.11 144.2 36.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 CA-C-O 120.809 0.337 . . . . 0.0 111.348 179.887 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -95.06 106.7 18.72 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.817 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.843 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.5 OUTLIER -134.66 178.25 7.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.223 -179.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 36' ' ' VAL . 13.5 m-85 -81.69 141.86 33.23 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.924 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.689 ' O ' HG22 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -65.52 -42.95 91.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.673 179.29 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 19.6 m120 -74.38 -38.14 63.24 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.298 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.489 ' CB ' HG23 ' A' ' 50' ' ' VAL . 7.9 mmtm -73.05 -38.67 66.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.91 -179.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 32' ' ' TYR . 64.1 t -68.49 -49.3 66.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.63 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 33' ' ' LYS . 31.0 m -61.14 -46.21 97.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.861 0.362 . . . . 0.0 110.622 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.84 ' O ' HG12 ' A' ' 43' ' ' VAL . . . -63.08 -41.4 99.8 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.638 -0.792 . . . . 0.0 111.986 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.51 ' HE3' ' HB3' ' A' ' 45' ' ' LYS . 4.8 t-105 -56.51 -55.14 37.55 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.863 0.363 . . . . 0.0 110.368 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -57.61 -36.35 71.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.295 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 11.3 t -60.6 -31.94 71.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.733 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.67 25.36 4.3 Favored Glycine 0 C--N 1.331 0.275 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.701 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.84 HG12 ' O ' ' A' ' 38' ' ' GLY . 12.0 p -93.74 151.21 3.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.833 0.349 . . . . 0.0 111.149 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.12 98.97 0.11 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.048 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HB3' ' HE3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -134.18 142.29 47.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.662 179.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.454 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -107.58 157.25 18.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.95 0.405 . . . . 0.0 111.168 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.683 HD21 ' HE2' ' A' ' 85' ' ' LYS . 3.6 mm? -63.08 -34.5 77.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.997 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.43 -6.77 45.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.761 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.2 mm-40 -120.69 -16.73 8.18 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 47' ' ' LEU . 13.1 p -99.82 -36.63 5.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.843 HD23 ' HB3' ' A' ' 31' ' ' CYS . 16.4 mt -87.99 132.83 34.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.912 0.387 . . . . 0.0 111.041 -179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -88.5 -46.98 8.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.868 HG22 ' HB3' ' A' ' 30' ' ' ALA . 14.7 t -106.42 -15.82 14.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.365 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.698 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.8 m80 68.13 -76.91 0.05 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.635 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -40.13 141.77 0.44 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.514 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.608 HG11 HD21 ' A' ' 71' ' ' LEU . 21.5 t -74.57 118.6 20.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.854 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.549 ' CE1' HG21 ' A' ' 53' ' ' THR . 3.6 m-85 -89.87 -178.09 5.39 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.375 0.607 . . . . 0.0 111.65 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.567 HG23 ' HB2' ' A' ' 66' ' ' ALA . 55.9 t -128.15 -44.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.667 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 28.3 t30 -136.71 69.45 1.41 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.029 179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.532 HG21 HG13 ' A' ' 17' ' ' VAL . 2.2 t -54.32 -35.82 31.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.176 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.5 t -51.66 -31.28 25.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.848 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.2 mtmp? -111.41 -26.1 9.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.883 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.8 50.72 1.07 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.454 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -113.51 116.3 29.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.843 0.354 . . . . 0.0 110.593 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 66' ' ' ALA . 21.5 t -83.42 154.94 3.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.312 -179.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.567 ' HB2' HG23 ' A' ' 58' ' ' VAL . . . -91.36 175.11 7.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.958 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 16.4 mttt -108.58 142.23 39.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.926 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -58.36 -32.2 68.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.15 -46.31 90.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -71.66 -33.4 68.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.765 179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.953 HD22 HD13 ' A' ' 83' ' ' ILE . 9.3 mt -61.68 -46.33 90.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.2 mt -76.41 -34.04 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.5 t -72.78 -20.81 61.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.232 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.42 -26.37 13.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.539 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.745 ' CE2' HG23 ' A' ' 83' ' ' ILE . 75.8 m-85 -117.66 -43.97 2.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 111.329 -179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.71 26.21 54.46 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.512 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -113.72 -32.82 6.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.82 0.343 . . . . 0.0 110.848 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 45.5 t0 67.07 19.99 10.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.007 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -125.71 95.6 4.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.61 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.667 ' HA ' HD12 ' A' ' 83' ' ' ILE . 9.1 pm0 -51.8 -31.86 28.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.072 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.669 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -63.93 -54.39 35.38 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 110.336 179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.14 -43.66 95.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.034 0.445 . . . . 0.0 110.061 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.953 HD13 HD22 ' A' ' 71' ' ' LEU . 17.0 mt -59.67 -37.71 72.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.072 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.622 ' SG ' HG21 ' A' ' 29' ' ' ILE . 32.0 m -62.57 -44.96 95.02 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.683 ' HE2' HD21 ' A' ' 47' ' ' LEU . 2.5 mttt -57.18 -48.59 78.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.337 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -56.46 -44.51 80.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.655 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.905 HG23 ' HB2' ' A' ' 20' ' ' MET . 21.0 mt -71.85 -25.85 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.895 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 84' ' ' CYS . 4.8 mp -76.31 -33.18 59.03 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.961 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 83.1 m -93.15 -31.59 14.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.242 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -44.31 6.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.046 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -68.28 169.39 40.15 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.706 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.641 ' C ' HG13 ' A' ' 18' ' ' VAL . 5.5 pm0 -98.61 124.82 43.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.824 0.345 . . . . 0.0 110.725 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.847 HG23 HG22 ' A' ' 18' ' ' VAL . 11.2 p -89.42 132.9 32.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.172 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -84.42 105.72 15.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.813 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.9 m -122.04 149.45 25.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.179 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.9 m -101.95 169.86 8.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -59.83 -30.64 69.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.2 mttm -66.02 -54.66 23.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.824 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -60.29 -45.17 94.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.834 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.55 -36.81 83.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.869 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -73.08 -38.43 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.822 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 50.0 m -60.37 -45.26 94.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.787 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.35 -39.07 93.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.801 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.4 mt -61.88 -48.81 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.8 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -60.68 -47.67 85.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.716 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.63 -39.53 88.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.671 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.91 -41.45 91.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.734 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -59.71 -50.45 73.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.79 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.57 ' O ' HG23 ' A' ' 113' ' ' THR . 1.8 tpt180 -62.55 -37.03 84.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.64 ' OD1' HD11 ' A' ' 114' ' ' ILE . 6.9 t70 -60.25 -52.42 65.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.753 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.839 ' O ' HG23 ' A' ' 115' ' ' VAL . 41.8 mt -60.61 -39.58 81.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.829 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -66.6 -45.28 79.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.093 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 109' ' ' ARG . 38.9 p -59.38 -41.9 90.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.013 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.64 HD11 ' OD1' ' A' ' 110' ' ' ASP . 14.9 mt -68.58 -39.01 79.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.16 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.839 HG23 ' O ' ' A' ' 111' ' ' ILE . 41.3 t -75.39 -27.39 19.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.377 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.585 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.69 -27.24 17.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.344 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.9 t0 -91.59 -59.06 2.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.166 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -105.36 58.51 0.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.085 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 115' ' ' VAL . 0.0 OUTLIER -179.32 158.22 0.85 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.02 -179.984 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.704 HG21 ' HB2' ' A' ' 216' ' ' CYS . 16.0 m -150.47 171.5 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -80.87 127.87 73.4 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.833 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -79.15 0.99 9.56 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.571 2.181 . . . . 0.0 112.867 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.0 -43.41 6.38 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.796 0.331 . . . . 0.0 111.045 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 24.2 p -111.01 -14.39 13.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.418 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.9 mttp 62.91 36.21 12.92 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.912 0.387 . . . . 0.0 110.826 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.33 136.27 28.0 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.04 122.44 10.22 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.44 2.093 . . . . 0.0 112.217 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.526 ' CD1' HD13 ' A' ' 132' ' ' LEU . 2.5 m-85 -84.11 176.48 8.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.933 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.454 ' CG2' HG22 ' A' ' 131' ' ' ILE . 8.7 m -99.87 147.1 25.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.927 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.448 ' HA ' HD12 ' A' ' 133' ' ' ILE . 4.3 m -53.29 -30.62 17.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.165 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG22 ' CG2' ' A' ' 129' ' ' THR . 1.0 OUTLIER -70.13 -36.13 66.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.526 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.4 OUTLIER -69.91 -45.19 68.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.548 179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.585 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 9.6 mt -63.03 -47.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.726 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.8 -41.04 94.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.645 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -60.42 -43.98 96.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.56 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -61.04 -45.8 93.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.866 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 2.8 ttt -60.22 -39.27 86.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.721 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.21 -40.57 67.73 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.694 179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -60.33 -39.18 86.17 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.754 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -76.61 -5.89 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.438 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 69.58 53.02 0.42 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -73.96 159.4 32.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.742 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.7 m -111.42 -47.19 3.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.134 -179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 49.1 t 63.99 94.56 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.951 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm -73.24 116.73 14.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 18.6 p -56.68 -23.01 38.87 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.091 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.92 28.61 3.04 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -124.81 130.71 52.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.896 0.379 . . . . 0.0 110.749 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 23.1 t -65.59 156.31 33.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.048 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 44.2 p -60.71 -63.55 1.26 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.02 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -50.54 -42.76 55.59 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.19 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 48.4 mm-40 -67.04 -31.81 72.59 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.805 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.892 ' O ' HG23 ' A' ' 157' ' ' VAL . 18.8 tt0 -75.12 -29.92 60.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.035 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.432 ' O ' HD12 ' A' ' 158' ' ' ILE . . . -51.19 -31.96 21.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.365 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.66 -56.84 15.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.784 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -64.34 -34.89 79.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.923 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 153' ' ' GLN . 32.3 t -60.18 -57.17 13.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.112 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.664 ' HA ' HD12 ' A' ' 167' ' ' ILE . 7.7 mt -61.38 -43.25 96.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.181 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.6 -48.34 81.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.965 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -66.71 -55.33 15.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.622 HD12 HD11 ' A' ' 167' ' ' ILE . 14.8 mt -61.13 -22.07 64.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.159 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.29 -28.87 20.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.844 0.354 . . . . 0.0 111.117 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -71.83 -37.12 70.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.855 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.31 -71.5 0.69 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.842 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.9 mtm -126.29 112.24 15.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.905 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 mttt -69.3 144.72 53.47 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.924 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.664 HD12 ' HA ' ' A' ' 158' ' ' ILE . 13.3 mt -106.51 158.59 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.014 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.485 ' N ' HG22 ' A' ' 167' ' ' ILE . 15.3 tt0 -142.31 115.46 8.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.091 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 21.4 ttm180 -111.04 117.08 32.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.76 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -156.26 152.6 27.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.995 0.426 . . . . 0.0 111.367 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -99.09 170.95 8.34 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.639 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 mtt -148.27 107.15 3.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.917 0.389 . . . . 0.0 111.356 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.743 ' HG3' HG23 ' A' ' 212' ' ' ILE . 6.8 mtp180 -118.09 100.88 7.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.002 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.414 HD13 ' HA ' ' A' ' 237' ' ' LEU . 4.2 mm? -104.62 179.41 4.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 111.886 -178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 27.1 mtp180 -145.55 145.17 30.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.504 ' CZ ' ' HD3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -135.46 138.1 42.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.302 0.572 . . . . 0.0 112.468 -178.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.791 ' C ' HD13 ' A' ' 178' ' ' LEU . 8.2 mt -134.54 106.71 7.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.464 178.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.791 HD13 ' C ' ' A' ' 177' ' ' ILE . 0.0 OUTLIER -115.68 149.92 43.91 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.902 0.382 . . . . 0.0 111.644 -178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 182' ' ' GLU . 41.8 Cg_exo -56.98 -159.84 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.714 2.276 . . . . 0.0 112.445 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.716 HG12 ' C ' ' A' ' 205' ' ' GLN . 29.4 m -76.12 -35.24 28.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.995 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -81.63 -57.97 3.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.4 ' HB2' ' HD2' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -62.99 -27.07 69.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.29 -179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -55.39 -53.69 39.33 Favored Glycine 0 CA--C 1.518 0.22 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.898 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 1.3 pttm -64.04 -22.82 67.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.563 0.221 . . . . 0.0 111.47 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -85.1 -48.04 9.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.735 0.302 . . . . 0.0 111.277 -179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.863 HD11 ' HG3' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -64.52 -27.74 69.18 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.353 -179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 -63.01 1.29 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.449 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -68.6 -22.3 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.623 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.7 mmtt -85.02 -12.88 52.2 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.495 HD22 HD21 ' A' ' 211' ' ' LEU . 19.6 mt -113.35 -28.21 7.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.677 0.275 . . . . 0.0 111.517 -179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.407 ' HG3' HG21 ' A' ' 196' ' ' VAL . 0.0 OUTLIER -55.2 -52.95 67.08 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.477 -179.589 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 191' ' ' LYS . 94.8 Cg_endo -80.86 -41.22 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.533 2.155 . . . . 0.0 112.88 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -53.12 -53.23 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.292 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.6 mp -138.65 158.69 30.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.191 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.507 ' N ' HG22 ' A' ' 194' ' ' ILE . 2.3 mmtt -64.0 110.19 2.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.708 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.407 HG21 ' HG3' ' A' ' 191' ' ' LYS . 27.6 m -101.1 149.7 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.203 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 12.5 tt -149.13 157.99 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.116 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 60.95 32.25 19.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.61 118.2 21.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.22 130.28 16.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.773 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 26.4 p-10 -149.62 160.14 43.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.023 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.85 150.46 24.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.688 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.12 -26.97 4.94 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.804 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -140.44 43.5 1.88 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.962 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.716 ' C ' HG12 ' A' ' 180' ' ' VAL . 3.9 tt0 -141.62 177.77 7.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.003 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.554 HD23 ' HG2' ' A' ' 205' ' ' GLN . 2.6 pt? -72.94 149.11 43.66 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.954 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -102.62 137.52 40.75 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.358 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.3 pt -119.53 113.75 42.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.699 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.402 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.5 p -130.87 144.98 36.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.106 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 73.8 m -109.7 145.61 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.895 0.379 . . . . 0.0 110.791 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.495 HD21 HD22 ' A' ' 190' ' ' LEU . 19.6 mt -108.06 133.55 52.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.316 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.743 HG23 ' HG3' ' A' ' 173' ' ' ARG . 30.8 mt -149.35 125.02 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.024 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 172.94 135.69 0.11 Allowed Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.714 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -77.69 161.78 30.5 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.497 2.131 . . . . 0.0 112.436 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 105.09 -173.85 20.96 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.664 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.704 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.5 OUTLIER -100.81 44.81 1.0 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.916 0.389 . . . . 0.0 111.023 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -20.88 58.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.142 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -29.38 1.51 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.549 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -64.76 -64.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.794 0.33 . . . . 0.0 110.88 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.95 -38.77 81.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.535 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 225' ' ' LYS . 20.8 t0 -63.38 -48.62 77.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.62 179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.83 79.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.004 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -63.6 1.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.42 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.783 HG21 HD11 ' A' ' 193' ' ' LEU . 2.5 pp -60.27 -27.09 38.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.415 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 229' ' ' LYS . 1.3 mtmp? -62.65 -49.48 75.01 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.307 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 8.6 tttp -68.08 -39.81 82.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.427 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -79.18 -13.4 59.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.144 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.496 ' HB ' ' HE3' ' A' ' 229' ' ' LYS . 98.8 m -107.39 -31.53 8.13 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 111.701 0.259 . . . . 0.0 111.701 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.863 ' HG3' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -96.78 -28.29 14.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.694 0.283 . . . . 0.0 111.055 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.5 27.26 58.2 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.562 -0.827 . . . . 0.0 112.503 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 1.6 tttm 64.22 33.31 11.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 0.0 110.92 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -125.18 18.22 6.98 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.671 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.56 ' HB3' HD12 ' A' ' 178' ' ' LEU . 0.7 OUTLIER -131.71 173.05 11.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.749 0.309 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.56 132.18 54.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.101 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.454 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 0.1 OUTLIER -127.25 115.35 18.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.703 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.2 t -106.79 147.97 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.426 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.414 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.5 tt -102.65 138.88 38.97 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.626 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -83.85 -78.42 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.067 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -154.35 174.6 14.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.437 ' HD3' HG13 ' A' ' 242' ' ' VAL . 8.5 tmtt? -122.38 110.38 15.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.841 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.33 123.25 23.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.437 HG13 ' HD3' ' A' ' 240' ' ' LYS . 15.3 m -140.98 165.17 19.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.147 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.3 78.2 1.74 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.88 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -78.06 -35.3 49.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.952 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -162.2 -56.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.575 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -119.37 172.68 7.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.876 0.369 . . . . 0.0 110.981 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -70.24 -24.9 63.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.076 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 63.91 87.17 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -37.87 69.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.904 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.278 -0.868 . . . . 0.0 110.876 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.8 mtt . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.803 0.335 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.7 t -106.52 167.36 9.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.061 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 21.4 mt 73.31 -59.78 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.371 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -74.94 126.6 31.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.038 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.413 ' CB ' ' HD3' ' A' ' 6' ' ' PRO . 0.2 OUTLIER -91.1 -52.35 0.3 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.07 179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' CB ' ' A' ' 5' ' ' THR . 32.0 Cg_exo -58.38 97.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.572 2.181 . . . . 0.0 112.132 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m 63.64 136.29 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.024 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -107.56 93.86 4.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.962 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -137.59 -58.02 0.68 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.842 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.549 HG21 HD22 ' A' ' 14' ' ' ASN . 3.9 pt -88.35 147.38 5.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.112 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.2 mtp180 -74.26 -49.83 21.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.5 tt -169.9 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.92 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.6 p -61.03 122.59 15.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.549 HD22 HG21 ' A' ' 10' ' ' ILE . 4.1 t-20 -177.73 -40.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.541 HG21 ' HG2' ' A' ' 52' ' ' GLN . 22.1 t -107.86 159.53 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.039 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.33 138.41 41.76 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.904 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG13 HG21 ' A' ' 60' ' ' VAL . 34.1 t -116.38 116.45 52.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.096 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG22 HG23 ' A' ' 93' ' ' VAL . 4.6 t -107.52 123.85 63.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.927 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.15 158.23 16.98 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.149 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.885 ' HB2' HG23 ' A' ' 87' ' ' ILE . 11.2 tmm? -159.51 127.62 4.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.787 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.82 139.64 31.12 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.947 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.67 134.75 1.8 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.837 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 60.34 21.24 10.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.261 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.26 -43.94 2.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.65 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.0 168.19 15.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.765 0.317 . . . . 0.0 111.076 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.0 ttm105 -119.66 126.05 50.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.91 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -119.25 152.55 36.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.567 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.3 pt-20 -153.54 151.97 30.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.795 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.675 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -135.25 157.76 40.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.923 0.392 . . . . 0.0 111.533 -179.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -97.57 115.19 27.38 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.78 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.718 ' HB3' HD23 ' A' ' 51' ' ' LEU . 1.0 OUTLIER -142.95 177.82 8.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.019 -179.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.691 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.6 m-85 -83.74 142.63 30.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.141 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.681 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 15.8 mttt -66.45 -45.3 80.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.422 ' HA ' HG12 ' A' ' 37' ' ' VAL . 7.2 m-20 -74.36 -40.86 61.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.693 ' HB2' HG23 ' A' ' 50' ' ' VAL . 24.0 mmtm -66.28 -38.63 88.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.177 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 32' ' ' TYR . 78.3 t -72.52 -49.19 43.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.087 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' ASN . 11.5 p -56.3 -41.72 71.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.873 0.368 . . . . 0.0 110.742 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.42 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -68.73 -43.99 72.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.109 179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CH2' HD23 ' A' ' 47' ' ' LEU . 2.3 t-105 -61.68 -54.9 36.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.443 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.645 ' HA ' HG22 ' A' ' 89' ' ' THR . 0.0 OUTLIER -55.36 -44.3 75.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.961 179.972 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.401 ' OG ' HG23 ' A' ' 43' ' ' VAL . 27.9 p -59.44 -27.51 66.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.924 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 130.85 -19.33 4.98 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.763 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.401 HG23 ' OG ' ' A' ' 41' ' ' SER . 22.6 t -53.85 141.98 8.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.861 0.362 . . . . 0.0 111.329 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.14 131.98 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.95 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.0 OUTLIER -157.53 173.01 17.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.898 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.564 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -115.44 137.57 51.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.086 -179.966 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.667 HD21 ' HG2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -62.09 -34.06 75.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.32 -16.67 55.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.584 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 3.4 mm-40 -107.22 -55.24 2.36 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.716 0.294 . . . . 0.0 111.341 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.693 HG23 ' HB2' ' A' ' 35' ' ' LYS . 6.7 p -58.24 -47.54 87.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.343 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.718 HD23 ' HB3' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -75.73 126.16 30.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.626 179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.541 ' HG2' HG21 ' A' ' 15' ' ' VAL . 1.4 tp-100 -89.32 -32.59 17.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.358 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.607 HG21 ' CE1' ' A' ' 57' ' ' PHE . 40.2 m -127.53 112.4 14.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.654 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -78.37 59.99 2.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.892 0.377 . . . . 0.0 110.858 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.5 m -165.48 129.84 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.75 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.497 ' HA ' HG22 ' A' ' 29' ' ' ILE . 21.3 t -71.83 107.11 2.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.914 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.607 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.8 m-85 -81.68 -176.46 6.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.368 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.6 t -132.35 -47.52 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.388 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -137.12 73.83 1.46 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.2 179.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.567 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.1 t -55.79 -33.18 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.215 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 p -57.54 -28.83 63.87 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.092 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 7.4 mmmt -112.25 -26.05 8.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.092 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.22 50.94 1.1 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.15 126.25 53.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.88 0.372 . . . . 0.0 110.84 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.535 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.4 t -106.19 152.67 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.231 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.6 179.11 7.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.133 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.93 162.29 20.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.887 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.1 pttm -63.36 -35.14 79.41 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.931 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -59.34 -52.29 66.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.48 -32.06 70.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.834 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.082 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -63.29 -48.79 76.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.864 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.553 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.6 mt -71.67 -36.55 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.177 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.7 m -71.85 -22.75 61.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.241 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.47 -27.56 12.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.685 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.44 ' CE1' HG23 ' A' ' 83' ' ' ILE . 97.1 m-85 -118.29 -39.86 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.626 0.25 . . . . 0.0 111.444 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.45 42.39 18.28 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.325 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -133.76 -44.0 0.81 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.553 ' OD1' HD11 ' A' ' 72' ' ' ILE . 14.0 t0 79.28 -0.34 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.233 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -105.6 94.16 5.05 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 120.875 0.369 . . . . 0.0 110.601 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.87 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -48.49 -36.14 14.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.219 -179.7 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.5 -55.19 36.8 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.679 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -60.31 -39.51 87.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.429 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.082 HD13 HD22 ' A' ' 71' ' ' LEU . 29.2 mt -60.77 -44.88 98.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.382 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.71 ' O ' HD13 ' A' ' 88' ' ' LEU . 79.8 m -59.99 -42.57 94.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.068 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.667 ' HG2' HD21 ' A' ' 47' ' ' LEU . 56.6 mttt -54.91 -54.45 42.51 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.59 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -55.36 -43.21 74.84 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.886 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB2' ' A' ' 20' ' ' MET . 18.3 mt -67.51 -26.49 35.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.101 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.71 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.1 mp -74.57 -37.31 62.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.925 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 40' ' ' ARG . 6.1 p -90.77 -34.0 15.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.344 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 14.3 mttt -96.64 -44.26 7.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.768 0.318 . . . . 0.0 111.23 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.72 170.68 27.61 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.612 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.516 ' C ' HG13 ' A' ' 18' ' ' VAL . 2.0 pt-20 -101.15 124.3 46.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.339 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.599 HG23 HG22 ' A' ' 18' ' ' VAL . 11.7 p -85.59 125.82 40.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.096 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -85.72 105.66 16.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.812 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.4 146.88 21.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.167 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.2 m -67.72 160.82 27.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.85 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.56 -31.46 69.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.891 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.551 ' O ' HG22 ' A' ' 102' ' ' THR . 5.5 pttp -63.47 -38.53 91.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.908 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.92 -31.55 70.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.994 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -74.38 -43.73 55.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.888 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -65.4 -48.82 71.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.89 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.551 HG22 ' O ' ' A' ' 98' ' ' LYS . 9.7 t -60.35 -46.01 91.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.856 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.418 ' N ' HG23 ' A' ' 102' ' ' THR . 9.5 mm-40 -63.11 -39.59 95.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.78 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.46 -50.61 72.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.774 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -61.64 -45.4 94.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.772 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -60.15 -44.49 94.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.811 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.77 -39.25 93.6 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.717 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.422 ' HA ' HD12 ' A' ' 111' ' ' ILE . 0.1 OUTLIER -60.72 -48.85 79.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.676 179.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -60.73 -41.44 95.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.662 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.779 ' HB3' HG21 ' A' ' 150' ' ' THR . 0.9 OUTLIER -58.8 -51.53 69.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.812 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.817 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.6 mt -59.12 -37.6 69.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.837 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -64.04 -37.45 87.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.838 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.5 m -69.76 -38.25 76.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.678 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 HD12 ' HA ' ' A' ' 111' ' ' ILE . 16.0 mt -70.14 -34.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.963 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.817 HG23 ' O ' ' A' ' 111' ' ' ILE . 32.3 t -79.82 -28.33 12.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.04 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.453 ' HB1' ' O ' ' A' ' 128' ' ' TYR . . . -90.5 -29.63 17.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.209 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -103.3 -48.26 4.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.04 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -94.92 44.12 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.454 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.1 OUTLIER 179.35 159.49 0.68 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.867 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 119' ' ' CYS . 4.9 m -156.57 167.78 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.184 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 30.7 t-20 -83.47 130.45 56.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.864 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -83.53 53.5 4.21 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.524 2.149 . . . . 0.0 112.559 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -146.85 -50.96 0.2 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.13 -11.35 7.54 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.518 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 62.8 75.03 0.41 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.88 0.371 . . . . 0.0 110.924 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -140.86 109.84 6.56 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.877 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_exo -51.5 116.71 2.89 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.471 2.114 . . . . 0.0 112.389 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.453 ' O ' ' HB1' ' A' ' 116' ' ' ALA . 15.1 m-85 -61.29 166.71 3.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 1.4 m -99.57 143.67 29.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 5.8 m -52.87 -35.8 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.133 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.6 pp -67.7 -34.14 66.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.973 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.19 -48.6 61.68 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.714 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 5.5 mt -64.92 -41.36 91.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.976 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.55 -49.14 78.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.819 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.72 -45.99 90.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -63.12 -47.96 80.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.077 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.409 ' HB3' ' CE2' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -58.65 -40.11 82.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.956 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.22 -36.86 66.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.901 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.22 -40.18 93.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 140' ' ' ILE . 35.3 mt -81.41 -0.63 4.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.507 -179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 60.79 43.26 12.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.888 0.375 . . . . 0.0 110.825 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -60.56 151.57 28.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.982 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -131.73 85.48 2.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.802 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.77 HG13 ' HG2' ' A' ' 153' ' ' GLN . 21.1 t -75.07 150.41 6.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.167 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -93.82 99.54 11.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.812 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 p -58.42 -30.35 66.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.979 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.421 ' HA ' HG23 ' A' ' 37' ' ' VAL . 2.0 m-20 -64.57 -30.62 71.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.918 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.9 179.56 5.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 16.4 m -91.25 148.74 22.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.903 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.779 HG21 ' HB3' ' A' ' 110' ' ' ASP . 32.6 p -65.09 -43.78 90.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.998 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 44.0 mmtm -45.07 -59.22 2.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.409 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -61.5 -27.46 68.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.914 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.903 ' O ' HG23 ' A' ' 157' ' ' VAL . 11.5 tp60 -75.09 -28.63 60.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.191 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -46.88 -36.29 7.36 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.522 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.87 -63.32 1.29 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.918 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -58.38 -31.13 67.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.8 t -63.39 -62.3 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.224 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.461 HG22 HG21 ' A' ' 167' ' ' ILE . 3.5 pt -59.6 -28.95 41.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.27 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.413 ' N ' HG13 ' A' ' 158' ' ' ILE . 1.3 tttp -69.09 -48.19 63.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.8 tp60 -71.72 -38.78 70.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.986 -179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 14.1 mt -58.02 -26.84 62.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.55 -28.75 56.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.792 0.33 . . . . 0.0 111.033 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -59.1 -31.65 69.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 19.1 mmtm -117.93 -63.47 1.42 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.826 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 11.5 tpp -113.37 108.06 16.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? -61.11 130.05 44.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 168' ' ' GLU . 19.4 mm -118.44 159.56 18.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.003 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.474 ' N ' HG22 ' A' ' 167' ' ' ILE . 0.9 OUTLIER -147.15 132.47 18.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.99 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.04 112.86 21.51 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -129.73 164.54 23.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.222 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 15.3 m80 -130.05 -177.7 4.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.85 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -170.43 134.98 1.18 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.791 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.427 ' HB2' ' CB ' ' A' ' 239' ' ' LEU . 10.3 mmm180 -89.05 135.45 33.55 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-O 121.052 0.453 . . . . 0.0 111.005 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 211' ' ' LEU . 6.8 mp -123.92 144.31 49.85 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.397 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -115.79 110.16 18.68 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.003 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.402 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 6.1 m-85 -101.13 123.18 44.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.065 0.46 . . . . 0.0 111.648 -179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.61 ' N ' HD13 ' A' ' 177' ' ' ILE . 0.0 OUTLIER -114.98 104.07 16.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.561 178.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.618 HD12 ' CA ' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -111.96 151.18 43.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.993 0.425 . . . . 0.0 111.739 -178.692 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 182' ' ' GLU . 72.2 Cg_endo -73.28 -165.17 0.23 Allowed 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.739 2.293 . . . . 0.0 112.116 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.675 HG12 ' C ' ' A' ' 205' ' ' GLN . 31.5 m -76.02 -51.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.167 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.54 ' N ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -81.88 -58.02 3.17 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.924 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.445 ' HB2' ' HG2' ' A' ' 179' ' ' PRO . 0.0 OUTLIER -60.57 -17.98 49.82 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -178.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.618 ' CA ' HD12 ' A' ' 178' ' ' LEU . . . -73.56 -54.17 6.9 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.958 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.07 -18.17 56.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.546 0.212 . . . . 0.0 111.558 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.78 -45.21 11.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.693 0.282 . . . . 0.0 111.599 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.726 HD12 ' N ' ' A' ' 187' ' ' LYS . 4.5 pp -83.14 -33.67 26.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.528 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.726 ' N ' HD12 ' A' ' 186' ' ' LEU . 14.9 tttt -56.66 -40.45 75.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.317 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -68.37 -36.99 80.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.567 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.711 ' HD3' HG21 ' A' ' 228' ' ' THR . 3.3 tttm -86.13 -5.74 59.14 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -179.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.457 HD12 HD13 ' A' ' 186' ' ' LEU . 14.6 mt -109.04 -30.64 7.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.644 0.259 . . . . 0.0 111.501 -179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.46 ' HB3' ' HD3' ' A' ' 192' ' ' PRO . 21.7 tttt -57.95 -48.81 96.46 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.583 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 191' ' ' LYS . 94.6 Cg_endo -80.47 -38.98 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.375 2.05 . . . . 0.0 112.91 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.714 HD21 HG22 ' A' ' 220' ' ' ILE . 0.4 OUTLIER -57.11 -51.31 69.8 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.432 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.56 HD13 ' OD1' ' A' ' 221' ' ' ASP . 1.3 mp -127.44 161.68 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.21 -179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.463 ' N ' HG22 ' A' ' 194' ' ' ILE . 13.1 mttm -77.31 121.6 23.95 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.432 ' HB ' ' CG1' ' A' ' 209' ' ' VAL . 4.4 m -114.04 131.18 66.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.266 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 11.6 mt -114.74 148.75 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 58.65 81.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.854 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 9.8 m -108.7 121.27 44.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.927 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -138.52 124.18 19.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.943 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -141.39 143.3 33.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.831 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.4 150.43 26.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.836 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.87 112.54 2.24 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.363 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 41.6 tp60 63.15 35.59 12.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.015 0.436 . . . . 0.0 110.471 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.675 ' C ' HG12 ' A' ' 180' ' ' VAL . 0.8 OUTLIER -131.47 176.46 8.28 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.909 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.3 pt? -73.09 149.12 43.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.465 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -109.09 140.09 43.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.124 0.487 . . . . 0.0 111.953 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pt -117.78 108.07 23.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.301 179.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.432 ' CG1' ' HB ' ' A' ' 196' ' ' VAL . 21.2 t -130.96 145.52 35.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 -179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 13.5 m -109.25 145.68 35.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.732 HD22 HD22 ' A' ' 174' ' ' LEU . 7.6 tt -122.31 152.91 39.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.141 0.496 . . . . 0.0 112.184 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 195' ' ' LYS . 1.4 tt -112.65 143.38 22.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.298 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -115.89 89.65 24.93 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.689 0.28 . . . . 0.0 111.505 -179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.61 93.95 1.08 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.983 2.456 . . . . 0.0 111.886 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 93.47 -92.98 1.67 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.648 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.404 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -148.48 40.54 0.93 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.388 . . . . 0.0 111.039 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -69.8 -20.9 63.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.234 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.5 ttm105 -46.73 -29.0 1.7 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.634 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.33 -64.25 0.99 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.034 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.714 HG22 HD21 ' A' ' 193' ' ' LEU . 5.1 mt -60.29 -38.14 76.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.873 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.56 ' OD1' HD13 ' A' ' 194' ' ' ILE . 23.8 t70 -59.44 -53.57 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.861 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -59.07 -38.4 79.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.839 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.67 -63.15 1.3 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.906 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.702 HG21 HD22 ' A' ' 193' ' ' LEU . 5.1 tp -58.59 -44.04 88.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.086 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.491 ' N ' HG23 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -59.83 -64.43 0.95 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.008 -179.841 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -54.34 -27.05 33.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.16 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -74.17 -41.47 61.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.711 HG21 ' HD3' ' A' ' 189' ' ' LYS . 17.0 p -105.74 13.98 28.92 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.47 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 225' ' ' LYS . 1.4 tmmt? -123.65 -37.45 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.648 0.261 . . . . 0.0 111.339 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 64.66 -76.98 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.26 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.81 31.48 0.05 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.818 0.342 . . . . 0.0 110.665 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -90.99 -49.29 3.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.904 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 14.1 p -107.2 172.46 6.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.84 0.352 . . . . 0.0 111.152 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 2.4 mp -138.03 160.15 40.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.978 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -134.98 115.24 13.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.919 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.3 t -107.02 116.26 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.445 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.527 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 0.5 OUTLIER -103.97 144.01 32.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.078 179.293 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -177.39 -34.99 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.427 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 2.7 mm? -80.23 112.65 17.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.06 0.457 . . . . 0.0 111.198 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -121.42 148.57 44.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -75.98 153.86 36.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.841 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.2 t 68.62 -68.64 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.255 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.55 71.88 0.98 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.824 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -123.25 31.26 6.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.825 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 130.34 -93.42 0.31 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.423 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 62.77 -79.82 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.738 0.304 . . . . 0.0 111.004 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 62.61 148.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.917 -179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -157.82 42.85 0.31 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.915 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -92.53 146.35 23.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.923 -179.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 ttt . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.875 0.369 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.65 174.98 7.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.868 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 4' ' ' PHE . 23.0 pt -110.73 -40.34 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.176 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.403 ' N ' HG13 ' A' ' 3' ' ' ILE . 23.1 p90 -112.21 -28.31 8.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.02 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.6 m 64.12 125.76 0.02 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.812 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -70.25 118.81 5.9 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.383 2.055 . . . . 0.0 112.316 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.9 m -89.99 -49.92 6.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -114.8 -51.9 2.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.672 ' C ' HD12 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -165.54 65.23 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.972 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.672 HD12 ' C ' ' A' ' 9' ' ' GLN . 0.7 OUTLIER 57.96 166.28 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.06 179.968 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.468 ' H ' HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -134.54 -49.86 0.78 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.019 HD13 HG12 ' A' ' 60' ' ' VAL . 8.7 tt -166.23 123.53 1.38 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.2 -56.71 2.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.723 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -138.7 29.88 2.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.71 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.644 HG21 ' HG2' ' A' ' 52' ' ' GLN . 61.0 t -74.49 155.09 6.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.124 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.73 134.52 40.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.804 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.641 HG12 ' HG2' ' A' ' 28' ' ' GLU . 13.9 t -112.72 122.04 66.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.246 -179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.557 ' HB ' HD12 ' A' ' 29' ' ' ILE . 21.7 t -110.54 129.98 64.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.999 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.403 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.01 152.19 36.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.9 0.381 . . . . 0.0 111.295 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.877 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.3 tmm? -157.33 149.88 23.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.9 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.43 142.97 33.66 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' HD2' ' CE1' ' A' ' 75' ' ' PHE . 17.3 ttt85 -170.81 134.03 0.99 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 59.59 37.64 22.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.02 27.62 70.72 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.523 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.82 157.03 47.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.83 0.347 . . . . 0.0 110.851 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -116.89 124.31 49.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.943 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -117.42 156.3 28.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG2' HG12 ' A' ' 17' ' ' VAL . 1.5 tt0 -147.82 137.47 22.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.158 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.893 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -127.91 147.45 32.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 CA-C-O 120.962 0.411 . . . . 0.0 111.019 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.817 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.14 106.82 18.69 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.895 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.582 ' SG ' HD11 ' A' ' 88' ' ' LEU . 0.0 OUTLIER -127.39 177.82 6.48 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.014 -179.509 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.608 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.9 m-85 -87.47 143.77 27.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.067 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.433 ' O ' HG12 ' A' ' 37' ' ' VAL . 0.0 OUTLIER -74.26 -34.9 63.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.171 179.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.48 -44.03 46.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.258 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.6 OUTLIER -70.75 -38.64 73.53 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.825 -179.946 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 32' ' ' TYR . 45.3 t -67.18 -48.8 77.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.539 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 38' ' ' GLY . 14.0 p -59.05 -43.94 90.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.881 0.372 . . . . 0.0 110.35 179.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -70.47 -24.67 76.61 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.083 179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.775 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.7 t90 -81.81 -66.29 0.91 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.916 0.389 . . . . 0.0 110.409 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.11 -26.08 67.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.404 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.45 25.46 11.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.504 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -156.84 -82.19 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.991 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.512 HG22 ' N ' ' A' ' 44' ' ' GLU . 8.4 p -166.58 160.62 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.711 0.291 . . . . 0.0 111.146 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.512 ' N ' HG22 ' A' ' 43' ' ' VAL . 6.5 mt-10 -43.99 143.7 1.07 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.284 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.1 OUTLIER -135.76 170.47 15.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.054 -179.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.434 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -59.84 121.11 10.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 -179.556 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -53.86 -54.67 35.36 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.351 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -62.91 -15.44 55.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.651 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.67 -27.63 13.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.615 0.245 . . . . 0.0 111.395 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.775 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 12.3 p -92.04 -28.06 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.523 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.659 HD11 ' SG ' ' A' ' 84' ' ' CYS . 5.5 mt -100.85 135.11 42.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.866 0.365 . . . . 0.0 110.95 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.644 ' HG2' HG21 ' A' ' 15' ' ' VAL . 15.6 tp60 -85.44 -45.82 11.48 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.052 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.817 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.6 t -125.65 117.39 23.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -71.66 75.35 0.83 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.99 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 179.34 137.43 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.714 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.041 HG21 HD21 ' A' ' 71' ' ' LEU . 17.8 t -78.35 113.7 17.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.742 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.517 ' HB2' HG22 ' A' ' 60' ' ' VAL . 4.1 m-85 -89.97 -178.47 5.47 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.365 0.602 . . . . 0.0 111.703 -179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 50.6 t -126.94 -42.88 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.717 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -134.79 61.9 1.66 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.963 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 1.019 HG12 HD13 ' A' ' 12' ' ' LEU . 2.4 t -48.1 -40.35 9.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.474 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 t -54.27 -26.72 30.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.027 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -111.3 -26.06 9.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.051 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.61 38.61 2.36 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.584 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -103.17 125.09 49.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.616 0.246 . . . . 0.0 110.396 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 66' ' ' ALA . 20.9 t -100.75 156.4 4.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -179.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -90.44 -167.3 1.8 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.922 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -123.56 151.29 43.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.911 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 72' ' ' ILE . 5.0 mmpt? -64.56 -35.37 80.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.871 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -59.04 -45.91 89.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.67 -36.72 70.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.772 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.118 HD22 HD13 ' A' ' 83' ' ' ILE . 7.0 mt -57.61 -43.58 84.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.851 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 68' ' ' LYS . 4.1 mt -81.4 -37.93 15.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.027 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -62.99 -23.93 67.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.257 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -101.58 -46.78 4.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.498 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.55 ' CE1' HG23 ' A' ' 83' ' ' ILE . 96.4 m-85 -93.41 -42.64 9.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.343 -179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 77.29 27.98 58.79 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.488 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.449 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.3 p -110.99 -32.07 6.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.932 0.396 . . . . 0.0 110.81 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 66.0 20.03 11.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.96 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -133.87 99.97 4.61 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.598 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.57 -41.37 54.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.226 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.648 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -53.35 -58.33 7.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.913 0.387 . . . . 0.0 110.668 179.786 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.09 -50.06 74.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.159 179.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.118 HD13 HD22 ' A' ' 71' ' ' LEU . 56.7 mt -52.59 -38.47 26.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.362 179.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.893 ' SG ' HG21 ' A' ' 29' ' ' ILE . 79.3 m -62.84 -44.84 95.06 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.787 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HE3' HD21 ' A' ' 47' ' ' LEU . 30.8 mttt -54.34 -42.94 70.79 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.162 0.506 . . . . 0.0 109.709 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -59.43 -50.35 74.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.65 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.877 HG23 ' HB2' ' A' ' 20' ' ' MET . 31.7 mt -69.85 -24.86 27.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.085 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.582 HD11 ' SG ' ' A' ' 31' ' ' CYS . 0.6 OUTLIER -74.98 -30.97 61.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.939 179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.5 p -98.31 -39.5 8.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.182 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.6 mmtt -90.35 -35.29 15.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.116 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.27 176.8 54.57 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.613 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.4 tt0 -113.76 134.48 54.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.789 0.328 . . . . 0.0 110.857 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 p -90.64 147.1 5.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.089 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -101.87 106.67 17.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.6 m -108.59 155.91 9.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.196 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 m -85.66 175.82 8.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -66.54 -43.26 85.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -59.38 -51.92 67.86 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -60.83 -34.76 75.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.746 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -64.12 -41.9 97.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.746 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -69.7 -41.25 75.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 48.5 m -60.55 -45.72 92.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.834 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -65.25 -36.73 85.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.791 179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 tp -60.58 -50.27 74.2 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.806 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.82 -51.16 69.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.703 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.52 -42.19 87.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.72 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.566 ' CE ' HG22 ' A' ' 150' ' ' THR . 9.6 tpt -64.24 -39.41 93.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.603 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.636 ' HD1' HG21 ' A' ' 144' ' ' VAL . 1.0 OUTLIER -59.58 -53.57 56.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.725 179.835 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 7.0 mtp180 -63.07 -31.48 72.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.741 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.76 -52.01 49.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.895 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.546 HD11 ' HG3' ' A' ' 107' ' ' MET . 9.7 mt -58.98 -45.57 92.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.903 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -59.77 -47.35 86.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.311 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 4.9 p -60.77 -41.35 95.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.193 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.591 HG23 ' HD2' ' A' ' 118' ' ' LYS . 7.6 mt -67.6 -43.9 86.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.591 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.555 HG13 ' CD1' ' A' ' 133' ' ' ILE . 15.0 p -74.66 -18.43 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.643 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.733 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -100.22 -15.17 18.19 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -112.15 -37.04 5.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.713 0.292 . . . . 0.0 111.469 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.591 ' HD2' HG23 ' A' ' 114' ' ' ILE . 36.9 mttm -95.59 26.61 3.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.373 -179.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 36.8 m -148.94 139.92 22.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.79 0.329 . . . . 0.0 110.962 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 7.6 m -126.76 127.38 69.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.007 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -62.71 134.65 95.44 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.928 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -79.43 56.73 6.16 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.57 2.18 . . . . 0.0 112.445 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -129.5 -48.9 1.17 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.938 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.3 t -161.11 30.03 0.14 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.995 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 76.39 0.32 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -162.44 110.57 1.1 Allowed Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -68.32 147.17 71.39 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.319 2.013 . . . . 0.0 112.297 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 11.1 m-85 -72.25 172.85 9.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 6.0 m -85.44 148.95 25.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.6 m -54.28 -33.29 25.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.271 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 7.6 mt -69.37 -32.99 55.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.981 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.44 -56.47 5.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.889 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.733 HD13 ' HB2' ' A' ' 116' ' ' ALA . 16.1 pt -59.6 -35.92 62.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 65.7 tt0 -68.73 -45.45 71.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.693 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -44.24 85.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.715 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.41 83.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.945 179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.418 ' SD ' HG13 ' A' ' 157' ' ' VAL . 4.1 ttp -55.49 -38.91 69.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.82 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.48 -36.46 57.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.705 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -61.46 -32.4 72.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.608 HG22 ' O ' ' A' ' 140' ' ' ILE . 22.4 mt -95.63 22.27 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.307 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . 0.432 ' CG ' ' O ' ' A' ' 140' ' ' ILE . 27.9 p80 43.42 58.96 3.2 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.922 0.391 . . . . 0.0 111.493 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 11.3 t80 -94.9 104.64 16.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.89 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 78.2 p -74.06 172.2 12.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.881 -179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.636 HG21 ' HD1' ' A' ' 108' ' ' PHE . 22.0 t -126.49 144.24 37.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.107 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -117.24 98.95 6.71 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.893 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 28.1 p -55.66 -23.08 26.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.294 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.4 p30 -96.56 29.07 3.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.15 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -126.89 152.89 46.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.931 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 2.7 p -74.16 139.79 44.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.939 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.566 HG22 ' CE ' ' A' ' 107' ' ' MET . 17.3 p -65.08 -53.97 37.26 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.026 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -46.58 -56.96 5.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.237 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.4 mm-40 -62.1 -27.29 68.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.871 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp-100 -67.57 -41.04 84.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.959 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.647 ' O ' HG22 ' A' ' 158' ' ' ILE . . . -54.43 -36.35 63.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.291 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 3.2 tt -61.12 -50.97 71.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.005 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.25 -38.08 81.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.05 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.871 HG23 ' O ' ' A' ' 153' ' ' GLN . 36.4 t -64.17 -56.35 16.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.318 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.647 HG22 ' O ' ' A' ' 154' ' ' ALA . 19.4 tt -60.09 -41.63 87.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.196 -179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.427 ' N ' HG23 ' A' ' 158' ' ' ILE . 42.8 mtpt -65.13 -42.47 93.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.033 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 21.1 tp60 -69.25 -49.94 51.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.014 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 140' ' ' ILE . 21.3 mt -59.32 -28.7 67.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.092 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -55.74 -29.71 60.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.976 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.21 -32.58 74.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.832 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.601 ' HB2' HD11 ' A' ' 140' ' ' ILE . 0.0 OUTLIER -95.36 -63.92 1.11 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.833 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.12 -175.94 2.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.816 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -111.14 116.88 31.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.971 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 168' ' ' GLU . 2.1 mp -126.46 159.36 35.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.922 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.463 ' N ' HG22 ' A' ' 167' ' ' ILE . 2.8 tm-20 -147.9 127.32 13.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.21 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.471 ' HB2' HD13 ' A' ' 158' ' ' ILE . 5.0 ttp180 -111.58 124.59 52.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.48 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -112.48 136.86 51.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.989 0.423 . . . . 0.0 111.525 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -124.71 167.44 14.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.271 179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.3 mtt -171.55 118.61 0.44 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.002 0.43 . . . . 0.0 111.581 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.73 126.88 47.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.907 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.642 HD22 HD13 ' A' ' 211' ' ' LEU . 0.3 OUTLIER -118.18 142.49 47.4 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.157 0.503 . . . . 0.0 112.141 -179.022 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 4.3 mmm-85 -111.75 131.95 54.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.521 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.467 ' CE1' ' HB3' ' A' ' 235' ' ' GLU . 0.3 OUTLIER -132.54 148.13 52.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.182 0.515 . . . . 0.0 112.085 -178.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.44 ' N ' HD12 ' A' ' 177' ' ' ILE . 4.3 mp -134.69 100.25 2.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.904 179.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.582 HD22 HD13 ' A' ' 186' ' ' LEU . 0.8 OUTLIER -99.58 137.23 20.23 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.541 -178.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 182' ' ' GLU . 33.4 Cg_exo -59.1 -157.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.179 . . . . 0.0 111.973 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.721 HG22 ' HA ' ' A' ' 205' ' ' GLN . 27.3 t -76.07 -61.94 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.642 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 9.6 p-10 -74.51 -52.63 11.37 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.798 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.518 ' O ' HD12 ' A' ' 186' ' ' LEU . 0.4 OUTLIER -49.95 -53.06 28.77 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.758 0.313 . . . . 0.0 111.456 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.52 -22.78 40.2 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.916 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 2.0 tttp -58.97 -62.61 1.75 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.788 0.327 . . . . 0.0 111.213 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.65 -26.4 50.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.329 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.69 HD11 ' HA ' ' A' ' 229' ' ' LYS . 0.3 OUTLIER -66.34 -58.95 4.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.32 -179.657 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.44 -51.06 50.12 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.341 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -60.77 -26.55 67.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.15 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.47 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.8 OUTLIER -79.46 -39.46 32.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.36 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.62 HD13 HD21 ' A' ' 211' ' ' LEU . 5.4 mt -86.25 -21.45 27.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.459 -179.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -53.63 -60.25 7.59 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.359 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.66 -39.83 0.65 Allowed 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.696 2.264 . . . . 0.0 112.888 -179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.942 HD23 HG23 ' A' ' 194' ' ' ILE . 4.1 tt -56.0 -51.96 65.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.373 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.942 HG23 HD23 ' A' ' 193' ' ' LEU . 2.7 pp -131.74 175.11 12.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.312 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.1 mptm? -84.16 120.5 26.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.741 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 16.2 m -107.24 136.84 40.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.164 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.411 HG12 HD11 ' A' ' 212' ' ' ILE . 1.0 OUTLIER -134.88 155.66 38.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.113 179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 61.29 32.12 19.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.77 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 10.7 t -76.17 121.27 22.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.988 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.55 114.13 9.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.793 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.436 ' CB ' ' HB3' ' A' ' 207' ' ' GLU . 11.9 p-10 -118.84 142.64 47.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.019 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -104.32 150.32 24.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.766 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -50.57 105.49 0.19 Allowed Glycine 0 C--N 1.329 0.184 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.391 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.538 ' C ' HG13 ' A' ' 180' ' ' VAL . 3.5 tt0 61.03 37.91 17.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.908 0.385 . . . . 0.0 110.418 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.721 ' HA ' HG22 ' A' ' 180' ' ' VAL . 2.4 mt-30 -137.37 178.09 7.36 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.037 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.568 ' H ' HD13 ' A' ' 206' ' ' LEU . 0.0 OUTLIER -72.87 149.79 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.202 0.525 . . . . 0.0 111.335 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.436 ' HB3' ' CB ' ' A' ' 201' ' ' ASP . 3.5 pm0 -125.13 147.36 49.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.345 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 2.4 pt -109.45 116.62 52.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.744 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.93 144.86 36.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.471 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 88.0 m -109.74 145.7 36.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.399 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.642 HD13 HD22 ' A' ' 174' ' ' LEU . 2.6 mp -115.97 128.91 56.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.94 0.4 . . . . 0.0 111.7 -179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.411 HD11 HG12 ' A' ' 197' ' ' ILE . 30.7 mt -112.71 131.28 64.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.787 179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -122.78 82.9 49.14 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.288 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.85 89.66 0.29 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.756 2.304 . . . . 0.0 112.133 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 120.16 -123.67 5.68 Favored Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.544 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.2 m -114.56 29.01 8.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 0.0 111.002 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -78.81 -20.89 48.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.152 179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 4.8 ptm180 -46.65 -35.22 5.75 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.776 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -59.09 -55.91 28.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.739 0.304 . . . . 0.0 111.178 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.583 HG22 HD21 ' A' ' 193' ' ' LEU . 2.7 mt -61.32 -39.66 83.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.932 0.396 . . . . 0.0 110.916 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.487 ' OD1' HD22 ' A' ' 211' ' ' LEU . 28.8 t0 -62.9 -62.84 1.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.881 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.408 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -49.25 -38.15 25.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.371 -179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -65.72 -57.83 7.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.562 -179.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.613 HG21 HD13 ' A' ' 193' ' ' LEU . 1.0 OUTLIER -62.38 -41.37 91.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.315 -0.402 . . . . 0.0 112.044 -179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.472 ' HZ1' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -69.98 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.403 -179.355 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.403 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 5.7 tttp -74.17 -37.76 63.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.785 0.326 . . . . 0.0 111.067 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.71 -26.58 40.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.149 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.477 HG23 ' O ' ' A' ' 224' ' ' ILE . 33.4 p -84.28 -31.47 24.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.14 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.69 ' HA ' HD11 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -94.04 -26.61 16.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.026 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.29 -80.24 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.233 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 6.4 ptpt -167.73 31.94 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.83 0.348 . . . . 0.0 110.627 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -111.62 -18.78 7.77 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.805 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 m -107.23 163.76 12.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.825 0.345 . . . . 0.0 110.899 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 234' ' ' LEU . 3.7 mm? -104.92 154.38 20.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.467 ' HB3' ' CE1' ' A' ' 176' ' ' PHE . 14.9 pt-20 -141.9 115.22 8.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.159 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.9 t -106.85 138.81 30.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.964 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.52 122.45 39.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.76 -75.19 0.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.933 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.478 HD13 ' H ' ' A' ' 240' ' ' LYS . 0.2 OUTLIER -105.41 135.77 46.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.911 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.478 ' H ' HD13 ' A' ' 239' ' ' LEU . 39.4 pttt -139.24 132.72 30.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -79.04 154.81 29.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.872 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 11.0 p -72.29 -31.41 38.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.077 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -105.49 133.15 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.891 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.99 30.78 4.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.887 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 96.08 -40.12 2.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.497 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -153.25 133.47 13.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.834 0.35 . . . . 0.0 110.912 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -104.67 -77.59 0.58 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -111.09 -26.37 9.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 65.21 31.8 10.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.807 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.941 179.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 120.791 0.329 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t 61.09 112.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 3' ' ' ILE . 7.5 tt -171.3 55.1 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.789 ' HA ' HD11 ' A' ' 10' ' ' ILE . 64.9 t80 66.32 -73.21 0.07 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.052 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.84 114.47 0.02 OUTLIER Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.894 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -66.68 75.06 0.41 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.355 2.037 . . . . 0.0 112.217 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -157.31 160.14 38.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.839 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -67.02 79.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.923 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -138.22 -51.69 0.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.927 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.789 HD11 ' HA ' ' A' ' 4' ' ' PHE . 2.2 pp -142.77 167.28 14.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.187 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -156.18 93.15 1.4 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.71 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 60' ' ' VAL . 1.9 pt? -111.45 -20.76 12.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.334 -179.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.496 ' OG1' HG12 ' A' ' 60' ' ' VAL . 3.3 m -124.76 -68.47 0.85 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.762 0.315 . . . . 0.0 111.0 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.4 t30 52.43 29.63 7.21 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.017 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 16' ' ' ALA . 0.5 OUTLIER -157.4 -177.63 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.51 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -75.35 147.86 39.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.839 0.352 . . . . 0.0 111.086 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.613 HG13 HG21 ' A' ' 60' ' ' VAL . 32.8 t -118.79 130.74 73.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.294 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.685 HG22 HG13 ' A' ' 93' ' ' VAL . 15.2 t -121.03 133.86 66.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.057 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' CA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -121.49 157.19 31.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.263 -179.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 10.1 tmm? -154.85 150.44 27.47 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.989 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -94.61 124.92 38.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.789 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.47 124.09 10.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.926 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.83 34.99 25.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.176 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.52 25.18 69.96 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.544 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -118.02 174.02 6.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.748 0.309 . . . . 0.0 110.883 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -120.57 105.51 10.89 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -112.93 146.8 38.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.681 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -143.56 160.23 41.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.967 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.779 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -142.71 146.75 21.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.85 0.357 . . . . 0.0 110.792 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.001 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -92.91 106.83 18.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.928 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.944 ' HB3' HD23 ' A' ' 51' ' ' LEU . 0.6 OUTLIER -137.96 172.98 12.13 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.933 -179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.665 ' O ' HG23 ' A' ' 36' ' ' VAL . 20.3 m-85 -84.96 135.69 33.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.648 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 2.8 tmtt? -66.56 -31.38 72.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.593 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -78.16 -44.6 25.47 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -71.35 -33.52 69.67 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.632 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.769 HG13 ' HG ' ' A' ' 88' ' ' LEU . 56.0 t -73.57 -44.85 52.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.786 179.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.592 HG23 ' HA ' ' A' ' 147' ' ' ASN . 13.0 p -61.77 -45.54 98.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.772 0.32 . . . . 0.0 110.482 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.472 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -64.87 -41.4 97.48 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.735 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.531 ' CE3' ' HB3' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -62.9 -46.45 87.74 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.354 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 12.2 ttp180 -59.3 -40.81 87.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.009 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.4 m -59.27 -22.61 61.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.938 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.14 17.54 5.76 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.707 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.58 127.62 42.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.771 0.32 . . . . 0.0 110.992 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -55.12 135.53 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.531 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -159.42 171.75 19.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.167 -179.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.426 ' O ' HG12 ' A' ' 50' ' ' VAL . 3.1 t0 -119.92 145.03 47.1 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.052 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.943 HD12 HD12 ' A' ' 51' ' ' LEU . 3.5 mm? -55.39 -49.57 72.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.291 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -51.75 -23.51 4.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.714 -179.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -96.19 -54.42 3.3 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.744 0.307 . . . . 0.0 111.606 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG13 ' N ' ' A' ' 51' ' ' LEU . 11.1 p -68.79 -47.54 75.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.792 -179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.944 HD23 ' HB3' ' A' ' 31' ' ' CYS . 8.0 mt -79.04 128.6 33.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.852 0.358 . . . . 0.0 111.027 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.1 tp-100 -79.86 -43.19 22.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.925 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 1.001 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.1 t -127.91 116.64 20.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.6 179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.422 ' CD2' ' N ' ' A' ' 54' ' ' HIS . 6.1 m170 -73.52 67.62 1.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.134 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -166.5 138.99 3.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.738 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.62 HG21 HD21 ' A' ' 71' ' ' LEU . 16.6 t -78.95 104.75 7.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.816 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.702 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.7 m-85 -77.93 -176.82 4.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.587 -179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.11 -46.44 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.822 179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.61 70.21 1.46 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.882 179.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.639 ' O ' HD11 ' A' ' 12' ' ' LEU . 2.4 t -51.32 -35.62 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.6 -179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.9 p -62.41 -26.49 68.52 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.344 -179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 19.8 mttm -111.09 -21.53 11.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.28 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.518 ' CA ' HD12 ' A' ' 12' ' ' LEU . . . 95.96 46.12 2.72 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.367 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.04 120.3 42.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.812 0.339 . . . . 0.0 110.66 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 11.9 t -104.55 142.38 18.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.35 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.22 178.68 6.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.02 149.57 31.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.908 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.81 -31.9 70.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.947 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -62.47 -52.17 64.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.791 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.28 -31.92 73.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.684 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.057 HD22 HD13 ' A' ' 83' ' ' ILE . 8.9 mt -61.16 -51.49 68.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.793 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.2 mt -71.58 -29.8 36.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.157 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.3 -23.01 57.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.279 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.37 -31.65 10.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.519 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.715 ' CE2' HG23 ' A' ' 83' ' ' ILE . 69.6 m-85 -104.97 -40.73 5.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.224 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 111.19 -23.6 18.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.515 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -116.86 161.22 19.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.812 0.339 . . . . 0.0 110.869 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 33.4 t0 -95.69 -15.96 22.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.159 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -60.24 86.81 0.01 OUTLIER 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.881 0.372 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.885 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.5 OUTLIER -55.05 -40.06 69.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.761 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.555 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.88 -46.53 81.8 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.926 0.393 . . . . 0.0 110.334 179.499 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -59.51 -43.87 93.28 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.058 179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.057 HD13 HD22 ' A' ' 71' ' ' LEU . 34.4 mt -57.9 -37.6 61.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.196 179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.779 ' SG ' HG21 ' A' ' 29' ' ' ILE . 53.9 m -65.62 -42.36 91.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.291 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.686 ' CE ' HD21 ' A' ' 47' ' ' LEU . 57.1 mttt -56.68 -50.06 73.24 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.016 0.436 . . . . 0.0 110.313 179.471 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -57.75 -47.94 81.04 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.732 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 15.1 mt -64.93 -26.19 39.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.856 179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.769 ' HG ' HG13 ' A' ' 36' ' ' VAL . 4.0 tp -77.35 -30.45 53.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.913 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 2.3 p -92.79 -31.39 15.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.135 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -102.99 -44.16 5.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.266 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.62 168.52 17.46 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.683 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 124.56 41.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.82 0.343 . . . . 0.0 110.839 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.685 HG13 HG22 ' A' ' 18' ' ' VAL . 27.7 t -90.03 118.93 36.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.209 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 7.5 mt-30 -79.48 137.04 37.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.861 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -133.92 148.01 30.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.167 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.2 m -89.11 168.71 12.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.793 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -59.98 -35.66 75.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.958 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.1 mtmt -68.93 -46.72 67.5 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.058 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -68.62 -28.09 66.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.02 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.16 -32.27 44.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.018 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -73.01 -48.55 35.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 72.6 p -58.89 -49.06 79.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.004 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.13 -44.28 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.932 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.21 -50.26 68.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.918 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.76 -42.72 98.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.882 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -60.95 -53.88 51.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.88 -53.66 55.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.006 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -57.42 -45.79 84.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.94 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -64.37 -39.97 94.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.941 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.414 ' CB ' HG21 ' A' ' 150' ' ' THR . 1.0 OUTLIER -59.12 -55.57 33.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.001 -179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 5.9 mt -57.91 -44.77 87.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.153 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.661 ' HB1' HG13 ' A' ' 130' ' ' VAL . . . -64.94 -31.97 73.46 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.061 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 90.2 m -76.12 -56.01 5.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.272 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 1.1 pt -58.3 -32.19 44.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.458 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' ILE . 99.3 t -78.61 -44.72 25.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.712 0.291 . . . . 0.0 111.063 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.562 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -78.97 -13.78 59.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.573 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.28 -60.06 1.63 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.691 0.281 . . . . 0.0 111.319 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.404 ' HD3' ' ND1' ' A' ' 171' ' ' HIS . 0.7 OUTLIER -118.48 71.73 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.196 -179.617 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.752 ' HB3' HD11 ' A' ' 167' ' ' ILE . 0.6 OUTLIER 178.93 119.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.523 HG22 ' H ' ' A' ' 216' ' ' CYS . 34.7 m -123.96 169.86 14.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -107.39 147.48 35.34 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.78 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.99 -12.65 26.08 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.598 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.08 -43.21 13.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.786 0.327 . . . . 0.0 111.09 -179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 40.5 p -99.47 -32.1 11.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mttt 62.61 36.08 13.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -151.52 142.5 15.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.855 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.07 113.03 1.21 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.469 2.113 . . . . 0.0 112.186 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.708 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.1 m-85 -64.71 176.91 1.03 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.892 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 132' ' ' LEU . 14.9 t -105.1 153.69 21.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.071 0.462 . . . . 0.0 110.984 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.661 HG13 ' HB1' ' A' ' 112' ' ' ALA . 6.8 t -51.28 -28.74 7.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.407 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 2.1 mt -69.66 -39.98 78.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.012 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.708 HD13 ' CD1' ' A' ' 128' ' ' TYR . 0.2 OUTLIER -70.48 -39.06 74.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.771 179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.562 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 47.2 mt -69.44 -38.59 77.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.913 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.54 -46.34 76.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.719 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 21.8 mtp180 -61.07 -47.85 84.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -60.19 -48.1 83.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 43.9 ttm -56.41 -41.32 76.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.873 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 14.8 tttt -75.8 -34.39 60.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.74 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.24 -34.25 76.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.834 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 140' ' ' ILE . 18.1 mt -90.2 10.76 2.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.544 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 20.5 m170 57.43 35.86 26.41 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.853 0.359 . . . . 0.0 111.011 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CE2' HG22 ' A' ' 157' ' ' VAL . 1.2 t80 -71.06 125.0 25.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.897 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.2 t -125.91 82.04 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.852 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.444 HG11 HD13 ' A' ' 111' ' ' ILE . 17.4 m -58.54 130.56 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.128 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.82 118.13 26.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.871 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.4 p -56.5 -27.79 58.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.907 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.592 ' HA ' HG23 ' A' ' 37' ' ' VAL . 46.2 t30 -66.56 -15.49 63.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.285 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.1 mttt -101.46 178.41 4.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.846 0.355 . . . . 0.0 110.973 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 5.0 m -103.27 151.69 22.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.977 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.414 HG21 ' CB ' ' A' ' 110' ' ' ASP . 32.8 p -64.31 -61.25 2.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 -49.61 22.12 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.188 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -61.21 -34.26 74.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.731 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.515 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 tp60 -76.04 -25.23 55.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -49.13 -37.54 22.28 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.385 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -47.91 81.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.801 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.16 -38.84 92.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 153' ' ' GLN . 50.9 t -60.38 -48.88 86.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.923 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 167' ' ' ILE . 7.3 mt -63.06 -41.85 94.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.911 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 4.6 tttm -63.39 -41.38 98.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 30.5 tp60 -67.76 -59.97 2.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.798 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.564 HD23 HD11 ' A' ' 140' ' ' ILE . 19.4 mt -64.6 -17.52 64.07 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.24 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 166' ' ' LYS . 0.1 OUTLIER -51.67 -38.66 55.95 Favored 'General case' 0 CA--C 1.527 0.086 0 CA-C-O 120.815 0.341 . . . . 0.0 111.065 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -83.57 -20.03 34.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.085 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.47 -70.74 0.43 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.25 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.6 ttt -135.4 6.36 3.27 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.764 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 162' ' ' LYS . 2.1 tttt 63.05 136.06 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.893 0.378 . . . . 0.0 111.216 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.942 HG23 HG23 ' A' ' 158' ' ' ILE . 7.9 tp -138.55 144.81 29.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.893 179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -132.65 131.48 41.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.932 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 43.7 ttt180 -107.08 113.38 26.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.771 ' HB3' ' O ' ' A' ' 215' ' ' GLY . . . -153.36 154.5 34.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.165 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.404 ' ND1' ' HD3' ' A' ' 118' ' ' LYS . 8.1 t60 -173.17 129.81 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.093 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 7.3 ptm -174.16 157.6 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.984 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.23 126.22 31.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.671 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.7 164.74 12.11 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.764 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.531 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 0.1 OUTLIER -149.86 139.98 22.09 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.084 179.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CZ ' ' HG3' ' A' ' 225' ' ' LYS . 1.2 m-85 -129.44 142.41 50.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 111.416 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.494 HD11 ' CG2' ' A' ' 236' ' ' VAL . 33.9 mt -115.34 100.1 9.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.311 179.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.517 HD12 ' N ' ' A' ' 178' ' ' LEU . 7.0 mp -82.96 132.43 51.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.28 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HG2' ' N ' ' A' ' 183' ' ' GLY . 55.6 Cg_endo -70.08 -165.47 0.16 Allowed 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.404 2.069 . . . . 0.0 111.935 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.574 HG13 ' C ' ' A' ' 204' ' ' GLN . 44.3 t -72.56 -69.14 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.448 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -81.72 -57.85 3.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.462 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.581 ' O ' HD23 ' A' ' 186' ' ' LEU . 0.0 OUTLIER -54.2 -22.65 12.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.661 -179.498 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 178' ' ' LEU . . . -53.18 -56.48 18.99 Favored Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.017 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.08 -22.65 29.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.575 0.226 . . . . 0.0 111.445 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 62.4 tttt -68.03 -66.5 0.56 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.851 0.357 . . . . 0.0 111.382 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.878 HD12 HD11 ' A' ' 190' ' ' LEU . 1.4 pt? -70.81 -21.79 62.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.556 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.506 ' HB2' HD23 ' A' ' 178' ' ' LEU . 14.5 tttt -51.99 -63.09 1.25 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.782 0.325 . . . . 0.0 111.37 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.73 -21.88 66.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.434 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.706 ' HG3' HG21 ' A' ' 228' ' ' THR . 0.0 OUTLIER -80.46 -24.3 39.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.531 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.878 HD11 HD12 ' A' ' 186' ' ' LEU . 11.8 mt -99.6 -32.35 11.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.783 0.325 . . . . 0.0 111.496 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.435 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 21.0 tttt -47.21 -51.87 38.88 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.547 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.435 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 3.0 Cg_endo -80.97 -50.61 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.889 2.393 . . . . 0.0 112.657 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -46.91 -53.23 12.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.78 -179.446 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.715 ' CD1' HD13 ' A' ' 211' ' ' LEU . 3.5 pt -121.94 -178.9 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.863 0.363 . . . . 0.0 111.51 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 5.9 mtpp -99.07 119.54 37.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.065 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.4 m -111.68 177.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.015 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 6.9 tp -178.98 144.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.26 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 63.01 80.38 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.047 179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . 0.598 ' CB ' HG22 ' A' ' 209' ' ' VAL . 59.0 p -112.09 118.94 36.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -119.97 118.65 31.23 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.111 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -136.75 152.89 50.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.815 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -120.29 100.61 7.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.957 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 41.49 -97.13 0.01 OUTLIER Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.11 -0.567 . . . . 0.0 112.822 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.574 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.7 mm100 -109.16 60.18 0.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.02 0.438 . . . . 0.0 110.309 179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.79 178.48 7.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.029 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -72.56 145.85 47.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.807 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -111.72 126.21 54.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.48 -179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.2 pp -96.15 114.66 33.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.176 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 199' ' ' SER . 21.2 t -131.02 145.06 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.399 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 175' ' ' ARG . 83.7 m -109.52 145.45 36.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.14 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.715 HD13 ' CD1' ' A' ' 194' ' ' ILE . 0.1 OUTLIER -132.8 177.85 7.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.12 0.486 . . . . 0.0 111.792 -179.087 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 38.3 mt -141.69 134.97 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.382 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -108.51 82.89 1.78 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.474 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.17 77.04 3.63 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.533 2.155 . . . . 0.0 111.96 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.771 ' O ' ' HB3' ' A' ' 170' ' ' ALA . . . 125.04 -146.65 16.21 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.386 -179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.523 ' H ' HG22 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -95.12 42.2 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.783 0.325 . . . . 0.0 110.994 179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -78.33 -20.95 50.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.993 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -52.47 -25.81 11.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.419 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -70.25 -64.24 0.93 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.063 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.4 tp -64.42 -31.39 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.211 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 64.3 t0 -66.34 -53.43 36.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.034 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.6 mt-10 -61.94 -39.13 91.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.091 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.32 -63.59 1.23 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.241 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.723 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -56.91 -43.3 80.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.626 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.723 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -61.8 -55.05 34.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.131 -179.76 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 10.0 tttt -58.03 -28.77 64.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.035 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -81.26 -26.16 36.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.199 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.706 HG21 ' HG3' ' A' ' 189' ' ' LYS . 16.8 p -95.67 -20.3 19.03 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.464 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.75 -29.78 12.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.048 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 63.48 -80.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.371 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -161.18 30.07 0.14 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.819 0.342 . . . . 0.0 110.915 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -124.71 16.51 7.39 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.754 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.512 ' O ' HD22 ' A' ' 234' ' ' LEU . 3.7 t -134.44 165.98 23.92 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.869 0.366 . . . . 0.0 110.874 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.512 HD22 ' O ' ' A' ' 233' ' ' SER . 3.1 mm? -125.35 152.54 44.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.416 ' HG3' ' CE1' ' A' ' 176' ' ' PHE . 75.7 tt0 -130.59 115.09 16.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 175' ' ' ARG . 31.5 t -107.03 141.68 21.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.046 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.41 141.52 44.86 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.83 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -100.46 -30.42 11.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.898 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -135.8 132.45 36.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.918 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -143.66 119.25 10.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.865 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.87 101.74 9.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 21.5 t -85.0 -61.72 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.133 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -109.34 -28.21 9.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -57.36 121.52 10.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.992 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 109.49 29.88 3.76 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.429 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -143.41 -48.21 0.3 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.87 0.367 . . . . 0.0 110.936 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.06 147.21 30.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.65 -66.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 59.57 33.96 22.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.95 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.918 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.748 0.309 . . . . 0.0 111.128 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 60.1 p -160.25 -169.29 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.874 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 32.7 mt 66.61 107.34 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.177 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -161.68 96.23 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.967 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.2 p -147.97 115.1 4.01 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.7 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.63 18.91 1.47 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.604 2.203 . . . . 0.0 112.988 -179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 m 64.54 37.63 7.86 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.4 t-20 -146.23 -70.86 0.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -179.44 50.29 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.787 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 mt 71.94 -61.52 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.411 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.7 mtm105 67.9 37.92 2.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.77 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 tt -156.4 74.11 0.82 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.813 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.77 141.21 30.32 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.849 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -177.6 -58.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.436 HG12 ' N ' ' A' ' 16' ' ' ALA . 22.2 t -106.17 155.88 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.153 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.924 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.46 147.93 39.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.622 HG12 ' HG2' ' A' ' 28' ' ' GLU . 22.0 t -123.0 121.05 62.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.002 0.429 . . . . 0.0 111.294 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.595 HG22 HG23 ' A' ' 93' ' ' VAL . 21.8 t -108.31 141.39 23.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.689 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.408 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -119.97 158.25 27.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.961 0.41 . . . . 0.0 111.571 -179.442 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.797 ' HB2' HG23 ' A' ' 87' ' ' ILE . 2.6 tmm? -150.25 148.32 28.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.856 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -109.37 123.6 49.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.981 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.35 127.82 10.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.929 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.7 39.98 26.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.123 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.7 27.02 70.42 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.441 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.6 163.2 20.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.819 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.01 105.7 8.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.073 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.508 ' CD2' ' CE2' ' A' ' 75' ' ' PHE . 94.4 m-85 -103.63 159.26 15.76 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.673 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.622 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.88 147.8 28.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.305 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 HD11 HD12 ' A' ' 88' ' ' LEU . 0.2 OUTLIER -134.21 155.46 39.34 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.194 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.73 115.59 27.65 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.223 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.71 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.2 p -146.36 177.66 8.85 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.987 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -83.49 144.37 29.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.296 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.924 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 1.7 mttm -65.37 -55.69 16.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.219 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.95 -48.57 70.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.646 -179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -59.62 -38.56 81.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.498 -179.284 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 32' ' ' TYR . 51.9 t -67.97 -46.51 81.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.623 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.893 HG23 ' O ' ' A' ' 33' ' ' LYS . 35.5 t -58.85 -43.33 88.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 0.0 110.8 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -63.83 -44.96 95.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.233 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.733 ' CH2' HD23 ' A' ' 47' ' ' LEU . 3.1 t-105 -59.49 -51.42 69.93 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -56.96 -39.88 75.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.822 179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.4 t -64.38 -26.49 68.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.891 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.84 31.41 2.11 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.486 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 38' ' ' GLY . 21.6 t -98.73 135.75 32.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.825 0.345 . . . . 0.0 111.144 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -60.99 103.36 0.26 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.05 158.42 42.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.435 ' O ' HG12 ' A' ' 50' ' ' VAL . 1.2 m-20 -99.64 137.07 38.63 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.268 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -58.52 -44.08 89.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.161 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -58.61 -20.49 47.78 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.186 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -95.41 -55.26 3.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.789 0.328 . . . . 0.0 111.202 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG23 ' HB3' ' A' ' 35' ' ' LYS . 10.7 p -69.8 -45.03 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.197 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.786 ' HB2' HD13 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -91.9 109.38 20.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.584 179.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.56 -57.1 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.033 -179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.602 HG21 ' CE1' ' A' ' 57' ' ' PHE . 94.6 m -90.18 111.0 22.01 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.93 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 20.5 m-70 -82.8 57.56 3.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.038 0.447 . . . . 0.0 110.486 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -163.16 132.9 4.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.68 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.019 HG21 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.7 106.95 3.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.688 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 4.7 m-85 -83.87 -176.34 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.161 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 96.9 t -131.11 -56.2 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.319 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -123.62 71.25 1.08 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.215 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 17' ' ' VAL . 2.6 t -54.75 -34.06 29.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.204 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.3 t -56.84 -29.04 62.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -112.3 -26.07 8.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.103 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.04 49.74 1.12 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.515 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.71 119.13 35.63 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.858 0.361 . . . . 0.0 110.861 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.688 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.6 t -92.31 151.26 3.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.327 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -84.0 149.79 26.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 53.8 mmtt -80.06 149.66 30.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.842 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -36.63 77.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.851 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -59.3 -51.52 69.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.77 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -66.99 -33.14 74.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.738 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.019 HD21 HG21 ' A' ' 56' ' ' VAL . 2.4 mt -60.24 -44.17 95.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.625 HD11 ' OD1' ' A' ' 78' ' ' ASP . 8.8 mt -82.45 -45.93 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.226 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.7 t -60.77 -22.08 63.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.247 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -96.42 -55.06 3.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.473 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' CE2' ' CD2' ' A' ' 27' ' ' PHE . 76.8 m-85 -86.34 -46.61 10.13 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.305 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 84.98 53.99 3.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.34 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -147.65 -45.07 0.17 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.984 -179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.625 ' OD1' HD11 ' A' ' 72' ' ' ILE . 24.0 t0 80.26 -0.74 1.99 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.227 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -99.19 89.85 4.38 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.831 0.348 . . . . 0.0 110.627 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.499 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.0 OUTLIER -49.62 -33.24 14.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.094 -179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.21 -52.9 23.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.986 0.422 . . . . 0.0 110.31 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -57.45 -42.51 82.64 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.218 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.975 HD13 HD22 ' A' ' 71' ' ' LEU . 14.6 mt -63.89 -39.79 86.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.174 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.686 ' O ' HD13 ' A' ' 88' ' ' LEU . 22.9 m -57.87 -39.61 78.23 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.716 ' HG2' HD21 ' A' ' 47' ' ' LEU . 40.2 mttt -61.8 -57.59 11.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.425 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 83' ' ' ILE . 1.8 pt20 -50.46 -34.4 24.65 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.901 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.797 HG23 ' HB2' ' A' ' 20' ' ' MET . 39.7 mt -76.67 -30.85 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.63 179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 84' ' ' CYS . 7.7 mp -77.92 -18.15 56.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.161 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.8 p -91.48 -38.73 12.36 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.595 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.07 -33.12 5.49 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 87' ' ' ILE . . . -55.64 152.01 17.83 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.516 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.9 114.98 27.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.825 0.345 . . . . 0.0 110.97 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.595 HG23 HG22 ' A' ' 18' ' ' VAL . 12.1 p -74.27 111.75 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.068 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -75.04 107.99 7.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.817 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.2 m -124.95 150.68 30.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.147 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.99 163.34 26.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.929 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -59.65 -31.01 69.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.947 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.55 -55.17 33.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.917 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -60.21 -45.21 93.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.905 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.552 ' O ' HD13 ' A' ' 104' ' ' LEU . 4.3 tpt180 -61.96 -35.0 77.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.836 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.69 -41.12 63.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.849 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.6 m -60.1 -46.47 89.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.941 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.697 ' HB3' HG21 ' A' ' 146' ' ' THR . 0.9 OUTLIER -68.08 -39.39 82.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.925 179.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 100' ' ' ARG . 5.4 mp -65.26 -46.5 80.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.814 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -61.71 -50.94 70.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.808 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.3 74.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 3.1 mmt -68.33 -46.91 68.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.455 ' CE1' ' HB3' ' A' ' 143' ' ' SER . 0.2 OUTLIER -57.53 -48.22 79.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.3 tpt180 -60.69 -47.68 85.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.12 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.492 ' O ' HG22 ' A' ' 113' ' ' THR . 27.3 t0 -62.35 -52.64 62.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.165 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.593 ' O ' HG12 ' A' ' 115' ' ' VAL . 25.2 mt -59.1 -28.71 39.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.264 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.691 ' HB1' ' CD1' ' A' ' 133' ' ' ILE . . . -71.86 -49.44 38.15 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.302 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.492 HG22 ' O ' ' A' ' 110' ' ' ASP . 4.6 t -61.16 -40.86 95.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.792 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 36.2 mm -66.44 -56.51 14.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.015 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.645 HG13 HG21 ' A' ' 133' ' ' ILE . 14.3 p -58.84 -46.81 90.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.189 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.509 ' N ' HG13 ' A' ' 115' ' ' VAL . . . -58.08 -40.64 81.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.004 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -74.57 -35.58 63.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.931 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.675 ' O ' HG13 ' A' ' 120' ' ' VAL . 9.3 mmtm -80.96 -74.84 0.3 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.653 ' SG ' HD13 ' A' ' 167' ' ' ILE . 15.3 m -44.27 116.85 1.1 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.268 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.801 HG12 ' HA ' ' A' ' 127' ' ' PRO . 23.2 m -132.98 148.25 31.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.195 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -83.17 138.38 42.38 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.881 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.42 63.71 1.6 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.442 2.095 . . . . 0.0 112.223 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.78 84.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 125' ' ' LYS . 0.2 OUTLIER 61.25 51.32 4.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 124' ' ' THR . 0.0 OUTLIER 40.89 52.04 3.22 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.75 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -88.55 108.55 23.35 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.802 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.801 ' HA ' HG12 ' A' ' 120' ' ' VAL . 73.0 Cg_endo -75.7 165.74 29.69 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.404 2.07 . . . . 0.0 112.306 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -95.82 158.68 15.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.766 179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.511 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.8 OUTLIER -106.32 156.0 18.94 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.916 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.479 ' HA ' HD11 ' A' ' 133' ' ' ILE . 1.7 m -52.36 -29.62 13.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.19 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 132' ' ' LEU . 27.7 pt -70.83 -37.89 70.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.815 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.511 HD12 ' H ' ' A' ' 129' ' ' THR . 19.2 mt -68.11 -55.52 12.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.495 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.691 ' CD1' ' HB1' ' A' ' 112' ' ' ALA . 1.0 OUTLIER -59.77 -34.66 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.775 179.667 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -62.87 -50.51 70.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.537 179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.7 ttt-85 -57.08 -52.27 65.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.955 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.76 -58.51 6.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.292 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.683 ' CE ' HD11 ' A' ' 161' ' ' LEU . 0.0 OUTLIER -51.21 -26.72 7.45 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.255 -179.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -81.13 -52.07 7.77 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.638 179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -47.81 -42.01 25.08 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.0 0.428 . . . . 0.0 110.599 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -86.73 -22.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.607 179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.1 71.07 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.965 179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -162.01 113.4 1.66 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.454 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.455 ' HB3' ' CE1' ' A' ' 108' ' ' PHE . 0.2 OUTLIER -178.08 49.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.855 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.6 t -149.38 144.7 18.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.109 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -172.28 50.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.739 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.697 HG21 ' HB3' ' A' ' 103' ' ' GLN . 59.6 p -55.64 -30.39 60.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.032 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -98.46 33.38 2.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.934 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.86 162.39 11.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 21.0 m -65.68 133.93 52.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.43 -64.53 0.91 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.993 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -48.97 -35.84 16.1 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.12 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -41.79 99.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.843 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.584 ' O ' HG23 ' A' ' 157' ' ' VAL . 3.5 tp-100 -74.61 -28.22 60.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.053 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -52.86 -37.7 60.61 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.02 -48.15 82.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -62.17 -41.17 98.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.795 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 153' ' ' GLN . 20.9 t -60.63 -49.98 82.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.219 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.57 HG22 ' CD1' ' A' ' 167' ' ' ILE . 45.0 pt -65.66 -31.3 53.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.11 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.87 -58.59 6.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.198 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -65.02 -32.39 74.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.281 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.683 HD11 ' CE ' ' A' ' 137' ' ' MET . 11.0 mt -64.17 -21.58 66.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 19.8 mtpt -55.37 -26.39 40.9 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.331 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -59.69 -50.14 75.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 111.041 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -52.75 10.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.023 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.4 mtm -153.37 163.7 39.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.017 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.71 128.34 39.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.841 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.653 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.3 pp -140.3 150.27 21.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.264 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 119' ' ' CYS . 14.7 mt-10 -136.17 113.47 10.68 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.681 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.477 ' HG2' HG21 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -93.81 114.25 26.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.529 -179.611 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.868 ' HB3' ' C ' ' A' ' 215' ' ' GLY . . . -170.22 175.01 5.09 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.456 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 1.1 t-80 -175.8 119.56 0.16 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 2.5 mtm -174.37 170.37 3.62 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.186 0.517 . . . . 0.0 111.782 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 212' ' ' ILE . 7.4 mtt-85 -105.32 112.25 25.28 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.871 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 211' ' ' LEU . 6.5 mt -91.74 115.87 28.42 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -98.09 128.86 44.85 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 178.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.442 ' CD2' HD13 ' A' ' 190' ' ' LEU . 11.2 m-85 -122.6 129.94 52.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.086 0.469 . . . . 0.0 111.997 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 7.1 mt -115.09 100.07 9.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.679 178.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.681 HD21 ' OE1' ' A' ' 207' ' ' GLU . 0.2 OUTLIER -94.56 146.03 30.73 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.784 -178.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -79.84 -166.36 0.41 Allowed 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.843 2.362 . . . . 0.0 112.322 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.695 HG22 ' HA ' ' A' ' 205' ' ' GLN . 16.5 t -76.1 -58.82 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.66 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -80.13 -57.83 3.44 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.682 -179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.409 ' HG3' ' HD2' ' A' ' 229' ' ' LYS . 0.0 OUTLIER -62.2 -21.17 64.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.252 -179.776 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.454 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -84.2 -22.9 53.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.135 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 7.7 tttt -47.06 -52.94 13.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.724 0.297 . . . . 0.0 111.639 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.2 tmmm? -85.87 -36.98 19.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.492 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.687 HD21 ' HG2' ' A' ' 225' ' ' LYS . 0.1 OUTLIER -56.57 -37.84 71.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.632 -179.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 14.6 ttpt -54.28 -63.04 1.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.4 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -65.81 -18.41 65.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.526 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HG3' HG21 ' A' ' 228' ' ' THR . 4.1 mmtt -80.81 -21.33 40.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.668 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.646 ' CD1' HD23 ' A' ' 186' ' ' LEU . 59.0 mt -105.38 -22.53 13.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.62 0.248 . . . . 0.0 111.578 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -55.74 -60.62 8.12 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.423 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.63 -38.53 1.31 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.612 2.208 . . . . 0.0 112.94 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.755 HD13 HD13 ' A' ' 224' ' ' ILE . 0.9 OUTLIER -55.18 -52.88 61.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.376 -179.635 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.807 ' HB ' HD22 ' A' ' 211' ' ' LEU . 4.7 mt -122.14 158.82 25.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.275 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.493 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -72.43 106.36 4.51 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.085 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.6 m -81.69 168.68 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.448 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.73 HG21 ' CD1' ' A' ' 212' ' ' ILE . 7.2 tp -172.17 132.7 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.83 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 54.06 75.18 0.29 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.035 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 53.1 p -109.08 128.44 54.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.915 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -126.29 125.47 42.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.012 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.413 ' HB3' ' CG ' ' A' ' 207' ' ' GLU . 1.2 p30 -127.18 144.05 51.12 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.039 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -111.96 150.4 30.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.657 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.36 104.05 0.07 OUTLIER Glycine 0 C--N 1.331 0.253 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.666 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.406 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.2 OUTLIER 63.22 41.04 8.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.928 0.394 . . . . 0.0 110.51 -179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.695 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -133.77 178.04 7.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.984 -179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.566 HD23 ' H ' ' A' ' 206' ' ' LEU . 0.5 OUTLIER -72.96 149.0 43.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.969 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.681 ' OE1' HD21 ' A' ' 178' ' ' LEU . 7.8 tm-20 -113.43 127.54 56.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.045 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.0 pt -104.46 113.51 41.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.693 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.1 p -130.96 144.98 36.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.371 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 197' ' ' ILE . 50.9 t -109.72 149.4 29.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.143 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.807 HD22 ' HB ' ' A' ' 194' ' ' ILE . 1.0 OUTLIER -132.1 157.15 44.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.196 0.522 . . . . 0.0 112.013 -179.232 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.73 ' CD1' HG21 ' A' ' 197' ' ' ILE . 4.4 mp -148.69 125.04 2.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.319 179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.7 150.91 4.88 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 120.928 0.394 . . . . 0.0 111.545 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 95.4 Cg_endo -84.13 -174.97 2.02 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.864 2.376 . . . . 0.0 112.556 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.868 ' C ' ' HB3' ' A' ' 170' ' ' ALA . . . 61.34 158.91 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.84 -0.618 . . . . 0.0 113.026 179.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.488 ' N ' ' HB3' ' A' ' 170' ' ' ALA . 3.5 m -74.24 60.08 0.8 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.848 0.356 . . . . 0.0 110.988 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -75.47 -21.02 58.42 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.186 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -46.85 -29.41 1.97 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.468 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -60.97 -64.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.935 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 224' ' ' ILE . 3.9 mt -60.16 -31.61 48.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.11 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.549 ' CG ' HD11 ' A' ' 194' ' ' ILE . 13.0 m-20 -62.86 -58.31 7.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.954 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.65 -29.14 70.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.054 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 15.5 tp -69.14 -62.16 1.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.755 HD13 HD13 ' A' ' 193' ' ' LEU . 15.8 tt -58.81 -29.86 41.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.218 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.687 ' HG2' HD21 ' A' ' 186' ' ' LEU . 0.2 OUTLIER -68.76 -55.12 12.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.768 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 230' ' ' GLY . 22.1 tttt -64.36 -37.53 87.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.78 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -67.47 -33.85 75.96 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.861 179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.594 HG21 ' HG3' ' A' ' 189' ' ' LYS . 15.9 p -76.29 -31.6 58.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.752 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.409 ' HD2' ' HG3' ' A' ' 182' ' ' GLU . 0.0 OUTLIER -176.42 73.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.866 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 226' ' ' LYS . . . -45.33 140.78 4.74 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 121.101 -0.571 . . . . 0.0 113.028 -179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 10.5 tttm 58.71 21.3 8.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.085 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . 0.406 ' HA3' ' HG2' ' A' ' 182' ' ' GLU . . . -85.5 -54.73 2.74 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.647 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.1 m -118.18 162.63 17.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 111.032 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 7.8 mt -109.75 141.91 41.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.684 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.419 ' HG2' ' CE2' ' A' ' 176' ' ' PHE . 14.0 mt-10 -106.28 115.14 29.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.977 0.418 . . . . 0.0 111.183 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.99 139.98 26.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.94 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 4.4 mp -86.43 119.17 26.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.647 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.416 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 1.0 OUTLIER -70.41 -74.2 0.15 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.867 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -144.37 141.31 29.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 7.8 ttmm -97.89 121.13 39.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -77.49 136.05 38.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.888 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 15.4 m -145.99 127.15 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.14 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.87 81.38 1.76 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.85 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -98.72 -63.53 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.918 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -93.66 -65.42 1.05 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.471 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -171.13 -55.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.753 0.311 . . . . 0.0 110.829 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -171.4 -46.95 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.5 tttp -177.38 105.52 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.926 179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -97.97 30.81 2.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.934 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpp? . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.805 0.336 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -179.68 150.88 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.2 mp -80.78 -75.94 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -179.42 66.79 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.895 0.378 . . . . 0.0 110.849 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 7' ' ' THR . 0.8 OUTLIER -63.62 111.07 4.48 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.745 179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.37 111.64 0.93 Allowed 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.439 2.093 . . . . 0.0 112.233 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 9' ' ' GLN . 8.8 t -174.49 -178.02 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.96 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -97.9 37.48 1.4 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.946 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.439 ' H ' HG23 ' A' ' 7' ' ' THR . 0.0 OUTLIER -106.68 -33.03 7.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.861 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.3 pt -128.56 -179.69 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 mtt180 -119.06 -58.14 1.96 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.603 HD22 HG21 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -162.2 117.16 1.9 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.934 -179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.1 p -99.81 -169.81 1.8 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.865 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 m120 60.34 80.17 0.22 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.761 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.698 HG21 ' HG2' ' A' ' 52' ' ' GLN . 48.5 t 65.07 153.9 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.996 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.777 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.32 147.8 39.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.203 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.603 HG21 HD22 ' A' ' 12' ' ' LEU . 21.5 t -120.04 114.27 43.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.118 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.678 HG22 ' HA ' ' A' ' 93' ' ' VAL . 78.9 t -108.22 121.28 60.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.876 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -111.75 158.16 19.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.032 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.883 ' HB2' HG23 ' A' ' 87' ' ' ILE . 5.7 ttt -141.64 160.94 39.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.837 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -104.27 130.92 52.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.927 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -170.32 124.16 0.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.885 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.08 30.22 19.35 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.099 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 58.6 28.66 62.91 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.567 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.08 164.05 15.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.871 0.367 . . . . 0.0 110.872 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.04 112.66 24.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.869 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -125.64 120.48 30.88 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.806 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' OE2' HG23 ' A' ' 60' ' ' VAL . 4.8 pt-20 -132.26 152.2 51.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.731 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.709 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.2 OUTLIER -133.96 154.61 38.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.378 . . . . 0.0 111.41 179.886 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 108.61 19.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.566 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.639 ' SG ' HG21 ' A' ' 36' ' ' VAL . 2.5 p -132.15 177.91 7.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.273 -179.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 6.6 m-85 -90.23 147.98 23.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.404 -179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.777 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -70.05 -52.83 20.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.266 179.885 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -69.72 -41.36 75.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.539 -179.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.723 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -67.26 -38.46 85.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.147 -179.577 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.639 HG21 ' SG ' ' A' ' 31' ' ' CYS . 25.5 t -68.5 -47.23 78.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.887 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 38' ' ' GLY . 19.9 m -59.43 -46.13 93.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.624 0.249 . . . . 0.0 111.091 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 37' ' ' VAL . . . -67.16 -34.12 85.18 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.528 -0.844 . . . . 0.0 112.119 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.819 ' CE3' HG11 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -69.46 -51.62 34.4 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.317 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 33.7 ttp180 -58.81 -37.84 77.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.714 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.5 t -59.57 -27.22 66.05 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.93 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.54 27.2 3.4 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.483 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 24.1 t -96.87 140.33 17.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.783 0.325 . . . . 0.0 111.07 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.54 117.24 5.05 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.894 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.61 ' HB3' ' CE3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -135.15 179.91 6.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.616 179.944 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.16 150.02 40.75 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.115 0.483 . . . . 0.0 111.342 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.77 HD12 HG22 ' A' ' 81' ' ' THR . 0.6 OUTLIER -55.73 -52.81 62.65 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.622 -179.831 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -79.55 2.53 21.88 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.64 -179.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -97.62 -34.6 10.89 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.698 0.285 . . . . 0.0 111.196 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CE3' ' A' ' 39' ' ' TRP . 9.0 p -102.91 -32.61 3.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.805 -179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.684 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -91.34 116.24 28.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.804 0.335 . . . . 0.0 111.053 -179.453 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.698 ' HG2' HG21 ' A' ' 15' ' ' VAL . 3.8 tp-100 -79.79 -33.69 40.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.222 179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.554 HG21 ' CE1' ' A' ' 57' ' ' PHE . 83.9 m -130.07 107.02 9.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.66 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.598 ' HA ' HD13 ' A' ' 51' ' ' LEU . 51.4 m80 -75.09 62.9 1.22 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.9 0.381 . . . . 0.0 110.904 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -164.54 131.3 3.05 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.964 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.666 ' CB ' HD21 ' A' ' 71' ' ' LEU . 21.4 t -71.98 104.64 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.89 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.9 m-85 -82.24 -178.98 7.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.238 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.9 t -129.72 -51.21 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.281 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.47 67.9 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.188 179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.463 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.7 t -52.69 -33.83 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.128 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.0 t -58.0 -28.12 64.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.057 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.2 mmtm -112.63 -26.03 8.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.116 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.49 46.98 1.16 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.569 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -114.18 132.26 56.16 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.821 0.343 . . . . 0.0 110.741 179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.493 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 21.5 t -111.97 152.94 13.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.303 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.73 -177.31 5.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -123.26 157.58 32.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.874 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.24 -36.87 78.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.909 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -58.69 -45.7 88.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.97 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -75.61 -35.2 60.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.856 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.759 HD22 ' CD1' ' A' ' 83' ' ' ILE . 13.1 mt -62.9 -49.53 74.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.906 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.497 HD11 ' OD1' ' A' ' 78' ' ' ASP . 19.5 mt -74.21 -35.56 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.212 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 24.3 t -71.53 -22.37 61.78 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.43 -26.91 13.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.66 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -117.16 -42.87 2.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.742 0.306 . . . . 0.0 111.334 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 79.37 24.46 60.97 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.584 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.4 p -112.09 -33.83 6.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.758 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.497 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.0 t0 65.56 19.83 11.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.063 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -121.12 85.9 2.48 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.476 179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -41.71 -49.56 4.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.525 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.77 HG22 HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -56.28 -59.09 5.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.855 0.36 . . . . 0.0 110.473 179.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -49.99 -41.94 48.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.447 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.759 ' CD1' HD22 ' A' ' 71' ' ' LEU . 75.1 mt -63.65 -36.26 75.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.709 ' SG ' HG21 ' A' ' 29' ' ' ILE . 70.7 m -63.0 -39.35 94.5 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.482 179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.575 ' HD3' ' CH2' ' A' ' 39' ' ' TRP . 0.2 OUTLIER -67.72 -43.02 81.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.119 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.61 -33.24 73.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.214 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.883 HG23 ' HB2' ' A' ' 20' ' ' MET . 23.7 mt -80.4 -25.56 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.716 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.639 ' CD1' HD11 ' A' ' 29' ' ' ILE . 4.1 mp -74.99 -33.16 61.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.009 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -93.34 -30.5 15.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.297 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -100.57 -44.28 5.91 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.111 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -64.77 -171.02 2.54 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.593 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -127.29 140.6 52.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 110.903 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.678 ' HA ' HG22 ' A' ' 18' ' ' VAL . 12.2 p -85.57 110.68 19.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 -83.25 105.81 14.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.821 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.516 HG13 HG22 ' A' ' 93' ' ' VAL . 11.8 m -131.39 149.85 33.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.115 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 16.8 p -76.35 176.0 8.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -59.58 -37.89 79.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.943 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.61 -47.05 67.67 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.803 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -60.05 -36.58 77.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.817 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.72 -37.47 55.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.77 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -60.6 -39.55 88.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.718 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.6 m -59.79 -35.76 75.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -65.11 -46.8 79.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.684 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp -64.3 -44.98 89.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.632 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -64.24 -45.6 87.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.663 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -63.31 -43.67 97.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.672 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . 0.693 ' HB3' HG11 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -64.75 -42.59 95.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.66 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HD1' HG21 ' A' ' 144' ' ' VAL . 0.0 OUTLIER -57.45 -53.81 53.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.757 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -62.04 -32.85 73.4 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.585 179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -54.54 37.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.566 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.673 ' O ' HG23 ' A' ' 115' ' ' VAL . 66.2 mt -60.02 -36.93 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.741 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.524 ' O ' HD13 ' A' ' 133' ' ' ILE . . . -59.74 -47.46 85.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.819 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 3.9 m -63.69 -39.97 95.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.587 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.91 HG23 ' HD2' ' A' ' 118' ' ' LYS . 64.7 mt -62.71 -43.03 98.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.817 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 111' ' ' ILE . 21.3 t -78.79 -18.36 13.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.596 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -95.49 -25.5 16.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.532 -0.303 . . . . 0.0 111.624 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -108.95 -51.13 2.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 111.329 -179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.91 ' HD2' HG23 ' A' ' 114' ' ' ILE . 63.4 mttt -83.55 3.59 31.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.621 -179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . . . . . . . . . 32.7 m -148.9 157.18 43.24 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.901 0.381 . . . . 0.0 111.153 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.879 HG13 ' HB2' ' A' ' 170' ' ' ALA . 3.7 m -144.49 -179.58 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.918 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -94.32 121.07 64.44 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.87 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.05 -15.55 36.06 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.478 2.119 . . . . 0.0 112.648 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.81 -60.49 3.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.854 0.359 . . . . 0.0 111.083 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 41.6 p -136.8 25.77 3.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 55.31 40.08 31.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.975 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -104.02 104.21 42.12 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_exo -55.54 128.03 28.7 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.452 2.101 . . . . 0.0 112.292 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -78.79 164.69 24.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.781 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.682 ' O ' HD12 ' A' ' 133' ' ' ILE . 0.6 OUTLIER -105.29 161.59 14.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.795 179.878 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 4.4 m -54.8 -31.21 23.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.192 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -72.25 -32.18 41.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.947 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -50.97 23.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.729 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.682 HD12 ' O ' ' A' ' 129' ' ' THR . 2.2 mp -63.93 -38.21 81.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -65.27 -46.28 81.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -60.32 -48.51 81.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.844 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.37 -48.64 78.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.21 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.474 ' SD ' HG13 ' A' ' 157' ' ' VAL . 0.7 OUTLIER -57.53 -34.7 69.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.908 179.977 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 tttp -79.16 -35.56 41.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.804 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.56 -37.44 86.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.2 tt -84.92 3.34 3.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.623 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 59.16 38.95 23.47 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.799 0.333 . . . . 0.0 110.909 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -68.77 125.27 26.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.78 126.77 36.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.905 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.693 HG11 ' HB3' ' A' ' 107' ' ' MET . 31.7 t -85.93 117.07 30.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.047 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.87 96.59 10.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.85 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.427 HG22 ' SD ' ' A' ' 107' ' ' MET . 70.6 p -57.11 -20.97 28.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.355 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -92.39 24.1 3.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.349 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? -131.62 139.95 49.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.844 0.354 . . . . 0.0 110.837 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.12 139.74 58.44 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.868 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 35.5 p -57.75 -60.82 3.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.01 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.61 -48.89 38.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.142 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -64.27 -30.88 71.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.81 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.901 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 tt0 -71.13 -29.91 65.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.038 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -53.07 -31.21 40.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.295 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.45 -56.51 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.809 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -63.09 -36.47 83.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.008 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.901 HG23 ' O ' ' A' ' 153' ' ' GLN . 30.4 t -59.57 -54.2 37.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.104 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.855 HG23 ' HB ' ' A' ' 167' ' ' ILE . 13.7 mt -62.97 -45.32 99.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.1 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -59.71 -56.06 26.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -58.92 -51.55 69.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.955 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.409 HD12 HG12 ' A' ' 157' ' ' VAL . 72.7 mt -60.8 -28.22 68.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.82 -23.69 31.83 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.114 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.93 -39.45 78.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.237 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -126.09 5.34 7.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.507 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 9.1 tpt -174.63 113.23 0.16 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.911 0.386 . . . . 0.0 111.026 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.59 150.31 34.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.872 179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.855 ' HB ' HG23 ' A' ' 158' ' ' ILE . 24.5 mt -132.69 152.22 35.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.147 -179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -144.0 156.78 44.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.754 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 4.5 mmm180 -72.13 144.22 48.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.986 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.879 ' HB2' HG13 ' A' ' 120' ' ' VAL . . . -105.16 162.4 13.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.133 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 26.1 p80 -162.64 177.09 9.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.133 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -165.6 170.4 14.28 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.175 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.07 147.75 51.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.587 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.584 HD13 ' H ' ' A' ' 175' ' ' ARG . 0.1 OUTLIER -128.94 140.66 51.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.423 -179.484 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.584 ' H ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -118.72 108.03 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.027 179.542 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.412 ' HD2' HD12 ' A' ' 178' ' ' LEU . 0.2 OUTLIER -104.06 133.72 48.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.041 0.448 . . . . 0.0 111.674 -179.244 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mt -129.74 100.24 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.204 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.693 HD22 ' HA2' ' A' ' 183' ' ' GLY . 0.2 OUTLIER -105.16 149.44 37.66 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.322 -179.32 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.822 ' HA ' HD23 ' A' ' 206' ' ' LEU . 22.4 Cg_endo -60.17 -165.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.741 2.294 . . . . 0.0 112.289 179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.582 HG22 ' C ' ' A' ' 205' ' ' GLN . 13.5 t -76.14 -55.59 10.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.039 -0.528 . . . . 0.0 112.206 -179.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -81.7 -57.88 3.25 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.476 ' CB ' ' HG2' ' A' ' 179' ' ' PRO . 0.7 OUTLIER -53.94 -22.56 10.49 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.83 0.308 . . . . 0.0 111.83 -179.101 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.693 ' HA2' HD22 ' A' ' 178' ' ' LEU . . . -63.63 -52.19 48.02 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.776 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -56.6 -21.67 28.55 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.614 0.245 . . . . 0.0 111.462 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . 0.475 ' HE2' HG23 ' A' ' 228' ' ' THR . 22.4 tttt -84.81 -51.15 6.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 111.389 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.852 HD11 ' HA ' ' A' ' 225' ' ' LYS . 0.8 OUTLIER -75.01 -39.84 60.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.381 -179.535 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 10.5 ttpt -51.58 -41.56 61.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.268 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -65.98 -36.45 83.35 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.194 -179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -83.82 -12.21 55.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.732 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 4.4 mt -86.48 -39.28 16.44 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.648 0.261 . . . . 0.0 111.318 -179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.438 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 0.0 OUTLIER -54.19 -51.79 74.41 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.358 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.438 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 13.8 Cg_exo -69.35 -34.99 14.73 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.68 2.253 . . . . 0.0 112.325 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.441 HD11 HG22 ' A' ' 220' ' ' ILE . 0.7 OUTLIER -57.61 -53.22 60.68 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.209 -179.781 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.758 HD11 HD22 ' A' ' 211' ' ' LEU . 1.2 pp -146.33 173.58 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.282 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.26 125.66 28.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.026 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' HB3' ' A' ' 211' ' ' LEU . 4.6 m -104.19 168.94 2.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.217 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 9.1 tp -170.97 150.12 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 61.26 52.45 3.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 1.9 m -83.24 106.17 14.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.901 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -121.73 124.34 44.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.753 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -134.92 152.57 51.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.016 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.443 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 2.0 m-85 -109.26 142.48 40.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.709 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -48.65 117.27 3.82 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.518 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 19.3 tp60 57.28 36.73 27.66 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.051 0.453 . . . . 0.0 110.299 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.582 ' C ' HG22 ' A' ' 180' ' ' VAL . 0.6 OUTLIER -136.35 178.51 7.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.168 -179.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.822 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.4 OUTLIER -72.37 149.03 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.926 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -106.25 145.66 31.31 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.406 -179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.6 pt -129.72 108.39 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.768 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 10.3 p -130.93 144.84 36.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 -179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 60.8 m -109.82 145.72 36.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.317 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.758 HD22 HD11 ' A' ' 194' ' ' ILE . 1.6 pp -144.56 171.02 14.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.999 0.428 . . . . 0.0 111.974 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 27.8 mm -104.46 128.21 58.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.11 179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -139.34 126.61 12.93 Favored Pre-proline 0 C--N 1.328 -0.327 0 C-N-CA 120.774 -0.371 . . . . 0.0 111.865 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.577 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 38.4 Cg_endo -67.01 164.47 29.85 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.311 2.007 . . . . 0.0 111.863 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -58.35 -24.36 55.58 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.785 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 10.9 t -81.5 -50.67 9.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.66 0.244 . . . . 0.0 111.66 -179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.402 ' HB2' ' HG2' ' A' ' 214' ' ' PRO . 4.0 m-85 -53.98 -22.62 10.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.793 -179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.6 ttp180 -43.77 -36.63 2.35 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.889 0.376 . . . . 0.0 111.293 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.49 -43.93 68.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.776 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.441 HG22 HD11 ' A' ' 193' ' ' LEU . 23.4 mt -66.39 -46.32 87.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.03 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -60.74 -45.98 92.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.737 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -64.35 -34.74 78.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.898 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.71 -63.6 1.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.93 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.57 HD12 HD21 ' A' ' 186' ' ' LEU . 1.2 pp -58.38 -29.59 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.024 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.852 ' HA ' HD11 ' A' ' 186' ' ' LEU . 3.1 tmtt? -66.41 -43.5 85.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.895 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -32.24 31.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.177 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -76.34 -23.23 54.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.482 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.475 HG23 ' HE2' ' A' ' 185' ' ' LYS . 67.6 m -103.81 -28.53 11.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.371 -179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.86 0.78 17.32 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 -179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.7 25.26 50.95 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.768 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 25.9 tttt 69.93 32.75 3.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.859 0.361 . . . . 0.0 111.11 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -117.54 26.93 7.85 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.386 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.55 173.02 7.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.846 0.355 . . . . 0.0 110.894 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 1.1 mt -120.33 119.96 34.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.83 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.47 118.93 21.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.89 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.5 t -106.76 124.4 62.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.112 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.2 pp -89.01 127.49 35.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.944 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -63.92 -167.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.89 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.444 ' H ' HD12 ' A' ' 239' ' ' LEU . 3.7 mp -92.62 170.17 9.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.919 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 22.7 mttt -106.1 145.42 31.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.794 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -60.33 116.49 4.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.451 HG23 ' N ' ' A' ' 243' ' ' GLU . 15.3 m -137.15 -46.76 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.118 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . 0.451 ' N ' HG23 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -103.91 48.91 0.83 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.934 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -69.15 -33.52 73.55 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -157.26 -43.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.577 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -56.91 -176.91 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.874 0.369 . . . . 0.0 110.949 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -68.65 -73.62 0.14 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 59.32 85.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.874 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -137.21 133.13 34.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.915 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.821 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.836 0.351 . . . . 0.0 111.179 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -135.88 128.81 31.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 45.0 mm -102.52 -78.07 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.957 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.414 ' HD1' HG23 ' A' ' 13' ' ' THR . 0.4 OUTLIER -164.93 -171.1 2.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.861 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.472 ' CB ' ' CD ' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -104.66 -67.23 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.457 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.472 ' CD ' ' CB ' ' A' ' 5' ' ' THR . 57.7 Cg_endo -71.8 -47.15 0.49 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.225 1.95 . . . . 0.0 112.507 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.0 p -105.61 -179.49 3.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 -179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -156.79 76.35 0.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.87 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.99 -45.95 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.056 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 pt -104.9 179.7 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.152 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -125.77 80.17 1.88 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.898 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.406 ' HB3' ' CE1' ' A' ' 4' ' ' PHE . 4.9 tt -83.29 -36.62 24.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 HG23 ' HD1' ' A' ' 4' ' ' PHE . 72.6 p -64.69 116.78 6.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -178.16 -39.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.873 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.429 HG12 ' O ' ' A' ' 31' ' ' CYS . 21.0 t -113.18 152.98 14.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.091 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.647 ' HB2' ' HG2' ' A' ' 33' ' ' LYS . . . -75.41 147.98 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.826 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG12 ' HG2' ' A' ' 28' ' ' GLU . 20.3 t -131.02 105.37 10.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.4 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.888 HG22 HG12 ' A' ' 93' ' ' VAL . 1.4 t -85.11 137.42 20.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.622 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' CB ' ' HG3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -130.56 139.38 50.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.077 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 4.0 ttp -143.04 154.18 43.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.75 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tttt -126.03 109.29 12.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.368 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.411 ' NH2' ' HB2' ' A' ' 27' ' ' PHE . 0.0 OUTLIER -139.47 151.33 46.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.139 179.375 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 57.57 24.15 10.08 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.113 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 91.02 -53.14 3.25 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.511 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.2 166.62 22.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.8 0.333 . . . . 0.0 111.015 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.33 154.0 46.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' HB3' HG12 ' A' ' 56' ' ' VAL . 67.4 m-85 -138.73 163.75 31.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.04 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.731 ' HG2' HG12 ' A' ' 17' ' ' VAL . 0.7 OUTLIER -149.58 151.29 33.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.721 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.823 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.5 OUTLIER -144.32 150.51 16.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.938 0.399 . . . . 0.0 111.367 179.913 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.19 118.94 29.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.036 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.82 ' SG ' HG21 ' A' ' 36' ' ' VAL . 26.7 p -131.49 177.77 7.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.465 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.591 ' O ' HG23 ' A' ' 36' ' ' VAL . 5.0 m-85 -97.6 132.39 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.822 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ALA . 10.1 mttp -57.27 -49.31 76.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.545 -179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -72.31 -41.86 66.11 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.696 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB2' HG23 ' A' ' 50' ' ' VAL . 14.2 mmtm -66.39 -38.62 87.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.214 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 93' ' ' VAL . 64.3 t -70.13 -50.91 43.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.852 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG13 ' N ' ' A' ' 38' ' ' GLY . 9.2 p -55.03 -44.54 74.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.656 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -69.41 -34.89 74.91 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.592 -0.813 . . . . 0.0 111.783 179.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.749 ' CZ3' HG11 ' A' ' 50' ' ' VAL . 1.5 t90 -63.71 -57.97 8.34 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.859 0.361 . . . . 0.0 110.275 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 8.1 ttt180 -58.25 -39.26 78.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.871 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.1 p -59.36 -26.49 65.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.086 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 132.1 -22.87 4.19 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.664 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.5 t -57.29 129.13 18.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.798 0.332 . . . . 0.0 111.215 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -66.97 118.78 10.91 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.803 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.416 ' O ' ' CZ3' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -137.28 149.81 47.36 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.728 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.418 ' O ' HG12 ' A' ' 50' ' ' VAL . 0.2 OUTLIER -101.35 147.83 25.86 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.287 -179.586 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.862 ' HG ' HG22 ' A' ' 81' ' ' THR . 2.2 mm? -59.6 -30.32 68.6 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.987 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.73 -17.5 35.44 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.603 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -119.47 -37.97 3.08 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.749 HG11 ' CZ3' ' A' ' 39' ' ' TRP . 10.9 p -80.0 -30.49 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.821 HD11 ' SG ' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -97.4 106.27 18.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.788 0.327 . . . . 0.0 110.835 -179.906 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -68.82 -29.87 68.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.006 0.432 . . . . 0.0 110.136 179.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.677 HG21 ' CE1' ' A' ' 57' ' ' PHE . 51.9 m -129.01 118.02 21.87 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.753 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -85.9 53.97 2.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.024 0.44 . . . . 0.0 110.622 179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -162.4 130.63 4.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.321 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 1.026 HG21 HD21 ' A' ' 71' ' ' LEU . 5.4 t -72.71 107.41 3.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.045 0.45 . . . . 0.0 110.909 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.677 ' CE1' HG21 ' A' ' 53' ' ' THR . 4.7 m-85 -80.2 -174.02 4.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.26 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 94.6 t -132.13 -48.33 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.251 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -135.85 71.88 1.43 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.079 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.535 HG21 HG13 ' A' ' 17' ' ' VAL . 2.3 t -54.41 -34.58 28.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.211 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.6 t -56.45 -28.09 58.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.934 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.7 mttp -112.12 -25.99 9.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.026 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.75 47.46 1.37 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.562 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -113.16 125.9 54.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.789 0.328 . . . . 0.0 110.619 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.547 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 23.2 t -101.91 151.89 5.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.236 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB3' ' O ' ' A' ' 56' ' ' VAL . . . -82.54 -172.76 4.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.06 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.52 154.5 33.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.856 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.56 -42.42 98.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.877 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -59.01 -58.49 8.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.918 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.33 -31.06 68.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.782 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.026 HD21 HG21 ' A' ' 56' ' ' VAL . 2.6 mt -62.2 -48.28 80.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.713 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.402 ' O ' ' N ' ' A' ' 76' ' ' GLY . 25.1 mt -76.66 -34.69 24.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.194 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.1 p -69.07 -25.57 64.51 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.17 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -90.28 -42.38 11.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.472 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.57 ' CE2' HG23 ' A' ' 83' ' ' ILE . 77.3 m-85 -98.09 -51.01 4.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.221 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 126.38 -14.81 6.85 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.723 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.72 164.32 20.89 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.899 0.381 . . . . 0.0 110.89 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -97.21 -18.31 19.33 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.12 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -62.07 90.22 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.79 0.329 . . . . 0.0 110.904 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.665 ' HA ' HD12 ' A' ' 83' ' ' ILE . 3.0 pm0 -57.32 -31.36 65.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.716 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.862 HG22 ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.51 -49.97 74.59 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.344 179.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 85' ' ' LYS . 1.1 tt0 -60.81 -46.15 91.64 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.056 0.455 . . . . 0.0 110.39 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.891 HD13 HD22 ' A' ' 71' ' ' LEU . 23.2 mt -57.51 -42.14 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.353 179.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.823 ' SG ' HG21 ' A' ' 29' ' ' ILE . 91.6 m -63.18 -37.35 86.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.31 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HE2' ' CH2' ' A' ' 39' ' ' TRP . 3.4 mttm -58.71 -53.94 52.64 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.03 179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 -54.82 -48.81 72.34 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.955 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.636 ' O ' HG11 ' A' ' 18' ' ' VAL . 44.2 mt -62.93 -28.61 45.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.664 HD12 HG21 ' A' ' 18' ' ' VAL . 1.7 mp -76.22 -29.15 57.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.006 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.7 p -94.43 -32.77 13.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.255 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.73 -44.22 5.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.233 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -62.18 162.87 27.15 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.547 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -92.1 114.95 27.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.729 0.3 . . . . 0.0 110.948 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.973 HG11 HG11 ' A' ' 36' ' ' VAL . 34.0 m -81.91 122.66 37.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.18 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.0 mm-40 -80.33 111.72 16.99 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.591 HG12 ' HD3' ' A' ' 33' ' ' LYS . 27.6 m -126.5 160.05 34.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.16 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 84.9 p -79.43 173.23 12.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.87 -36.11 42.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.911 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.627 ' O ' HG22 ' A' ' 102' ' ' THR . 0.0 OUTLIER -68.05 -35.77 78.78 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.08 -33.55 68.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.752 179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -77.87 -32.01 51.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.627 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -69.93 -50.03 46.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.654 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.3 t -62.61 -37.94 88.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.682 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -66.73 -46.42 75.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.63 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.1 tt -60.58 -43.6 97.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.652 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -67.92 -39.6 83.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.595 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -48.57 81.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.692 179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -64.73 -38.29 90.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.657 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.403 ' CE1' ' O ' ' A' ' 143' ' ' SER . 0.1 OUTLIER -61.66 -39.0 89.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.367 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.64 -35.58 70.45 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.419 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -53.19 21.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.662 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.832 ' HA ' HD12 ' A' ' 114' ' ' ILE . 7.1 tt -57.96 -45.89 87.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 121.091 0.472 . . . . 0.0 110.709 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.453 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -59.37 -44.26 92.74 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.726 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 85.2 m -59.58 -43.19 93.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.577 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.832 HD12 ' HA ' ' A' ' 111' ' ' ILE . 9.0 mt -61.27 -40.72 87.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.687 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 111' ' ' ILE . 38.7 t -75.05 -20.69 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.178 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.857 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -92.97 -26.81 17.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.563 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -101.48 -30.99 11.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.389 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -95.37 21.17 8.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.395 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.406 ' O ' HG13 ' A' ' 120' ' ' VAL . 8.8 m -147.51 148.78 31.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.842 0.353 . . . . 0.0 110.901 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.62 HG11 ' H ' ' A' ' 216' ' ' CYS . 5.5 m -154.95 141.16 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.176 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.55 137.75 47.93 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.19 -10.77 21.04 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.494 2.129 . . . . 0.0 112.598 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.24 -62.11 1.93 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.967 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.05 14.44 9.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.287 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt 52.78 70.66 0.55 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.776 0.322 . . . . 0.0 111.116 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -159.48 141.99 10.09 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.839 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.94 155.67 43.22 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.497 2.131 . . . . 0.0 112.339 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.499 ' CE2' HD22 ' A' ' 132' ' ' LEU . 5.6 m-85 -77.22 -177.38 4.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 50.4 p -109.54 143.38 39.28 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.046 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.424 HG12 ' HG3' ' A' ' 134' ' ' GLU . 11.6 t -53.74 -33.25 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.232 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.401 HG13 ' N ' ' A' ' 132' ' ' LEU . 22.0 pt -65.13 -36.45 77.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.917 179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.499 HD22 ' CE2' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -71.24 -50.43 32.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.614 179.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.857 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 8.5 mt -62.49 -39.08 83.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.653 179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . 0.424 ' HG3' HG12 ' A' ' 130' ' ' VAL . 3.2 mt-10 -62.33 -50.53 71.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.633 179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 43.8 mtp85 -56.01 -45.83 78.96 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.804 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -64.13 -53.46 49.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.966 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.504 ' HE1' ' CG2' ' A' ' 133' ' ' ILE . 0.1 OUTLIER -52.24 -31.43 32.19 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.932 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 tptp -72.11 -56.15 6.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.65 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -47.03 -44.06 20.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.972 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 9.3 tp -88.69 -18.97 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.126 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 73.2 m-70 57.07 66.76 1.1 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.74 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -150.48 -167.12 2.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.296 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.417 ' HB3' ' HG2' ' A' ' 137' ' ' MET . 1.3 t 66.19 77.71 0.28 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.022 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 146' ' ' THR . 13.2 p -137.4 148.49 25.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.974 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HD2' HG23 ' A' ' 150' ' ' THR . 9.7 tmtt? -140.25 14.58 2.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.442 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.492 ' H ' HG22 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -40.46 -40.92 1.31 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.649 -179.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.46 43.11 1.75 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.972 0.415 . . . . 0.0 110.81 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 145' ' ' LYS . 1.6 tttt -149.29 -161.42 1.34 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.107 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.85 134.93 49.25 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.71 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.639 HG23 ' HD2' ' A' ' 145' ' ' LYS . 0.2 OUTLIER -63.16 -66.06 0.6 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.185 -179.684 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -47.26 -35.58 7.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.323 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.29 -42.15 88.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.882 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.887 ' O ' HG23 ' A' ' 157' ' ' VAL . 8.0 mm100 -80.67 -29.52 36.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.014 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.44 -39.32 47.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.45 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.18 -53.59 55.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.029 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -62.04 -36.37 81.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.977 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.887 HG23 ' O ' ' A' ' 153' ' ' GLN . 34.9 t -61.85 -55.11 26.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.255 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.764 ' HA ' HD11 ' A' ' 167' ' ' ILE . 40.1 pt -61.43 -35.56 67.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.238 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -61.38 -50.31 73.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.991 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -73.84 -38.91 64.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.062 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.486 HD12 HG12 ' A' ' 157' ' ' VAL . 12.7 mt -63.25 -26.74 68.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.25 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 5.7 mtpp -50.14 -27.79 6.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.241 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -71.11 -41.05 71.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.879 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.44 -67.29 0.85 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.866 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 7.9 ttm -119.42 130.46 55.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.847 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.14 139.38 31.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.926 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.764 HD11 ' HA ' ' A' ' 158' ' ' ILE . 0.2 OUTLIER -133.79 135.34 55.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.1 179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.78 106.23 15.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.963 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.66 112.41 21.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.904 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -141.2 142.53 33.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.189 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 169.22 9.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.917 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 1.9 ttp -174.14 141.93 0.79 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.943 0.402 . . . . 0.0 111.379 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -122.92 133.12 54.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.398 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.73 ' HB3' HD13 ' A' ' 211' ' ' LEU . 0.2 OUTLIER -115.41 176.68 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.186 0.517 . . . . 0.0 111.792 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -148.69 144.43 27.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.027 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.625 ' CE2' HD11 ' A' ' 190' ' ' LEU . 1.6 m-85 -136.34 148.04 47.7 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.221 0.534 . . . . 0.0 111.925 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.629 HD11 HG23 ' A' ' 236' ' ' VAL . 3.9 mp -134.38 102.42 4.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.61 178.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.686 HD23 ' HB3' ' A' ' 186' ' ' LEU . 0.0 OUTLIER -102.64 147.05 33.48 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.806 -178.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.545 ' HA ' HD23 ' A' ' 206' ' ' LEU . 11.3 Cg_exo -70.5 -156.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.891 2.394 . . . . 0.0 111.998 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.787 HG22 ' HA ' ' A' ' 205' ' ' GLN . 21.2 t -76.07 -67.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.484 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -75.81 -53.21 8.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.344 -179.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.04 -24.28 9.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.416 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 178' ' ' LEU . . . -65.95 -52.84 34.26 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.823 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 13.6 ttmt -49.18 -30.96 7.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 111.386 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -85.83 -63.17 1.37 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.295 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.686 ' HB3' HD23 ' A' ' 178' ' ' LEU . 43.6 tp -56.18 -31.66 63.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.487 -179.484 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.21 -62.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.253 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -54.69 -24.31 21.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.514 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.22 -19.75 42.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.537 -179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.625 HD11 ' CE2' ' A' ' 176' ' ' PHE . 4.1 mt -104.9 -25.99 12.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.659 0.266 . . . . 0.0 111.455 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.431 ' N ' ' CD ' ' A' ' 192' ' ' PRO . 0.1 OUTLIER -53.04 -50.5 81.67 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.428 -179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.431 ' CD ' ' N ' ' A' ' 191' ' ' LYS . 88.3 Cg_endo -83.4 -36.21 0.22 Allowed 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.567 2.178 . . . . 0.0 112.648 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.853 HD11 HG21 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -54.62 -53.9 48.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.31 -179.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.492 HD12 ' HB3' ' A' ' 193' ' ' LEU . 2.1 mp -134.11 159.68 42.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.197 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . 0.483 ' N ' HG22 ' A' ' 194' ' ' ILE . 0.0 OUTLIER -71.48 122.19 19.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.639 179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 197' ' ' ILE . 6.0 m -114.73 163.26 12.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.388 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.642 HD12 ' HB2' ' A' ' 198' ' ' GLU . 2.7 pp -157.46 160.72 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.078 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.642 ' HB2' HD12 ' A' ' 197' ' ' ILE . 0.1 OUTLIER 61.56 40.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.066 179.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 4.0 m -75.82 112.64 12.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -124.43 114.07 19.0 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.951 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -120.14 131.23 54.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.774 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.484 ' HB3' ' CB ' ' A' ' 205' ' ' GLN . 41.3 t80 -99.1 142.72 30.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.552 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -42.98 116.36 1.24 Allowed Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.169 -0.539 . . . . 0.0 113.018 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.48 ' C ' HG13 ' A' ' 180' ' ' VAL . 0.0 OUTLIER 51.36 43.41 29.46 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.012 0.434 . . . . 0.0 110.371 -179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.787 ' HA ' HG22 ' A' ' 180' ' ' VAL . 1.4 mt-30 -143.88 178.64 7.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.391 -179.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.58 HD12 ' H ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -72.65 149.13 44.14 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.524 -179.078 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.479 ' O ' HD12 ' A' ' 178' ' ' LEU . 8.8 tt0 -117.8 139.91 50.42 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.994 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.65 118.7 57.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.449 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.412 ' CG2' ' HB ' ' A' ' 196' ' ' VAL . 10.1 p -130.96 144.91 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.301 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 14.2 m -109.86 149.41 29.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.665 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.73 HD13 ' HB3' ' A' ' 174' ' ' LEU . 1.4 mp -118.72 156.1 29.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.097 0.475 . . . . 0.0 111.656 -179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.422 HG23 ' O ' ' A' ' 212' ' ' ILE . 10.5 tt -158.65 125.0 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.664 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -177.75 115.74 0.24 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.104 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_exo -59.22 163.81 11.55 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.458 2.105 . . . . 0.0 112.176 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 97.89 -164.85 21.82 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.472 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.62 ' H ' HG11 ' A' ' 120' ' ' VAL . 2.1 m -107.95 39.24 1.99 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.914 0.388 . . . . 0.0 110.803 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.438 ' O ' HG22 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -58.5 -20.92 49.88 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.165 179.941 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 25.9 ttt-85 -47.52 -29.92 3.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.809 0.338 . . . . 0.0 111.271 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.12 -64.06 1.05 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.438 HG22 ' O ' ' A' ' 217' ' ' PHE . 6.3 tp -59.41 -32.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.863 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.566 ' OD1' HD21 ' A' ' 190' ' ' LEU . 48.5 t0 -72.41 -38.1 68.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.814 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -66.17 -40.28 90.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.79 -50.7 40.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.853 HG21 HD11 ' A' ' 193' ' ' LEU . 2.6 pp -65.27 -41.86 92.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.542 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.58 ' N ' HD12 ' A' ' 224' ' ' ILE . 44.9 pttt -62.91 -48.44 78.95 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.984 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . 0.482 ' N ' ' HG3' ' A' ' 225' ' ' LYS . 3.2 tttp -66.48 -33.56 75.97 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.0 111.096 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -77.63 -21.92 51.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.362 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.7 m -103.93 -20.62 13.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.629 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.419 ' HG2' ' O ' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -97.09 -27.65 14.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.739 0.304 . . . . 0.0 111.214 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.71 43.1 59.72 Favored Glycine 0 CA--C 1.518 0.238 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.758 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 59.98 29.24 18.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.881 0.372 . . . . 0.0 110.962 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -115.58 -17.21 6.63 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.764 -179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 1.4 t -107.28 170.23 8.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.841 0.353 . . . . 0.0 110.991 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.72 165.66 13.02 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.025 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -157.93 121.1 3.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.855 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.629 HG23 HD11 ' A' ' 177' ' ' ILE . 21.2 t -106.82 147.93 11.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.081 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' A' ' 240' ' ' LYS . 4.1 pp -103.23 142.72 33.68 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -103.42 -66.48 0.94 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.957 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 13.2 tp -119.75 146.56 45.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.849 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.587 ' HD2' HD22 ' A' ' 237' ' ' LEU . 20.8 mtpp -144.19 143.12 30.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.902 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -64.78 103.41 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 27.6 m -102.33 135.6 38.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.126 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -145.35 59.46 1.28 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.817 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -152.24 34.02 0.52 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 133.09 176.89 14.6 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 64.0 -78.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.789 0.328 . . . . 0.0 110.947 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -83.35 174.81 10.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.849 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.8 -75.04 0.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.9 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -122.66 -43.5 2.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.865 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.959 179.954 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.849 0.357 . . . . 0.0 111.228 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.75 35.5 3.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.924 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 3.0 pt -82.83 -29.09 8.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.169 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -107.26 14.37 26.18 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.292 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.458 HG22 ' OG1' ' A' ' 7' ' ' THR . 3.5 m 53.16 80.74 0.28 Allowed Pre-proline 0 C--N 1.331 -0.197 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.223 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.16 83.07 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.656 2.237 . . . . 0.0 112.119 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.458 ' OG1' HG22 ' A' ' 5' ' ' THR . 0.2 OUTLIER -130.05 -168.57 1.98 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.887 -179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' H ' HG22 ' A' ' 7' ' ' THR . 23.7 m-80 -98.24 30.33 3.19 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.5 -27.23 11.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.617 HD13 HD12 ' A' ' 12' ' ' LEU . 2.5 pp -118.68 -179.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.893 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.7 ptt-85 -152.44 56.21 0.81 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.061 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.776 HD22 ' HB ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -65.4 -13.83 59.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.543 -179.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.776 ' HB ' HD22 ' A' ' 12' ' ' LEU . 1.1 m 165.35 -56.36 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 120.883 0.373 . . . . 0.0 110.239 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 75.23 -59.67 0.53 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.943 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.552 HG12 HG23 ' A' ' 13' ' ' THR . 0.5 OUTLIER -52.3 178.38 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.954 179.869 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HG3' ' A' ' 33' ' ' LYS . . . -75.3 147.92 39.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.777 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.2 t -117.95 129.09 74.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 121.066 0.46 . . . . 0.0 111.452 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 88' ' ' LEU . 48.5 t -117.67 137.97 49.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.614 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -124.79 147.49 48.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.058 0.456 . . . . 0.0 111.486 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.431 ' HE1' ' HG3' ' A' ' 86' ' ' GLN . 1.7 ttp -144.83 147.86 33.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.469 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.45 119.36 35.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.07 -179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -152.35 138.96 18.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.77 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.8 20.02 11.08 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.342 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.75 -46.3 2.94 Favored Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.717 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.0 tptt -66.7 154.5 40.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.848 0.356 . . . . 0.0 111.136 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.3 mtp180 -109.86 126.33 53.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.723 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.12 143.01 47.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.436 ' HB3' HG23 ' A' ' 60' ' ' VAL . 2.0 tt0 -138.29 153.69 49.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.605 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.473 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.3 OUTLIER -143.89 148.65 18.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.747 0.308 . . . . 0.0 111.562 -179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' OG1' ' A' ' 53' ' ' THR . . . -93.89 106.68 18.64 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.983 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.536 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 38.4 m -126.9 170.18 12.51 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.764 ' O ' HG23 ' A' ' 36' ' ' VAL . 4.8 m-85 -85.42 140.84 30.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.102 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.951 ' HG3' ' HB2' ' A' ' 16' ' ' ALA . 48.3 mttp -59.18 -51.27 70.7 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 111.076 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -70.07 -41.86 73.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.419 -179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.759 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -68.37 -34.23 75.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.056 -179.739 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 32' ' ' TYR . 48.2 t -69.82 -48.88 61.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.777 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 38' ' ' GLY . 6.3 p -58.52 -47.62 87.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.809 0.338 . . . . 0.0 110.387 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.831 ' O ' HG22 ' A' ' 43' ' ' VAL . . . -67.0 -36.33 90.78 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.577 178.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.492 ' CE3' ' HB2' ' A' ' 45' ' ' LYS . 19.4 t-105 -63.21 -48.19 79.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.941 0.4 . . . . 0.0 109.985 179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -57.56 -44.1 84.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.004 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.26 -26.54 67.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.373 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.78 42.06 5.49 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.786 -0.721 . . . . 0.0 113.153 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.831 HG22 ' O ' ' A' ' 38' ' ' GLY . 3.7 m -101.49 27.99 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.813 0.339 . . . . 0.0 111.367 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 59.2 103.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.33 179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.641 ' CE ' HG23 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -124.78 125.73 44.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.907 179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -59.31 119.62 7.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.646 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.71 HD21 ' HD2' ' A' ' 85' ' ' LYS . 3.2 mm? -52.68 -37.76 59.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.264 -179.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -71.72 -10.28 59.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.635 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.3 mm-40 -108.74 -36.37 6.17 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.651 0.262 . . . . 0.0 111.303 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG23 ' HB3' ' A' ' 35' ' ' LYS . 11.7 p -78.18 -46.7 25.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.655 -179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.947 HD11 ' CB ' ' A' ' 84' ' ' CYS . 2.3 mt -92.11 109.75 21.11 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.852 0.358 . . . . 0.0 110.963 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -81.62 -29.5 33.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.866 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.66 ' OG1' ' HB3' ' A' ' 30' ' ' ALA . 2.0 m -95.46 -39.93 9.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.517 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.747 ' HA ' HD13 ' A' ' 51' ' ' LEU . 90.8 m-70 72.84 -57.75 0.62 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.403 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.86 140.09 56.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.915 0.388 . . . . 0.0 110.601 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.606 HG11 HD21 ' A' ' 71' ' ' LEU . 24.7 t -72.13 116.81 14.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.008 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.561 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.7 m-85 -94.61 -175.23 3.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.451 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 81.9 t -132.04 -48.05 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.109 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.89 76.64 1.64 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.975 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.436 HG23 ' HB3' ' A' ' 28' ' ' GLU . 2.1 t -58.93 -32.57 47.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.163 -179.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -54.19 -30.05 48.26 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 4.2 mmpt? -113.92 -25.61 8.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.093 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.28 56.41 0.93 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.3 113.66 21.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.87 0.367 . . . . 0.0 110.753 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 12.0 t -90.85 158.71 2.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.312 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 65' ' ' VAL . . . -95.88 172.47 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.015 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.07 153.54 21.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.847 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -35.28 76.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -58.39 -49.13 78.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.81 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 23.3 m-20 -69.72 -34.06 73.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.013 HD22 HD13 ' A' ' 83' ' ' ILE . 9.4 mt -62.02 -41.28 97.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.589 HD11 ' OD1' ' A' ' 78' ' ' ASP . 11.1 mt -77.41 -35.08 21.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.121 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 3.8 t -72.23 -22.6 61.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.36 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.48 -25.79 13.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.66 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CE2' HG23 ' A' ' 83' ' ' ILE . 96.7 m-85 -121.34 -39.75 2.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.673 0.273 . . . . 0.0 111.42 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 72' ' ' ILE . . . 75.19 28.46 62.07 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.526 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.432 HG23 ' HB3' ' A' ' 75' ' ' PHE . 3.4 p -111.06 -32.83 6.66 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.988 0.423 . . . . 0.0 110.866 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.589 ' OD1' HD11 ' A' ' 72' ' ' ILE . 25.7 t0 66.7 20.23 10.71 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.084 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.17 101.95 5.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.466 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.505 ' CB ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -54.08 -34.92 61.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.126 -179.609 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.514 HG22 HD12 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -62.8 -53.18 58.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.586 179.709 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -59.74 -48.9 79.83 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.07 0.462 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 1.013 HD13 HD22 ' A' ' 71' ' ' LEU . 59.0 mt -55.76 -48.74 77.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.284 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.947 ' CB ' HD11 ' A' ' 51' ' ' LEU . 63.6 m -56.13 -52.68 63.48 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.824 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HD2' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -44.22 -48.46 9.34 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.852 179.158 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.431 ' HG3' ' HE1' ' A' ' 20' ' ' MET . 0.3 OUTLIER -68.42 -28.96 67.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.213 -179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.779 HD11 HG22 ' A' ' 83' ' ' ILE . 27.7 mt -77.11 -46.6 28.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.85 ' HA ' HG11 ' A' ' 18' ' ' VAL . 0.3 OUTLIER -80.2 -18.26 50.07 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.291 -179.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' ARG . 96.8 m -90.49 -22.53 21.31 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.637 0.256 . . . . 0.0 110.969 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.52 -44.27 2.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.846 0.355 . . . . 0.0 111.007 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' ILE . . . -58.46 -167.69 0.16 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.714 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.548 ' O ' HG13 ' A' ' 18' ' ' VAL . 0.8 OUTLIER -104.03 125.12 50.14 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.8 0.333 . . . . 0.0 110.98 -179.991 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.741 ' HA ' HG22 ' A' ' 18' ' ' VAL . 14.3 p -95.14 138.97 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.234 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -94.8 107.69 19.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.8 m -107.04 141.77 21.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.259 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 37.7 m -97.98 176.07 5.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -77.66 -36.47 51.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.987 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 ptpp? -58.78 -50.51 73.67 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.014 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -72.26 -38.03 68.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.697 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -61.13 -31.32 71.03 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.719 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -79.39 -51.35 9.51 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.714 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.3 p -58.06 -40.13 80.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.827 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -60.89 -44.23 97.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.652 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.1 mt -60.68 -47.55 85.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.545 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.3 mt-10 -61.52 -44.09 97.7 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.68 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.2 -40.49 94.15 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.669 179.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -40.86 98.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.668 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 144' ' ' VAL . 1.1 m-85 -62.31 -45.6 92.5 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.638 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 42.6 mtm180 -68.74 -41.37 79.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.647 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -63.9 -58.11 7.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.769 ' O ' HG23 ' A' ' 115' ' ' VAL . 2.5 tt -54.06 -45.85 65.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.094 0.473 . . . . 0.0 110.986 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.459 ' N ' HG23 ' A' ' 111' ' ' ILE . . . -60.15 -37.74 81.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.918 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 78.8 m -65.05 -45.32 85.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.782 HG23 ' HD3' ' A' ' 118' ' ' LYS . 40.0 mm -63.24 -36.48 76.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.883 HG13 HG21 ' A' ' 167' ' ' ILE . 23.1 t -73.7 -30.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.058 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 133' ' ' ILE . . . -88.97 -24.91 22.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.264 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -95.7 -50.79 4.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.0 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.782 ' HD3' HG23 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -95.95 39.78 1.13 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.046 -179.839 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.44 ' SG ' HG22 ' A' ' 167' ' ' ILE . 0.8 OUTLIER -175.54 141.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.971 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 216' ' ' CYS . 8.3 m -124.1 154.89 31.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.116 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.419 ' HB3' ' CE2' ' A' ' 128' ' ' TYR . 25.9 p30 -86.41 148.44 46.91 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.905 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.47 -15.0 27.9 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.586 2.191 . . . . 0.0 112.565 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -55.16 -61.23 2.45 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.132 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 m -137.21 20.25 2.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.155 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.8 mtmm 53.67 32.84 15.34 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.766 0.317 . . . . 0.0 111.003 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.3 mtt-85 -114.41 144.7 32.27 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.974 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.44 142.82 57.46 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.554 2.169 . . . . 0.0 112.381 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.2 OUTLIER -86.49 152.51 22.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.869 179.929 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.462 HG22 ' H ' ' A' ' 131' ' ' ILE . 12.3 m -79.97 134.86 36.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.016 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 14.8 p -52.71 -30.08 14.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.355 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.462 ' H ' HG22 ' A' ' 129' ' ' THR . 9.7 mt -71.89 -36.19 57.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.8 mt -70.22 -40.76 74.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.71 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.491 ' CD1' ' HB2' ' A' ' 116' ' ' ALA . 38.9 mt -68.12 -43.01 85.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.914 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -62.13 -49.62 75.13 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.772 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -59.86 -46.44 89.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.77 -42.45 99.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.188 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.459 ' O ' HG22 ' A' ' 140' ' ' ILE . 0.5 OUTLIER -58.42 -46.3 86.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.999 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 1.5 mtpt -70.24 -38.44 75.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.825 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.35 -36.49 80.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.951 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 137' ' ' MET . 1.1 tt -82.57 0.62 4.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.677 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 64.01 38.28 8.72 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.902 0.382 . . . . 0.0 110.969 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.474 ' CE2' HG22 ' A' ' 157' ' ' VAL . 2.8 t80 -74.64 170.96 14.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.867 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.5 t -156.67 118.81 3.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.57 HG23 ' CE1' ' A' ' 108' ' ' PHE . 24.6 t -87.79 107.06 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.109 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 4.9 mttp -64.88 103.44 0.71 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.877 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 41.6 p -55.91 -29.71 60.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.073 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -81.58 -25.89 35.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.068 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.5 148.78 25.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.928 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.44 135.35 56.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.867 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 1.3 p -60.51 -59.07 5.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.945 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -47.33 -47.6 25.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.168 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -61.56 -35.49 77.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.812 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -79.06 -25.27 43.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -50.36 -33.88 22.06 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.324 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.74 -51.58 68.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.826 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.61 -36.02 82.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.975 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 153' ' ' GLN . 21.5 t -60.29 -50.62 79.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.101 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.871 HG23 ' HB ' ' A' ' 167' ' ' ILE . 33.6 mt -62.94 -48.63 87.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.058 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.74 -53.71 54.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 1.2 tp-100 -61.79 -41.02 97.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.464 ' CD1' HG12 ' A' ' 157' ' ' VAL . 15.4 mt -59.13 -21.31 59.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.219 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -52.62 -30.45 31.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.072 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -61.87 -31.59 71.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.807 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.18 -69.69 0.84 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.796 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.79 128.48 56.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.893 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -88.63 113.98 24.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.954 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.883 HG21 HG13 ' A' ' 115' ' ' VAL . 25.9 mm -101.27 140.4 20.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.101 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -134.65 134.37 41.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.021 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -106.21 128.6 54.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.661 ' HB1' ' HE2' ' A' ' 240' ' ' LYS . . . -130.72 136.9 49.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.27 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.1 p80 -136.43 146.94 46.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.659 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 32.5 ttp -158.59 147.16 18.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.056 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -83.33 146.74 28.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.647 179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' A' ' 211' ' ' LEU . 42.7 mt -127.8 139.14 52.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.975 0.417 . . . . 0.0 111.371 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 11.5 ttm180 -139.87 107.78 5.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.019 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -115.15 152.11 33.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.009 0.433 . . . . 0.0 111.501 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.945 HD12 HG22 ' A' ' 208' ' ' ILE . 26.1 mm -120.16 102.23 12.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.528 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.452 HD11 ' HB3' ' A' ' 207' ' ' GLU . 1.7 pp -89.79 137.34 28.49 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.298 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 182' ' ' GLU . 42.9 Cg_endo -67.54 -166.8 0.14 Allowed 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.7 2.267 . . . . 0.0 112.54 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.735 HG22 ' HA ' ' A' ' 205' ' ' GLN . 6.4 t -75.99 -63.59 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.479 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 25.7 m120 -81.63 -57.77 3.31 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.42 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . 0.423 ' HB2' ' CG ' ' A' ' 179' ' ' PRO . 3.5 mp0 -57.92 -21.33 43.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.316 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.401 ' CA ' ' HB2' ' A' ' 178' ' ' LEU . . . -82.55 -23.16 57.0 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.878 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 30.5 mttp -56.25 -38.26 70.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.813 0.34 . . . . 0.0 111.192 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -85.83 -33.75 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.658 HD21 ' HG3' ' A' ' 229' ' ' LYS . 4.0 mt -57.19 -39.97 76.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.228 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -57.9 -61.98 2.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.201 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -60.69 -19.48 58.64 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.343 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -83.91 -22.07 31.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.499 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 13.6 mt -107.64 -32.27 7.74 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.703 0.287 . . . . 0.0 111.486 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.09 -56.99 12.74 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.322 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.28 -35.22 0.91 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.697 2.264 . . . . 0.0 112.644 -179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.713 HD23 HG23 ' A' ' 194' ' ' ILE . 0.6 OUTLIER -58.5 -52.25 66.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 -179.736 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.799 HD13 ' HB3' ' A' ' 211' ' ' LEU . 2.5 pp -137.8 179.37 3.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.887 0.375 . . . . 0.0 111.327 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -84.19 127.46 33.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.033 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 1.093 HG12 HD22 ' A' ' 211' ' ' LEU . 35.3 m -112.12 173.72 2.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.968 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -178.63 142.28 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.826 0.346 . . . . 0.0 111.356 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 69.36 74.17 0.24 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.194 179.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 2.6 m -106.31 110.6 22.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.801 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . 0.432 ' HG3' HD11 ' A' ' 208' ' ' ILE . 7.6 mt-10 -123.59 134.89 53.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.157 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . 0.419 ' HB3' ' CB ' ' A' ' 207' ' ' GLU . 6.3 p30 -158.43 160.3 36.67 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -116.16 100.6 8.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.037 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 44.78 -104.31 0.06 OUTLIER Glycine 0 C--N 1.332 0.309 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.832 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.459 ' C ' HG13 ' A' ' 180' ' ' VAL . 2.1 mt-30 -101.46 61.41 0.92 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 0.0 110.571 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.735 ' HA ' HG22 ' A' ' 180' ' ' VAL . 7.9 mt-30 -136.34 178.57 6.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.122 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.479 HD12 ' CG2' ' A' ' 177' ' ' ILE . 1.7 pt? -72.48 140.6 48.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.62 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.452 ' HB3' HD11 ' A' ' 178' ' ' LEU . 26.6 tt0 -105.5 142.0 36.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.615 -179.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.945 HG22 HD12 ' A' ' 177' ' ' ILE . 1.2 pp -105.98 114.91 46.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.055 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 11.8 p -130.87 145.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.895 0.378 . . . . 0.0 111.651 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.411 ' O ' HD23 ' A' ' 211' ' ' LEU . 7.6 m -109.79 145.56 36.48 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.124 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 1.093 HD22 HG12 ' A' ' 196' ' ' VAL . 1.7 mt -127.15 166.69 17.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.961 0.41 . . . . 0.0 111.405 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 28.2 mm -112.14 139.59 35.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.817 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -113.37 74.04 2.02 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.192 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -77.71 74.81 5.03 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.605 2.203 . . . . 0.0 112.366 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 122.4 -128.55 7.2 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.602 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.799 ' HB2' HG11 ' A' ' 120' ' ' VAL . 0.1 OUTLIER -112.9 35.36 3.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.797 0.332 . . . . 0.0 110.99 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.428 ' CD1' ' CG2' ' A' ' 194' ' ' ILE . 0.5 OUTLIER -61.61 -21.03 64.0 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 179.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -49.42 -28.39 5.13 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.3 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.81 -64.15 0.91 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.973 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 13.2 tt -62.32 -38.08 80.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.015 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -62.6 -49.78 73.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.915 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -59.94 -42.32 93.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.019 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . 0.447 HD23 ' HA ' ' A' ' 223' ' ' LEU . 12.4 mt -58.48 -63.64 1.21 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.015 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.9 -34.97 61.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.944 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.41 ' HG2' ' HD2' ' A' ' 229' ' ' LYS . 0.8 OUTLIER -60.53 -51.9 67.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.887 179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -68.14 -28.21 67.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.986 -179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -74.52 -27.8 60.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.165 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 1.1 m -98.6 -28.36 13.6 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.291 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.658 ' HG3' HD21 ' A' ' 186' ' ' LEU . 62.7 mttm -81.88 -40.07 22.93 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.181 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 57.7 31.2 63.6 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 66.68 30.41 8.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.754 0.311 . . . . 0.0 110.837 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -126.79 22.76 5.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.681 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.442 ' HB2' ' HD3' ' A' ' 229' ' ' LYS . 38.2 m -144.82 173.08 12.16 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.561 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -107.77 143.6 36.08 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.846 0.355 . . . . 0.0 111.286 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.71 115.17 8.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.859 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 18.3 t -106.92 141.58 21.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.112 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 24.8 mt -122.81 124.36 43.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.862 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -73.87 -179.67 3.82 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.972 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 1.1 mt -82.33 153.43 25.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.661 ' HE2' ' HB1' ' A' ' 170' ' ' ALA . 11.3 tttt -105.91 123.99 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -98.9 116.39 31.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 242' ' ' VAL . 9.7 p -150.51 109.35 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -161.02 167.2 26.9 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -137.52 -47.15 0.56 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.901 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -73.42 -8.64 76.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.922 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -94.98 -36.48 11.55 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.765 0.316 . . . . 0.0 110.985 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -108.13 154.87 21.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.967 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -154.95 -46.63 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -60.8 123.69 18.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.947 -179.994 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.956 179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.397 0 CA-C-O 120.755 0.312 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.2 m -143.65 98.89 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.854 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.5 pt -138.06 36.47 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.031 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -163.8 -50.34 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.525 ' N ' ' HD3' ' A' ' 6' ' ' PRO . 7.6 p 54.56 55.69 11.61 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.247 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.732 ' CG ' HG23 ' A' ' 10' ' ' ILE . 74.8 Cg_endo -91.83 72.87 0.72 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.939 2.426 . . . . 0.0 112.362 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m 69.97 -65.59 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.812 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -112.81 -83.19 0.59 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.849 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 36.8 tp60 -176.56 101.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.756 0.312 . . . . 0.0 110.684 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.732 HG23 ' CG ' ' A' ' 6' ' ' PRO . 0.8 OUTLIER -53.4 106.55 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.084 -179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.8 mtt-85 -53.54 -24.93 14.86 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.064 -179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.422 ' HG ' HD12 ' A' ' 10' ' ' ILE . 0.4 OUTLIER 66.61 98.26 0.05 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.089 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.51 -13.82 62.38 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.033 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' O ' HG12 ' A' ' 15' ' ' VAL . 0.2 OUTLIER 78.24 -61.89 0.36 Allowed 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.931 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.741 HG23 ' CD1' ' A' ' 32' ' ' TYR . 0.5 OUTLIER 48.44 179.36 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.488 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.547 ' HB2' ' HB3' ' A' ' 33' ' ' LYS . . . -90.03 135.16 33.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.5 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t -111.08 110.0 30.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.997 0.427 . . . . 0.0 111.477 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG12 HG22 ' A' ' 87' ' ' ILE . 2.9 t -86.22 112.59 22.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.527 179.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 147.74 33.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.306 -179.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.59 ' HB3' HG23 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -140.94 167.99 20.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.738 179.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 11.3 ttpt -128.11 101.28 6.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.16 136.73 38.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 64.92 14.96 9.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.545 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 92.46 -33.61 4.88 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.701 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.06 144.1 31.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.83 0.347 . . . . 0.0 111.0 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.07 129.53 44.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -116.04 133.48 55.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.033 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -126.72 130.61 50.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.615 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.773 HG22 ' HA ' ' A' ' 56' ' ' VAL . 0.9 OUTLIER -123.69 144.37 33.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.301 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB3' ' CB ' ' A' ' 53' ' ' THR . . . -90.92 106.71 18.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.363 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.856 ' SG ' HG22 ' A' ' 50' ' ' VAL . 7.8 t -129.71 162.55 28.12 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.985 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -88.49 111.91 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.41 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.547 ' HB3' ' HB2' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -44.49 -36.35 2.91 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.597 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -65.93 -54.57 24.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.671 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.774 ' CB ' HG23 ' A' ' 50' ' ' VAL . 2.0 mptp? -69.88 -21.47 63.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.003 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 32' ' ' TYR . 47.3 t -72.64 -48.77 44.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.866 0.365 . . . . 0.0 110.543 179.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 147' ' ' ASN . 8.7 p -67.32 -42.56 87.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.613 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.419 ' N ' HG13 ' A' ' 37' ' ' VAL . . . -65.63 -37.42 93.56 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.858 179.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.462 ' CH2' ' CD2' ' A' ' 47' ' ' LEU . 3.2 t-105 -68.58 -50.31 52.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.895 0.379 . . . . 0.0 110.244 179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.7 ttp180 -60.59 -37.1 80.24 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.642 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -59.49 -24.55 63.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.88 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 112.82 24.51 4.89 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.427 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.6 t -102.08 132.46 48.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.838 0.351 . . . . 0.0 111.134 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -59.5 122.84 15.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 49' ' ' GLU . 0.1 OUTLIER -141.0 150.58 43.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.924 179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.42 130.23 34.75 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.092 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.691 ' HA ' HG12 ' A' ' 50' ' ' VAL . 1.7 mm? -58.69 -41.0 85.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.221 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.87 -20.89 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.932 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' CB ' ' HE2' ' A' ' 45' ' ' LYS . 0.6 OUTLIER -104.77 -50.7 3.22 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -179.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.856 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.2 p -53.09 -46.33 54.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.79 -179.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.879 HD13 ' HA ' ' A' ' 54' ' ' HIS . 7.8 mt -89.52 117.61 28.55 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.765 0.317 . . . . 0.0 110.745 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.85 -21.15 32.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.964 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.843 ' CB ' ' HB3' ' A' ' 30' ' ' ALA . 1.9 m -114.59 -34.19 5.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.534 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.879 ' HA ' HD13 ' A' ' 51' ' ' LEU . 39.7 m80 71.93 -71.99 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.038 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.445 ' O ' HG22 ' A' ' 53' ' ' THR . 0.9 OUTLIER -60.41 138.38 58.0 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.732 0.301 . . . . 0.0 110.681 179.852 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.773 ' HA ' HG22 ' A' ' 29' ' ' ILE . 2.1 t -71.07 129.59 34.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.902 0.382 . . . . 0.0 110.634 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.725 ' CZ ' HG22 ' A' ' 65' ' ' VAL . 3.8 m-85 -103.31 -179.04 3.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.381 0.61 . . . . 0.0 112.13 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 65.6 t -123.77 -35.68 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.153 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -147.18 61.27 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.79 179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.512 HG22 ' HB2' ' A' ' 57' ' ' PHE . 2.0 t -43.82 -50.35 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.857 -179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.6 p -53.57 -25.0 15.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.229 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -104.4 -26.1 12.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.941 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.29 33.5 4.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.594 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 -103.92 128.84 51.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.36 . . . . 0.0 110.734 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.725 HG22 ' CZ ' ' A' ' 57' ' ' PHE . 32.3 t -107.73 151.2 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.219 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.59 177.9 7.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.004 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 15.6 mmtm -115.11 146.77 41.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 19.4 mtpt -59.93 -32.92 71.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.918 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.15 -42.67 81.47 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.882 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -77.01 -36.77 56.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.713 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.735 HD22 HD13 ' A' ' 83' ' ' ILE . 12.4 mt -58.61 -40.95 84.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.948 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.667 HD11 ' OD1' ' A' ' 78' ' ' ASP . 28.5 mt -79.61 -51.15 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.08 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.2 p -55.85 -23.61 31.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.226 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -98.27 -63.0 1.17 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.382 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.649 ' CD1' HG23 ' A' ' 83' ' ' ILE . 93.3 m-85 -79.37 -43.08 24.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.228 -179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 80.6 28.59 46.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.431 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.2 p -115.41 -36.89 4.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.931 0.396 . . . . 0.0 110.815 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.667 ' OD1' HD11 ' A' ' 72' ' ' ILE . 28.7 t0 69.24 20.97 7.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.101 -179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -131.84 95.52 3.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.468 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -50.05 -34.22 20.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.195 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.459 HG22 HD12 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -64.67 -49.48 70.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.888 0.375 . . . . 0.0 110.412 179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -63.79 -43.04 97.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.376 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.792 HG22 HD11 ' A' ' 87' ' ' ILE . 33.3 mt -63.83 -40.6 89.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.252 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.658 ' SG ' HG21 ' A' ' 29' ' ' ILE . 23.5 m -58.22 -51.13 71.03 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.501 179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.674 ' CE ' HD21 ' A' ' 47' ' ' LEU . 9.1 mttt -59.65 -37.69 79.39 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -63.36 -36.4 83.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.808 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.792 HD11 HG22 ' A' ' 83' ' ' ILE . 9.9 mt -80.46 -23.85 11.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.52 179.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.55 HD21 ' SG ' ' A' ' 31' ' ' CYS . 2.1 mp -75.64 -31.87 60.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.989 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 64.5 m -93.15 -29.52 15.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.449 -179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 60.1 mmtt -105.82 -44.26 4.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.786 0.327 . . . . 0.0 111.243 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.07 -168.84 1.01 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.667 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.23 127.61 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.0 110.799 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.575 ' O ' HG13 ' A' ' 93' ' ' VAL . 10.6 p -85.42 111.7 21.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.035 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -76.49 108.02 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.885 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.554 HG11 ' OE2' ' A' ' 99' ' ' GLU . 29.4 m -110.82 161.67 9.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.116 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 65.7 m -111.76 175.9 5.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -60.89 -36.3 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 14.4 pttt -53.05 -43.3 66.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.005 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.554 ' OE2' HG11 ' A' ' 95' ' ' VAL . 1.9 tt0 -68.99 -43.57 74.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 179.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.1 mmt85 -55.14 -35.66 64.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.837 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -76.28 -46.37 28.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.78 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 67.8 p -65.95 -39.2 90.25 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -66.08 -41.25 90.93 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.733 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.83 -45.67 88.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.732 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -69.23 -51.18 40.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.766 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -60.4 -52.45 65.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.651 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 7.9 tpt -56.17 -49.07 75.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.734 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -53.56 -45.47 69.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.681 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -36.4 80.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.361 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.44 -55.34 21.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.794 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.505 HG13 HG12 ' A' ' 144' ' ' VAL . 17.7 mm -54.51 -39.11 43.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.973 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HB1' ' HA ' ' A' ' 130' ' ' VAL . . . -64.43 -42.9 95.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.83 179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.6 m -59.8 -43.59 94.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.74 HG23 ' HG3' ' A' ' 118' ' ' LYS . 38.6 mm -64.03 -61.62 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.782 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 111' ' ' ILE . 30.6 t -58.63 -20.47 16.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.307 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -76.16 -46.84 26.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.445 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.39 -55.67 2.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.283 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.74 ' HG3' HG23 ' A' ' 114' ' ' ILE . 5.1 mmtt -56.49 -43.76 80.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.018 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.412 ' HA ' ' HA ' ' A' ' 169' ' ' ARG . 96.0 m -103.11 162.29 13.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.865 0.364 . . . . 0.0 110.922 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.657 ' CG2' ' HB2' ' A' ' 170' ' ' ALA . 23.7 m -149.34 -179.21 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.307 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . . . . . . . . . 52.9 t-20 -98.08 128.64 33.05 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.737 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.55 -17.25 47.43 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.466 2.11 . . . . 0.0 112.516 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -56.11 -53.96 50.8 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.069 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -146.86 23.58 1.22 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.118 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 ttmt 53.8 30.45 11.35 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.029 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.8 126.47 59.44 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.886 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.17 131.11 41.29 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.544 2.162 . . . . 0.0 112.224 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.514 ' CD1' HD13 ' A' ' 132' ' ' LEU . 1.9 m-85 -70.26 179.67 2.33 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 43.5 p -112.13 144.48 41.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.811 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.471 ' HA ' ' HB1' ' A' ' 112' ' ' ALA . 15.5 m -51.81 -39.89 25.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.312 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 4.5 pt -69.22 -30.76 47.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.088 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.514 HD13 ' CD1' ' A' ' 128' ' ' TYR . 6.9 mt -69.71 -54.66 12.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.821 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 3.6 mt -60.34 -41.62 87.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -60.33 -50.0 75.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.747 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -47.15 86.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.858 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -62.72 -44.5 96.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.413 ' HE3' HG21 ' A' ' 111' ' ' ILE . 0.0 OUTLIER -57.81 -40.42 79.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.844 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.5 -35.77 68.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.733 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.24 -38.6 89.86 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.856 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.438 HG23 ' HB2' ' A' ' 142' ' ' TYR . 1.6 tt -84.63 3.57 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 32.5 m-70 61.68 40.29 13.37 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.893 0.378 . . . . 0.0 110.969 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.438 ' HB2' HG23 ' A' ' 140' ' ' ILE . 22.9 t80 -77.84 143.35 37.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.929 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 94.0 p -121.84 104.26 9.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.837 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 111' ' ' ILE . 3.5 m -58.69 152.28 3.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.33 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.96 121.21 26.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.593 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.683 ' O ' HG21 ' A' ' 37' ' ' VAL . 78.2 p -59.0 -17.52 25.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.478 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.702 ' O ' HG22 ' A' ' 37' ' ' VAL . 49.0 p30 -54.46 -20.75 8.19 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.699 0.285 . . . . 0.0 111.008 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.3 mttt 72.68 21.83 3.38 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.584 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 42.6 p -92.16 132.56 36.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.829 0.347 . . . . 0.0 110.277 179.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.562 HG22 HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -79.53 -66.15 0.91 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.542 -179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.35 -46.36 55.76 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.427 -179.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.6 mt-30 -58.11 -33.98 69.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.819 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.905 ' O ' HG23 ' A' ' 157' ' ' VAL . 1.1 mm-40 -82.33 -47.48 12.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.171 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.16 -28.51 3.0 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.659 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.97 -64.64 0.88 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.965 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.13 -30.39 71.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.113 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.905 HG23 ' O ' ' A' ' 153' ' ' GLN . 39.7 t -60.86 -60.18 3.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.157 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 62.6 mt -60.81 -42.74 93.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.1 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -52.34 65.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.958 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -65.31 -55.77 16.41 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.145 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.503 HD12 HG12 ' A' ' 157' ' ' VAL . 27.6 mt -56.57 -27.31 57.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.182 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.56 -28.2 59.58 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.018 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -87.81 -30.2 20.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.107 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.53 -69.9 0.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.124 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -96.84 -177.35 3.86 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.66 78.96 1.65 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.837 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.625 ' O ' HD12 ' A' ' 167' ' ' ILE . 2.5 pp -123.15 120.83 61.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.147 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.32 148.44 50.24 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.951 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 119' ' ' CYS . 0.2 OUTLIER -69.04 142.81 54.45 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.555 179.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.657 ' HB2' ' CG2' ' A' ' 120' ' ' VAL . . . -105.14 136.77 44.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.028 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.502 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 2.8 m80 -107.2 155.54 19.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.078 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -140.61 147.94 40.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.816 ' HG2' HD12 ' A' ' 212' ' ' ILE . 47.3 mtp180 -98.51 147.75 24.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.579 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.427 ' N ' ' O ' ' A' ' 211' ' ' LEU . 10.6 mt -131.77 146.36 52.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.047 0.451 . . . . 0.0 111.59 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.5 120.8 37.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.672 179.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 225' ' ' LYS . 0.3 OUTLIER -123.12 143.03 50.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.178 0.513 . . . . 0.0 112.109 -178.835 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 19.6 mt -130.72 100.39 4.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.058 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.843 HD12 ' HA2' ' A' ' 183' ' ' GLY . 0.1 OUTLIER -100.66 141.31 22.42 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.202 -179.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.802 ' HA ' HD23 ' A' ' 206' ' ' LEU . 53.2 Cg_exo -55.08 -167.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.633 2.222 . . . . 0.0 112.585 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 205' ' ' GLN . 12.4 t -75.85 -58.18 4.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.275 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -65.2 -57.9 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.146 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -60.82 -19.47 59.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.242 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.843 ' HA2' HD12 ' A' ' 178' ' ' LEU . . . -55.13 -25.26 38.67 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.912 -179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -24.41 40.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.718 0.294 . . . . 0.0 111.314 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -85.84 -66.24 0.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.438 -179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.772 ' HB3' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -47.43 -39.1 14.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.548 -179.574 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 13.9 ttmt -63.26 -57.82 9.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.068 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.98 -24.53 67.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.391 -179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 -10.46 58.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.788 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 1.018 HD13 HD21 ' A' ' 211' ' ' LEU . 89.7 mt -112.03 -27.68 8.31 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.703 0.287 . . . . 0.0 111.516 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.412 ' CB ' ' CD ' ' A' ' 192' ' ' PRO . 15.6 mtpt -55.06 -60.97 6.69 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.486 -0.324 . . . . 0.0 111.18 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 191' ' ' LYS . 60.3 Cg_endo -72.69 -31.93 10.04 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.624 2.216 . . . . 0.0 112.65 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 224' ' ' ILE . 0.4 OUTLIER -56.5 -54.62 43.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.055 -179.787 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.611 HD11 ' HB3' ' A' ' 211' ' ' LEU . 13.4 pt -151.66 179.57 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 111.344 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -68.54 129.54 40.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.002 -179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 19.5 m -113.68 133.65 58.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.017 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.466 ' CG2' HD11 ' A' ' 212' ' ' ILE . 2.1 tp -122.68 141.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.133 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . 0.411 ' N ' HG13 ' A' ' 197' ' ' ILE . 7.8 tp10 64.97 79.62 0.25 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.961 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 3.8 t -94.66 89.46 5.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.979 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -93.19 134.34 35.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -152.72 124.28 7.76 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.42 ' HB2' ' HB3' ' A' ' 205' ' ' GLN . 5.9 m-85 -103.47 145.29 30.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.722 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -47.79 108.39 0.33 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.502 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.41 39.98 17.9 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.122 0.487 . . . . 0.0 110.127 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.626 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -136.75 178.62 6.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.369 -179.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.802 HD23 ' HA ' ' A' ' 179' ' ' PRO . 0.5 OUTLIER -72.52 148.94 44.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.371 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.7 134.93 52.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.102 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 3.2 mt -106.92 105.76 19.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.706 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 27.4 t -123.02 144.75 31.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.254 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . 0.447 ' HB2' HG23 ' A' ' 197' ' ' ILE . 33.5 m -109.82 145.99 35.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.483 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 1.018 HD21 HD13 ' A' ' 190' ' ' LEU . 2.7 mt -115.48 128.9 56.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.038 0.447 . . . . 0.0 111.56 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.816 HD12 ' HG2' ' A' ' 173' ' ' ARG . 2.8 mm -117.17 124.95 73.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.07 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 214' ' ' PRO . 4.4 p-10 -168.52 156.4 7.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.829 0.347 . . . . 0.0 111.738 -179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.502 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 30.1 Cg_endo -63.35 165.65 16.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.559 2.173 . . . . 0.0 112.132 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -49.82 -24.75 6.41 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.875 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . 0.421 ' HA ' ' CD ' ' A' ' 118' ' ' LYS . 43.0 t -69.33 -64.28 0.91 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.703 0.287 . . . . 0.0 111.383 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.464 ' HA ' HD12 ' A' ' 220' ' ' ILE . 0.3 OUTLIER -50.8 -25.18 4.13 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.531 -179.557 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.73 -36.24 35.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.778 0.323 . . . . 0.0 111.019 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -67.48 -60.19 2.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.879 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.464 HD12 ' HA ' ' A' ' 217' ' ' PHE . 3.2 mt -56.72 -31.1 34.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.493 ' OD2' HD13 ' A' ' 211' ' ' LEU . 0.1 OUTLIER -65.73 -53.74 36.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.736 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . 0.415 ' HA ' ' CG ' ' A' ' 225' ' ' LYS . 5.2 tm-20 -58.46 -36.97 74.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.066 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.09 -58.97 3.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.398 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 225' ' ' LYS . 2.7 pp -63.33 -41.23 91.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.819 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.635 ' N ' HD12 ' A' ' 224' ' ' ILE . 0.0 OUTLIER -65.9 -37.83 87.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.642 0.258 . . . . 0.0 111.302 -179.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 1.1 tttp -68.83 -41.45 78.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.84 0.353 . . . . 0.0 110.9 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -74.57 -24.5 58.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.207 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.55 HG21 ' HA ' ' A' ' 186' ' ' LEU . 53.4 m -86.75 -31.53 20.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.173 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.407 ' HB2' ' CB ' ' A' ' 233' ' ' SER . 16.1 pttt -84.4 -28.72 26.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.005 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 52.93 49.25 55.68 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.678 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 2.0 mmtp 52.93 29.19 7.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.734 0.302 . . . . 0.0 111.021 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -129.41 30.99 3.52 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.743 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.407 ' CB ' ' HB2' ' A' ' 229' ' ' LYS . 5.0 t -148.49 168.23 23.27 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.759 0.314 . . . . 0.0 111.023 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 3.5 mt -113.49 145.69 40.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.755 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . 0.443 ' HG3' ' CD2' ' A' ' 176' ' ' PHE . 0.0 OUTLIER -151.27 115.32 5.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.269 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 21.7 t -106.81 146.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.961 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.95 134.14 35.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.86 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . 0.409 ' CB ' ' HB2' ' A' ' 173' ' ' ARG . 12.3 m-80 -89.28 -169.81 2.64 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.705 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.47 170.74 13.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.086 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . . . . . . . . . 8.8 pttm -91.1 110.55 21.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.828 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 -102.64 121.31 42.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.893 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . . . . . . . . . 13.4 p -115.37 -37.14 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.11 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -147.49 86.91 1.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -88.78 -65.44 1.02 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . -143.56 80.23 0.24 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -108.41 -68.9 0.88 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.759 0.314 . . . . 0.0 110.916 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.61 -30.1 67.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.901 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 61.83 100.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.925 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -75.08 -34.0 61.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.896 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.934 179.954 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.847 0.356 . . . . 0.0 111.217 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.1 m -138.07 -54.39 0.64 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.945 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 4.4 mp -112.91 -73.69 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.202 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER 179.35 74.87 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.798 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -138.16 99.2 9.05 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.875 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -68.86 -46.08 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.454 2.103 . . . . 0.0 112.284 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 p -152.44 -65.36 0.17 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.957 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.81 -62.27 1.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.428 ' HA ' HG23 ' A' ' 5' ' ' THR . 1.6 tp60 -157.7 -64.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.086 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 HG12 ' HB ' ' A' ' 13' ' ' THR . 0.6 OUTLIER -168.88 146.63 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.056 -179.793 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.464 ' N ' HG13 ' A' ' 10' ' ' ILE . 3.1 mmt85 -109.46 14.44 23.58 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.77 HD22 ' H ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -161.74 -71.67 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.77 ' H ' HD22 ' A' ' 12' ' ' LEU . 8.9 t 39.81 -157.98 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.592 0.234 . . . . 0.0 111.537 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.413 ' HB2' ' O ' ' A' ' 13' ' ' THR . 9.2 m-20 68.74 7.96 6.45 Favored 'General case' 0 CA--C 1.529 0.144 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 179.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.716 HG22 ' O ' ' A' ' 31' ' ' CYS . 0.3 OUTLIER 177.72 174.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 120.723 0.296 . . . . 0.0 111.16 179.554 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.425 ' N ' HG13 ' A' ' 15' ' ' VAL . . . -90.53 139.57 30.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.01 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG13 HG21 ' A' ' 60' ' ' VAL . 21.3 t -101.95 127.06 55.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.245 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.701 HG21 HD12 ' A' ' 88' ' ' LEU . 21.3 t -112.58 123.2 68.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.781 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.98 158.16 27.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.884 0.374 . . . . 0.0 111.252 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.853 ' HB2' HG23 ' A' ' 87' ' ' ILE . 13.9 tmm? -160.92 141.64 11.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.694 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -101.11 134.51 44.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.024 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.9 mtt-85 -164.19 131.03 3.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.855 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 61.59 25.33 15.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.251 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.52 -49.2 3.41 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.559 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -66.73 147.07 53.76 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.728 0.299 . . . . 0.0 111.011 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -106.83 119.73 40.11 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.811 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.407 ' HB3' ' CG1' ' A' ' 56' ' ' VAL . 63.2 m-85 -115.01 145.43 42.28 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.041 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.612 ' OE2' HG23 ' A' ' 60' ' ' VAL . 6.5 pt-20 -152.08 147.77 26.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.498 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.87 HG21 ' SG ' ' A' ' 84' ' ' CYS . 0.7 OUTLIER -131.49 155.38 41.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.924 0.392 . . . . 0.0 111.344 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.949 ' HB3' HG22 ' A' ' 53' ' ' THR . . . -89.03 106.65 18.57 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.724 179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.902 ' SG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -122.55 177.07 5.58 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.075 -179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.791 ' O ' HG23 ' A' ' 36' ' ' VAL . 7.3 m-85 -102.97 124.8 49.16 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.871 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.566 ' HB2' HG11 ' A' ' 95' ' ' VAL . 28.8 tttm -53.6 -40.03 65.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.744 -0.207 . . . . 0.0 111.424 -179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.596 ' O ' HG12 ' A' ' 37' ' ' VAL . 17.6 t-20 -66.44 -55.06 17.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 111.115 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.78 ' HB3' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -66.1 -26.11 67.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.775 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 32' ' ' TYR . 65.5 t -76.88 -43.87 32.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.598 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.769 HG23 ' HA ' ' A' ' 147' ' ' ASN . 8.0 p -62.34 -39.26 83.56 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.79 -38.04 60.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.392 178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CZ2' ' HE2' ' A' ' 85' ' ' LYS . 65.2 t-105 -64.95 -56.17 14.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.867 0.365 . . . . 0.0 110.342 179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.62 -34.31 74.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.684 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.8 t -59.25 -25.53 64.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.979 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 117.41 24.79 3.37 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.78 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.438 HG12 ' HE3' ' A' ' 45' ' ' LYS . 2.7 t -112.17 152.97 13.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.775 0.321 . . . . 0.0 110.968 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -72.44 119.55 16.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.252 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HE3' HG12 ' A' ' 43' ' ' VAL . 0.0 OUTLIER -131.93 117.02 17.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.777 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -59.25 122.95 15.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.811 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.611 HD21 ' CE ' ' A' ' 85' ' ' LYS . 3.1 mm? -53.65 -35.73 61.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.043 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.46 -14.67 53.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.68 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -108.52 -52.54 2.75 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.512 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.902 HG22 ' SG ' ' A' ' 31' ' ' CYS . 7.3 p -58.95 -42.08 84.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.662 -179.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.702 HD11 ' CB ' ' A' ' 84' ' ' CYS . 7.7 mt -85.5 115.62 23.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.801 0.334 . . . . 0.0 111.084 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.451 ' HG3' HG21 ' A' ' 15' ' ' VAL . 0.0 OUTLIER -64.96 -39.8 94.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.855 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.949 HG22 ' HB3' ' A' ' 30' ' ' ALA . 12.4 t -133.56 115.87 15.22 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.905 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -76.37 65.93 2.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.172 0.511 . . . . 0.0 111.099 -179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -162.37 124.87 2.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.03 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.937 HG21 HD21 ' A' ' 71' ' ' LEU . 3.8 t -69.55 108.41 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.968 0.414 . . . . 0.0 111.409 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.63 ' CE1' HG21 ' A' ' 53' ' ' THR . 9.3 m-85 -78.87 -179.16 6.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.206 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 66' ' ' ALA . 70.0 t -130.6 -47.56 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.891 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.88 70.29 1.46 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.877 179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.612 HG23 ' OE2' ' A' ' 28' ' ' GLU . 2.4 t -52.6 -38.7 27.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.277 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.9 t -54.42 -26.5 31.05 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.971 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 10.8 mttt -112.14 -26.03 9.03 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.952 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.74 44.84 2.03 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.522 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.81 119.57 39.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.726 0.298 . . . . 0.0 110.703 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 57' ' ' PHE . 8.1 t -97.96 145.89 8.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.342 -179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.524 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . . . -80.93 -168.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.925 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.95 160.93 32.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.937 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.12 -33.27 75.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.858 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 7.7 mt-10 -58.55 -55.82 30.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.799 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -64.9 -34.76 79.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.684 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.995 HD22 HD13 ' A' ' 83' ' ' ILE . 11.5 mt -58.48 -45.64 88.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.777 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.751 HD11 ' OD1' ' A' ' 78' ' ' ASP . 13.3 mt -79.16 -36.29 18.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 m -65.77 -23.71 66.78 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.259 -179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -102.08 -40.85 6.65 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.546 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' A' ' 83' ' ' ILE . 92.3 m-85 -98.98 -43.21 6.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.368 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 78.09 24.62 63.57 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.586 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.6 p -112.34 -33.21 6.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.842 0.353 . . . . 0.0 110.821 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.751 ' OD1' HD11 ' A' ' 72' ' ' ILE . 27.3 t0 66.87 19.98 10.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.054 -179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -122.29 92.12 3.65 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.601 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.563 ' HA ' HD12 ' A' ' 83' ' ' ILE . 0.2 OUTLIER -48.57 -54.5 14.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.275 -179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.3 -51.96 23.58 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.78 0.324 . . . . 0.0 110.982 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -60.85 -46.94 88.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.451 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.995 HD13 HD22 ' A' ' 71' ' ' LEU . 25.7 mt -56.32 -40.07 64.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 179.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.87 ' SG ' HG21 ' A' ' 29' ' ' ILE . 59.8 m -63.18 -42.89 99.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.136 179.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.611 ' CE ' HD21 ' A' ' 47' ' ' LEU . 8.2 mttt -55.02 -52.04 64.4 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.318 179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -55.87 -47.41 77.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.54 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.853 HG23 ' HB2' ' A' ' 20' ' ' MET . 24.2 mt -67.5 -25.4 33.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.854 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 18' ' ' VAL . 5.4 tp -73.6 -33.52 64.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.797 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.4 p -93.12 -35.45 13.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.239 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.9 mttm -93.69 -44.18 8.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.142 -179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -63.44 -175.63 3.37 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.519 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -115.0 127.86 55.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.811 0.339 . . . . 0.0 110.855 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG21 HG11 ' A' ' 36' ' ' VAL . 15.3 t -91.2 103.38 14.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.073 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -81.13 120.99 25.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.01 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 33' ' ' LYS . 4.2 m -137.57 161.7 33.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.287 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.89 176.07 7.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.146 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.77 -38.26 64.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.06 -179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.498 ' O ' HG22 ' A' ' 102' ' ' THR . 37.9 mtmt -59.39 -43.64 92.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.899 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB3' ' CD ' ' A' ' 33' ' ' LYS . 3.0 mm-40 -63.71 -26.67 68.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.939 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 -83.56 -33.99 25.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.949 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -73.63 -42.97 60.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.498 HG22 ' O ' ' A' ' 98' ' ' LYS . 4.2 t -58.7 -39.82 81.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.889 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -65.5 -44.44 87.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.883 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 10.1 tp -60.23 -43.32 96.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.846 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -62.18 -47.65 83.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.801 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.67 -40.92 96.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.745 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' MET . . . . . . . . . . . . . 15.4 tpp -63.07 -45.8 90.46 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.713 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.521 ' CE2' HG21 ' A' ' 144' ' ' VAL . 2.3 m-85 -60.78 -47.25 87.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.716 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.24 -39.59 93.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.737 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -59.91 -47.41 85.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.668 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 115' ' ' VAL . 24.9 mt -68.07 -29.46 44.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.747 ' HB1' HG12 ' A' ' 130' ' ' VAL . . . -71.14 -48.66 50.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.204 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.423 HG23 ' N ' ' A' ' 114' ' ' ILE . 6.6 t -63.72 -48.54 76.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.107 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.423 ' N ' HG23 ' A' ' 113' ' ' THR . 29.9 mm -60.65 -49.86 82.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.982 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 111' ' ' ILE . 58.4 t -70.05 -24.33 26.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.044 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 112' ' ' ALA . . . -73.8 -34.37 64.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.001 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.75 -64.84 1.01 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.961 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.26 60.83 3.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.981 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' CYS . . . . . 0.792 ' SG ' HD13 ' A' ' 167' ' ' ILE . 0.7 OUTLIER 175.89 84.44 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.678 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.709 HG21 ' HE2' ' A' ' 125' ' ' LYS . 29.0 m -111.7 157.28 12.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.26 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.458 ' HA ' ' HD3' ' A' ' 122' ' ' PRO . 35.8 t30 -69.67 123.56 88.79 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.813 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 121' ' ' ASN . 14.2 Cg_exo -68.68 -6.88 18.97 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.527 2.151 . . . . 0.0 112.762 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -88.69 -45.73 9.58 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 111.661 0.245 . . . . 0.0 111.661 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -138.45 19.89 2.73 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.709 ' HE2' HG21 ' A' ' 120' ' ' VAL . 0.4 OUTLIER 50.0 29.17 3.3 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.749 0.309 . . . . 0.0 111.318 179.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 2.4 mtp180 -59.23 107.13 0.87 Allowed Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.156 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.84 103.25 0.98 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.637 2.224 . . . . 0.0 112.174 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -71.35 148.23 47.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.95 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.58 ' OG1' HD23 ' A' ' 132' ' ' LEU . 0.3 OUTLIER -108.25 165.39 11.53 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.747 HG12 ' HB1' ' A' ' 112' ' ' ALA . 17.9 m -52.8 -32.04 17.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.282 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 32.9 mt -68.19 -36.72 76.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.978 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.58 HD23 ' OG1' ' A' ' 129' ' ' THR . 4.5 mm? -70.45 -46.46 63.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.812 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.496 HG23 HD11 ' A' ' 161' ' ' LEU . 3.9 mt -64.87 -40.8 90.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.065 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -63.98 -47.21 81.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -58.84 -48.03 82.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.958 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 140' ' ' ILE . . . -62.5 -42.92 99.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.074 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.445 ' CE ' HG22 ' A' ' 133' ' ' ILE . 0.0 OUTLIER -62.17 -40.65 96.73 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -68.9 -42.5 76.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -58.66 -46.06 88.01 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.928 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.442 HG22 ' O ' ' A' ' 136' ' ' ALA . 2.4 tt -80.83 -1.11 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.543 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' HIS . . . . . . . . . . . . . 40.9 m80 61.42 61.66 1.47 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.896 0.379 . . . . 0.0 110.86 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.442 ' CG ' ' HG3' ' A' ' 137' ' ' MET . 1.1 t80 -62.86 166.02 6.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.832 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -112.97 -34.8 5.63 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.071 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.521 HG21 ' CE2' ' A' ' 108' ' ' PHE . 47.5 t 68.25 -63.35 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.299 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 64.51 85.0 0.14 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.026 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.3 p -60.4 -25.74 66.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . 0.769 ' HA ' HG23 ' A' ' 37' ' ' VAL . 83.3 m-20 -56.82 -29.22 62.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.962 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 mttp -90.18 -176.11 4.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' SER . . . . . . . . . . . . . 4.9 m -101.07 156.78 17.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 68.1 p -62.01 -58.23 8.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.986 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.5 mptt -47.46 -52.3 17.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.206 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.01 -31.25 70.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.913 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 tp60 -73.14 -27.64 61.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -48.9 -40.21 29.05 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.436 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.31 -56.0 26.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.871 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -59.61 -34.97 73.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.956 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.913 HG23 ' O ' ' A' ' 153' ' ' GLN . 23.9 t -63.89 -55.56 21.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.154 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.459 ' HA ' HD11 ' A' ' 167' ' ' ILE . 44.0 pt -59.26 -34.07 52.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.132 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . 0.415 ' N ' HG13 ' A' ' 158' ' ' ILE . 0.0 OUTLIER -70.15 -55.0 10.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.915 -179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -59.85 -53.3 59.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.966 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.669 HD12 HG12 ' A' ' 157' ' ' VAL . 26.8 mt -57.89 -27.11 63.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.082 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -58.31 -31.18 67.28 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.982 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -66.85 -32.29 73.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.965 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -87.77 -56.36 3.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -131.36 -171.5 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -116.34 125.07 51.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ILE . . . . . 0.792 HD13 ' SG ' ' A' ' 119' ' ' CYS . 2.7 pp -140.23 147.43 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.17 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -132.17 121.87 24.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.865 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . . . . . . . . . 20.4 ttp180 -71.05 118.69 14.14 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.966 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.407 ' HB3' ' C ' ' A' ' 215' ' ' GLY . . . -161.54 146.11 13.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.041 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.467 ' HA ' ' HA ' ' A' ' 214' ' ' PRO . 15.5 t-160 -175.0 131.04 0.31 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.746 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -174.08 170.29 3.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.074 0.464 . . . . 0.0 111.477 -179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.604 ' HG2' HG23 ' A' ' 212' ' ' ILE . 8.2 mtt-85 -108.54 132.21 54.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.487 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.679 ' O ' HD12 ' A' ' 211' ' ' LEU . 1.4 mt -110.18 120.58 42.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.892 0.377 . . . . 0.0 111.64 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.1 mtp180 -97.92 123.18 41.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.193 -0.458 . . . . 0.0 109.829 179.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -115.45 126.89 54.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.013 0.435 . . . . 0.0 111.893 -178.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 29.2 mt -107.47 100.1 10.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.68 178.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.853 ' HB3' HD11 ' A' ' 186' ' ' LEU . 0.5 OUTLIER -93.97 144.92 28.9 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.914 -178.648 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 178' ' ' LEU . 12.6 Cg_exo -69.76 -160.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.807 2.338 . . . . 0.0 112.046 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.775 HG22 ' HA ' ' A' ' 205' ' ' GLN . 31.4 t -76.32 -69.2 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.763 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.2 p30 -81.76 -52.69 6.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.851 -179.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -55.74 -20.26 14.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.685 ' HA3' HD12 ' A' ' 178' ' ' LEU . . . -77.02 -45.95 11.07 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.225 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.97 -26.41 1.74 Allowed 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -85.81 -52.48 5.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.402 -179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.853 HD11 ' HB3' ' A' ' 178' ' ' LEU . 3.6 pp -67.22 -32.27 73.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.666 -179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -54.29 44.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.825 0.345 . . . . 0.0 111.345 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -63.84 -25.61 68.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.378 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.699 ' HD3' HD11 ' A' ' 224' ' ' ILE . 0.1 OUTLIER -81.22 -22.09 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.627 -179.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.68 -25.86 22.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.429 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.454 ' CB ' ' HD3' ' A' ' 192' ' ' PRO . 1.5 mtpt -54.68 -52.46 69.96 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.199 -179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.454 ' HD3' ' CB ' ' A' ' 191' ' ' LYS . 4.8 Cg_exo -77.66 -30.7 3.71 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.961 2.441 . . . . 0.0 112.345 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.559 HD11 HG22 ' A' ' 220' ' ' ILE . 7.5 tp -58.14 -54.1 50.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.357 -179.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . 0.812 HG13 HD22 ' A' ' 211' ' ' LEU . 4.0 pt -142.95 171.84 8.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.371 . . . . 0.0 111.391 -179.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.59 122.44 19.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.0 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 209' ' ' VAL . 51.3 t -95.77 140.65 16.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.243 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ILE . . . . . 0.595 HD12 ' C ' ' A' ' 196' ' ' VAL . 3.6 mp -147.39 138.18 17.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.104 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 59.55 79.72 0.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.96 115.57 30.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.811 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.73 121.31 31.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.112 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -132.27 147.16 52.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.846 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -110.09 150.01 29.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.798 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -49.07 107.9 0.35 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.444 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLN . . . . . 0.53 ' C ' HG13 ' A' ' 180' ' ' VAL . 25.4 mt-30 61.17 45.7 8.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.955 0.407 . . . . 0.0 110.419 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.775 ' HA ' HG22 ' A' ' 180' ' ' VAL . 0.0 OUTLIER -143.05 178.21 7.85 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.08 -179.659 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.589 HD23 ' H ' ' A' ' 206' ' ' LEU . 1.0 OUTLIER -72.86 149.01 43.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.828 -179.85 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.443 ' HB3' HD11 ' A' ' 178' ' ' LEU . 68.5 tt0 -115.99 128.84 56.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.367 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 1.1 pt -97.9 118.52 44.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.132 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.644 ' CG1' HG13 ' A' ' 196' ' ' VAL . 23.5 t -130.86 144.99 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.998 0.428 . . . . 0.0 111.933 -179.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' CYS . . . . . . . . . . . . . 16.3 m -109.69 149.77 29.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.795 -0.638 . . . . 0.0 109.996 179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . 0.812 HD22 HG13 ' A' ' 194' ' ' ILE . 0.8 OUTLIER -132.65 156.36 47.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.128 0.489 . . . . 0.0 111.718 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.604 HG23 ' HG2' ' A' ' 173' ' ' ARG . 15.9 mt -149.87 125.03 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.655 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -157.35 133.28 5.97 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 120.788 0.328 . . . . 0.0 111.482 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 171' ' ' HIS . 87.5 Cg_endo -86.17 116.42 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.859 2.373 . . . . 0.0 112.369 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.407 ' C ' ' HB3' ' A' ' 170' ' ' ALA . . . 137.09 -169.77 23.82 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.681 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' CYS . . . . . . . . . . . . . 4.1 t -97.52 41.95 1.11 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.404 ' CZ ' ' O ' ' A' ' 193' ' ' LEU . 0.3 OUTLIER -62.71 -20.93 65.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.244 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.39 -34.0 2.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.471 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.05 -61.49 2.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.973 0.416 . . . . 0.0 110.786 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.764 ' O ' HG22 ' A' ' 224' ' ' ILE . 37.8 mm -60.16 -27.0 38.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.961 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ASP . . . . . 0.521 ' HA ' HD21 ' A' ' 193' ' ' LEU . 0.8 OUTLIER -67.03 -50.55 61.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.93 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -64.39 -39.85 94.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.724 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.58 -62.98 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.513 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ILE . . . . . 0.764 HG22 ' O ' ' A' ' 220' ' ' ILE . 11.2 tt -59.39 -34.06 53.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.488 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.6 tttm -58.69 -40.88 84.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.482 179.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.01 -45.4 61.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.093 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -81.7 -2.66 51.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.064 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 58.8 m -117.54 -31.59 5.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.615 0.245 . . . . 0.0 111.637 -179.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LYS . . . . . 0.439 ' HG3' HD22 ' A' ' 186' ' ' LEU . 0.6 OUTLIER -113.79 -17.82 11.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.319 -179.792 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' GLY . . . . . . . . . . . . . . . 56.82 35.27 67.29 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.378 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp 63.28 29.74 15.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.847 0.356 . . . . 0.0 110.874 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' GLY . . . . . . . . . . . . . . . -103.65 -14.22 25.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 41.7 t -107.32 172.54 6.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.791 0.329 . . . . 0.0 110.924 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 6.3 mp -114.79 164.14 14.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -164.97 117.47 1.21 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.938 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.4 p -106.78 146.52 13.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.027 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.17 132.17 33.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -87.92 -56.93 3.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.856 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.38 125.38 50.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.929 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 242' ' ' VAL . 0.0 OUTLIER -119.54 115.53 24.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -64.17 106.88 1.16 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.933 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' VAL . . . . . 0.592 ' O ' HG12 ' A' ' 242' ' ' VAL . 16.4 t -117.45 30.5 2.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.1 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -106.72 52.23 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.997 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -98.27 34.29 2.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.805 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLY . . . . . . . . . . . . . . . 68.82 117.5 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.467 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -155.94 -57.24 0.09 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.812 0.339 . . . . 0.0 110.851 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -158.06 142.09 15.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.861 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -96.42 -47.9 5.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.9 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 61.27 31.69 19.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.229 -0.891 . . . . 0.0 110.865 -179.98 . . . . . . . . 1 1 . 1 stop_ save_